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Abstract 
Neuroscientific research frequently utilises loss of function experiments to attribute function 
to a brain region. Gain of function experiments via cortical re-wiring would aid in validation of 
these studies and could allow the repair of damaged neural circuitry or the creation of novel 
neural structures. Research into neuronal re-wiring within the central nervous system 
demonstrates insufficient neurite extension upon implantation and highlights the need for 
similarity between exogenous and endogenous neurons. An aligned poly-L-lactic acid (PLLA) 
nanofibre scaffold was developed that induced the three dimensional aggregation of primary 
cortical neurons into a physiological structure of clustered soma and aligned, fasciculated 
neurites in a controlled way. Due to the self-assembling and physiological architecture of these 
3D structures and subsequent detection of electrophysiological activities, these 3D structures 
were classified as “organoids”. Cerebral cortical organoids generated using the nanofibre 
based methodology were demonstrated to be more developmentally advanced than their two-
dimensional counterparts and mechanisms were elucidated for the aggregation of the neurons 
and the development that occurred post-aggregation. Analysis of gene expression suggested 
that the organoids were also undergoing advanced developmental processes and proposed a 
mechanism by which this occurs. Optogenetic depolarisation of the implanted neurons and 
detection of downstream electrophysiological activity was selected as the means of confirming 
integration of exogenous neurons into endogenous circuitry post-implantation. Methods were 
optimised to facilitate efficient viral transfection of the optogenetic protein 
(Channelrhodopsin-2). Aligned PLLA nanofibres were found to significantly enhance 
transfection rates relative to the 2D control and the process by which this occurs was 
investigated.  The work presented within suggests that aligned PLLA nanofibres may be used 
to generate a cerebral cortical organoid that is suited to implantation and cortical re-wiring 
and may have additional in vitro applications within diverse fields such as high throughput 
pharmacology, computational neuroscience and bioengineering.  
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Chapter 1: Literature Review 
1.1 Introduction 
The study of the central nervous system (CNS) and the treatment of neurological disorders is 
dependent on the ability to alter or replace neural circuitry. Despite extensive study, the CNS 
remains poorly understood and limitations in knowledge hamper attempts to change the 
brain’s architecture. Lesion studies are a staple of neuroscience to gain understanding of brain 
regions, yet they are inherently flawed (Vaidya et al, 2019). Neuroengineering and biomaterial 
approaches have advanced our ability to manipulate neurons and thus counter some of the 
limitations of lesion studies and in doing so, have opened other avenues of research relating 
to the manipulation of neurons in vivo. While studies aiming to repair neural circuitry have 
been met with little success thus far, recurring observations in these studies highlight several 
key aspects that must be considered to achieve successful rewiring/repair.  
 
1.2 Lesion studies 
Connectivity is key in the computational processes of the brain, where functions arise from the 
emergent properties of ensembles of neurons and synapses; the typical form of connection 
within the brain (Bettencourt et al, 2007; Yuste, 2015). The importance of connectivity within 
the brain is illustrated by studies in brain architecture. Neurons receive many inputs whilst 
sending outputs to many other neuronal cells. Most excitatory connections are weakly able to 
induce action potentials in order to facilitate integration of as many inputs as possible prior to 
summating to an output whilst inhibitory neurons synapse to nearly 100% of neighbouring 
excitatory neurons (Yuste, 2015). Alterations to connectivity have been documented to 
correlate with multiple pathophysiological changes, reinforcing the role of connectivity in 
function (DeKosky et al, 1990; Shimada et al, 2003). Thus, lesions which induce changes in 
connectivity through alterations to brain architecture induce functional changes, allowing 
14 
 
causal relationships to be uncovered. However, lesion studies can only be performed for loss 
of function experiments; inhibition of neural circuits through alterations to structure. 
Conversely, gain of function (whether that be restoring lost capacity via repair or integration 
of new structures and thus functionality) has yet to be achieved to a significant degree (Harris 
et al, 2016). In essence, structures can be destroyed but cannot yet be added to the brain. 
Lesion studies also introduce additional complications. The loss of cells that occurs within a 
lesion study adds to the complication of confounding causality; is the observed change due to 
a loss of connectivity of the network, perturbances in surviving cells’ electrophysiological 
activity or due to non-electrophysiological alterations to the neural network due to the loss of 
cells? 
1.3.1 Limitations to lesion studies 
Lesion studies induce loss of function through targeted destruction of specific neuronal 
populations and remain an essential tool within the neuroscience community, as they can be 
used to demonstrate a causal relationship between brain structures and function. Advances in 
neuroimaging methodologies such as functional magnetic resonance imaging (fMRI) and 
electrophysiological methods have enabled a significant volume of non-invasive work to be 
performed. However as the techniques can only observe regions that are more or less active 
during a behaviour, they can only demonstrate correlation between brain structures and 
behaviour, they cannot demonstrate that neural activity in specific regions causes specific 
behaviours (Adolphs, 2016). In addition, the temporal resolution for fMRI is limited; the 
haemodynamic response to a stimulus peaks 4-8 seconds after the initial stimulus, a limitation 
in correlating relatively rapid behaviours with particular neural networks (Nicolas et al, 2017). 
In contrast, electrophysiological studies using techniques such as electrodes or patch clamping 
take rapid temporal readings but suffer from the limitation of spatial resolution over long time 
periods. Additionally, invasive electrodes can record with high spatial resolution for relatively 
short periods of time prior to neurodegeneration, whilst non-invasive recordings have poorer 
15 
 
spatial resolution (Hochberg and Donoghue, 2006). Thus, lesion studies remain a useful tool 
for studying the connectome, albeit with their own limitations. 
 
Electrophysiological perturbances and non-electrophysiological mechanisms occurring post-
lesion play a role in disturbing functionality, although to what degree remains unclear. 
Functional impairment does not always correlate with the number of cells lost, suggesting that 
alterations to the electrophysiology of the remaining network play a role in observed changes 
(Cohen et al, 2007). Surviving neurons exhibit altered electrophysiological behaviours post-
injury; cortical neurons have been demonstrated to exhibit depressed synapse induced calcium 
(Ca2+) oscillations and excitatory postsynaptic currents with reduced amplitude up to 2 days 
after the injury (Goforth et al, 2011). At a more distal location to the injury, electrophysiological 
suppression is present but for a shorter period prior to the onset of hyperexcitability of the 
network (Ding et al, 2011). These alterations to the surviving neural network may be involved 
in alterations to behaviour, limiting the ability to ascribe function to a region.  
 
Lesions inherently induce changes to connectivity due to the loss of synapses resulting from a 
loss of neurons but non-synaptic connectivity is rarely considered in lesion studies. Neurons 
possess several non-synaptic mechanisms that can influence their electrophysiological activity 
and thus the loss of neurons in a lesion would cause the loss of these non-synaptic methods of 
connectivity and induce changes to behaviour via loss of these mechanisms. These non-
synaptic connections can influence the afferent (upstream neuronal networks) and efferent 
networks (downstream neuronal networks) and neighbouring neurons, affecting the 
connectome at the scale of synapses (nanoscale connectome), individual neurons (the 
microscale connectome), neuronal sub-populations (the mesoscale connectome) and between 
16 
 
regions (the macroscale connectome) (Swanson and Lichtman, 2016). Lesion studies fail to 
take these factors in to account when inhibiting the neural circuitry.  
 
Non-synaptic mechanisms used by neurons to communicate intercellularly are ephaptic 
signalling, volume transmission and gap junctions (figure 1.1) (Bentley, 2017). Ephaptic 
signalling is a contactless, electrical mechanism with limited range (Bentley, 2017). Action 
potentials in neuron A induce influx of Ca2+ and efflux of K+ ions which then can alter the 
likelihood of neuron B firing. Ephaptic signalling is thought to be a result of the summation of 
all variables involved in determining the extracellular field potential such as synaptic currents 
and astrocytic ion waves (Martinez-Banaclocha, 2018). 
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Ephaptic signalling cannot independently induce action potentials when neurons are at resting 
potential but is capable of modulating the timing of spikes receiving suprathreshold inputs 
(Anastassiou et al, 2011). Volume transmission is the communication between neurons 
through secreted molecules, peptides and gases that can influence neighbouring cells (Bentley, 
2017). Volume transmission can regulate the survival of surrounding neurons, a property that 
can affect the functionality of the network. Neurotrophic factors such as nerve growth factor 
(NGF), brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and leukaemia 
inhibitory factor (LIF) are capable of promoting neuronal survival in a diverse array of brain 
regions (Korsching, 1993) and are secreted by neurons (Matsumoto et al, 2008; Thoenon, 
1995; Houlgatte et al, 1989). Glutamate has been demonstrated to be a trophic factor in the 
adult brain thus, lesioning excitatory cells in one network would additionally cause cell death 
in the efferent neurons (Balazs, 2006); lesioning one region may induce death in another. Thus, 
removal of neurons from a network through lesioning may impact function by reducing 
afferent and efferent network survival, affecting networks beyond the one that was originally 
lesioned. Extracellular vesicles are also classified as a means of volume transmission and have 
exhibited secretion of proteins involved in regulating synaptic activity. Proteins such as L1CAM, 
GluR2/3, MAP1b and activity-related miRNAs are secreted in response to synaptic activity 
(Budnik et al, 2016; Zappulli et al, 2016; Pastuzyn et al, 2018) whilst the Arc protein, a protein 
essential for synaptic plasticity has also demonstrated functionality through exosomes 
(Pastuzyn et al, 2018).  
 
Gap junctions are intercellular channels that link adjacent cells; they facilitate exchange of ions 
and small molecules, forming a low-resistance path, enabling synchronisation of neuronal 
electrophysiology. Gap junctions are comprised of connexins that form hexameric structures 
on each cellular membrane prior to docking with adjacent cells (Goodenough and Paul, 2009). 
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Typically, a neuron will form gap junctions with multiple other neurons, facilitating the spread 
of an action potential to a horizontal neuronal ensemble rather than a single neuron (Traub et 
al, 2018).   
 
The role of the three non-synaptic mechanisms of intercellular communication in behaviour is 
unclear. Lesioning of one neuronal pathway abolishes all of the mechanisms of intercellular 
communication, both synaptic and non-synaptic. Whilst the role of gap junctions can be 
studied with relative ease through the use of connexin knockout or knockdown animal models 
(Lo et al, 1999), the role of ephaptic signalling and volume transmission on neural network 
functionality compared to synaptic neurotransmission is more difficult to quantify due to their 
diffuse effects and influence on afferent and efferent networks.  
 
Thus, clarification for lesion studies is needed. Are alterations in functionality due to a loss of 
synaptic connectivity as a result of lesions within the network or are they due to changes in 
the surviving neural network as a result of the injury? How much of an effect do non-synaptic 
communicative mechanisms have on the function of the network as a whole? Lesion studies 
have enabled the study of the synaptic connectome for over a century but as knowledge of 
how information is encoded within the brain has advanced, so too should lesion studies, 
through gain of function experiments. The rebuilding of lost neural architectures and 
subsequent re-gain of function with sufficient accuracy would further validate any functions 
that have been ascribed to a particular brain region.  
 
1.3.2 Use of an implant to overcome these limitations 
Tissue engineered neural networks (TENNs) represent a potential method of clarifying the 
causal relationship by allowing (re)gain of structure (and thus potentially function) 
20 
 
experiments. Previously, attempts to integrate exogenous neurons into the brain caused 
integration of exogenous neurons into existing neural networks in a relatively random manner 
(Chen et al, 2016). Upon implantation into the brain, neuronal cell bodies do not cluster to 
form nodes, as is usually observed physiologically while neurites extend at random to a 
distance that is insufficient for brain repair (Harris et al, 2016). TENNs are biomaterial-based 
implants formulated externally to the body and have generated physiological architectures in 
vitro; clustered soma, interconnected by fasciculated neurite bundles (Tang-Schomer et al, 
2014). Due to the ability to generate physiological structures and exhibit their 
electrophysiological properties and morphologies in vitro, TENNs are an appealing 
methodology for rewiring the lesioned brain to study functionality.  
 
Figure 1.2: The Cullen group TENN. The dotted line marks the agarose shell that encapsulates the 
neurites and hydrogel. Adapted from Harris et al, 2016. Scale bar = 100µm 
Implantation of a TENN along an ablated axonal pathway of the cortex could potentially restore 
the neuronal architecture to its pre-injury state. This has the potential to facilitate ephaptic 
signalling and volume transmission upon implantation, whereas studies typically report 
synaptic integration of exogenous neurons into the CNS several months after implantation 
(Pothayee et al, 2018; Tornero et al, 2013; Falkner et al, 2016). This ability to ablate and restore 
the non-synaptic connectivity within a neural network should aid in elucidating the roles of 
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both synaptic and non-synaptic communication within a network. Integrating a TENN with 
primary neurons transfected with fluorescent proteins modulated by a promoter that is 
synaptic activity dependent (such as the synaptic activity response element (SARE) promoter) 
(Kawashima et al, 2013) and implanting along the ablated pathway would allow for the degree 
of integration of exogenous neurons into the existing circuitry to be tracked. This would 
determine the role of connectivity or electrophysiological perturbances in functional 
impairment, removing a key limitation of lesion studies. Attributing function to architecture is 
fundamentally flawed if the act of ablation is the cause of the functional change via 
electrophysiological perturbance. Currently, few TENNs fulfil the criteria of generating the 
desired neural architecture of clustered cell bodies and aligned neurites projecting from node 
to node whilst retaining the ability to be implanted. The TENNs generated by the Cullen group 
(figure 1.2) (Harris et al, 2016; Struzyna et al, 2018; Adewole et al, 2018) are currently the only 
ones that fulfil the criteria of being an implantable, pre-fabricated structure that exhibits 
clustered cell bodies and aligned, fasciculated neurites. The structure designed by the Cullen 
group is an agarose based cylindrical shell that has an extracellular matrix (ECM) hydrogel 
within the lumen of the agarose shell. Cells are then seeded to a single end of the structure, 
creating a unidirectional TENN. However, due to the agarose shell of the structure, ephaptic 
signalling and volume transmission are limited. Thus, whilst the model may serve to reconnect 
disconnected regions synaptically, elements of non-synaptic neuronal communication are 
ignored until the agarose shell has been degraded. A TENN that allows for non-synaptic 
connectivity in addition to synaptic connectivity is needed in order to overcome the limitations 
that are inherent to lesion studies. 
 
1.4 Additional uses for an implant capable of re-wiring the cortex 
In addition to the use of implants to overcome limitations of lesion studies, implants that are 
capable of re-wiring the cortex could be utilised for (i) repairing damaged neural circuitry for 
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therapeutic purposes; (ii) integrating non-physiological brain architectures in order to allow 
gains of non-physiological functions; and (iii) to study the temporal dynamics of neural 
networks by altering degrees of myelination within the TENN. 
 
1.4.1 Integration of physiological neural circuit components into 
the cerebral cortex as a therapy 
To facilitate the re-wiring of lesioned pathways, an implant must be capable of restoring 
damaged pathways and restoring functionality. For many neurodegenerative diseases or 
injuries, loss of neurons induces disruption of neural circuitry and thus functionality, leading to 
development of the symptoms associated with the disease. Whilst neurodegenerative diseases 
are increasingly associated with disruptions to the temporal dynamics of whole brain 
electrophysiology (Jones et al, 2012), white matter pathways (Hattori et al, 2011; Rieckmann 
et al, 2016) and the electrophysiology of individual afflicted neurons (Amin et al, 2017), 
neuronal loss remains a key causative factor. This neuronal loss could be corrected by replacing 
lost neurons with implanted exogenous neurons highlighting how an implant that can rewire 
the cerebral cortex can be used therapeutically to rebuild damaged pathways. 
 
Research on the repair of neural circuitry for therapeutic purposes typically focuses on 
conditions such as Parkinson’s disease (PD) (Steinbeck et al, 2015; Lindvall and Kokaia, 2010; 
Wang et al, 2016; Wernig et al, 2008; Kim et al, 2011; Hargus et al, 2010) but serves as a model 
for limitations to therapeutic re-wiring of the cerebral cortex. PD is frequently used as a model 
for neural circuitry restoration studies due to the targeted nature of the disease; only one 
subset of neurons are damaged and reinnervate one target, the striatum. Whilst studies on re-
wiring of the striatum (introduction of exogenous neurons that integrate into striatal neural 
circuitry) frequently observe benefits and functional recovery upon implantation of neurons 
and other CNS-derived cells, these observed effects can be induced through mechanisms other 
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than integration of neurons into the endogenous neural circuitry (Table 1). Few studies 
demonstrate full integration of a significant number of implanted neurons into the 
endogenous circuitry due to a lack of guidance of the neurite outgrowths (Harris et al, 2016). 
Thus, if an implant can be generated that promotes integration of a significant number of 
exogenous neurons into endogenous circuitry, it could facilitate the rebuilding of injured 
endogenous neural circuits, thus allowing functional recovery from neurodegenerative 
diseases. Whilst the rebuilding of neural circuitry would not combat the β-amyloid plaques, 
cellular prion protein and neurofibrillary tangles of Alzheimer’s disease or the mutant 
Huntingtin gene of Huntingdon’s disease (Manoharan et al, 2016), it would counter the loss of 
neuronal populations that are common to these diseases. Re-wiring would aid in the 
amelioration of the symptoms of these diseases but not the underlying cause.   
 
Mechanism of beneficial 
effects induced by the 
introduction of exogenous 
neurons 
Overview of the mechanism 
Positive effects of surgical 
intervention 
The act of surgery may stimulate endogenous neuroregenerative 
mechanisms or lesion pathways that were overactive  
“Bystander effects” Mitigation of neurodegeneration through the modulation of 
support cell activity rather than neurons. 
Trophic support Exogenous cells deliver trophic factors that aid in survival or 
regeneration of endogenous neural circuitry 
Support of efferent 
endogenous neurons 
Provide a replacement target for endogenous neurons, 
preventing atrophy of endogenous neurons due to lack of 
targets.  
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Replacement of 
neuroprotective glial cells 
Glial cells provide mechanical, metabolic and homeostatic 
support; restoring glial populations restores this support.  
Pharmacological support  Implanted neurons release deficient neurotransmitters that 
diffuse to nearby synapses, restoring some functionality at a 
tonic level to downstream targets. 
Diffuse reinnervation Implanted neurons release deficient neurotransmitters at a 
physiological concentration to downstream targets. 
Passive bridging Passive bridges act as guidance for regenerating endogenous 
neurons to rebuild lost neural circuitry. 
Active bridging Neurons connect two host targets and relay electrical signals but 
do not contribute to information processing. 
Reciprocal graft-host 
reinnervation 
Implanted neurons integrate into host neural circuitry fully and 
contribute to information processing.  
Full reconstruction of neural 
circuitry 
Full integration of exogenous neurons into the host neural 
circuitry and restoration of the properties of the circuit to pre-
injury levels. 
Table 1.1: Possible outcomes from transplantation of neurons and glial cells in to the CNS 
(adapted from Dunnett and Bjorklund, 2017) 
   
1.4.2 Integrating non-physiological components into the cerebral 
cortex   
Loss of function studies are one of the primary tools used to study the connectome. These 
approaches typically target neuronal populations, silence them and monitor alterations to the 
connectome, observing changes to function caused by altered structure. Gain of function 
experiments have been conducted by teaching a behaviour to an animal model and monitoring 
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the effects on the macroscale connectome (Table 1.2; Bennett et al, 2018); altering the 
function and then observing changes to the connectome. Whilst lesion studies/loss of function 
experiments demonstrate causality, the gain of function experiments indicate a correlation 
between behaviours and subsequent changes to structures. 
Authors Paradigm Evidence of rewiring 
Boyke et al (2008) Motor learning Increased grey matter in regions associated with 
task 
Scholz et al (2009) Motor learning Increased grey matter and alterations to white 
matter microstructure in regions associated with 
task 
Oberlaender et al 
(2015) 
Sensory stimulation Restructuring of axons in the thalamocortical 
projection 
Hihara et al (2006) Motor learning Conversion of unimodally to bimodally responsive 
neurons due to the formation of new connections 
Boele et al (2013) Associative learning Axonal sprouting and terminal formation in the 
cerebellum 
 Table 1.2: Induced architectural rewiring at the macroscale 
Rewiring of the physiological connectome at the macroscale level has been demonstrated in 
the cerebral cortex of several animal models and each is associated with a gain of function; the 
animal could perform behaviours that they were not previously able to. For example, Japanese 
monkeys trained in tool use demonstrated novel connections from the high level visual cortex 
to the parietal cortex that were absent in the untrained control (Hihara et al, 2006); the 
architecture supported the function. What was previously a unimodal input from the 
somatosensory cortex became a bimodal input from both somatosensory and visual cortex, 
allowing the animal to perceive the tool at hand as an extension of their body and use the tool. 
Wistar rats exposed to the Morris water maze task exhibited structural changes in the dentate 
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gyrus and several regions of the limbic system whilst the swimming only control group 
exhibited structural changes in the primary and secondary somatosensory cortices, 
highlighting the role of attention on the task for inducing structural changes (Blumenfeld-Katzir 
et al, 2011). Each of these physiological macroscale rewiring events occurred in line with the 
acquisition of new skills or behaviours that were not present previously. This raises the 
possibility that successful non-physiological rewiring of the brain could be performed, enabling 
the acquisition of skills/capabilities that may not have been physiologically possible even with 
training, as the brain lacked the structure to allow for function. This could lead to the 
integration of non-physiological modules of neural tissue or prosthetics. At least one group has 
considered using a TENN as a biological brain-machine interface (BMI) (Serruya et al, 2017); a 
non-physiological gain of function, due to integration of a structure that did not previously 
exist within the brain.   
While non-physiological modules of neural tissue with specified function have been explored 
in a limited way to date, brain-machine interfaces (BMIs) are a developing aspect of 
neuroscience and can be utilised for repair, such as the cochlear implant for hearing loss or 
deep brain stimulation for movement disorders (Serruya et al, 2017) or eventually, 
enhancement; the gain of non-physiological functionalities. BMIs require 3 components: a 
sensor capable of recording from a neuron population, a decoder to interpret the 
electrophysiological signals in to commands and actuators to induce the effects (Hochberg et 
al, 2006). TENNs represent one strategy for a stable, long term sensor capable of 
recording/stimulating activity with high resolution within the cortex. Intracortical electrodes 
have several benefits over extra-cranial systems, e.g. higher resolution of neuronal signal 
recordings and the ability to directly interface with the substrate that controlled activities prior 
to injury/disease, reducing the amount of time between input and output (Hochberg and 
Donoghue, 2006). However, chronic implantation of invasive electrodes typically results in 
progressive loss of signal. Due to the mismatch between the elastic modulus of the brain and 
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the electrode, chronic shear and differential motion occurs, resulting in microtraumas and 
chronic inflammation (Harris et al, 2011), which is inherently neurodegenerative to the local 
neuronal population (McConnell et al, 2009). Methods of reducing the elastic modulus or 
reducing the shear stress/movement of the implant are being developed (Wu et al, 2015; Sohal 
et al, 2016; Sridharan et al, 2015) and a variety of methods of delivery that do not require 
needles, insertion shuttles or catheters are also being trialled such as flexible electrodes and 
microfluidic delivery devices (Harris et al, 2016; Vitale et al, 2017).  
 
Implanted intracortical electrodes attain their high resolution through their close contact to 
the neuron from which the signal originates, in contrast to tools such as 
electroencephalography, which has low spatial resolution due to the large distance between 
the origin and the point of signal recording (Hochberg and Donoghue, 2006). Due to the 
potential role for TENNs in re-wiring the brain as a long-term implant, TENNs used to rewire 
must by necessity be non-inflammatory and possess a low elastic modulus to minimise glial 
scarring. As a result, TENNs could theoretically be used to reroute outputs to the surface of the 
brain, allowing for greater spatial resolution with a less invasive technique. The re-routing of 
connections could be achieved by inserting a unipolar TENN through the cortex, with the 
seeded end acting as a “biological electrode” and neurites extending within the niche of the 
TENN to the surface of the brain. Non-invasive, previously low-resolution recording techniques 
could then be used to detect neural signals from relatively deep regions of the cortex with a 
higher degree of resolution. Currently, only the Cullen research group (Harris et al, 2016; 
Adewole et al, 2017; Struzyna et al, 2018) has developed a TENN that possesses the pre-
requisites to perform the rewiring. 
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1.4.3 Temporal dynamics of neural networks 
Whilst re-wiring of the brain is predominantly an effort to alter the existing spatial architecture, 
for information to be processed physiologically, the temporal aspects of computation within 
the brain should also be considered. Connectivity can occur at specific spatial nodes, specific 
temporal intervals or both (Köse-Dunn et al, 2017). The encoding of information through 
spatially distributed networks within the brain has been extensively studied through 
investigations of the brain’s structure but increasingly, function is attributed to temporally 
dynamic, spatially distributed neural networks. Temporally dynamic fluctuations of 
electrophysiological activity have been extensively documented in single cell recordings and 
local fields but only recently in fMRI studies (Allen et al, 2014). Global temporal dynamics have 
also been observed; fMRI utilising non-stationary correlation methods, such as sliding window 
correlation have illustrated transient activation of regions during behaviours that would not 
have been detected if only the spatial activation had been considered (Hindricks et al, 2016). 
The importance of the temporal dynamics of neural networks is further illustrated through the 
neurological conditions that feature disruption of temporal connectivity such as schizophrenia 
(Sakoglu et al, 2010) and Alzheimer’s disease (Jones et al, 2012). Thus, temporal aspects of 
functional connectivity should be considered when attempting to re-wire the brain.  
 
In order to study the temporal dynamics of neural networks, attempts to re-wire the cortex 
should consider two factors in particular: path length and myelination. The laminar 
architecture of the brain was theorised to maximise efficiency of spatial organisation and 
ensure consistent path length to synchronise action potentials that originate and terminate at 
the same point. However, Reeler mutant mice have no laminar architecture and suffer from 
no behavioural or functional deficits (Guy and Staiger, 2017). Thus, ensuring that the neurites 
of implanted exogenous neurons all possess a similar length may not aid in the synchronisation 
and temporal dynamics of exogenous neurons. In contrast, myelination facilitates saltatory 
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conduction, a process that can increase the speed of action potentials by 300-fold (Purves et 
al, 2001). The degree of myelination of axons is a factor that could be manipulated by seeding 
varying densities of oligodendrocytes to the structure, influencing the degree of myelination 
and saltatory conduction and action potential speed. Theoretically, this may be a method for 
manipulating the temporal dynamics of action potentials and thus study the temporal 
dynamics of networks. Cortical maps have been theorised to expand through exposure of 
latent connections rather than through the creation of novel connections (Albieri et al, 2014); 
by reducing the temporal dynamics within a network, latent connection may be revealed as 
the neural circuit utilises a more efficient path, shedding light on the connectome of the brain.   
 
1.5 How can the cortex be re-wired: considerations and existing 
methodologies 
The reasons for developing a method of rewiring the cortex are diverse, yet evidence of 
significant rewiring of the cerebral cortex is limited within the literature. However, substantial 
progress has been made in the field, which can be drawn upon to inform the work moving 
forward. The following considerations must be made for any implant that aims to facilitate re-
wiring. 
 
1.5.1 Cellular sub-populations 
To facilitate the re-wiring of the cortex, the biological architecture must be restored. The 
cerebral cortex is composed of a diverse population of cell types and subtypes. Forty-seven 
molecularly distinct subclasses of cells have thus far been described within the rodent cortex 
(Zeisel et al, 2015) but they can be broadly divided in to two categories; glia and neurons.  
 
Glial cells are divided into two dominant subclasses; astrocytes and oligodendrocytes. 
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Astrocytes were historically viewed as maintenance cells, the purpose of which was to regulate 
pH and osmolarity, provide metabolic substrates and clear neurotransmitters from the 
synaptic cleft (Kandel, 2012). However, in recent years, astrocytes have been attributed with 
further vital roles within the CNS. Lactate is shuttled from the astrocyte to neurons that require 
metabolic support, astrocytes control the diameter of blood vessels and thus blood flow within 
the brain and astrocytes are even capable of modulating neuronal activity (Brown and Ransom, 
2015; Teschemacher and Kasparov, 2015). Similar to astrocytes, oligodendrocytes have 
traditionally been attributed with one major role, the myelination of axons. However, in recent 
years, an increasing number of functions have been attributed to them. Myelination of axons 
reduces the capacitance of the axon membrane whilst increasing the electrical resistance, 
facilitating faster conduction speed of action potentials and altering the overall dynamics of 
the neural network (Kandel, 2012). Oligodendrocytes are also thought to provide metabolic 
and trophic support to axons and aberrant oligodendrocytes are associated with numerous 
psychiatric disorders (Edgar and Sibille, 2012).  
 
Neurons are the effectors of the CNS: computation is performed through the activity-
dependent release of neurotransmitters targeted towards a downstream neuron 
(Teschemacher and Kasparov, 2015). The Neuron Doctrine (Ramon y Cajal, 1888) suggested 
that neurons were the smallest functional unit of the brain. This hypothesis was supported by 
the techniques that dominated the field of neuroscience for almost a century and a half; single-
cell techniques such as Golgi staining and microelectrodes were used to study individual cells 
of neural circuits to elucidate the structure of the brain. The discovery of receptive fields, 
specific stimuli that activate individual neurons, further cemented neurons as the smallest 
functional units of the CNS (Yuste, 2015). However, in contrast to the Neuron Doctrine, neural 
network models propose that the smallest functional units of the CNS are networked neurons 
(Yuste et al, 2015). Anatomically, distributed connectivity is evident in the structure of the 
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brain. Neurons receive inputs from numerous other neurons, each of the excitatory inputs 
possibly being significantly below the threshold for depolarisation; this feature allows the 
integration of numerous excitatory signals prior to depolarisation without saturation (Abeles, 
1991). Inhibitory neurons utilise gap junctions as a form of connectivity, reinforcing their ability 
to act as a single unit whilst dendritic spines increase connectivity between excitatory neurons 
via the axons (Kandel, 2012). By increasing connectivity between neurons, each individual 
neuron within a circuit becomes less important; thus function is likely to arise from the 
composite interactions of ensembles of neurons rather than any one individual neuron (Yuste, 
2015). This is also evident pathologically. Clinical symptoms of PD appear when approximately 
50-60% of the dopaminergic neurons in the substantia nigra are lost, suggesting that the 
network can adapt to the loss of single neurons to a point, contradicting the Neuron Doctrine 
(Gorman, 2008).  
To facilitate re-wiring, the cellular sub-populations of the brain should be accounted for rather 
than using the reductionist approach of solely replacing neurons.   
 
1.5.2 Tissue-wide organisation 
Neurons in the cerebral cortex display distinctive cellular and tissue-wide architectures to 
support brain function. The cellular architectures of a neuron of the cerebral cortex are shared 
with the architecture of the majority of other neurons within the CNS. Cerebral cortical 
neurons have a soma (cell body), containing the nucleus, and from the soma extends the axon, 
the output component of a neuron, and dendrites, the input component of neurons (Kandel, 
2012). Within the CNS, neural circuits are comprised of cell bodies, typically clustered together 
(grey matter), that are interconnected by fasciculated, myelinated bundles of axons (Kandel, 
2012; Tang-Schomer et al, 2014). In order for a network of neurons to be generated, synapses 
form. Synapses are the point of electro-chemical communication between neurons within the 
CNS and serve to convert an electrical signal in the pre-synaptic neuron to a chemical signal 
32 
 
that is converted back to an electrical signal by the post-synaptic neuron. Synapses can form 
between axons-dendrites, axons-somas, axons-axons, axons-dendritic spines and dendrites-
dendrites (Bear et al, 2016). Non-synaptic communication between cells can occur but 
synapses are the predominant method of information flow within the CNS (Bentley et al, 2017). 
Notable non-synaptic manners of communication between adjacent neurons are ephaptic 
transmission (communication through extracellular electric fields) (Su et al, 2012), through 
secretion of extracellular vesicles containing proteins and RNA (Pastuzyn et al, 2018) and even 
through quantum entanglement via calcium phosphate molecules (Fisher, 2015). Of note is the 
importance of proximity for each method of communication; structure leads to function. The 
close proximity that results from the clustering of cell bodies and bundling of axons is 
fundamental to each of the methods of communication that neurons employ to process 
information.  
  
Within the cerebral cortex, cells are also arranged into a laminar structure (Table 3). The 
laminar structure of the cortex is theorised to enhance the computational abilities of the brain. 
The cerebral cortex has demonstrated the ability to process top-down information from higher 
cortical areas, bottom-up information from sensory organs and lateral signals from 
neighbouring neurons, all within the same region. The laminar architecture has been theorised 
to facilitate this function (Raizada and Grossberg, 2003) however, evidence suggests a simpler 
role for the lamination of the cerebral cortex. The reelin protein plays a role in the 
development of the laminar structure of the cortex; loss of the reelin protein from a mouse 
model results in loss of lamination, yet functional connectivity within the brain is unaffected. 
Furthermore, in various studies, reeler mutant mice were found to have unaltered cortical 
function or behaviours (Guy and Staiger, 2017). The authors hypothesise that the laminar 
structure serves to optimise neuronal placement thus minimising neuronal length, saving 
space and the metabolic cost of maintaining the network. In addition, they note a lack of layers 
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and organisation generates  more variable neurite lengths to reach the downstream target; if 
conduction velocity is consistent, a lack of lamination may lead to temporal desynchrony, 
limiting summation of action potentials.  
Layer Properties 
I – the molecular layer Acellular layer, mainly comprised of apical dendritic tufts of neurons 
originating in deeper layers and horizontal axons that pass through or form 
connections within the layer 
II – the external granular layer Composed predominantly of granule cells, small spherical morphology. 
Contains the apical dendrites of cells within layers V and VI.  
III – the external pyramidal layer Contains vertically orientated small and medium sized pyramidal neurons, 
typically larger than cells of the more superficial layers. Contains the apical 
dendrites of cells within layers V and VI. 
IV – the internal granular layer Similar to layer II, comprising of predominantly granular cells. 
V – the internal pyramidal layer Composed mainly of pyramidal neuronal cell, typically larger than the 
pyramidal neurons of layer III. Contains the basal dendrites of cells within 
layers III and IV. 
VI – the polymorphic/multiform 
layer 
Contains a diverse cellular population; few pyramidal neurons, many 
multiform neurons and small spindle-like pyramidal neurons. Contains the 
basal dendrites of cells within layers III and IV. 
 
Table 1.3: The diverse properties of the layers. Layer I is the most superficial layer, whilst layer VI is the deepest. It 
is important to note that these are general observations, not all cortical regions follow this organisation; the primary 
visual cortex has a prominent layer IV which has subdivisions, whilst the perirhinal cortex lacks layer IV and has no 
clear border between layers II and III. The layering of the cortex allows the efficient organisation of inputs and 
outputs to and from the cortex; the main projections of layer VI are to the thalamus, for layer V, the midbrain, 
hindbrain and spinal cord whilst layers II and III and some cells of layer V form the majority of intracortical 
connections (Kandel et al, 2000; Furtak et al, 2007; Espuny-Carmacho et al, 2013). 
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1.5.3 Existing methods of re-wiring the cerebral cortex 
Literature on re-wiring of the brain in a manner that is not directly related to repair of damaged 
pathways are limited. However, the aims of repair and re-wiring are analogous; to implant 
exogenous neurons into a host brain and integrate neurons into the existing host circuitry. Due 
to the analogous nature of the aims, publications on the repair of lost connectivity within the 
brain using exogenous neurons make an excellent source for information regarding strategies 
to facilitate brain re-wiring. Key concepts identified in these studies are applicable to work 
within the cortex such as areal identity, integration of exogenous neurons in to the existing 
neural circuitry, survival of cells upon implantation and failure to extend neurites in a targeted 
way to a significant degree. 
1.5.3.1 Areal Identity 
Areal identity is the concept that neurons of different areas have different molecular, 
electrophysiological and laminar profiles. Studies that utilise stem cells illustrate this concept 
well. For example, stem cells to be utilised to re-wire the striatum are consistently 
differentiated to a midbrain dopaminergic fate prior to implantation (Steinbeck et al, 2015; 
Hargus et al, 2010; Wang et al, 2016). Only ventral mesencephalon dopaminergic neurons are 
capable of reinnervating the striatum whilst neurons isolated from other dopaminergic regions 
lack this property. Interestingly, dopaminergic neurons within the ventral mesencephalon are 
comprised of two populations; substantia nigra pars compacta neurons and ventral tegmental 
area neurons. Only neurons of the nigral subtype can reinnervate the striatum, demonstrating 
the need to match areal identity for successful rewiring (Thompson et al, 2005). Studies take 
care to ensure ventral mesencephalon identity of implanted neurons (Steinbeck et al, 2015; 
Hargus et al, 2010; Wang et al, 2016). The concept of areal identity has also been demonstrated 
within the cortex. Pyramidal neurons with an occipital areal identity implanted within the 
visual cortex show significant integration whilst implantation of pyramidal neurons with an 
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occipital identity within the motor cortex exhibited negligible integration (Michelson et al, 
2015). However, several studies provide evidence of limited area plasticity within the cortex 
(Gaspard et al, 2008; Hansen et al, 2011; Ideguchi et al, 2010) although greater areal plasticity 
was noted for neurons isolated from younger embryos. Interestingly, areal matching of implant 
to implanted region is conserved across species; Espuny-Carmacho et al (2013) implanted 
human cells into a mouse host and observed integration in the occipital cortex by occipital-
identity human neurons but not within the motor cortex. Thus, in order to maximise 
integration of exogenous neurons, matching the areal identity of exogenous neurons is key. 
This represents a crucial distinction between repair of damaged endogenous neural networks 
and re-wiring to create entirely new neural architectures. Due to the need to match the areal 
identity of implanted neurons and the region to be innervated, it may be difficult to force 
integration of neurons that physiologically should not form synapses, limiting construction of 
non-physiological neuronal networks.  
 
1.5.3.2 Cell Survival 
Survival of implanted neurons is another hurdle identified by previous studies. Attrition of cells 
upon implantation is high. A number of factors play a role in this, namely anoikis (apoptosis 
due to lack of ECM), ischaemia and withdrawal of trophic factors (Sortwell et al, 2000; Pires, 
2013). The attrition of cells typically occurs within the first week of implantation but beyond 
this point, studies have shown exceedingly high survival (Falkner et al, 2016). Biomaterial 
scaffolds are frequently used to ameliorate anoikis. Cells are implanted attached to a scaffold 
rather than implantation as a cell suspension (Wang et al, 2016; Vaysse et al, 2015; Cooke et 
al, 2010; Wang et al, 2012) although it should be noted that not all the named studies used 
scaffolds that were solid, as in some cases hydrogels that gelate in response to light or heat 
were employed instead. The mechanical support of the scaffold limits the level of cell death 
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due to anoikis. By implanting on a scaffold, detachment of cells from a surface is not necessary 
and thus, anoikis is limited with a greater number of cells able to integrate. This effect can be 
further enhanced by coating the scaffold with ECM proteins such as a fibronectin or laminin 
(Cooke et al, 2010), although it should be noted that survival as high as 76±11% has been noted 
for primary neurons cultured on glass beads and implanted in to the CNS in the absence of 
ECM coatings (Jgamadze et al, 2012).  
 
1.5.3.3 Neurite Extension 
However, implanted neurons that survive do not extend neurites to a significant degree in the 
correct direction, preventing effective repair (Harris et al, 2016). Oki et al (2012) induced neural 
stem cells (NSCs) (derived from induced pluripotent stem cells) towards a cortical neuronal 
fate prior to implantation and observed differentiation into the correct phenotype, axonal 
extension to the correct target and electrophysiological activity characteristic of mature 
neurons. However, axonal extension to the correct appropriate target was only noted for cells 
implanted into the striatum and not for those implanted into the cortex. The study utilised 
human cells in a rodent brain; human derived neurons extend axons to a greater degree than 
rodent derived neurons upon implantation into a rodent brain, likely due to the degree of 
axonal extension within the native species’ brain (Hurelbrink and Barker, 2005) and thus, an 
allograft may not have seen the same degree of neurite extension. Oki et al (2012) highlight 
the need for axonal guidance for restoring neural circuitry within the cortex. Human cells fail 
to extend axons to distant targets and migrate to a greater degree than rodent cells in a rodent 
model, hence translating to a clinical setting (human cells in human model) will require a great 
deal more work on guidance of axon extension towards distant targets. 
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1.5.3.4 Integration into existing neural circuitry 
Current research into neural circuitry replacement for PD has demonstrated rapid 
reinnervation of the striatum by the implant to a great extent, yet this is less true of cells 
implanted within the cortex. Early retrograde labelling studies indicate that only 1 in 3 cortical 
neurons grows axons into an implant of fetal tissue, although these fibres do form synapses 
with the implanted neurons that have been demonstrated as functionally active via 
electrophysiology (Peschanski et al, 1995). Innervation is not limited to host afferents, 
implanted neuron-derived efferents have also been observed for fetal neurons. Studies have 
demonstrated fetal implants within the cortex extending axons towards the globus pallidus; 
structural analysis confirmed functional synapses were established with the correct targets but 
axon extension towards more distant areas was more limited. Human xenografts in a similar 
study did demonstrate distant projections, but again this may be due to the size of the brain 
that the NSCs were derived from; if the brain of the donor species was larger than that of the 
host species, greater axonal extension is often observed (Peschanski et al, 1995; Hurelbrink 
and Barker, 2005). These studies suggest that one of the reasons cortical implants fail is due to 
a lack of axonal guidance/extension resulting in a lack of integration rather than an inherent 
inability to integrate into existing neural circuitry. Studies also suggest that utilising human 
cells in animal models may have limitations with respect to axon extension; allografts 
demonstrate poor axonal extension whilst human xenografts demonstrate axonal extension. 
As clinical implants will utilise human cells as an implant within human patients (allografting), 
poor axonal extension is likely to be observed. 
 
1.6 Biomaterials and nanofibres 
Scaffolds have demonstrated multiple properties beneficial to implanted cells. The ideal 
scaffold should be capable of guiding organisation and growth of exogenous neurons, allowing 
diffusion of oxygen and nutrients whilst also allowing vascular infiltration, limiting the extent 
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of ischaemia (Park et al, 2002). The ideal scaffold for a neural implant is biocompatible (during 
culture, implantation or degradation), promotes beneficial biological activities (such as 
enhanced survival) (Chen et al, 2011), enhances neurite outgrowth (Yang et al, 2005), degrades 
at a similar rate to tissue growth of the cells within the implant, possesses a 3D porous 
structure facilitating infiltration and diffusion of nutrients, reproducible structure and similar 
mechanical “stiffness” to the brain to prevent microtraumas upon movement (Pettikiriarachchi 
et al, 2010). The choice of material for the scaffold is heavily dependent on the aims of the 
implant. Different materials induce different effects on various cellular populations: 
Polycaprolactone promotes oligodendrocyte differentiation at the expense of neuronal and 
astrocytic differentiation in NSCs (Nisbet et al, 2007), ideal for studies working on 
remyelination for a multiple sclerosis therapy but less than suitable for studies into cellular 
replacement of neurons for PD or Huntington’s disease. Scaffolds can be used to guide axonal 
extension of the cells; facilitating targeted reinnervation that is lacking in their absence (Harris 
et al, 2016). Whilst studies have focused on increasing the rate of axon growth either by direct 
stimulation of the neuronal growth (Yip et al, 2010; Liu et al, 2010) or by engineering the 
environment to be more permissive for axon outgrowth (Tang et al, 2007). Neither method 
ensures axonal extension to the correct target; however, scaffolds can be used to direct axon 
extension to the desired region (Yang et al, 2005). 
 
Neuronal cells have been grown on nanofibres in an attempt to mimic the topographical 
features of the ECM. Aligned nanofibre structures promote guidance of axon extension and 
rate of growth due to “contact guidance”, beneficial to neural tissue engineering as cell 
replacement strategies often lack directionality (Harris et al, 2016). Upon random nanofibres, 
neurite extension can be observed to be random, whilst on aligned nanofibres, neurite 
extension demonstrates increased directionality and rate of growth (Yang et al, 2005; Corey et 
al, 2007; Lee et al, 2011).  
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Thus, aligned nanofibres are able to counter two of the key hurdles that are expected to hinder 
re-wiring; cell death upon implantation due to anoikis and failure to extend targeted neurites 
from point A to point B. Of the ideal properties for a tissue engineering scaffold that were 
previously mentioned (biocompatible, promotes beneficial behaviour, enhanced neurite 
outgrowth, degrades, porous structure for diffusion and cellular infiltration, reproducible and 
similar elastic modulus to the brain (Pettikiriarachchi et al, 2010)), aligned nanofibre 
membranes satisfy two of the criteria; porosity and reproducibility. Nanofibres can be 
electrospun from a variety of materials that can promote the other ideal properties.  
 
1.7 Goals of the PhD project 
In order to develop an implant capable of re-wiring the brain, several aims were established:  
1. Development of a method of inducing cellular aggregation of primary cortical neurons 
and aligned neurite extension through use of a biocompatible nanofibre scaffold 
2. Characterisation of the resultant cellular structures to ensure that they are sufficiently 
viable and developed for implantation 
3. Elucidation of the mechanism through which aggregation occurs 
4. Development of a method to detect successful integration of exogenous cortical 
neurons in to endogenous neural circuitry  
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Chapter 2: Materials and methods 
2.1 Methods common to all chapters 
2.1.1 Isolation of E18 Sprague Dawley rat cortex 
Timed pregnant CD Sprague Dawley rats were killed on embryonic day 18 by overdose of 
inhaled isoflurane in accordance with the UK Animals (Scientific Procedures) Act 1986 by 
Nottingham Trent Barrier Unit. Death was confirmed by cervical dislocation. Embryos were 
removed rapidly and decerebrated on ice. Microdissection was performed under sterile 
conditions. Briefly, the meninges were removed and the hemispheres of the brains were 
separated. The olfactory bulb, midbrain, hindbrain and hippocampus were removed. The 
isolated cortex was then placed in Hibernate EB (HEB) medium and stored at 4°C until use.   
2.1.2 Dissociation of primary cortical neurons  
E18 Sprague Dawley rat cortex was stored in HEB prior to dissociation. Using a silanised Pasteur 
pipette, HEB solution was removed, leaving only the tissue with minimal HEB. Papain (2mg/ml) 
in Hibernate-E without Ca2+ was kept on ice prior to use. Tissue was transferred in to the papain 
and incubated in a water bath for 10 minutes at 30oC. The tissue with minimal medium was 
then transferred back in to HEB medium and triturated (approximately 8 passes were needed 
to disperse the tissue); undispersed pieces were allowed to settle for 1 minute prior to removal 
of the supernatant. Supernatant was then centrifuged for 1 minute at 200g. The supernatant 
was then discarded and the pellet resuspended in 1ml of NbActiv1 prior to cell counting using 
a Biorad TC20 cell counter and a 1:1 dilution in Trypan Blue to assess cell viability. 
2.1.3 Maintenance of primary cortical neurons  
Primary cortical neurons were cultured in NbActiv1 supplemented with gentamicin to a final 
concentration of 50µg/ml. Flasks were maintained at 37oC in a humidified chamber of 5% v/v 
CO2 and 95% air v/v. Half medium changes were performed on alternate days. Cells were 
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plated out at a density of 25,000 cells/cm2 and were not subcultured due to the post-mitotic 
nature of primary neurons.   
2.1.4 Cryopreservation 
Cells were cryopreserved in the vapour phase of liquid nitrogen. After dissociation of the tissue, 
primary neurons were resuspended in cryopreservation medium (90% v/v NbActiv1 and 10% 
v/v DMSO) and placed in a -80oC freezer overnight prior to being moved to liquid nitrogen 
storage.  
2.1.5 Thawing 
Cryopreserved cells in cryovials were retrieved from the liquid nitrogen storage. Cryovials were 
then placed in a water bath at 37oC for 1-2 minutes and their thawed contents transferred to 
a sterile tube. Growth medium (10ml) was then added dropwise to the cells to dilute the DMSO. 
The tube was then centrifuged for 5 minutes at 300g, after which the supernatant was 
discarded and the pellet was re-suspended in 1ml of NbActiv1 medium prior to seeding. 
2.1.6 Electrospinning of nanofibres  
A custom electrospinning rig was employed and a patented method was used to generate 
aligned nanofibres (UK patent application number GB2553316A). Briefly, nanofibres were 
collected on non-conductive polyester collecting sheets that were cut in to the design used to 
generate aligned nanofibres (figure 2.1) using a Trotec CO2 laser cutter. For non-conductive 
collecting sheets that are sufficiently thin, electrostatic attraction is capable of drawing the 
nanofibres between the two rectangles of the aligned nanofibre design on the collecting sheets. 
Polyester sheets were 600mm x 300mm x 0.075mm and cutting parameters were: 100% speed, 
28% power and 1000 pulses per inch. Poly-L-lactic acid (MW 40,000) was dissolved overnight 
at 50°C in the solvent hexafluoroisopropanol (HFIP) to a concentration of 30% (w/v). This 
solution was delivered at a controlled rate of 1ml/hr to a needle (21 gauge, stainless steel) 
which was subjected to an electrical potential of 25kV. The needle was separated from the 
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grounded collector by 15cm. The grounded collector was a rotating polystyrene drum wrapped 
in an aluminium sheet. The high voltage applied to the electrospinning solution decreases the 
surface tension at the tip of the needle and as the charge density exceeds the surface tension, 
a Taylor cone forms and the solution is drawn in the direction of the grounded collector. 
Desolvation occurs as the electrospinning solution is in the air, entangling high molecular 
weight molecules in order to form a nanofibre which is attracted by the collector. The process 
is non-sterile; prior to use for cell culture, sterilisation of the nanofibres was achieved by 
exposure to ultraviolet (UV) light at 256nm for 20 minutes. 
Figure 2.1: The experimental set up for electrospinning of aligned nanofibres. A high voltage power supply is used 
to apply an electric field to the polymer solution which is ejected in the direction of the grounded, rotating collector.  
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2.1.7 Preparation of samples for fluorescence microscopy 
Cells were fixed in 4% w/v paraformaldehyde (PFA) and permeabilised using 0.1% v/v Triton X-
100 for twenty minutes each. Cells were then incubated in blocking buffer (3% w/v bovine 
serum albumin in PBS) for 1 hour at room temperature prior to overnight incubation in primary 
antibody (concentration stated for each specific antibody alongside the images) at 4°C on an 
orbital shaker. Incubation in secondary antibody (concentration stated in the antibody sub-
section) was performed at room temperature for 2 hours. Subsequent nuclear staining was 
performed with DAPI. Visualisation was performed using a Leica SP5 microscope. Between 
each stage, three 5 minutes washes were performed using phosphate buffered saline (PBS).  
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Chapter 3: Method optimisation 
3.1 Introduction 
3.1.1 Choosing a cellular model for use in rewiring studies 
Research into repair of the CNS thus far has highlighted the need for similarity between the 
implanted neurons and the region of implantation for successful synaptic integration and thus, 
rewiring. In order to rewire the cerebral cortex, implanted cells should be cortical neurons. 
Even within the cortex, mismatch of cortical areas between exogenous and endogenous 
neurons limits synaptic integration (Michelsen et al, 2015). Earlier developmental stages of 
neurons appear to be more plastic and more easily integrated into existing synaptic circuitry 
than later developmental stages (Ideguchi et al, 2010; Gaspard et al, 2008; Espuny-Carmacho 
et al, 2013). This may circumvent the areal identity issue (lack of integration for mismatching 
cortical areas between host and exogenous neurons) raised by Michelsen et al (2015), 
therefore, neurons at an early developmental stage are more desirable for rewiring studies. 
The physiological architecture of the brain is composed of clustered cell bodies and projections 
of aligned neurites (Tang-Schomer et al, 2014); thus the neurons of the implant should be 
arranged into this cytoarchitecture. Full reconstruction of neural circuitry requires integration 
of neurons and restoration of electrophysiological properties of the circuit; therefore, 
electrically active cells must be employed (Dunnett and Bjorklund, 2017).  
 
Stem cell technology is the gold standard for cellularised biomedical implants into the CNS. 
Due to the easily scalable nature of mitotic stem cells and the advent of induced pluripotent 
stem cell technology and personalised medicine, many studies make use of stem cells (Forbes 
and Andrews, 2019). Embryonic stem cells (ESCs) are totipotent and can be used to generate 
mixed neural populations composed of neurons, astrocytes and oligodendrocytes; however, 
they are no longer implanted due to their ability to form teratomas (Brustle et al, 1997). They 
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are currently used as a source of generating neural stem cells that are subsequently 
differentiated into neurons and implanted into the CNS (Daadi et al, 2016; Boehm-Sturm et al, 
2014; Mezzanotte et al, 2013). In contrast to the pluripotency of ESCs, neural stem cells are 
lineage restricted and can only generate neurons, oligodendrocytes and astrocytes, limiting 
their ability to form teratomas (Bonnamain et al, 2012). However, for targeted repair of the 
central nervous system, neural stem cells (NSCs) have some key limitations. NSCs are capable 
of migrating towards a site of injury (Tamaki et al, 2002) and thus to retain the desired neurite 
guidance that is induced by aligned nanofibres and key to this research, the migration of NSCs 
away from the nanofibres would have to be curbed. NSCs have also demonstrated the ability 
to undergo fusion events; rather than differentiate into neurons capable of rewiring in vivo, 
they may instead fuse with existing neurons (Brilli et al, 2012; Cusulin et al, 2012). 
Differentiation may not even occur; studies have reported large percentages of 
undifferentiated NSCs post-implantation (Aboody et al, 2000; Chaubey and Wolfe, 2013; 
Weerakkody et al, 2013). Large populations of undifferentiated NSCs can inhibit cortical 
excitability, neuronal death and microgliosis (Weerakoddy, 2014). Thus, differentiation of NSCs 
in vitro is required to curtail migration away from the nanofibres and the targeted region of 
rewiring, to limit the undifferentiated NSC population and to prevent fusion events that may 
obfuscate data. 
 
Whilst neuronal cell lines are extensively utilised for in vitro neurobiology studies, they are 
poorly suited to in vivo usage and rewiring the cerebral cortex. The NT2 cell line can be used 
to generate electrically active neurons that are capable of integrating but possesses an 
abnormal karyotype (Le Friec et al, 2017) and are legally barred from use in clinical trials as a 
result. The SH-SY5Y cell can also be differentiated to a dopaminergic neuron phenotype but 
the neuronal cell line possess two distinct sub-types, epithelial and neuronal; implantation may 
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result in teratoma formation within the CNS. One cell line (CTX0E03) has been approved for a 
clinical trial in humans (Le Friec et al, 2017) although these are neural stem cells (NSCs) rather 
than neurons and suffer the same differentiation concerns (fusion, failure to differentiate, 
migration from target region) as primary NSCs. Upon implantation during human clinical trials, 
amelioration of cognitive deficits in stroke patients was observed, although this is not 
necessarily evidence of rewiring as NSCs can exert a range of beneficial effects that result in a 
degree of functional recovery (table 1.1, Chapter 1; Ottoboni et al, 2017). Post-mortem analysis 
would be required to confirm synaptic integration and rewiring rather than behavioural 
restoration. The CTX0E03 cell line therefore represents a potential candidate for cellular 
implantation.  
 
Whilst stem cells (both clonal and primary) have the benefits of multipotency and the ability 
to be sub-cultured to generate cellular stocks, the process of differentiation of stem cells to a 
neuronal fate is the greatest limitation of the cells for biomaterials-based research. Wettability, 
elastic modulus, conductivity, nanofibre diameter, nanoroughness and cell density have all 
been demonstrated to influence differentiation of stem cells (Saha et al, 2008; Christopherson 
et al, 2009; Blumenthal et al, 2014; Lee and Arinzeh, 2012; Moon et al, 2012). Subtle changes 
in the environment may induce changes to the proportion of each neural sub-population 
(neurons, oligodendrocytes, astrocytes, etc) as a result of changes to the implant or 
environment and thus result in the need for re-optimisation of the differentiation process. 
Primary neurons were selected as the cellular model despite their finite, post-mitotic nature. 
Whilst all of the listed cell types are capable of rewiring neural circuitry through the generation 
of neurons, primary neurons have no capacity to differentiate to any population other than 
neurons, eliminating the potential for negative interactions between the biomaterials and the 
intrinsic differentiation programmes of stem cells. Primary cortical neurons can be used from 
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embryonic day 18; prior to terminal differentiation but far enough through the developmental 
programme to be lineage restricted to neurons (Semple et al, 2013). A potential limitation to 
using primary neurons as the cellular model for the research is the non-physiological 
homogeneity of the culture; a mix of cell types are found within the cerebral cortex (Kandel, 
2012). Future work should focus on the use of stem cells to develop the model further as stem 
cells have the ability to generate heterogeneous neural cultures (neurons, oligodendrocytes 
and astrocytes), can be scaled up due to their mitotic nature and eventually, to personalise the 
treatments using induced pluripotent stem cells.  
 
3.1.2 Generation of physiologically relevant cytoarchitectures 
The use of embryonic primary cortical neurons ensures that cells are plastic and as similar as 
possible to the desired area for implantation and are an electrically active cell type. It should 
be noted, however, that use of the whole embryonic cortex to generate primary cortical 
neurons overlooks the areal identity issue highlighted previously but the early developmental 
stage may circumvent this. The use of nanofibres to promote aligned neurite extension was 
discussed in Chapter 1 and allows the targeted outgrowth necessary for rewiring to take place 
but this is only one half of the desired cytoarchitecture. The brain has grey and white matter 
structures composed of clustered cell bodies and tracts of myelinated axon interconnections 
respectively (Kandel et al, 2012). Nanofibres promote the targeted neurite extensions that can 
be used to mimic the white matter. Aggregation of cell bodies is fundamental to mimicry of 
the grey matter.  
 
Generation of neuronal aggregates has been performed using several methods previously. 
Studies have used stem cells to generate neurospheres and differentiated the cells from these 
to generate the desired cytoarchitectures (Lancaster and Knoblich, 2014), whereas others have 
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seeded cells to pre-cast molds to generate aggregates (Kato-Negishi et al, 2013; Harris et al, 
2016). Generation of aggregates from neurospheres is precluded by the use of primary cortical 
neurons as a choice of cell. Whilst the use of pre-cast molds is a relatively simple method of 
generating aggregates, extracellular environments that have a high elastic modulus relative to 
the native tissue can negatively influence terminal neuronal differentiation. One notable 
example is yes-activated protein (Yap) expression. Yap protein levels are negatively correlated 
with neuronal differentiation (Hindley et al, 2016; Zhang et al, 2011) and its expression can be 
influenced by the extracellular environment. Cells cultured on surfaces with high elastic 
modulus have demonstrated a transient increase in Yap and after a threshold “mechanical 
dose”, demonstrate constitutive expression (Yang et al, 2014). Similarly, culture of neurons on 
harder surfaces was associated with inhibition of differentiation relative to a soft, hydrogel 
surface (Ali et al, 2015). Thus, whilst molds are an attractive method of generating aggregates 
due to their simplicity, the non-physiological properties of the molds may negatively influence 
the cells. 
 
Hydrophilicity of cell culture substrates is typically employed by cell biologists to ensure cells 
adhere to a surface in a homogenous manner (Ryan et al, 2008). In contrast, hydrophobicity 
limits cellular adhesion (Ishizaki et al, 2010) and often results in the formation of cellular 
aggregates. Through use of highly hydrophobic nanofibre surface, aggregates with aligned 
neurite projections should be generated; thus, hydrophobicity is proposed as a method of 
generating self-assembling aggregates. 
 
Aligned nanofibres are easily generated through electrospinning using a defined process. 
Electrospinning dissolves polymers in a solvent, exposes the solution to a high electrical charge 
and directs the solution towards a grounded collector. The attraction of the solution to the 
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collector draws the solution from point A to point B, stretching the solution in to an elongated 
fiber with nano-dimensions and causing rapid evaporation of the solvent, solidifying the 
polymer into this fibrous form (Leach et al, 2011). However, electrospinning affords a great 
degree of flexibility through tailoring of the parameters used (kV, rate of flow, temperature, 
etc) and choice of polymers. Different polymers and polymer blends have been used to tailor 
the properties of the nanofibre to the desired function such as conductivity, piezoelectricity, 
bioactivity or antibiotic properties (Son et al, 2006; Chang et al, 2012; Zhang et al, 2007). 
Nanofibre diameters can be tailored through alterations to the voltage, distance between 
charged solution and grounded collector or polymer concentration to induce greater or smaller 
air-surface interfaces to decrease/increase the wettability (Hekmati et al, 2014; Wu et al, 2008). 
Alterations to the temperature (cryogenic electrospinning; Leong et al, 2009) or the grounded 
collector (airgap electrospinning; Jha et al, 2011) can be used to influence the porosity. Thus, 
aligned nanofibre structures with desired material chemistries can be created using 
electrospinning. Optimisation aims to maximise alignment of the nanofibres to enhance the 
guidance of neurites that are grown upon the fibres whilst retaining the small diameter of the 
nanofibres to attain the desired wettability and ehance guidance, polarity and growth.  
 
Poly lactic acid (PLA) is a hydrophobic polymer that is one of the most widely used materials 
within the biomedical sciences (Santoro et al, 2016). It is FDA-approved for in vivo uses (Jung 
et al, 2005) and has found use as a material for drug delivery and scaffolds for tissue 
engineering, often in the form of nanofibres (Wang et al, 2016; Evans et al, 2000; Hwang et al, 
2014; Koh et al, 2010). The poly-L-lactic acid (PLLA) isomer is favourable for tissue engineering 
purposes due to its tunability as a material, biocompatibility and degradability. Several 
mechanical properties such as degradation rate, mechanical strength and solubility can be 
adjusted (Lopes et al, 2012). Degradation and mechanical strength can be adjusted through 
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stereocomplexing, blends of polymers, crystallinity or altering the molecular weight (Lopes et 
al, 2012; Ishii et al, 2009; Weir et al, 2004). Additionally, the only by-product of PLLA 
degradation is the physiological metabolite lactic acid (Santoro et al, 2016). Biocompatibility 
has been demonstrated in rodent models with a range of different PLLA based structures and 
limited inflammation and immune response has been observed (Jaiswal et al, 2013; Koh et al, 
2010; Evans et al, 2000; Evans et al, 1999), including those implanted in the CNS (Wang et al, 
2016; Hwang et al, 2014; Rivet et al, 2015). Thus, PLLA was selected as the polymer for the 
fabrication of nanofibres in the current work.  
 
In summary, aligned nanofibres are capable of inducing aligned neurite outgrowth from 
primary neurons whilst hydrophobic structures can be used to induce aggregation of cells. This 
chapter describes efforts to optimise a system that can be used to generate 3D cell clusters 
with aligned neurites, spanning hundreds of microns that will comprise the cellular aspect of 
the implant. The ability to control the dimensions of the cell clusters that can be generated is 
ideal. Poly-L-lactic acid was selected as it is a hydrophobic polymer that can be electrospun and 
is FDA-approved for implantation studies (Jung et al, 2005). 
3.2 Methods 
3.2.1 Electrospinning of aligned PLLA nanofibre scaffolds 
This was achieved as described previously (Chapter 2)  
3.2.2 Dissociation and maintenance of primary cortical neurons 
This was performed as described previously (Chapter 2) 
3.2.3 Adherence time course assays 
The iCelligence E-Plate L8s were loaded with NbActiv1 medium and a background cellular 
impedance reading was taken for medium alone at 37°C in a humidified incubator. Primary 
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cortical neurons were isolated and dissociated as previously described (Chapter 2) and seeded 
to iCelligence E-plate L8s at a density of 25,000 cells/cm2. Electrical impedance was measured 
every minute for 4 hours and the values for 4 replicates were averaged. Non-linear regression 
was used to determine the time of plateau, half-time and rate constant (K).  
 
3.2.4 Optimising electrospinning parameters 
Aligned PLLA nanofibres were electrospun with a custom electrospinning rig as described 
previously (Chapter 2). Chapter 2 describes the optimised protocol common to all experiments. 
Initially, aligned PLLA nanofibres were electrospun using the following parameters; 25kV 
electrical voltage, 15cm needle tip to collector distance and 1ml/hr flow rate. These 
parameters were established by troubleshooting using the protocol of Leach et al (2011). 
Optimisation was performed through modulation of the polymer concentration whilst these 
parameters remained constant. Several polymer concentrations were tested to optimise the 
alignment while retaining the low diameter. PLLA was dissolved overnight at 50°C to a 
concentration of 26, 28, 30, and 32% w/w in HFIP. These were spun using the existing 
parameters, sputter coated with 5nm of gold using a sputter coater and visualised using a Jeol 
scanning electron microscope (JSM-7100F). Nanofibre diameter was measured using ImageJ. 
Ten nanofibre diameters were measured per field of vision, with 3 fields of vision used per 
independent replicate.  
 
Hydrophobicity was measured using a Kruss Drop Shape Analyzer 10 MK2. A 5 µL droplet was 
placed on the nanofibre membrane and the contact angle between the droplet and the surface 
was measured using a polynomial fit. Each replicate used 3 nanofibre membrane and 3 
independent electrospins were used to generate membranes for the 3 independent replicates.     
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3.2.5 Primary optimisation – medium changes and suspension 
culture 
A multifactorial experimental design was used in the design of the optimisation experiments. 
Primary cortical neurons were seeded to nanofibres and exposed to 1 of four conditions: 
“Normal medium change/non-suspended”, “normal medium change/suspended”, “alternate 
day medium change/non-suspended” or “alternate day medium change/suspended”. Neurons 
within the suspended conditions were elevated from the base of the well using custom PDMS 
rings; the aligned nanofibre membrane extended across the negative space of the ring, 
ensuring that the medium could access the basal aspect of the nanofibre membrane. Neurons 
of the non-suspended conditions were seeded to nanofibre membranes that rested on the 
basal surface of the well. Neurons within “normal medium change” subcategory had 50% 
medium changes performed based on the recommended procedure of Brainbits LLC (Brainbits 
LLC, 2017), once every 4 days. Neurons within the “alternate day medium change” conditions 
had 50% medium changes performed every other day.  
After 11 days in vitro (DIV), neurons were fixed, permeabilised, incubated with primary and 
secondary antibody and nuclear stained with DAPI, as described in Chapter 2. The primary 
antibody for immunostaining was anti-βIII-tubulin (1:100) and the secondary was FITC-labelled 
anti-mouse IgG (1:50). Samples were visualised using a Leica SP5 fluorescence microscope. 
Neuronal morphology (cell cluster diameter, neurite length, neurite bundle diameter and 
dispersion) was then quantified using ImageJ. Cell cluster diameter, neurite length and neurite 
bundle diameter were measured using basic functionalities within ImageJ; the distances of 10 
clusters/neurites/neurite bundles was measured for 3 fields of vision per replicate, with 3 
replicates employed. Dispersion is a measure of neurite alignment; decreasing dispersion 
indicates increasing neurite alignment. Dispersion was measured using the Directionality 
plugin on ImageJ. To quantify dispersion, whole fields of vision were analysed for their 
dispersion, 3 fields of vision were used per replicate with 3 replicates employed. 
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Statistical analysis was performed using Graphpad Prism 7 and IBM SPSS Statistics software 24. 
Initially, one-way ANOVA and Tukey’s post hoc test were used in Graphpad Prism to determine 
if any condition significantly enhanced neuronal morphologies. Multifactorial ANOVA was 
utilised in SPSS to investigate the interaction between factors. If interactions between factors 
were confirmed to be significant (p = <0.05), interaction plots were generated within the 
software to visualise the interactions. 
3.2.6 Secondary optimisation – controlled seeding 
Secondary optimisation focused on optimising the seeding procedures. Seeding thus far had 
entailed applying the cells as a droplet on to the hydrophobic surface, allowing adhesion for 
60 minutes. The size of droplet was determined by the cell count after dissociation. For this 
optimisation, cells were seeded in this manner for the control. The experimental conditions 
utilised droplets of controlled sizes. For the experimental conditions, after a cell count was 
performed, cells were centrifuged again and resuspended in either 3µL or 30µL, ensuring that 
the number of cells seeded to the surface was 25,000 cells/cm2.  
Cell culture, preparation for immunofluorescence visualisation and visualisation was 
performed in an identical manner to that employed for the primary optimisation. As only one 
factor was optimised in this optimisation, one way ANOVA and Tukey’s post hoc test were 
employed for statistical analysis.   
3.3 Results 
3.3.1 Establishing a control cell culture condition 
Primary neuronal culture using Brainbits protocol yielded poor results initially. Cells attached 
poorly, failed to survive longer than 24 hours and a negligible percentage extended neurites 
(figure 3.1A). After optimisation of the density of the cell culture (data not shown), cells 
adhered properly, a greater percentage were extending neurites after 24 hours and less visible 
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debris were present (figure 3.1B). After 13 DIV, cells exhibited random networked 
morphologies. Little alignment of neurites can be observed and cells have a stellate 
morphology (figure 3.1C). Staining for a neuron-specific marker (βIII-tubulin) confirmed that 
the cultured cells were neuronal (figure 3.1D) although some cultures exhibited a negligible 
percentage of cells that were non-neuronal (data not shown).    
 
 
 
 
 
 
 
 
 
 
Figure 3.1: E18 primary cortical neurons from Sprague-Dawley rats. Scale bar = 50µm (A) Cortical neurons 24 hours 
after seeding using Brainbits protocol. Apoptotic cell bodies can be seen to make up the majority of the culture with 
relatively few cells extending neurites. The quantity of cellular debris is also notable. (B) Cortical neurons 24 hours 
after seeding using an optimised protocol. A higher proportion of cells are extending neurites and clusters of cell 
bodies can be observed (C) 13 DIV of culture of primary cortical neurons using the updated protocol. Network 
formation, neurite fasciculation and cell clustering are all present. (D) Cells stained for a neuron specific antigen 
(βIII-tubulin), demonstrating that cells were predominantly neuronal 
A B 
C 
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3.3.2 Electrospinning PLLA nanofibres with the desired material 
properties 
The electrospinning protocol was optimised in order to maximise the alignment of the 
nanofibres. Only one parameter, the polymer concentration, was altered in order to do so. 
Increasing the polymer concentration from 28% to 30% was observed to significantly increase 
the alignment (figure 3.2A) without significantly affecting the diameter of the nanofibres 
(figure 3.2B). Aligned PLLA nanofibre membrane exhibited a high degree of hydrophobicity; 
131±4° (figure 3.2C).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Optimisation of electrospinning PLLA nanofibres. (A) Alignment of nanofibres; decreasing dispersion 
indicates increasing alignment. 30% PLLA (w/w) in HFIP had the greatest alignment. Significant difference was 
detected by one-way ANOVA (F = 6.046, p = 0.0022). Tukey’s post hoc test was applied; significant difference was 
observed between 26% and 30% (q = 5.595,p = 0.0021) and 28% and 30% (q = 4.043, p = 0.0355) (B) Nanofibre 
diameter. Significant difference was detected by one-way ANOVA (F = 76.69, p = <0.0001). Tukey’s post hoc test 
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was applied; significant difference was observed between 32% and all other conditions (p = <0.0001 for all, q = 16.7, 
17.68 and 18.05 for 26%, 28% and 30% respectively) (C) Aligned PLLA nanofibres electrospun at 30% w/w in HFIP 
demonstrating hydrophobicity and a high contact angle (D) PLLA nanofibres demonstrated a high degree of 
hydrophobicity (131° ± 1.35) that was significantly elevated relative to the control, a PLLA film (89.42° ± 2.61) 
(unpaired t-test; t = 15.98, df = 16, p = <0.0001) 
3.3.4 Adherence assays 
Cells were found to maximally adhere to the surface at 72 minutes whilst the half time of the 
adherence was 9.94 minutes (figure 3.3). As a result, to ensure that neurons attached to the 
nanofibres, they were seeded as a single droplet to the membrane, allowed to attach for 60 
minutes prior to the addition of the medium required to fill the well.  
 
 
 
 
 
Figure 3.3: Adherence behaviours of E18 Sprague Dawley primary cortical neurons using the iCelligence. N = 4. (A) 
Cell attachment was quantified using electrical impedance; one phase association to the surface was observed (B) 
Non-linear regression was performed in Graphpad Prism using the equation for one phase association.  
3.3.5 Initial optimisation 
Initial optimisation used a multi-factorial optimisation experiment which focused on two 
factors; the frequency of medium changes (“normal medium change” and “alternate medium 
change”) and suspension cultures. Only one of the initial conditions demonstrated properties 
that were suitable for further experiments – non-suspended nanofibres with alternate medium 
changes. Whilst each of the conditions tested had cells that stained for DAPI and βIII-tubulin 
and were quantified for their cell cluster diameter, single cells were typically observed (figure 
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3.4A). These cells did not extend neurites (figure 3.4B) and thus did not fasciculate (figure 3.4C). 
One-way ANOVA and subsequent Tukey’s post hoc test demonstrated that non-suspended 
neurons that received a medium change on alternate days significantly outperformed all 
conditions on every quantified assessment (one-way ANOVA; cell clustering - F = 74.53, p = 
<0.0001 , neurite length - F = 100.4, p = <0.0001, neurite diameter - F = 271.2, p = <0.0001, 
neurite alignment - F = 2514305, p = <0.0001).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Initial multi-factorial optimisation of 3D cell cluster formation. Of the 4 tested conditions, only non-
suspended cultures with alternate medium changes allowed for long-term survival, clustering and neurite 
growth/fasciculation. Susp = suspended nanofibre membranes, Non-Susp = non-suspended nanofibre membranes, 
NMC = normal medium change, AMC = alternate day medium change. N = 3.(A) Diameter of the 3D cell clusters 
grown in the separate conditions. Cells clustered significantly more on the non-suspended, alternate medium day 
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medium change condition (one-way ANOVA; F = 74.53, p = <0.0001)  (B) Neurite length. Non-susp/AMC resulted in 
significantly greater neurite outgrowth (one-way ANOVA; F = 100.4, p = <0.0001) (C) Neurite bundle diameter. 
Neurites were significantly more fasciculated in the non-susp/AMC condition (one-way ANOVA; F = 271.2, p = 
<0.0001) (D) Neurite alignment. (one-way ANOVA; F = 2514305, p = <0.0001). Statistical analysis was performed by 
one-way ANOVA and Tukey’s post hoc test.  
 
Alternate day medium changes for neurons grown on non-suspended nanofibre membranes 
was the optimal condition of those tested. Due to the multifactorial design, the ability of 
factors to influence each other was investigated using a multifactor ANOVA. A significant 
interaction was detected between medium change frequency and suspension of the nanofibre 
membranes for cell cluster diameter, neurite length and neurite bundle diameter (figure 3.5A-
C). Whilst culture of primary cultured neurons on the uncoated aligned PLLA nanofibres 
appeared to kill the cultured neurons, this could be ameliorated by two out of the four 
conditions. The condition with “normal medium changes” in non-suspended culture exhibited 
greater clustering than the suspended cultures  but the comparative culture with alternate day 
medium changes exhibited greater clustering (figure 3.4A). Whilst the alternate day medium 
change was beneficial enough to the culture to allow some clustering in the suspension culture, 
it was not sufficient to allow the cells to survive, blunting the cell clustering and inhibiting the 
neurite extension (figure 3.4A, 3.4B and 3.4C). 
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Figure 3.5: Multifactorial ANOVA of the data generated in the primary optimisation. N = 3 (A) Whilst medium 
changes on alternate days significantly increase clustering, this effect is enhanced by conventional culture/reduced 
by suspension culture (p = <0.0001) (B) Neurite extension shows an interaction between factors; only the 
combination of alternate medium changes and conventional culture is capable of inducing neurite outgrowth from 
neurons cultured on uncoated PLLA nanofibres (p =  <0.001) (C) Neurite bundle diameter shows an interaction 
between factors; only the combination of alternate medium changes and conventional culture is capable of inducing 
fasciculation of neurites from neurons grown on the uncoated PLLA nanofibres (p =  <0.001) (D) Primary cortical 
neurons at 11 DIV, cultured on aligned PLLA nanofibres in the non-suspended, alternate day medium change 
condition.   
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Figure 3.6: Secondary optimisation of cell cluster formation. Cells were delivered in either 3 or 30µL of medium and 
allowed to attach for 1 hour whilst the control (Non-susp/AMC) were delivered in a randomly sized droplet 
dependent on the cell count. Statistical testing was performed using one-way ANOVA and Tukey’s post hoc test. 
Delivery of cells in a controlled 30µL droplet resulted in greater cell cluster size, neurite length and neurite bundle 
diameter. No significant change in alignment of neurites was observed. N = 3 (A) Diameter of the 3D cell clusters in 
the 3 optimisation conditions (B) Neurite length in the 3 optimisation conditions (C) Neurite bundle diameter in the 
3 optimisation conditions (D) Neurite alignment in the 3 optimisation conditions  
The seeding process was also identified as a part of the process that could be optimised. Cells 
were initially delivered as a droplet that was between 15-25µL depending on the cell count 
that was attained upon dissociation of the tissue. A single droplet was placed on the nanofibre 
membrane, allowed to attach for 60 minutes before addition of the remaining media to the 
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well. Through changing the volume of the droplet, the size of the area that cells could adhere 
to would also be altered. Cells were delivered in either a 3 or 30µL drop and compared to the 
control; the previously identified optimal condition. Cells delivered in controlled volumes of 
medium (3 and 30µL) both displayed a significant increase in clustering (one way ANOVA; F = 
7.072, p = 0.0018. Tukey’s multiple comparison; q = 3.832 and 5.054 for 3 and 30 µl respectively, 
p = 0.0237 and 0.002 respectively) with an approximately 2-fold increase in clustering for the 
3 µL droplet and a 2.4-fold increase for the 30 µL drop delivery. However, whilst both 
conditions increased the cell cluster diameter, decreasing the size of the droplet had a 
significantly negatively effect on the neurite length, neurite bundle diameter and the 
alignment (positively affected the dispersion) of the neurons (figure 3.6B, 3.6C and 3.6D). 
 
 
 
 
 
 
 
Figure 3.7: Representative images used for quantification of neuronal morphologies for primary cortical neurons 
grown on aligned PLLA nanofibres under different conditions at 11 DIV (A) Primary cortical neurons grown in 
suspension conditions with alternate day medium changes. Some clustering is observed but neurites are absent 
within the culture (B) Neurons grown in a non-suspension culture, seeded within a 3µL droplet. Clustering is 
observed with extensive neurite outgrowth but relative to the 30µL seeding conditions, clustering is limited (C) 
Neurons grown under the ideal condition: non-suspension cultures with alternate day medium changes and 
seeded within a 30µL droplet 
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3.4 Discussion 
3.4.1 Optimisation of the generation of cellular architectures 
Once cell culture conditions that allowed survival of neurons on a 2D surface had been 
established, culture work transitioned to the 3D aligned PLLA nanofibres. Initial optimisation 
for generating clustered cellular architectures investigated the influence of factors known to 
inhibit/aid the growth of neurons in three dimensions. The need for an external homeostatic 
mechanism is a common problem in the generation of 3D cellular architectures, whether this 
is for maintenance of oxygen and nutrients or the removal of waste (McMurtrey, 2016). In this 
experiment, regulation of these diffusible molecules was performed through manual means 
via medium changes, maximising the concentration gradient of nutrients diffusing into the 
aggregates while maximising the gradient of waste diffusing out. Primary cortical neurons 
typically undergo a 50% medium change every 3-4 days whereas alternate day medium 
changes were performed during the optimisation. In the absence of alternate day medium 
changes, neurons failed to cluster or extend neurites and had poor viability (figure 3.4). This 
contrasts with the 2D control; cells were cultured for up to 13 DIV with half media changes 
every 4 days and remained healthy (figure 3.1). Due to the ability to mitigate the cell death 
with medium changes, it is likely that the nanofibres produce a diffusible factor in to the 
medium that accumulates and induces cell death. PLLA degrades to lactic acid (Garlotta, 2002) 
and neurons are sensitive to lactic acid accumulation (Goldman et al, 1989; Nedergaard et al, 
1991). Whilst the degradation of the nanofibres to an acidic by-product is hypothesised to be 
the cause of cell death, experiments to elucidate the mechanism of cell death were not 
performed as the aim was to find only the optimal conditions for aggregation and aligned 
neurite outgrowth. Suspension cultures are often used to generate and maintain neuronal 
aggregates to promote basolateral access of the aggregates to nutrients/waste disposal (Paşca 
et al, 2015; Knoblich and Lancaster, 2015; Kadoshima et al, 2013). These cultures are not true 
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suspension cultures, they utilise spinning bioreactors or ultra-low adherence plates to limit the 
contact of the cell with the substrate. Maximisation of basolateral access of nutrients is key to 
the generation of neuronal aggregates. Thus, one of the optimised conditions was the 
suspension of the nanofibre membranes within the well whilst the other was conventional 
(membrane resting against the base of the well). However, suspension had a negative effect 
on the cells with suspension cultures demonstrating poor viability and minimal clustering even 
in the presence of medium changes on alternate days (figure 3.4A-D). This may occur due to 
the acidification of the medium due to the degradation of PLLA. By suspending the nanofibres 
across a space, the porosity of the nanofibres allows greater access of the neurons to the 
medium through the basal membrane. The increased exposure to the medium may facilitate a 
greater exposure to and thus, uptake of lactic acid. Alternately, the suspension of the 
nanofibres exposes more surface area of the fibres to the medium, accelerating the 
degradation and subsequent acidification, exposing the neurons to harsher conditions, 
resulting in their reduced viability. Further elucidation was not performed due to time 
constraints. 
 
Subsequent optimisation was performed in order to enhance the growth of the desired cellular 
architectures. Cells were initially seeded at a known density in volumes determined by the cell 
count after dissociation of the tissue. It was theorised that by reducing the size of the droplet 
used to seed to the nanofibres, the seeded neurons would adhere within a smaller area and 
thus, due to the close proximity of cells, aggregation would be enhanced. Additionally, 
controlled seeding and the ability to localise where a cell cluster formed was desirable for the 
later developmental stages of the implant to facilitate re-wiring. At the current stage, 
aggregates form on a nanofibre membrane of large surface area that cannot be implanted. 
This structure would need to be refined to make a deliverable structure and control over the 
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aggregation aids in facilitating that. Controlling the volume that neurons were seeded into 
significantly increased the size of the cell clusters produced, both increasing the droplet size 
(30µL) and decreasing the droplet size (3µL) (p = 0.0237 and 0.002 respectively). However, 
despite the ability of the smaller droplet (3µL) to increase cell cluster size relative to the control 
(p = 0.0237), the neurite length, diameter and alignment were all significantly reduced by 
seeding in a smaller, controlled volume (figure 3.6B, 3.6C and 3.6D; p = 0.0007, 0.003 and 
0.0027 respectively). The increase in cell cluster size is likely to be due to restricting the area 
of adherence caused by the reduction in droplet size. The decrease in neurite length, diameter 
and alignment may be due to the density of the cells at the point of seeding. To seed cells at 
25,000 cells/cm2 on the surface, cells seeded in a 3 µL droplet have a density of 16 million 
cells/mL whilst those seeded within a 30 µL droplet have a seeding density of 1.6 million 
cells/mL. Harris et al (2016) achieved better neural network topologies at low plating densities 
and observed “acute neuronal survival and neurite outgrowth” at 3.6-7.2 million cells/mL. 
Whilst it is not directly stated, the implication is that above 7.2 million cells/mL resulted in poor 
survival and neurite outgrowth, which was observed in the current study when plating neurons 
on the nanofibres in a 3 µL droplet (16 million cells/mL). In contrast, no significant change was 
induced by seeding the cells in a larger droplet (30µL).   
 
3.4.2 Future directions 
A method of generating the desired architecture was established but further improvements 
can be made. Whilst alternative day medium changes had positive effects on the aggregation 
and viability of the neuronal culture, a potential alternative to alternate medium changes that 
could be employed in future experiments would be to utilise a microfluidic systems (Kelava et 
al, 2016). Microfluidic systems would take on the role of in vitro vasculature and ensure a 
dynamic removal of waste products/supply of fresh nutrients/gases, potentially enhancing the 
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formation further or to provide targeted spatiotemporal cues to the aggregate to manipulate 
cellular behaviours (Millet and Gillette, 2012). Additionally, a mixed culture could be produced 
by using a chamber filled with glial cells that is upstream of the neurons, allowing for the supply 
of soluble neurotrophic factors to the developing neurons (Gao et al, 2016).  
 
Currently, neurons aggregate on the surface at a random location, although typically the 
cellular structures were relatively centralised on the nanofibre membrane. In order to facilitate 
the assembly of an implant for rewiring, a greater degree of control is needed over where the 
aggregates form. The prepared nanofibre membranes form a large elliptical structure, which 
is not suited to being drawn up into a needle and injected along a damaged axonal pathway to 
facilitate rewiring. The current membrane would have to be cut in to a linear format before or 
after seeding of the neurons. Preliminary data suggest that laser ablation of acellular nanofibre 
membranes into a linear format significantly influences the hydrophobicity of the surface and 
thus, may limit the aggregation behaviours of the cell (figure 3.8C). Whilst the reduction in 
hydrophobicity is limited, it is significant. This may not be a great enough reduction in 
hydrophobicity to influence the aggregation behaviours but it is possible that cells may need 
to be delivered on to the membrane as an aggregate or the membrane should be cut, post self-
assembly. Cutting the membrane post-assembly would require accurate knowledge of where 
the neuronal clusters form to avoid damage to the cellular structures, thus, greater control 
over location of aggregate formation is needed.   However, the alterations to hydrophobicity 
induced by laser ablation may be beneficial in another context. Anchor points, highly adhesive 
regions on an otherwise poorly adhesive surface, have been used to provide neurons with a 
location on a surface to adhere to and act as “hot spots” for the formation of clusters (Limongi 
et al, 2015; Gabay et al, 2005). Anchor points can be produced using nanotopography, changing 
the surface wettability or chemical modification (Gabay et al, 2005). By introducing these 
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elements on to the surface, migration of cells can be controlled; limited in “hot spots” and 
promoted everywhere else, inducing the formation of aggregates in a controlled manner. Laser 
treatment of the nanofibres could be used to generate these hot spots and facilitate controlled 
aggregation in a desired location. Conversely, due to the abilities of bioactive extracellular 
matrix (ECM) proteins such as laminin to induce adhesion, inhibit anoikis, stimulate neurite 
outgrowth and its hydrophilic properties (Yamada and Sekiguchi, 2015), laminin would make 
an appealing treatment to create these hotspots. 
 
An alternative to allowing cells to self-assemble on the surface of the nanofibres, either in a 
specified location or by limiting the place they can form, would be to place pre-assembled 
neuronal clusters onto the surface and allowing them to extend neurites from the clusters. The 
model of Harris et al (2016) utilises pre-assembled cell clusters that are placed onto the surface 
of the implant. Previously discussed was the use of molds and the negative impact that could 
have on cellular biology. However, alternate methods exist for the mechanical assembly of 
cellular structures in the absence of molds. Studies have employed holographic optical 
tweezers that allowed cells to be assembled in to complex 3D architectures without manual 
handling (Kirkham et al, 2015). Additionally, hanging drop culture has demonstrated the ability 
to induce aggregation of cells at the base of the droplet upon inversion of the culture surface 
and subsequent culture (Fennema et al, 2013). This method could be used to induce 
aggregation into small, cellular clusters. These could then be pipetted on to the aligned 
nanofibre surface and allowed to grow along the surface. 
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3.5 Summary 
A method for generating clustered neuronal cell bodies extending aligned neurites has been 
described in this chapter. These clustered cell bodies grow along an engineered biomaterial 
structure that may be used for rewiring and repair within the CNS. Further characterisation of 
the cellular effect of clustering and culture on the 3D surface is required before consideration 
of its insertion into the brain. Optimisation was relatively limited due to time constraints but 
many avenues exist for developing the neuronal aggregation in to 3D architectures using 
hydrophobic aligned nanofibres further. 
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Chapter 4: Characterisation of the organoid 
4.1 Introduction 
In Chapter 3, a method of generating the characteristic clustered cell bodies and aligned 
neurites of the cerebral cortex was developed. However, characterisation was required to 
determine any functional changes in the cells that occurred as a result of the aggregation and 
the cell culture process. Characterisation was also employed to determine the mechanism that 
induces the formation of the organoids which could facilitate future work to manipulate 
parameters of the cell culture to generate desirable cellular behaviours. 
 
In vivo, cells are arranged in three dimensional matrices with cell-cell and cell-extra cellular 
matrix (ECM) interactions and complex transport dynamics into, out of and throughout the cell 
(Antoni et al, 2015). In conventional cell culture, cells do not grow in three dimensions; they 
are homogenously distributed across a surface and, with the exception of suspension cells, 
attached using charged molecules or bioactive ligands (Ryan et al, 2008). This divergence 
between cells in vivo and in vitro leads to altered cellular properties (table 4.1). 
 
 
 
 
 
 
 
 
69 
 
Advantages Limitations 
Physiological cell phenotype Scaffolds will not be perfectly reproducible, 
introducing variability  
Physiological cell genotype Extracting cells for molecular 
characterisation becomes more complicated 
Increased viability Scaling experiments up 
Enhanced differentiation Imaging 3D cultures can be difficult 
depending on the scaffold transparency, 
autofluorescence, and depth  
Physiological response to stimuli  Integration of 3D cell culture into high-
throughput techniques  
Increased cell-cell communication Control of cell culture conditions such as pH 
and temperature 
Cell polarisation   
2D cultures demonstrated decreased 
sensitivity to apoptotic signals 
 
More physiological drug susceptibilities  
 
Table 4.1: Advantages and limitations of three dimensional cell culture relative to conventional 
two dimensional cell culture. Adapted from Antoni et al, 2015 and Ravi et al, 2014. 
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Additionally, cell aggregation results in heterogeneous distribution of cells, which in turn 
results in changes to cell density. The electrophysiological activity of neurons can be altered 
by different densities of cells (Biffi et al, 2013). Electrical activity in turn can also influence the 
expression of genes. Numerous transcription factors are directly activated by Ca2+ but calcium 
driven intracellular signalling cascades can result in post-translational modification and 
activation/inactivation of transcription factors or transcriptional co-regulators as well (West 
and Greenberg, 2011). Calcium influx as a result of depolarisation can induce alterations to the 
morphology and cellular behaviours such as altered axon pathfinding, neurite outgrowth, 
migration, synapse maturation and neurotransmitter phenotype (West and Greenberg, 2011).  
 
Organoids are cellular structures that more accurately recapitulate the tissue of origin than 
conventional cultures and are extensively used in the pharmaceutical industry although 
typically, they take a much longer period of time to assemble than the 3D structures presented 
in Chapter 3 (Lancaster and Knoblich, 2016). Organoids are defined as 3D cellular clusters that 
are derived from primary tissues or induced pluripotent/embryonic stem cells that 
demonstrate self-renewal and self-assembly and exhibit similar functionality to the tissue of 
origin (Fatehullah et al, 2016). For neuronal cultures, due to the post-mitotic nature of mature 
neurons, self-renewing organoids would require a mixed culture including multipotent neural 
stem cells. However, within the adult brain, neurogenesis is limited to the olfactory bulb, 
rostral migratory stream, the subventricular zone and the subgranular zone (Yamagishi et al, 
2015); thus, a self-renewing organoid would not accurately recapitulate the cerebral cortex. 
Thus in order to recapitulate cerebral cortical organoids, the cellular structures must self-
assemble in such as a way as to mimic the architecture of the cerebral cortex and they should 
also demonstrate electrophysiological activity and responsiveness to appropriate 
neurotransmitters. Due to the nature of the 3D cellular structures that are generated using the 
previously defined methodology (Chapter 3), further work will also focus on the potential to 
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use aligned PLLA nanofibres for the generation of organoids for high-throughput 
pharmaceutical purposes.  
In summary, alterations to the conditions of cell culture can significantly affect cellular 
behaviours. Whilst the desired cellular architectures have been generated from the work 
present in Chapter 3, other cellular behaviours remained an unknown. The aim of this chapter 
was to quantify the characteristics of the culture during organoid formation, to form 
hypotheses for the molecular mechanism involved and to determine if these cellular clusters 
can be considered to be “organoids”. 
4.2 Methods 
4.2.1 Quantification of morphological features and sub-cellular 
populations within the organoid cultures 
Aligned PLLA nanofibres were fabricated as described in Chapter 2. Primary cortical neurons 
were dissociated and maintained as described in Chapter 2. Neurons were seeded to aligned 
PLLA nanofibres or to PDL and laminin coated tissue culture plastic, prepared as described in 
Chapter 2. Neurons were cultured for 11 days and on 1, 3, 7 and 11 days in vitro (DIV), cells 
were prepared for immunofluorescence staining as described in Chapter 2. The primary 
antibody used was anti-βIII-tubulin (1:100). Imaging was performed using a Leica SP5 
fluorescence microscope. 
 
Quantification was performed using ImageJ. Quantification was identical for each of the time 
points. Neurite length was quantified by measuring the length of 10 neurites in each field of 
vision, with 3 fields of vision used for each of 3 replicates. The same method of quantification 
was used for neurite bundle diameter and cell cluster diameter. At later time points, fewer cell 
cluster diameter measurements were performed as fewer cell clusters could be visualised per 
field of vision. Non-neuronal cells were defined as cells that stained for DAPI, indicating nuclear 
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DNA, in the absence of staining for βIII-tubulin. These cells were counted manually. Dispersion 
was measured using the Directionality plugin for ImageJ. A region of interest that was 100 x 
100 microns (L x W) was placed within the neurite arbor of the forming organoid and quantified. 
Three measurements were performed for each field of vision and 3 fields of vision were used 
for each of 3 replicates. For each time point, the average value was used for each quantitative 
measure. Normalisation was performed to the value of the first measurement for each 
measure.  
Correlation analysis was performed using Graphpad Prism. Data for each of the time points 
were used individually before repeating with the pooled data. Heatmaps and scatterplots were 
generated using the Graphpad Prism or Morpheus Heatmap software.  
Sholl analysis was employed to investigate differences in neurite morphologies. Images of 
primary cortical neurons cultured on both the control and aligned PLLA nanofibres for 11 days 
were converted into 8-bit and thresholded to produce black and white images for Sholl analysis. 
Using the neurite tracer plugin of ImageJ, the arbors were drawn. The Sholl analysis plugin for 
ImageJ was employed for quantification with a step size of 0.01µm. The arbors of 3 neuronal 
clusters were employed for 3 independent replicates, results were pooled and quadratic non-
linear regression was performed using Graphpad Prism 7.  
4.2.2 Cell viability assay 
A lactate dehydrogenase (LDH) assay was performed to determine the cell viability of the 
organoid over time. The LDH assay was performed according to manufacturer’s protocols 
(Thermofisher Scientific). Briefly, neurons were dissociated, seeded and cultured as described 
previously for 28 days. On 1, 7, 14, 21 and 28 DIV, 50µL of supernatant were removed from the 
cultures and frozen at -80°C until usage. For use in assays, samples were thawed at room 
temperature and transferred to a 96 well plate. To each 50µL aliquot of supernatant, 50µL of 
LDH reaction mix were added. The solution was then incubated for 30 minutes at room 
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temperature before addition of 50µL of LDH stop solution was added. Absorbance was 
measured in a BMG Labtech Clariostar plate reader at 680nm. Blanks were subtracted and 
values were normalised to the control; the amount of LDH activity that was detected at 0 DIV. 
4.2.3 Plasma treatment of aligned PLLA nanofibres 
Aligned PLLA nanofibres were prepared as described previously. To plasma treat nanofibres, a 
Tegal Plasmaline 415 Asher was used. Nanofibres were exposed to argon/oxygen plasma at 
200W for 5 minutes at 200 mTorr pressure.  
The wettability of the nanofibre membranes was measured using a Kruss Drop Shape Analyser 
10 MK2. Deionised water (5 µL) was applied onto untreated and plasma treated nanofibre 
membranes and the contact angle between the liquid and surface was measured using a 
polynomial fit. For each determination of contact angles, 3 measurements were performed per 
membrane and 3 independent electrospins were used to generate each of the replicates for 
the membranes. 
Neurons were cultured on the plasma treated nanofibres as described previously for untreated 
nanofibres. Cells were fixed for immunostaining with anti-βIII-tubulin (1:100) as described 
previously (Chapter 2). Neurite length, neurite bundle diameter, neurite dispersion and cell 
cluster diameter quantification was performed as described in the section “Section 4.2.1: 
Quantification of morphological features and sub-cellular populations within the organoid 
cultures”. 
4.2.4 Quantifying electrical activity from the organoid 
To determine whether the cortical neurons of the organoid were responsive to 
pharmacologically relevant compounds, a voltage sensitive dye was used. Primary cortical 
neurons were dissociated and cultured for 14 days as described previously. At 14 DIV, the 
supernatant was removed from the organoids, which were then washed with Hank’s buffered 
saline solution (HBSS) twice. Fluovolt loading solution was added to the cells which were then 
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incubated at 37°C for 30 minutes. The Fluovolt loading solution was then removed and cells 
were washed twice in HBSS. Fluovolt-loaded cells were maintained in HBSS with a 1:10 dilution 
of Neuro Backdrop Background Suppressor. During fluorescence quantification, cells were 
maintained in 5% CO2 at 37°C. Fluorescence intensity readings were taken at 488nm.  
 
For recordings of elicited activity of neurons, fluorescence readings were performed using a 
BMG Labtech Clariostar plate reader to a temporal resolution of 1 value every 60 milliseconds. 
Drugs were administered automatically by the plate reader, AMPA was administered to a final 
concentration of 10µM whilst GABA was administered to a final concentration of 25µM. 
Fluorescence was normalised using equation 1. 
𝛥𝐹
𝐹
=  
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒
𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝑎𝑡 𝑡𝑖𝑚𝑒 𝑝𝑜𝑖𝑛𝑡 0
 
Equation 1: Normalisation of global fluorescence intensity 
For recordings of spontaneous activity from neurons, fluorescence readings were performed 
using a Leica SP5 confocal microscope to a temporal resolution of one value per 12 milliseconds. 
Recordings were taken for 60 seconds and normalised using equation 2.  
𝛥𝐹
𝐹
=  
(𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 − 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦)
𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 𝐹𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦
 
Equation 2: Normalisation of fluorescence intensity using the Leica SP5 confocal microscope 
Spiking events were then identified within the dataset using thresholding. Briefly, the root 
mean square was calculated for the dataset and values that exceeded 4 times the root mean 
square were labelled as spiking events.  
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4.3 Results 
Primary cortical neurons were fixed and immunostained with anti-βIII-tubulin (1:100) at 1, 3, 
7 and 11 DIV (figure 4.1). Over the time period assessed, the organoid can be seen to form; 
from initial homogenous distribution to increasingly aggregated, demonstrating that the 
observed results are not due to a failure to disaggregate.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Growth of primary cortical neurons over a period of 11 days. A-C: Primary cortical neurons grown on 
nanofibres. D: Primary cortical neurons grown in 2D (A) At 1 DIV, neurons exhibit homogenous distribution across 
the nanofibre scaffold. Neurites can be observed from a negligible percentage of neurons and some non-neuronal 
cells (DAPI stained, non-βIII tubulin stained) have been detected. Scale bar = 50µm (B) At 5 DIV, neuron clustering 
can be observed although neurite extension is still somewhat random with neurons extending towards other 
clusters rather than with any alignment Scale bar = 50µm (C) By 11 DIV, cell clusters are fully formed and extending 
highly aligned, fasciculated neurites. Scale bar = 100µm (D) Primary cortical neurons grown on conventional 2D 
A B 
D C 
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tissue culture plastic. Neurites extend at random over relatively short distances. Minimal clustering can be observed. 
Scale bar = 50µm 
Initial morphological analysis of the neuronal cultures demonstrated that neurons cultured on 
the nanofibres were significantly more clustered (figure 4.2A) and extended longer (figure 
4.2A), thicker (figure 4.2B) and less branched neurites (figure 4.2C).   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2: Quantification of morphological features of neurons at 11 DIV for the control and nanofibre surfaces (A) 
Neurites and cell clusters are significantly shorter and less smaller respectively in the 2D culture conditions 
(unpaired t-test: p = <0.0001, t(6) = 7.178) (B) Neurites are significantly less fasciculated within the 2D cultures 
(unpaired t-test: p = 0.0014, t(148) = 3.266) (C) Sholl analysis of neurites indicates that neurites cultured on 
nanofibres are less branched and extend over further distances. Black  - control, red = primary cortical neurons 
cultured on aligned PLLA nanofibres 
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Subsequent quantitative analysis of the neuronal cultures on nanofibres was then performed 
at each of the described time points (1, 3, 7 and 11 DIV) using ImageJ. Neurite length, neurite 
bundle diameter, cell cluster diameter and the percentage of non-neuronal cells were all 
quantified. Neurite length and neurite bundle diameter exhibited linear growth for the initial 
7 days before exhibiting an exponential increase (figure 4.3A and 4.3B). Cell cluster diameter 
exhibited a more gradual increase but still appeared to be in the early lag phase of an 
exponential curve (figure 4.3C). In contrast, the percentage of the culture identified as non-
neuronal cells decreased early on and then progressively increased, achieving levels that were 
observed at the beginning of the culture by 11 DIV (figure 4.3D). Normalisation of the data 
against the values for 1 DIV demonstrates that relative to the control, neurite length exhibited 
the greatest increase, closely followed by the cell cluster diameter (figure 4.4A). The viability 
of the culture remained stable through this time period with a significant increase in LDH only 
appearing at 14 DIV, although this remained consistent until 28 DIV (figure 4.4B).  
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Figure 4.3: Time course for absolute changes to morphology and sub-cellular populations for primary cortical 
neurons grown on aligned PLLA nanofibres (A) Neurite length (B) Neurite diameter (C) Cell cluster diameter (D) 
Percentage of the total cell count that were non-neuronal  
 
 
 
 
 
 
 
Figure 4.4: Time course for normalised changes to primary cortical neurons grown on aligned PLLA nanofibres (A) 
Analysis of cell morphology and sub-cellular populations. Data for each category were normalised to the value of 1 
DIV.  (B) Cell viability was significantly decreased relative to the control after 14 days although remained stable up 
until 28 DIV (One-way ANOVA: p = 0.0011, F(5,12) = 8.738. Dunnett’s multiple comparisons test was used for post-
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hoc testing. Control vs D1: p = 0.9999. Control vs D7: p = 0.9429. Control vs D14: p = 0.0114. Control vs D21: p = 
0.0086. Control vs D28: p = 0.0039. 
Correlation analysis was used to investigate relationships between factors at different time 
points (figure 4.5). At 1 DIV, neurite length was significantly positively correlated with every 
other factor (figure 4.5A and 4.5B). By 3 DIV, only the neurite bundle diameter and cell cluster 
diameter correlated with neurite length significantly (figure 4.5A and 4.5C. By 7 DIV, no 
significant correlations were observed (figure 4.5A and 4.5D). At 11 DIV, neurite length 
significantly correlated with neurite bundle diameter and cell cluster diameter; however, 
whilst neurite length positively correlated with neurite bundle diameter, a significant negative 
interaction was observed for neurite length and cell cluster diameter   (Figure 4.5A and 4.5E).  
The significant correlations for neurite bundle diameter were identical for neurite bundle 
diameter as they were for neurite length with the exception of 11 DIV; neurite bundle diameter 
was significantly positively correlated with cell cluster diameter whereas for neurite length, 
the relationship was negative (figure 4.5A and 4.5E) 
The cell cluster diameter was significantly negatively correlated with the percentage of the 
culture comprised of non-neuronal cells at the majority of time points (figure 4.4A, 4.4B, 4.4C, 
4.4E). The relationship between cell cluster diameter and neurite length and neurite bundle 
diameter has been described in the previous points.    
The percentage of the culture that was made up of non-neuronal cells had only significant 
negative effects on the other factors examined at all time points although this negative 
influence was mitigated at later time points (figure 4.5A-E).  
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Figure 4.5: Correlation analysis for various morphological properties of cortical neurons grown on aligned PLLA 
nanofibres at different time points (A) Heat map visualisation of R2 values for neurite length, neurite bundle 
diameter, cell cluster diameter and the percentage of cells that were non-neuronal. Red = positive correlation, blue 
= negative correlation (B) Heat map visualisation of p values for the correlation analysis. Red = significant, blue = 
non-significant, purple = borderline significant  
 
A regression analysis was performed using the data from all time points to determine whether 
factors could be used to consistently predict the values of other factors and potentially infer a 
mechanism of formation for the organoids (figure 4.6A-F). Regression analysis revealed that 
the strongest correlation was between neurite length and neurite diameter (figure 4.6D; R2 = 
0.7599), closely followed by cell cluster diameter/neurite length (figure 4.6C; R2 = 0.5301) and 
cell cluster diameter/neurite bundle diameter (figure 4.6B; R2 = 0.3171). Alignment of neurites 
(dispersion) was found to be a poor predictor of any other factor (figures 4.6A, 4.6E, 4.6F). 
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Figure 4.6: Regression analysis for morphological features of primary cortical neurons grown on aligned PLLA 
nanofibres. For all figures, significance was confirmed at p = <0.0001. (A) Cell cluster diameter and neurite dispersion 
exhibited a negative correlation; increasing cell cluster diameter correlated with decreasing dispersion (R2 = 0.1876). 
(B) Cell cluster diameter and the diameter of neurite bundles exhibited positive correlation  (R2 = 0.3171). (C) Cell 
cluster diameter and neurite length exhibited positive correlation (R2 = 0.5301). (D) Neurite bundle diameter and 
neurite length exhibited positive correlation (R2 = 0.7599). (E) Neurite dispersion and neurite bundle diameter 
exhibited negative correlation; with decreasing dispersion/increasing alignment of neurites, neurite bundle 
diameter increased (R2 = 0.1983). (F) Neurite dispersion and neurite length exhibited a negative correlation; 
decreasing dispersion/increasing alignment correlate with increasing neurite length (R2 = 0.2251).  
Plasma treatment of aligned PLLA nanofibre membranes was utilised to alter the wettability of 
the surface. Plasma treatment resulted in pitting of individual nanofibres (figure 4.7A) and a 
significant reduction in the hydrophobicity (figure 4.7B). Culture of primary cortical neurons 
on the hydrophilic plasma treated nanofibres significantly altered cellular morphologies (figure 
4.7C). Relative to the neurons grown on untreated PLLA nanofibres, neurons grown on plasma 
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treated PLLA nanofibres generated significantly smaller cell clusters with shorter, less 
fasciculated and less aligned neurites (figure 4.8A-D).  
 
 
 
 
 
 
Figure 4.7: Plasma treatment induces significant changes to nanofibre wettability and cellular behaviours. (A) 
Plasma treated PLLA nanofibres (B) Significant reduction in contact angle was observed for plasma treated PLLA (p-
PLLA) (Unpaired t-test: p = 0.0001, t(16) = 26.44) (C) Primary cortical neurons grown on plasma treated PLLA 
nanofibres; a reduction in clustering, neurite extension and neurite alignment is observed.  
 
 
 
 
 
 
 
 
Figure 4.8: Morphological changes to primary cortical neurons induced by nanofibres cultured on untreated and 
plasma-treated PLLA nanofibres. (A) Cell cluster diameter was significantly reduced by plasma treatment (Unpaired 
t-test: p = <0.0001, t(21) = 23.38) (B) Alignment of the neurites was significantly reduced by plasma treatment of 
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the nanofibres; low dispersion indicates highly aligned neurites (Unpaired t-test: p = 0.0007, t(12) = 4.56) (C) 
Diameter of the neurite bundles was significantly reduced by plasma treatment of the nanofibres (Unpaired t-test: 
p = <0.0001, t(18) = 13.37) (D) Neurites were significantly shorter on plasma treated nanofibres (Unpaired t-test: p 
= <0.0001, t(18) = 14.12) 
Stimulation of the organoid with pharmacologically relevant compounds elicited responses 
from the organoid. Using a Clariostar plate reader to measure changes in fluorescence in 
voltage-sensitive dye-loaded neurons revealed that in response to an glutamatergic agonist to 
excitatory cortical neurons (AMPA, 10µM), the membrane potential of cells increased. This 
increase in membrane potential could then be significantly reduced through administration of 
the inhibitory neuron agonist, GABA (25µM) (figure 4.9A and B).  
Spontaneous activity was detected using confocal microscopy of voltage sensitive dye loaded 
cells. Root mean square was used as a measure of noise within the system and the threshold 
for spike detection was set at 3 times the root mean square. For each of the repeats used, 
spontaneous spikes were detected from the organoids (figure 4.9C). 
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Figure 4.9: Fluovolt-loaded organoids exhibit changes in membrane potential spontaneously or when exposed to 
pharmacological ligands. Recordings were taken using a Clariostar fluorescent plate reader with a sampling rate of 
60 milliseconds (A-B) or an SP5 Leica confocal microscope (C) with a sample rate of 6 milliseconds (A) 
Pharmacologically induced changes in global fluorescence in fluovolt loaded organoids. AMPA (10µM) (1) was 
administered at 12 seconds whilst GABA (25 µM) (2) was administered at 26 seconds. An increase in membrane 
potential is observed after stimulation with an excitatory ligand (AMPA) whilst a decrease is observed after the 
addition of an inhibitory ligand (GABA) (B) Mean ΔF/F for each of the three time points; significant changes were 
induced by each of the treatments (One-way ANOVA; p = <0.0001, F(1.968,1348) = 1432. Tukey’s multiple 
comparisons test was performed as a post-hoc test. Spontaneous vs AMPA: p = <0.0001. Spontaneous vs GABA: p 
= <0.0001. AMPA vs GABA: p = <0.0001) (C) Spontaneous spiking events were observed in the organoids; spikes 
were identified as datapoints that exceed four times the value of the root mean square 
4.4 Discussion 
4.4.1 Mechanistic hypotheses for the aggregation of neurons 
Neuronal aggregation occurs on the aligned PLLA nanofibres (figure 4.1A-C). The self-assembly 
behaviour is attributed to the hydrophobicity of the nanofibres. From a physical perspective, 
adhesive forces are likely to be a factor that promotes aggregation. Hydrophilic surfaces are 
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typically used to adhere cells and generate homogenous cultures on the culture surface (Ryan, 
2008) whereas the PLLA nanofibres are hydrophobic and thus inhibit adhesion. Neurons are 
capable of generating approximately 150 µdyn of force through the neurites (Segev et al, 2003). 
When neurites extending from the soma come into contact with other neurites, they exert this 
force on each other. When the force exerted on the soma is greater than the force of adhesion 
holding the cell in place, the cells will migrate towards each other to form cell clusters (Segev 
et al, 2003). By inhibiting the physical adhesion of the cells to the surface, the ability of neurons 
to form clusters is enhanced. Biologically, the cell-cell and cell surface adhesion have been 
suggested to be inversely proportional (Limongi et al, 2012; McCain et al, 2012). Through 
inhibition of adhesion of cells to the surface, decreased expression of cell-substrate adhesion 
proteins and upregulation of cell-cell adhesion proteins may have occurred, compounding the 
lack of adhesion induced by the alterations to the wettability of the surface.  
 
The hypothesis that the surface wettability of the PLLA nanofibres aided the formation of the 
organoids was tested by altering the wettability of the nanofibres through plasma treatment 
(figure 4.7). Plasma treated PLLA nanofibres were observed to have a lower contact angle than 
untreated PLLA nanofibres (figure 4.7B) and cellular aggregation was attenuated (figure 4.7C). 
Quantification of the neuronal morphologies demonstrated a significant decrease in cell 
cluster diameter (figure 4.8A), neurite alignment (figure 4.8B), neurite bundle diameter (figure 
4.8C) and neurite length (figure 4.8D). Therefore, surface wettability is an influencing factor in 
the formation of the cellular aggregates that are observed. 
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4.4.2 Molecular hypotheses for generation of altered cellular 
morphologies 
The consistent significant positive correlation between cell cluster diameter, neurite bundle 
diameter and neurite length (figure 4.5) may be indicative of the mechanism that induced the 
significant alterations relative to the control 2D culture (figure 4.2). Whilst the mechanism 
behind the clustering of cells is theorised to be due to reduced adhesion and consistent 
mechanical tension within the neurites, the increase in neurite length and diameter is 
hypothesised to be due to the aggregation of neurons. Increasing cell cluster diameter is 
positively correlated with neurite bundle diameter and length; proximity of cells appears to 
induce an increase in these cellular features. Neurons express cell adhesion molecules (CAMs) 
on their membranes which are capable of inducing an increase in neurite outgrowth and cell-
cell adhesion (Missaire and Hindges, 2015). The theorised mechanism is that through increased 
clustering of cell bodies, neurites are in closer proximity and more probable to come into 
contact with other neurites and allow for ligand-receptor interactions between CAM and CAM-
receptor. Signalling molecules downstream of CAMs have roles in differentiation, gene 
transcription, metabolism, morphogenesis and cellular migration (Kleene et al, 2010; Shima et 
al, 2007; Noren et al, 2000); thus, further molecular characterisation is warranted as a means 
of establishing those changes that result from the increased proximity of neurons.  
 
4.4.3 Avenues for further optimisation of the cell culture 
conditions for promoting cerebral cortical organoid formation  
The choice of medium (NbActiv1) selects for neuronal cells while inhibiting 
proliferation/survival of non-neuronal cells. A small percentage of cells within the culture were 
stained with DAPI while not staining for βIII-tubulin, suggesting that they were non-neuronal 
cells. The percentage of non-neuronal cells was found to be consistently negatively correlated 
with all other factors at all time-points (figure 4.5). The main non-neuronal cells that comprise 
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the cerebral cortex are the astrocytes and oligodendrocytes (Kandel, 2012). Whilst astrocytes 
enhance the extension of neurites (Kanemaru et al, 2007), oligodendrocytes are inhibitory (Ma 
et al, 2009). The inhibition of neurite growth that is observed due to the increasing percentage 
of non-neuronal cells is suggestive that these cells are oligodendrocytes and therefore, 
removing the non-neuronal cells may increase the growth of the organoids. However, the 
mechanism of formation is theorised to be dependent on the force that neurites exert on each 
other during the formation of a neural network (Segev et al, 2000). Probabilistically, the greater 
the number of non-neuronal cells, the lower the chance of neurites coming in to contact with 
a neuron that can generate force and thus form a cluster, decreasing the size of the average 
aggregate. Smaller clusters correlate with lower neurite length and neurite bundle diameters. 
Thus, it is also possible that non-neuronal cells negatively correlate with other factors by virtue 
of being non-neuronal rather than a specific cellular sub-type (oligodendrocytes). Whilst the 
distinction appears minor, it has implications with respect to potential methods of optimising 
cluster formation. If oligodendrocytes are inhibitory to organoid formation, then removal of 
this specific sub-set of cells would yield larger organoids whilst retaining the beneficial growth-
promoting properties of astrocytes. If the non-neuronal cells are inhibitory cells because they 
are non-neuronal then purification could be performed more easily with fluorescence assisted 
cell sorting using a neuronal marker alone although the beneficial properties of the astrocytes 
would also be lost. Medium conditioned with primary cortical astrocytes could potentially be 
used to promote growth and survival in the absence of glia (Mena et al, 1996) although the 
use of conditioned medium precludes feedback loops between the organoids and the 
astrocytes. 
4.4.5 Classification as an organoid 
Organoids are classified as 3D cell clusters that recapitulate the in vivo behaviours of the target 
organ (Fatehullah et al, 2016). Thus far, the cellular clusters formed in the current work have 
demonstrated self-assembly into 3D clusters and more representative morphologies but a key 
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aspect of the central nervous system is the electrophysiological aspect. Assemblies of neurons 
are the basis of computation within the central nervous system (Yuste, 2015) and within the 
cerebral cortex, neurons are typically excitatory (e.g. glutamatergic) or inhibitory (e.g. 
GABAergic) (Kandel, 2012). Putative organoids were stimulated with AMPA and GABA, a 
glutamatergic and GABAergic agonist respectively to confirm that the cell clusters were 
responsive to physiologically relevant compounds. 
 
AMPA is a non-physiological agonist of the AMPA glutamate receptor and has demonstrated 
an EC50 of approximately 5 µM in cortical neurons (Di Angelantonio et al, 2015), although 
several studies have utilised concentrations as high as 100 µM to stimulate the tissue (Rojas et 
al, 2012; Carunchio et al, 2007). To elicit a response, 10 µM was selected for this study. In 
contrast to AMPA, GABA is a physiological agonist. At the synapse, concentrations of GABA 
upon neurotransmission are relatively broad dependent on the region of the cortex and the 
study that was performed; studies estimate peak concentrations ranging from 0.3mM to 3mM 
with constitutive GABAergic concentrations at approximately 0.2-2.5µM (Roth and Draguhn, 
2012). In 2D culture, 10 µM GABA alone was sufficient to abolish neuronal activity in cortical 
cultures (Han et al, 2017); in the current work, 25 µM GABA was selected as a concentration 
that would be capable of attenuating the increased activity induced by the previously 
administered AMPA. Pharmacological stimulation of the organoid with AMPA and GABA 
induced an increase and decrease in activity respectively (figure 4.9A and 4.9B), confirming 
that the cell cluster expresses receptors that are typical of physiological neurons. In the 
absence of pharmacological stimulation, spiking behaviours were also observed.  
 
Within the cerebral cortex, neurons are capable of spontaneous depolarisation. To 
recapitulate behaviours of the organ in question, cerebral cortical organoids should be capable 
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of generating spontaneous depolarisation. Whilst the voltage sensitive dye exhibits kinetics 
that are quick enough to capture the action potentials of cortical neurons (2ms/action 
potential; Kandel, 2012), the temporal resolution of the confocal fluorescence microscope 
(12ms) does not; thus these spikes within the recorded data set are referred to as “spiking 
events” rather than true spikes. For each of the tested organoids, numerous spiking events 
were detected using thresholding as a means of spike detection (figure 4.9C). A limitation of 
RMS as a thresholding method for spike detection is the susceptibility to bias that results in 
failure to detect low-amplitude spikes due to high amplitude, high frequency spike trains; due 
to their inclusion in the signal-noise ratio, the RMS will subsequently be increased, thus 
generating false negatives. This limitation has lead on to the use of the more sophisticated 
techniques. However, this experiment aimed to determine whether or not the organoids were 
capable of generating spikes at all rather than accurately characterising the electrophysiology 
of the organoids. Due to the ease of implementation, low computational cost and the 
predisposition towards false negatives rather than false positives, RMS was selected as a 
means of detecting spiking behaviours.  
 
4.5 Conclusion 
The 3D cellular structures that are generated through primary culture of cortical neurons on 
aligned PLLA nanofibres fulfil the criteria to be considered as organoids (Fatehullah et al, 2016). 
The organoids self-assemble, exhibit electrical activity, recapitulate structures of the organ in 
question through the segregation of neurite and soma and possess a mixed culture. Multiple 
avenues to develop the sophistication of the organoid have been discussed, but more in-depth 
characterisation is needed.   
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Chapter 5: Proteomic Characterisation of the Cerebral 
Cortical Organoids 
5.1 Introduction  
Initial characterisation of the organoid focused on the behaviours of the whole cell or even 
networks of cells through morphological or electrophysiological quantification. Mass 
spectrometry can be employed as a high-throughput method for molecular elucidation of 
biological systems. Within this chapter, mass spectrometry will be used to perform broad 
characterisation of the organoid to gain insight into developmental aspects of it and to probe 
for potential upregulation of various markers of plasticity that may have implications for the 
potential integration of the organoids into endogenous circuitry upon implantation.  
 
The shotgun approach of mass spectrometry-based quantification of the proteome allows an 
increase in the depth and breadth of the data collection of the system in question relative to 
targeted tools such as western blotting or qPCR (Angel et al, 2012). Using the mass of data that 
can be generated by mass spectrometry, bioinformatic analyses was employed to characterise 
the system. Bioinformatics evolved as a means of analysing the extensive gene sequence data 
that could be collected as a result of genome sequencing but has since evolved into a means 
of computationally analysing a wide range of data from genomics to metabolomics to 
proteomics (Ramsden, 2015), therefore, bioinformatic analyses shall be used to enrich the 
“proto-data” generated by mass spectrometry to a usable form that can be used to examine 
the responses of various systems and biological processes in a meaningful way.  
 
Artificial neural network inference (ANNI) was used to characterise the interactome of the 
organoids as a means of probing the protein network as a whole rather than fixating on the 
fold changes of individual proteins. Whilst mass spectrometry provided a list of proteins that 
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were differentially expressed and provided a global image of the changes to the cell, it did not 
indicate which proteins are key influencers within the system. Proteins that are greatly up- or 
down-regulated are frequently treated as causative factors of pathologies and targeted, 
resulting in therapeutic failure (Tong et al, 2014) as this approach fails to understand the 
system as a whole, instead focusing on the most deregulated protein. The most deregulated 
protein may be downstream of a potent transcription factor, signalling cascade initiator or 
synergistic inhibitory/excitatory protein that is causative rather than symptomatic. ANNI 
modelling allows the discovery of influential proteins within the interactome, regardless of 
whether the fold-change of expression is high or low, facilitating increasingly accurate 
characterisation of the system. Regression analysis performed in chapter 4 suggests that the 
mechanism of cerebral cortical organoid formation on the PLLA nanofibres is due to the 
clustering of cells on a hydrophobic surface, inducing neurite bundling and subsequent guided 
outgrowth. The molecular mechanism proposed for this in chapter 4 is that the close proximity 
of neurons allows neuronal cell adhesion molecules (NCAMs) expressed on the surface of one 
neuron to stimulate neighbouring neurons. NCAMs have demonstrated growth promoting 
abilities for neurites through alterations to gene expression or modulation of the cytoskeleton, 
in addition to neurite guidance properties (Missaire and Hindges, 2015). Alternate models of 
organoids within the CNS and the physiological architecture of the CNS highlight the 
importance of close proximity of cell bodies (Lancaster and Knoblich,2014; Harris et al, 2016; 
Kato-Negishi et al, 2013) and support the NCAM hypothesis as all previous models have 
demonstrated clustered cell bodies as a necessity for the formation and differentiation of their 
respective organoids. Lancaster and Knoblich (2014) note that neural rosettes (clusters of 
neural stem cells) are capable of recapitulating the radial organisation that is typical of the 
neuroepithelium upon differentiation. Harris et al (2016) and Kato-Negishi et al (2013) pre-
assemble clusters of embryonic neurons prior to seeding and note the extensive generation of 
thick, fasciculated axons and the formation of synapses. Whether the neuronal clustering is 
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induced through proliferation of neural stem cells into a rosette or mechanical clustering, close 
proximity of the soma appears to be a necessity for forming cerebral cortical organoids. 
5.2 Methods 
5.2.1 Generation of cell lysates for mass spectrometry 
To attain lysates for proteomic analysis, primary cortical neurons were seeded to aligned PLLA 
nanofibres as described previously for 11 days. Cells were then incubated in lysis buffer (1% 
protease inhibitor, 9.5mM Urea, 130mM dithiothreitol and 34mM octyl-beta-glycopyranoside 
in ddH2O) for 2 minutes at 37°C. The lysate was then collected and sonicated in an iced water 
bath, 3 times for 5 minutes. Between each 5 minute sonication, the lysates were chilled on ice 
for 5 minutes. Samples were centrifuged at 12,000g for 10 minutes. The supernatant was 
removed and stored at -80°C until protein quantification and mass spectrometry was 
performed. Protein quantification was performed using a Lowry assay according to the 
manufacturer’s protocols. Briefly, BSA protein standards were prepared at a range of 
concentrations, diluted to a final volume of 100µL with distilled water and Western Blot lysis 
buffer. Samples were diluted using distilled water. Working Lowry solution (1ml; 2% Na2CO3, 
0.1M NaOH, 1% CuSO4, 2.7% Na+K+-Tartrate) was added to each of the samples and standards 
which were subsequently vortexed and incubated for 15 minutes at room temperature. Folin-
Ciocalteau reagent was diluted at a 1:1 ratio with distilled water and 100µL was added to each 
sample. After 30 minutes of incubation at room temperature, samples were then transferred 
in to a 96 well plate and the absorbance was read at 750nm using a Clariostar fluorescent plate 
reader. Standards were then used to generate a standard curve to calculate the protein 
concentration of the lysates. 
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5.2.2 Mass spectrometry sample preparation 
Performed by Dr. Amanda Miles 
Cell lysates were diluted in tri-ethyl ammonium bicarbonate (TEAB, Sigma Aldrich UK; 50mM) 
before being reduced in DTT (5mM, 56°C for 20 min) and alkylated in iodoacetamide (15 mM , 
room temperature for 15 min in the absence of light) and then digested for 16 hours using 
Trypsin (Promega, UK)  at 37°C at a 20:1 protein:protease ratio (w/w) in a thermomixer 
(650 rpm). Samples were then de-salted and HyperSep C18 spin tips (10-200 µL size) (Thermo 
Scientific) were used according to the manufacturers protocol to concentrate. A vacuum 
concentrator was then used to concentrate the samples before resuspension in 5 % 
acetonitrile + 0.1 % formic acid.  
 
5.2.3 Mass Spectrometry 
Performed by Dr. Amanda Miles 
Lysates were analysed on a Sciex TripleTOF 6600 mass spectrometer coupled in line with a 
eksigent ekspert nano LC 425 system utilising micro flow. Samples (4 L) were injected and 
trapped onto a YMC Triart-C18 pre-column (0.3 x 5 mm, 300 µm ID) (mobile phase A; 0.1 % 
formic acid, B; acetonitrile with 0.1 % formic acid)  at a flow rate of 10 µL/min mobile phase A 
(2 minutes) prior to gradient elution onto the YMC Triart-C18 analytical column (15 cm, 3 µm, 
300 µm ID) in line to a Sciex TripleTOF 6600 Duospray Source using a 50 m electrode, positive 
mode +5500V. Lysates underwent information dependent acquisition (IDA) to generate a 
spectral library and Data Independent Acquisition (SWATH) to quantify the spectra. The 
parameters for the linear gradients for IDA were: mobile phase B increasing from 3 %-30 % for 
68 minutes; 40 % B at 73 minutes. A column wash was performed at 80 % B and re-equilibrated 
(total run time = 87 minutes).  The parameters for the linear gradients for SWATH MS were: 3-
30 % B for 38 minutes; 40 % B at 43 minutes, re-equilibration was performed as before after a 
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wash stage (total run time = 57 minutes). IDA acquisition mode was utilised to generate the 
spectral library, with a top 30 ion fragmentation (TOFMS m/z 400-1250; product ion 100-1500). 
Subsequently, exclusion using rolling collision energy was performed for 15 seconds, 50 ms 
accumulation time; 1.8 s cycle. For SWATH acquisition 100 variable windows were used with 
an accumulation time of 25 ms and a 2.6 s cycle (m/z 400-1250) (Mele et al, 2018). ProteinPilot 
5.0.2 was used to search the spectral library generated by IDA (Swissprot rat database June 
2018). Sciex OneOmics software was used to analyse the SWATH data (Lambert et al, 2013) 
extracted against the locally generated library (false discovery rate filtering of 1 % and 
excluding shared peptides). Parameters used within the OneOmics software were: 12 
peptides/protein, 6 transitions/peptide, XIC width 30 ppm and a retention time window of 5 
minutes. 
 
5.2.4 Principal Component Analysis 
Principal component analysis (PCA) was performed on the mass spectrometry data. ClustVis 
was used to perform the PCA and generate the subsequent figures. Pareto scaling was used to 
normalise the data. The Pareto scaling factor was identified using equation 3 and all fold 
changes were subsequently divided by the scale factor to normalise them. 
?̃?𝑖𝑗 =  
𝑋𝑖𝑗 −  𝑋𝑖̅̅̅
√𝑆𝑖
 
Equation 3: Pareto scaling using to normalise data for Principal Component Analysis 
 
5.2.5 Artificial neural network inference (ANNI) modelling 
Artificial neural network inference modelling was used to simulate protein-protein interactions 
in silico. Proteins that were significantly de-regulated and above 50% confidence (186 proteins 
total) were uploaded to the artificial neural network (ANN). Confidence value cutoffs were 
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relaxed for the ANNI modelling to allow a larger and more robust network to be generated. 
The ANN used was a 3-layered multilayer perceptron with back-propagation learning and 
utilised a sigmoidal activation function (Lancashire et al, 2009). For each protein, the 
interaction between it and every other protein was calculated based off the mass spectrometry 
data and through this, negative and positive influences were calculated, generating 35,000 
total interactions for the list of proteins. Monte Carlo cross validation was used to prevent 
overfitting with a 60:20:20 ratio used for training, testing and validation.   
 
5.2.6 Network analysis 
To identify processes that were significantly overrepresented within the network generated by 
mapping the interactome in cytoscape, the BiNGO plugin was used (Maere et al, 2005). To 
identify proteins that were vital to the process, the network was analysed using Cytoscape’s 
in-built analytical tools (“Network Analyzer”) and betweenness centrality was used to 
determine key proteins within the network. Proteins that were identified to have high 
betweenness centrality were isolated in to their own sub-network and the BiNGO plugin was 
used again to determine enriched gene ontologies within the sub-network. Sub-networks were 
also created for the influence of the top 10 highest betweenness centrality proteins on 
ribosomal and developmental proteins.  
 
To gain insight in to the mechanism behind formation and organoid development, the top 100 
influencers were then mapped using Cytoscape. Three key proteins (Snp25, Rtn4 and Dpysl2) 
were highlighted by the ANNI as key nodes of influence within the protein-protein interactions. 
The mechanism that these 3 proteins exerted their effects on the proteome was investigated 
further. An average interaction value and standard deviation was found for the total 35,000 
interactions. This was performed by investigating the strongest negative and positive 
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interactions up and downstream from the key nodes (SNAP-25, RTN4 and Dpyl2). For each of 
the 3 key nodes, the 3 strongest negative and positive interactions of the 185 possible 
interactions were listed (generation 1 of interactions). From each of these 3 upstream and 3 
downstream proteins, the 3 strongest positive and negative interactions was listed (generation 
2 of interactions), generating a layered network. For each of these generation 2 proteins, 2 
further positive and negative interactions were generated (generation 3 of interactions). This 
process was also repeated for the “median protein” – CISY which had the median interaction 
strength. At each generation of interactions, the strengths of the key nodes interactions were 
compared to the average and tested for significance using an unpaired t test.  
 
5.2.7 Bioinformatic analysis 
Proteins that were identified by mass spectrometry with a confidence value of greater than 
70% were used for bioinformatic analysis. Proteins that were uniquely expressed by the 
neurons cultured upon nanofibres were identified by generating a Venn diagram of total 
proteins detected in all replicates of the lysates of the control and the nanofibre condition. 24 
proteins were detected that were unique to the nanofibre condition. The function of these 
proteins was determined through the STRING bioinformatics database.  
Data enrichment was also performed to process the data in to a more usable format. Several 
gene ontologies of interest were present within the list and were selected for further analysis. 
The 5 gene ontologies were: “Synaptic”, “Developmental”, “Adhesion”, “Adherens junctions” 
and “Mitochondrial”. Markers for lamination were manually searched for using the Uniprot 
database and a literature search. For each of these gene ontologies, the proteins associated 
with the process were extracted from Metacore. The normalised mass spectrometry data for 
each protein was grouped and run through Morpheus visualisation software to generate 
heatmaps of up- or down-regulation. Furthermore, the lists of up- and down-regulated 
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proteins was also uploaded in to Venny visualisation software to generate Venn diagrams of 
each gene ontology to determine multi-functional proteins and infer causative mechanisms for 
the development of organoids. 
 
5.2.8 Transcription factor analysis 
The 186 proteins identified by mass spectrometry were uploaded to Metacore and a network 
analysis was performed. The transcription factors for each of the identified proteins were 
examined and those that were more common than were mathematically predicted were 
highlighted with P values. The only transcription factor highlighted was the ARX transcription 
factor. A network was generated in silico using Metacore to map possible protein-protein 
interactions that were not detected by mass spectrometry but were predicted due to the 
activity of the ARX transcription factor. 
 
5.2.9 Comparisons to an existing epithelial-mesenchymal 
transition (EMT) dataset 
The mass spectrometry dataset output by OneOmics software was compared with an 
unpublished EMT dataset, generated by RNA-seq, provided by Sarah Wagner. The DU145 
prostate cancer cell line was used and treated with TGF-β, an inducer of EMT. Genes/proteins 
that were present in both datasets were compared initially for directionality of fold change to 
determine similarities within the datasets. Several identified genes were disqualified from 
quantification as they were detected in the RNA-seq but present at levels low enough that fold 
change data was unreliable. Data was then normalised using equation 4 and used to generate 
scatterplots and perform regression analysis using Graphpad Prism 7. Graphpad was also used 
to check normality of distribution.  
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𝑥′ =
𝑥 − min (𝑥)
max(𝑥) − min (𝑥)
 
 
Equation 4: Min-Max scaling used for normalising RNA-seq data for comparison with mass 
spectrometry data 
5.2.10 Preparation of lysates for Western Blotting 
Primary cortical neurons were dissected from embryonic rats on embryonic day 18, seeded 
and cultured on PLL/laminin surfaces and aligned PLLA nanofibres as described previously 
(Chapter 2; section 2.2.2, 2.2.3, 2.2.6). On 11 DIV, cultures were washed three times in PBS and 
exposed to boiling Western Blot lysis buffer (500nM TRIS, pH 6.8, 5mM EDTA, 1% SDS, 1% v/v 
protease inhibitor cocktail) for 2-3 minutes. Cells were then scraped and lysis buffer was 
collected and boiled at 100oC for a further 5 minutes. Lysates were then stored on ice, 
sonicated in a water bath with ice for 15 minutes, centrifuged at 13,000 RPM and the 
supernatant was then removed and stored at -80 oC until protein estimation. 
Protein estimation was performed using a mini-Lowry assay, following the manufacturer’s 
protocol, as described in a previous section 
5.2.11 Sodium dodecyl sulphate-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
Prior to SDS-PAGE, resolving and stacking gels were prepared. For each resolving gel, resolving 
gel solution (H2O – 6.1ml, 30% acrylamide – 1.3ml, Tris-HCl, 0.5M, pH 6.8 – 2.5ml, 10% SDS – 
100ul, TEMED – 10ul, 10% ammonium persulphate – 100ul) was prepared, cast between two 
glass plates and allowed to set. Once the resolving gel had set, the stacking gel (H2O – 4.1ml, 
30% acrylamide – 3.3ml, Tris-HCl, 1.5M, pH 8.8 – 2.5ml, 10% SDS – 100ul, TEMED – 10ul, 10% 
ammonium persulphate – 32ul) was added, a comb was inserted to form the wells and the 
stacking gel was then allowed to set. Combs were withdrawn, the completed SDS-PAGE gel 
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was inserted in to the electrophoretic tank and submerged in running buffer (25mM Tris buffer, 
192mM glycine, and 0.1% SDS, pH 8.5).   
 
5.2.12 Western Blotting 
Lysates were diluted 1:1 with 2x reducing Laemmli buffer, boiled for 5 minutes to denature the 
proteins. For each of the samples, an equal amount of protein was used. Samples were then 
loaded in to the wells of the stacking gel alongside 1µL molecular weight ladder. Gels were run 
at 140V for 90 minutes to separate the proteins.  
After electrophoresis, proteins were transferred to a nitrocellulose membrane by wet blotting. 
A blotting sandwich was prepared with the gel and nitrocellulose membrane sandwiched 
between filter paper. The blotting sandwich was soaked in ice cold transfer buffer (25mM Tris 
buffer, 192mM glycine, pH 8.3 and 20% v/v methanol), bubbles were removed from the blot 
using a roller and the blotting sandwich was moved to a western blot cassette. The cassette 
was then loaded in to the electrophoretic tank with the nitrocellulose membrane on the side 
of the anode. Transfer was performed for 16 hours at 40V and copper staining was used to 
assess transfer success. Copper staining was performed by soaking the nitrocellulose 
membrane in 0.05% (w/v) copper phthalocyanine 3, 4’, 4’’, 4’’’ tetrasuphonic acid terasodium 
salt in 12mM HCl. Copper staining was then imaged using an ImageQuant Las 4000. Following 
imaging, copper staining was removed with 12mM NaOH.  
Immunostaining was performed by initially blocking the membrane with blocking buffer (3% 
BSA in TBS-Tween) for 1 hour at room temperature. The blot was then incubated in primary 
antibody (VDAC2; 1:1000, VDAC1; 1:1000, HSP60; 1:1000) overnight on a roller at 4°C, at a 
concentration stated by each of the blots. Four 15 minute washes were performed in TBS-
Tween before staining with the secondary antibody. Secondary antibody was prepared to a 
dilution of 1:1000 in marvel milk (3% w/v in TBS-Tween). Blots were washed for 4 times for 15 
100 
 
minutes before addition of ECL Western Blotting substrate. Blots were than imaged using an 
ImageQuant Las 4000. Quantification was performed using Aida image analyser v4.03. Band 
intensity was quantified for equal areas for each of the bands. Intensities were normalised 
against the housekeeper protein and results were expressed as a fold change against the 
control.  
5.3 Results 
5.3.1 Validation of the mass spectrometry data  
Principal component analysis was run on the mass spectrometry data for proteins that were 
detected at a confidence value above 70% and were significantly deregulated; a significant 
change within the proteome was observed. The generated heatmap and cluster analysis 
demonstrated significant differences between the proteome of the control and the nanofibre-
cultured neurons (figure 5.1A and 5.1B). Cluster analysis reveals precise clustering of the 
control data whilst heterogeneity is evident within the data of the nanofibre-culture neuronal 
proteome (figure 5.1B). 
 
 
 
 
 
 
 
Figure 5.1: Overview of mass spectrometry (A) Heatmap of the results of a principal component 
analysis of the results of mass spectrometry. Each row of the heatmap represents the 
A B 
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quantified expression of a protein while each column is an independent replicate (B) Cluster 
analysis of the mass spectrometry data; significant difference is observed between the control 
and the proteome of neurons cultured on aligned PLLA nanofibres.  
Western blots were used to validate the mass spectrometry data. Vdac2 and HSP60 were 
selected as target proteins. Vdac1 was used as a housekeeper due to its consistent expression 
within the ProteinQuant data. Commonly used housekeepers such as GAPDH, lamin, vinculin, 
various actins and tubulins were judged to be inappropriate due to the extensive deregulation 
that was observed within the mass spectrometry dataset. For HSP60 and VDAC2, deregulation 
was observed in the same direction for both the western blot and the mass spectrometry, with 
relatively little difference between the fold changes observed between the two techniques 
(figure 5.2A and 5.2B). 
 
 
 
 
 
Figure 5.2: Validation of the mass spectrometry dataset. (A) Western blots for VDAC2 (1:1000), HSP60 (1:1000) and 
VDAC1 (1:1000). NF1-3 are independent replicates for lysates of neurons grown on aligned PLLA nanofibres while 
C1-3 are lysates of neurons grown on the control surface (B) Comparison of fold changes relative to the control 
observed for the selected proteins using mass spectrometry and western blots. No significant difference was 
detected between the fold changes for VDAC2 or HSP60.  
 
 
  NF1      NF2     NF3      C1        C2        C3  
VDAC1 
HSP60 
VDAC2 
V
D
A
C
2
H
S
P
6
0
0
1
2
3
4
F
o
ld
 C
h
a
n
g
e
 R
e
la
ti
v
e
 t
o
 C
o
n
tr
o
l
M a s s  s p e c
W e s te rn
A B 
102 
 
5.3.2 Protein interactions inferred by the artificial neural 
network 
Using an artificial neural network, a network comprised of 186 proteins was generated with 
each protein linked to every other protein. Each protein was omitted from the network in turn 
and the change in expression of each of the 185 proteins was quantified, generating 35,000 
interaction data points; significant interactions were mapped (figure 5.3). 
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Network analysis of the function of the proteins within the interactome revealed that within 
the interactome of the nanofibre cultured neurons, distinct gene ontologies were significantly 
overrepresented (figure 5.4). Within these overrepresented gene ontologies, developmental 
gene ontologies were most frequently observed (table 5.1). For the interactome itself, 
betweenness centrality was used to identify key proteins, listed in table 5.2. 
Enriched Gene Ontology Corrected p Value 
Regulation of cellular component organization 0.0000516 
Nervous system development 0.000585 
Anatomical structure development 0.000661 
Multicellular organismal development 0.000661 
Neurogenesis 0.000661 
Regulation of protein complex assembly 0.000706 
Developmental process 0.000925 
System development 0.00109 
Positive regulation of protein complex assembly 0.00180 
Regulation of neuron projection development 0.00308 
Table 5.1: The ten most significantly overrepresented gene ontologies within the interactome and associated p 
values. Analysis run through the BiNGO plugin of Cytoscape.  
 Proteins associated with protein synthesis were observed to decrease (SYTC, -6.36; RL35a, - 
24.08) while proteins involved with migration/motility (NSDHL, 2.71; NOVA1, 2.53; TPM3, 4.02; 
GOGA2, 3.63), synaptic plasticity (Map1B, 2.19; NOVA1, 2.53; TPM3, 4.02; PSMD9, 2.98) and 
morphological regulation (Map1b, 2.19; ODPB, 4.57; TPM3, 4.02; GOGA2, 3.63) exhibited 
increased expression. 
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Figure 5.4: Significantly overrepresented gene ontologies within the interactome. White = non-significant, yellow = 
significant, intensity is proportional to significance 
 
106 
 
   T
ab
le
 5
.2
: C
en
tr
al
ly
 lo
ca
te
d
 p
ro
te
in
s.
 H
ig
h
lig
h
te
d
 p
ro
te
in
s 
ex
h
ib
it
 t
h
e 
h
ig
h
es
t 
B
et
w
ee
n
es
s 
C
en
tr
al
it
y 
w
it
h
in
 t
h
e 
n
et
w
o
rk
. A
ve
ra
ge
 b
et
w
e
en
n
es
s 
ce
n
tr
al
it
y 
= 
0
.0
07
00
5
, s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
 =
 0
.0
11
22
55
 
107 
 
 
 The betweenness centrality was expanded to the top 25 proteins to build a larger, more robust 
network (figure 5.5); hypergeometric testing within the BiNGO plugin allowed the detection of 
significantly overrepresented gene ontologies (figure 5.6). 
 
Figure 5.5: The interactome of the 25 proteins with the highest betweenness centrality. The significant interactions 
attained from the ANNI were mapped using Cytoscape. Nodes = proteins, lines/edges = interactions. Edge  colour 
indicates the directionality of the interaction, red = positive, blue = negative. Node size indicates the betweenness 
centrality, blue = low betweenness centrality, red = high betweenness centrality.   
Similar to the full interactome, the interactome for the proteins with the highest betweenness 
centralities exhibited significant overrepresentation of developmental gene ontologies (table 
5.3).  
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Enriched Gene Ontology Corrected p Value 
Regulation of Cellular Component Organization 0.000026 
Neurogenesis 0.00070 
Nervous System Development 0.00070 
Regulation of Protein Complex Assembly 0.00070 
Multicellular Organismal Development 0.00070 
Anatomical Structure Development 0.00070 
Developmental Process 0.001077 
System Development 0.001420 
Positive Regulation of Protein Complex Assembly 0.001420 
Regulation of Neuron Projection Development0 0.002233 
Table 5.3: The ten most significantly overrepresented gene ontologies within the interactome of proteins with the 
highest betweenness centrality and associated Benjamini-corrected p values. Hypergeometic analysis run through 
the BiNGO plugin of Cytoscape.  
Developmental proteins were frequent targets of the proteins with the highest betweenness 
centralities (figure 5.7) with MAP1B, NOVA1, MYG1 and PDHB displaying notably high degrees 
of positive influence on developmental proteins. In contrast, Tars and RPL35a demonstrate a 
high degree of negative influence on developmental proteins. 
 
 
 
 
110 
 
Figure 5.7: Developmental sub-networks of the top 10 betweenness centrality proteins. The significant interactions 
attained from the ANNI were mapped using Cytoscape. Nodes = proteins, lines/edges = interactions. Edge  colour 
indicates the directionality of the interaction, red = positive, blue = negative. Node size indicates the betweenness 
centrality, blue = low betweenness centrality, red = high betweenness centrality.   
  
Ribosomal proteins were classified as developmental proteins but were processed separately. 
The majority of proteins with high betweenness centrality exhibit strong negative influence on 
ribosomal proteins (figure 5.8). 
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Figure 5.8: Ribosomal sub-networks of the top 10 betweenness centrality proteins. The top 10 proteins have a 
predominantly negative influence on the ribosomal proteins. The significant interactions attained from the ANNI 
were mapped using Cytoscape. Nodes = proteins, lines/edges = interactions. Edge  colour indicates the directionality 
of the interaction, red = positive, blue = negative. Node size indicates the betweenness centrality, blue = low 
betweenness centrality, red = high betweenness centrality.   
 
Within the 35,000 initial data points, the 100 highest values were used to generate figure 5.9; 
the strongest interactions between proteins. The strongest interactions are all inhibitory and 
are almost exclusively focused on negatively decreasing the expression of SNP25, DPYL2 and 
RTN4, which display an increased expression. The overlapping interactions between proteins 
regulating both DPYL2 and RTN4 suggests a similarity of function between the pathways that 
the two are involved in whereas SNP25 appears to be regulated by a diverse array of proteins 
with little overlap in regards to the interactions. These data suggest that as a result of 
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treatment (culture of neurons on the PLLA nanofibres), SNP25, Dpysl2 and Rtn4 are up-
regulated whilst the negative influencers of these 3 proteins are up-regulated as a way of 
returning the system to equilibrium.  
 
Figure 5.9: Artificial Neural Network Inference (ANNI) of protein interactions. The strongest influencers that are up-
/down-regulated by culture of primary cortical neurons on aligned PLLA nanofibers are displayed. The size of the 
node is relative to the number of interactions within the system. The colour of the node is dependent on the 
expression, red = increased expression, blue = decreased expression whilst the intensity is relative to the fold-
change. The arrows indicate the directionality of the influence. The colour of the arrows indicate the type of 
influence (red = positive influence, blue = negative influence) whilst the width of the arrow indicates the strength 
of the influence.   
Plotting of the interaction values for each protein that targets SNP25, Dpysl2 and Rtn4 against 
the protein with the median interaction values (Cisy) (figure 5.10) illustrates that whilst these 
proteins exhibit a small number of interactions that are positive, the majority of proteins have 
strong negative influences; at both ends of the curve, non-linear distribution is observed for 
the key proteins that is absent for the median protein, Cisy.  
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Figure 5.10: Frequency distribution of the strength of protein-protein interactions generated by the ANN inference.  
 
The interactome of the strongest influencers (figure 5.9) revealed SNP25, Dpysl2 and Rtn4 as 
key targets that were up-regulated as a result of culture of neurons on PLLA nanofibres.  
 
Table 5.4: Distinguishing between increased developed due to increased regulation of Snap-25, Rtn4 and Dpysl2 
and active induction of developmental mechanisms by these 3 proteins. All proteins displayed were detected in the 
developmental gene ontology in Metacore. For all of the 3 key proteins, developmental proteins that target them 
are predominantly negative influencers; the system is attempting to restore equilibrium to Snap25, Rtn4 and Dpysl2 
via down-regulation. Interestingly, Dpysl2 and Rtn4 are predominantly positive influencers of developmental 
proteins while Snap25 is again, predominantly a negative influencer of developmental proteins.   
The downstream targets of these proteins were investigated and interactions that were 
greater than 1 standard deviation from the global average were collated and filtered using the 
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“Development” gene ontology (table 5.4). Downstream developmental targets of Rtn4 and 
Dpysl2 were predominantly positively influenced whilst the downstream developmental 
targets of SNP25 were predominantly negatively influenced by SNP25. These results suggest 
that whilst all 3 key proteins drive expression of developmental proteins indirectly through a 
regulatory feedback as the system tries to reduce expression (figure 5.9 and table 5.4), both 
Rtn4 and Dpysl2 can also drive developmental protein expression through direct positive 
interactions at downstream targets. These results were not exclusive to the developmental 
proteins. Figure 5.15 shows the results of investigation into the strongest interactions up and 
downstream of the key nodes. Referring to the downstream networks, proteins that were 
influenced by the key nodes exhibited significant differences between the key nodes and the 
median protein CISY for only 2 generations (figure 5.11D and 5.11E). In contrast, upstream 
proteins exhibited significantly stronger interactions on proteins within the network across a 
minimum of 3 generations (Figure 5.11A and 5.11B). Similarly, the convergence of proteins-
protein interactions on specific targets was evident earlier in protein interactions upstream of 
the key nodes rather than the downstream proteins (figure 5.11C and 5.11F). 
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5.3.3 The ARX transcription factor and in silico protein network 
generation 
Metacore highlighted the ARX protein as a transcription factor of interest due to the number 
of proteins that were upregulated that ARX acts as a transcription factor for. A network was 
modelled for proteins that were upregulated by ARX, including proteins that were downstream 
of them (figure 5.12). Within this network, several developmental/differentiation proteins 
were identified that were not detected by the mass spectrometry that are upregulated as a 
result of increased ARX expression (SH3TC2, TAL1, SHC, SALL4, NMDAR, IL-1β, NuRD complex, 
cyclin D and ENPP2). Proteins involved with epithelial-mesenchymal transition (EMT) were also 
evident within this network (SMAD1, SMAD4 and Snai1). 
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5.3.4 Characterisation of the organoid and the mechanism of 
formation 
To investigate the mechanism of formation of the organoid, 3 gene ontologies were used: 
synaptic, developmental and adhesion. For each of these gene ontologies, clear differences 
between control and the experimental condition (neuronal culture on aligned PLLA nanofibres) 
were observed in the fold change of protein expression (figure 5.13). Adhesion proteins display 
a clear decrease in expression (figure 5.13A) whereas developmental proteins exhibit a 
predominant shift towards increased expression of developmental markers for cortical 
neurons grown on the aligned PLLA nanofibres (figure 5.17C). Ribosomal proteins are a notable 
exception. Synaptic proteins exhibit approximately equal increase and decrease in expression 
as a result of culture of cortical neurons on the aligned PLLA nanofibres (figure 5.13B). 
 
 
 
 
 
 
 
 
 
 
Figure 5.13: Fold changes for proteins that were deregulated for neurons grown on PLLA nanofibers relative to the 
control (NF = cortical neurons cultured on aligned PLLA nanofibres. Red = increased expression, blue = decreased 
expression). Proteins were sorted in to 3 gene ontology terms: adhesion (A), synaptic (B) and developmental (C) 
A Adhesion 
B Synaptic 
C Developmental 
Ribosomal 
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Numerous proteins were observed in multiple gene ontologies, suggesting that some proteins 
were involved in an array of signalling processes (figure 5.14). A low degree of overlap was 
observed between adhesion and other gene ontologies, suggesting that alterations to 
adhesion is a distinct process within the formation of the organoids. A high degree of overlap 
is observed between the neuron projection, synaptic and developmental ontologies with most 
exhibiting greater than 50% overlap, indicating a complex process.  
 
 
 
 
 
 
 
 
Figure 5.14: Multi- and uni-functional proteins that were differentially expressed as a result of culturing primary 
cortical neurons on aligned PLLA nanofibers. For both up-regulated (A) and down-regulated (B) proteins, a large 
degree of multi-functionality is observed, notably for the synaptic proteins. 
Comparison of the list of the strongest protein interactions against the Venn diagram of gene 
ontologies reveals that the strongest influencers are all up-regulated proteins (table 5.5). Of 
the strongest influencers, 37.1% were synaptic, 37.1% were neuron projection, 22.8% were 
developmental and only 2.9% were adhesion proteins. 
 
 
Up-regulated proteins  Down-regulated proteins  
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5.3.5 Metabolic changes induced by PLLA nanofibres 
Deregulation of mitochondrial proteins was induced by culture of the nanofibres (figure 5.15A). 
The majority of proteins involved within the oxidative phosphorylation pathway were 
upregulated. Within differentiating neurons, substantial changes to metabolism occur; data 
suggest that mitochondrial changes in protein expression mimic what is observed during in 
vivo differentiation (figure 5.15B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.15: (A) Deregulation of metabolic enzymes as a result of culture of primary cortical neurons on aligned PLLA 
nanofibres (B) Deregulated proteins with a role in oxidative phosphorylation. 92% of proteins identified with mass 
spectrometry exhibit a fold change that is observed during differentiation of neurons, suggesting a more developed 
proteomic profile   
A B 
122 
 
5.3.6 Comparisons with the epithelial-mesenchymal transition 
(EMT) 
Comparison with an EMT dataset (provided by Dr. Sarah Wagner) revealed similarities 
between directionality of protein/gene fold change (figure 5.16A) with approximately 55% of 
targets altering their expression in a similar direction whilst 39% were not in accordance. 
Whilst a significant positive correlation was observed between the expression of gene/proteins 
in the nanofibre and EMT datasets (p = 0.0144), the correlation was weak (R2 = 0.04146) (figure 
5.16B). Downregulation of adherens junctions is also a vital stage to EMT and thus, the 
deregulation of proteins belonging to the “adherens junction” gene ontology was investigated; 
the majority of proteins were downregulated (figure 5.16C). 
 
 
 
 
 
 
 
 
 
 
Figure 5.16: Similarities to the epithelial-mesenchymal transition (EMT) (A) Approximately 55% of proteins showed 
similar directionality of fold change between proteins of the organoid and EMT dataset whilst ≈39% showed an 
opposing directionality of fold change. Approximately 5% of values were discounted as the proteins were not 
detected in one or more of the EMT samples. (B) Linear regression for the two datasets: whilst a significant 
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correlation was observed (p = 0.0144), the R2 remained low (0.04146) (C) Metacore analysis revealed deregulation 
of adherens junction; a process that occurs in EMT. The majority of proteins related to adherens junctions were 
observed to decrease in expression.  
5.3.7 Markers of cerebral cortical lamination 
Markers of cerebral cortical lamination were detected in both conditions and were significantly 
deregulated. Of the fourteen markers of cortical lamination that were deregulated on the 
nanofibres, 9 were up-regulated whilst 4 were down-regulated (table 5.5). An additional 4 
markers of lamination were detected exclusively within the nanofibre treated lysates (table 
5.6). Whilst the number of gene ontologies that each lamination marker appeared in was not 
significantly different (unpaired t-test, t(9) = 2.002, p = 0.0763), results were bordering 
significance. 
 
Table 5.5: Markers of lamination and gene ontologies. Markers of lamination were filtered by the pre-selected gene 
ontologies. The average number of gene ontologies that up-regulated proteins appeared in was 1.5 whereas for 
down-regulated proteins, the average was 2.66.  
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5.3.8 Unique proteins  
The total list of proteins that were identified for each condition (control and experimental) was 
sorted into a Venn diagram (figure 5.17A) and 24 proteins that were unique to the nanofibres 
treated condition were identified and analysed further (figure 5.17B). These proteins were 
mostly involved in metabolism, organelle localisation and neuronal development. Relatively 
limited formation of networks were observed with the majority of proteins exhibiting no 
connections with other unique proteins.  
 
 
 
 
 
 
 
Figure 5.17: Proteins that were uniquely detected in the lysates of primary cortical neurons cultured upon aligned 
PLLA nanofibres. (A) Venn diagram representation; 24 unique proteins were detected (B) Network representation 
and functions of proteins uniquely detected for primary cortical neurons cultured on PLLA nanofibres. Red = 
Nervous system development, blue = establishment of localisation in the cell, light green = regulation of RNA splicing, 
yellow = regulation of metabolic process, pink = cytoskeletal organisation, dark green = organic substance metabolic 
process    
 
 
 
 
A B 
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5.4 Discussion 
5.4.1 Overview and comparison to previous literature 
In vitro three-dimensional culture of cells induces altered properties of those cells relative to 
their 2D counterparts. Cells cultured in 3D exhibit a greater susceptibility to pathologies and 
toxins, a greater degree of polarisation and altered Ca2+ dynamics, proliferation and 
differentiation (Irons et al, 2008). Whilst nanofibres induce relatively two dimensional growth 
of cells relative to growth of cells in a hydrogel, relative to traditional cell culture on tissue 
culture plastic, cell growth still occurs within three dimensions and the porosity of the 
nanofibres allows basolateral diffusion that is absent in the tissue culture plastic counterpart. 
As a result, the morphology, alignment and clustering behaviours of cells is altered upon 
culture on aligned hydrophobic nanofibres (Chapter 3 and 4) and thus, significant alterations 
to the proteome are expected and observed (figure 5.1).  
 
Previously, little work has been done on how nanofibres affect the proteome of neurons. A 
single study was identified as having a comparable dataset. Marote et al (2016) utilised a clonal 
neuroblastoma cell line (SH-SY5Y) cultured on both coated (laminin - 10µg/mL) and uncoated 
aligned PLLA nanofibres. However, Marote et al (2016) only identified 45 proteins that were 
differentially expressed in the control and experimental samples whereas our mass 
spectrometry yielded 186 proteins that were deregulated as a result of culture on PLLA 
nanofibres. The difference in numbers of proteins identified is likely due to the sample 
preparation; Marote et al (2016) performed mass spectrometry on several bands after 
performing gel electrophoresis rather than mass spectrometry of total lysates. Similar to 
Marote et al (2016), an increase in expression of markers associated with cell-cell adhesion 
was observed whilst the proteins involved in metabolism and protein synthesis were both 
observed to be deregulated, with a trend of down-regulation. The increased expression of 
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proteins involved in cell-cell adhesion and the decreased expression of cell-substrate adhesion 
is likely due to the hydrophobicity of the PLLA nanofibres. The adhesion of a cell to a cell or 
substrate are inversely proportional (Limongi et al, 2013; McCain et al, 2012) and this is 
reflected in both the proteome and the behaviour of the cells as they migrate across the 
surface to form the organoids.  An interesting contrast between the dataset of Marote et al 
(2016) and ours is the up-regulation of heat shock proteins observed by Marote et al (2016), 
the inverse of what was observed in our study. This may be due to the mitotic nature of the 
SH-SY5Y cell line and the role of the heat shock proteins in proliferation, in addition to the 
attenuation of heat shock protein expression that occurs during the differentiation of primary 
neurons (Marote et al, 2016; Yang et al, 2008). 
 
5.4.2 Characterisation of the cerebral cortical organoid 
Organoids represent a more physiological model of the organ of origin than conventional 2D 
culture (Fatehullah et al, 2016). The data generated by mass spectrometry and artificial neural 
network inference suggest that the neurons cultured upon the nanofibres are more developed 
than their counterparts cultured in 2D. Proteins involved in neuronal development are 
significantly over-represented in the interactome (figure 5.4 and table 5.1). Proteins that are 
identified as important within the interactome using the betweenness centrality almost 
unanimously play a role in enhancing development and plasticity (table 5.2) and proteins that 
were identified as developmental proteins are deregulated with a directionality indicating 
increasing development as a result of culture on the nanofibres (figure 5.13C). Proteins that 
promote proliferation/inhibit differentiation, induce neurogenesis in immature neurons and 
initiate neurite formation/arborisation were down-regulated (Pekovic et al, 2009; Moreb, 
2008; Fang et al, 2012; Dhaliwal et al, 2016; Broeke et al 2010; Leondaritis et al, 2015; Hamada 
et al, 2017; Brudvig et al, 2018), suggesting a more mature, differentiated neuronal culture 
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upon the nanofibres. The downregulation of ribosomal proteins and proteins involved in 
protein synthesis, also observed by the previously mentioned Marote et al (2016), is a further 
indication of the more advanced nature of the organoids; ribosomal proteins are 
downregulated throughout forebrain development (Chau et al, 2018).  Conversely, up-
regulated proteins had notable roles in radial migration/lamination of the cortex, fasciculation, 
guidance and growth of axons and neuronal polarisation (Jaglin et al, 2009; Wu et al, 2016; Ip 
et al, 2014; Inatani et al, 2001; Inoue et al, 2018; Haenisch et al, 2005; Latremoliere et al, 2018), 
indicative of development of physiological cytoarchitecture although immunohistochemistry 
is required to support this. 
Up-regulated proteins Down-regulated proteins 
Function Protein(s) References Function Protein(s) References 
Radial 
migration/cortical 
lamination  
Rab18, 
Dpysl2, 
Tubb2B, Ncan, 
DBNL, NOVA1, 
NSDHL 
Jaglin et al, 2009; Wu et al, 
2016; Ip et al, 2014; 
Inatani et al, 2001; Inoue 
et al, 2018 ; Störchel et al, 
2015; Xin et al, 2017 ; Hu 
et al, 2018 ; Cunningham 
et al, 2009 
 
Promote 
proliferation/inhibit 
differentiation  
Phb2, 
IMPDH2, 
Aldh2 
Kowno et al, 2014; 
Pekovic et al, 2009; 
Moreb, 2008 
Axon fasciculation, 
guidance and growth 
CNTN1, Ncan, 
Tubb3 
Haenisch et al, 2005; 
Inatani et al, 2001; 
Latremoliere et al, 2018 
Induce 
neurogenesis in 
immature neurons  
Dcx, 
HMGB1 
Fang et al, 2012; 
Dhaliwal et al, 2016 
Neuronal polarisation DBNL, Dpysl2 Inoue et al, 2018; Ip et al, 
2014 
Initiate neurite 
outgrowths and 
promote 
arborisation 
Marcks, 
Stxbp1 
Broeke et al 2010; 
Leondaritis et al, 2015; 
Hamada et al, 2017; 
Brudvig et al, 2018 
Table 5.7: Developmental proteins and their ascribed functions  
129 
 
5.4.3 Elucidation of the mechanism that promotes organoid 
formation 
The regression analysis of Chapter 4 (figure 4.6) suggests a relationship between the clustering 
behaviours and neurite outgrowth/fasciculation whilst proteomics thus far has heavily 
emphasised the highly developed nature of the organoid. Four gene ontologies were chosen 
to investigate whether the clustering of cells, bundling of neurites and neurite outgrowth 
influences the development of the organoids. “Adhesion” was chosen as a proxy for cell 
clustering as loss of cell-substrate adhesion/gain of cell-cell adhesion promotes the clustering 
of neurons (Limongi et al, 2013). “Neuron projection” was chosen to represent the neurite 
extension and fasciculation, “synaptic” was chosen due to the key role of SNP-25 in the 
interactome (figure 5.9) whilst “developmental” was selected due to the previous proteomic 
analysis. 
Neurons cultured upon the nanofibres exhibited reduced expression of cell-substrate adhesion 
proteins (Marcks, Arpc2) (Estrada-Bernal et al, 2009; Rotty et al, 2017) and an increase in 
expression of proteins that inhibit adhesion (catalase) (Yata et al, 2009). In contrast, changes 
to the proteome associated with dynamic adhesion and cell-cell interactions were observed 
(Prdx2, vimentin) (Park et al, 2011; Ivaska et al, 2007). The alterations to the proteome reflect 
the observed clustering behaviours of the cells described in Chapter 3 and 4; the loss of cell-
substrate adhesion is counter-balanced by increased cell-cell adhesion (Limongi et al, 2013; 
McCain et al, 2012), facilitating the increased migration and soma clustering behaviours (Segev 
et al, 2003).  
Upon clustering, the previous assumption of Chapter 4 was that the clustering stimulated the 
extensive neurite outgrowth through ligand-receptor interactions of cell surface ligands of the 
neurites. Figure 5.9, table 5.4 and figure 5.14 contradict this and suggest that synapse 
development is key to the observed behaviours of the neurons grown on the nanofibres. The 
majority of the strongest interactions of the interactome are all inhibitory and target SNP25, a 
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synaptic protein (figure 5.9). Additionally, synaptic proteins and neuron projection exhibited 
the highest degree of overlap with other gene ontologies (figure 5.14) and had the highest 
percentage of strongest influencers relative to other gene ontologies (table 5.5).  
 
Peter’s rule states that connectivity of neurons (via synapses) can be predicted based on the 
coincident availability of axons and dendrites (Peters et al, 1979; Braitenburg and Schüz, 1998); 
proximity generates synapses. For decades, the rule was quantitatively untested but recent 
validation of the rule demonstrated ≈ 85% accuracy in the entorhinal cortex and ≈ 100% 
accuracy in the hippocampus (Rees et al, 2017). Thus, the mechanism of generating the 
organoids is proposed to be induction of soma clustering due to limited adhesion of cells to 
the surface and promotion of cell-cell adhesion, subsequent fasciculation of neurites and 
generation of a number of synapses significantly higher than a conventional dispersed 2D 
culture due to the proximity and overlap of the neurite arbors. The subsequent proteomic 
changes to synaptic and neuron projection proteins are then able to drive the developmental 
changes that are observed due to the multi-functionality of the proteins (figure 5.14). The 
changes to morphology observed in Chapter 4, figure 4.4 corroborate this; all morphological 
features appear to follow a linear trend until day 7, at which point, neurite length, neurite 
bundle diameter and cell cluster diameter all exhibit a robust increase in the rate of growth. 
At approximately 7 DIV, synapses are mature and neurons become electrically active. 
 
5.4.4 Network analysis 
Global analysis of the network using Cytoscape validated the hypothesis that the organoid 
formation may be inducing a more developed profile within the cortical neurons; gene 
ontologies associated with development were significantly overrepresented (figure 5.4 and 
table 5.1). Betweenness centrality (BC) was used to explore the network further. Betweenness 
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centrality measures the degree to which a protein acts as a “hub” or bridge within the network. 
It is measured by calculating the shortest path length between each protein pair in a network 
and calculating what proportion of them pass through a third protein. The greater the 
betweenness centrality, the greater the protein's ability to act as a hub (Melak and Gakkhar, 
2015). This analysis serves to identify widely influential although potentially weak influencers 
within the system that are inducing the observed developmental changes. Within the results 
of the betweenness centrality analysis, the 10 proteins that were detected were all involved in 
processes such as development, polarity and synaptic plasticity and showed upregulation 
(table 5.2). Sub-networks were generated to determine the influence of the well-connected 
proteins on developmental proteins. Ribosomal proteins are known to decrease throughout 
forebrain development (Chau et al, 2018); the majority of the proteins with high BC exhibit 
strong influence on the ribosomal proteins, predominantly negative influence (figure 5.8). In 
contrast, the influence of high BC proteins on the developmental proteins is mixed (figure 5.7). 
Tars and RPL35a exert wide ranging negative influence, although their role in reducing protein 
synthesis may be key to explaining this negative influence of protein expression (Chau et al, 
2018; Uniprot). NOVA1, MAP1B, MYG1 and PDHB exert strong positive influence on 
developmental proteins and thus may represent targets that are crucial to the generation of 
the developed organoid proteome (figure 5.7). These proteins could be exploited to modulate 
the development of the organoid; to enhance or reduce development, in order to target 
specific developmental stages for research. In contrast, NSDHL, GOLGA2 and PSMD9 exhibit 
relatively negligible connectivity with the identified proteins, developmental or ribosomal 
(figure 5.7 and 5.8). NSDHL itself was identified as a developmental protein (figure 5.13) 
whereas GOLGA2 and PSMD9 have roles in asymmetric cell division and positive regulation of 
transcription respectively (Uniprot). Whilst they are important nodes within the network, they 
are not involved directly in development. 
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Analysis of the strongest influencers of the interactome demonstrated that SNAP-25, Dpyl2 
and RTN4 were key signalling nodes within the system; all of the strongest interactions were 
centred on downregulating these proteins, implying that the regulation of these proteins 
facilitates the greater changes that are observed. This was explored further by generating 
targeted interactomes, focused on these 3 nodes. Interactions up and downstream of these 
proteins were investigated. Referring to figures 5.11A and 5.11B, significant difference 
between interactions was maintained to a much greater degree for proteins that were 
upstream of the key nodes than they were for the average protein CISY, suggesting that it is 
the regulation of the proteins rather than the proteins themselves that are vital to the 
formation of the organoid. Further, within the expanded interactome network for each protein, 
a greater degree of convergence was observed with significantly fewer unique proteins 
appearing in the interactome networks upstream of the key nodes (figure 5.11C). Convergence 
within protein-protein interaction networks is indicative of a non-random network, a point of 
the signalling network that is important to the overall mechanism (Weßling et al, 2014) and 
thus, the expanded interactome identifies potential influencers for individual proteins that 
may not possess the strength of interaction to be considered a key node in the initial global 
network analysis but play a role for the individual nodes. These secondary nodes include 
MAP1B, a marker for synaptic plasticity (Tortosa et al, 2011), Myg1, a protein that is putatively 
associated with neuronal differentiation (Phillips et al, 2009), and FAF1, a protein associated 
with neurodevelopmental apoptosis (De Zio et al, 2008). 
 
5.4.5 The epithelial-mesenchymal transition (EMT), 
developmental process and integration into the endogenous 
circuitry of the host 
The epithelial-mesenchymal transition (EMT) is a process typically associated with cancer but 
plays other important physiological roles. Three types of EMT have been documented to date; 
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embryonic development (type 1), inflammatory, regenerative and in chronic cases, fibrotic 
processes (type 2) and cancer progression (type 3) (Kalluri and Weinberg, 2009). The three 
types of EMT are involved in distinct processes and whilst some variation is observed between 
the biochemical processes, a large number of signalling molecules are shared between them 
(Zeisberg and Neilson, 2009). 
 
Within the cerebral cortex, type 1 EMT occurs during the lamination of the cortex. The early 
neuroepithelium is comprised of columnar cells which generates the radial glial cells. During 
the development of the cortex, radial glial cells undergo indirect neurogenesis, with one 
progeny exhibiting ciliary components while the other becomes multipolar and exhibits EMT 
properties (Singh and Solecki, 2015). E-cadherin and adherens junctions that apically anchor 
neuronal progenitors to the ventricular zone are down-regulated and radial and tangential 
migration of the progenitors occurs (Singh and Solecki, 2015; Lamouille et al, 2014). Upon 
migration towards the cortical plate, polarised morphology is re-established as cell-cell 
contacts are re-established with the glial scaffolds that guide the migration of the progenitors 
(Famulski and Solecki, 2013). Maturation of the neurons then occurs as the soma translocates 
to the cortical plate and mature through interactions between the maturing neurons and the 
extracellular matrix, secreted molecules of neighbouring cells and cell-cell contacts with 
cortical plate neurons (Famulski and Solecki, 2013). The organoid that forms as a result of 
culture upon PLLA nanofibres demonstrated a 55.55% overlap with a neuroblastoma EMT 
model when investigating the directionality of the fold changes (figure 5.16). Linear regression 
was performed to quantify the relationship between the magnitude of the fold changes in the 
two datasets. A significant correlation was found between the two datasets although the 
correlation was weak (R2 = 0.048). This likely due to the use of protein data for the organoid 
and RNA data for the EMT dataset. One meta-study revealed that the average R2 value from 
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plots of mRNA and protein concentration for the same cells was 0.4 (Vogel and Marcotte, 
2012); quantitative comparison between the organoid data (primary neurons) to an EMT 
model (prostate cancer) would yield even lower correlation of global data. Thus, whilst the 
results are significant, the correlation is poor as the magnitudes of the fold change do not 
necessarily translate between mRNA and protein. Due to this, the semi-quantitative 
directionality of fold change is suggested to give a greater representation of cellular behaviours 
than the quantitative comparison. 
 
Key markers for EMT such as CADH and FINC were not detected within the mass spectrometry. 
Further validation would be needed to determine the degree to which the organoid formation 
captures the EMT-like process that occurs during corticogenesis. Targeted metacore analysis 
revealed deregulation of adherens junctions; the majority of the proteins associated with 
adherens junctions were downregulated as a result of neuronal culture on aligned PLLA 
nanofibres (figure 5.16C). A more targeted approach is needed to further determine the 
similarity of the mechanism to EMT-like corticogenesis. 
 
The epithelial-mesenchymal transition may also be indicative of the ability of the cells within 
the implant to integrate into host circuitry. Due to the role of EMT in the wound healing process, 
it has been suggested as a means of characterising wound healing in transplantation studies, 
however, elevated levels of EMT markers are associated with rejection and fibrosis (Fintha et 
al, 2019). This is proposed to be due to two factors; overactive EMT increases the proliferation 
of myofibroblasts that contribute to inflammation and partial EMT, resulting in de-
differentation of cells without subsequent re-differentiation (Fintha et al, 2019). A partial EMT 
phenotype is observed for cells of the organoid; both mesenchymal markers (vimentin) and 
epithelial markers (multiple keratins) are expressed. A partial EMT phenotype has been 
135 
 
observed for cells migrating in clusters (Aiello et al, 2018). Previous chapters discuss the 
formation of organoids as being dependent on basin collapse and the migration of clusters 
towards each other. The partial EMT phenotype that is present within the organoid may be 
necessary to facilitate the assembly, yet that same partial EMT phenotype is suggestive of 
elevated capacity for fibrosis and rejection upon implantation. Within the CNS, glial scarring is 
the fibrosis associated with injury and chronic inflammation and is an inducer of localised 
neurodegeneration (McConell et al, 2009). However, transplantation studies that investigate 
the partial EMT phenotype typically use adult kidneys and lungs as a tissue source (Fintha et 
al, 2009), tissues which vary significantly from embryonic neurons. Limited transplantation 
studies have been done with neurons and data is scarce; it is unclear whether these trends will 
be reflected in neurons as well as kidneys and lungs. 
5.4.6 Metabolic changes 
Extensive changes to the mitochondrial proteome were also observed for neurons cultured 
upon the PLLA nanofibres. The observed changes to the metabolism of the cell are likely due 
to the abundance of lactate that occurs upon degradation of poly-L-lactic acid nanofibres 
(Santoro et al, 2016) in addition to the altered differentiation state induced by the fibres. 
 
 Lactic acid has previously been discussed as a bioactive molecule with beneficial properties to 
the implanted cells, including promotion of angiogenesis, wound healing, neuroprotection and 
suppression of inflammation (Sun et al, 2017). Lactic acid is also buffered to lactate which can 
be used as an energy substrate by neurons to perform oxidative phosphorylation and generate 
ATP in the absence of glucose, likely the cause of the metabolic changes observed in figure 
5.15A (Mason et al, 2017). 
 
136 
 
Neurons cultured on the nanofibres appear to exhibit a shift away from aerobic glycolysis as a 
source of ATP in favour of alternative mechanisms. Acat1, FABP7 and Dbi are involved in the 
conversion of ketones to acetyl Co-A and storage of acetyl Co-A respectively (Bouyakdan et al, 
2015; Pfieger and Ungerer, 2011) and were up-regulated, circumventing glucose-dependent 
production of acetyl Co-A to a degree. Conversely, LDHa increases glucose uptake (Zhang et al, 
2017), Rap1b is expressed as a defence against hyperglycaemia (Sun et al, 2008) and GAPDH is 
involved in gluconeogenesis and these aerobic glycolytic proteins were all down-regulated. In 
contrast to the proteins of aerobic glycolysis, the majority of detected proteins involved in 
oxidative phosphorylation were upregulated (figure 5.15B). Proteins involved in oxidative 
phosphorylation typically increase during differentiation of the cerebral cortex (Agostini et al, 
2016), although there are some exceptions (Zheng et al, 2016). Approximately 92% of proteins 
appear to exhibit deregulation in the direction that would be expected of increasing 
differentiation (figure 5.15B), further supporting the hypothesis that the organoids are more 
differentiated than their 2D counterparts. 
 
 The decrease in aerobic glycolytic proteins may be explained by the differentiation and 
development of the neurons. Both predicted and measured aerobic glycolysis increases in the 
early developing brain and decreases to a steady baseline in adult life (figure 5.15B; Goyal et 
al, 2014). These results suggest that the decrease in aerobic glycolytic proteins appears to 
indicate that the cortical neurons are more developed than the neurons grown in 2D, 
appearing to further support the developmental hypothesis. However, whilst this trend is true 
for the whole brain, neotenous regions of the brain, including the cerebral cortex, are noted 
for being exceptions to the rule of decreasing glycolysis during maturation; within the cerebral 
cortex, aerobic glycolysis increases during development and plateaus due to the high plasticity 
of the region (Goyal et al, 2014). The study notes that decreasing glycolysis in the cerebral 
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cortex is associated with reduced plasticity and growth of spines but is correlated with 
maintenance and stability of spines. It is possible that culture on the nanofibres may decrease 
the plasticity of the neurons contained within the system. Whilst this is not necessarily an issue 
if the organoid were to be used for a high throughput in vitro cell culture for toxicology, 
pharmacology, etc, it represents a hurdle for the use of the organoid for implantation as the 
organoid would form a closed-circuit and would poorly integrate in to the existing host circuitry. 
Further research is required to determine the exact cause of the decrease expression of 
glycolytic enzymes and whether this relates to the plasticity of the neurons within the organoid. 
Additionally, the shift towards oxidative phosphorylation suggests a greater dependence on 
oxygen. Upon implantation, one of the greatest causes of death for exogenous cells is the lack 
of vascularisation and subsequent ischaemia that results (Sortwell et al, 2000). Whilst lowering 
the glycolytic capacity and increasing the oxidative phosphorylation capacity may indicate well 
for the differentiation aspect of the neurons, it is a poor indicator for the survival of neurons 
within the implant. 
 
5.4.7 Evidence for lamination within the organoid 
Discussed previously in Chapter 1, the lamination of the cortex has been theorised to play a 
role in maximising spatial efficiency and temporal synchronisation of action potentials through 
control of the length of the neurons utilised by a neuronal ensemble during activity. Whilst 
mass spectrometry does not yield any spatial information of protein expression or tell us about 
the cytoarchitecture, the proteomic profiles warrant further investigation in regards to 
lamination. In the nanofibre sample, 9 proteins associated with lamination of the cortex were 
upregulated whilst 4 were down-regulated. Four additional proteins associated with 
lamination were expressed by the neurons of the nanofibre sample (table 5.6). Of note, down-
regulated proteins were involved in more gene ontologies than up-regulated proteins (table 
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5.5). Whilst the sample size is limited, the relevance of this is illustrated by the decreased 
expression of Marcks. Marcks is a multi-functional protein with roles in a diverse array of cell 
signalling pathways. The expression of Marcks, a marker of cortical lamination, is decreased, 
Marcks also plays a role in adhesion (figure 5.13A) and may have been down-regulated as a 
result of the reduced adhesion on hydrophobic nanofibres. Whilst the expression of cortical 
lamination markers is inconsistent, a trend is observed that is suggestive of cortical lamination 
on the nanofibres that is limited in the control. The absence of consistency indicates that whilst 
the nanofibres promote a near physiological developmental mechanism, it is not entirely 
accurate. Additional immunostaining to determine the cytoarchitecture of the neurons within 
the neurons will be required to further quantify the architecture and investigate the spatial 
expression of lamination markers further. Alternately, mass spectrometry imaging would be a 
powerful molecular technique to probe the expression of proteins in a spatial manner.  
 
5.4.8 Unique proteins  
Twenty-four proteins were detected that were uniquely expressed in the lysates gathered from 
the nanofibres that were not detected for the control whilst for the control, 501 proteins were 
detected that were not detected in the nanofibre lysates (figure 5.17A). Enrichment using 
bioinformatics tools revealed similarities to the pattern of increasing development that was 
revealed with the quantitative mass spectrometry data (figure 5.17B); 27% of unique proteins 
have a role in nervous system development whilst 15% play a role in cytoskeletal organisation. 
In addition to the observed changes to nervous system development and cytoskeletal 
organisation, metabolism again appears as a systemic process that is altered by culture of 
primary cortical neurons on the nanofibres. 
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5.4.9 Limitations to characterisation using proteomic analysis 
Significant alterations to the proteome were observed due to culture on the nanofibre 
substrate. These were attributed to the increased cell clustering and an intrinsic synaptic-
driven developmental program. However, numerous factors have changed due to the use of 
nanofibres and attributing the proteomic changes to any one factor would be reductionist. As 
previously mentioned, the PLLA nanofibres degrade to lactic acid, a bioactive molecule (Sun et 
al, 2017). Nanofibres have different mechanical properties (conductivity, porosity, Young’s 
modulus, etc) to tissue culture plastic (Hosseinkhani et al, 2014); alterations to mechanical 
properties have demonstrated a wide range of effects on cellular behaviours (Saha et al, 2008; 
Chao et al, 2009; Yang et al, 2005). Three-dimensional culture is yet another factor that is able 
to contribute towards alterations in cell behaviours and protein expression (Irons et al, 2008). 
Thus, untangling the exact causative mechanism behind the development of the organoids is 
difficult and defining to what degree each factor contributes towards the final proteome would 
require a significant degree of further study and analysis. 
 
5.4.10 Future directions 
Mass spectrometry served to elucidate the mechanism of organoid formation and characterise 
the organoid but it also highlighted other avenues of research that require pursuing further; 
most notably the alterations to the metabolism of the cortical neurons and the lamination of 
the organoid.  
Neurons cultured upon the nanofibres exhibited an increase in proteins within the electron 
transport chain and an apparent shift away from glycolysis and towards fatty acid/lactate 
based metabolism. An increase in the expression of electron transport chain proteins may be 
a result of an increased number of mitochondria or an increase in expression of these proteins. 
Labelling of the mitochondria with a specific dye such as Mitotracker would allow for 
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quantification of mitochondrial number and mitochondrial fission/fusion as a means of 
assessing normal mitochondrial function (Waterham et al, 2007). The apparent shift from 
glycolytic to free fatty acid/lactate metabolism is an additional avenue that warrants further 
characterisation. Post-implantation into a host, exogenous neurons undergo apoptosis due to 
a range of factors including an energy deficit due to poor vascularisation (Sortwell et al, 2000). 
An organoid that can utilise lactate as an energy source, implanted on a scaffold that degrades 
to lactate, would be highly beneficial as a greater number of neurons may survive implantation 
as a result of the metabolic shift.  Further research is required on the metabolic capabilities of 
the organoid. 
Lamination has been touched upon previously; upregulation of markers of lamination is 
evident. Whilst the individual neurons may be expressing a molecular profile that is 
increasingly laminar, the laminar structure of the brain is comprised of many neurons, 
complexed into a tissue-wide architecture. Further work is needed to determine whether the 
increased expression of laminar markers induces a more representative profile at a single-cell 
level or induces the formation of a laminar tissue. 
 
5.5 Conclusion 
Proteomic analysis of the organoids aided in the characterisation of the organoid and 
elucidation of the mechanism of organoid formation but raised as many questions as were 
answered. Significant efforts must be made to explore the organoid further to determine the 
precise degree of similarity of the organoid to the in vivo developing cerebral cortex. In an 
effort to characterise their own cerebral cortical organoid, Camp et al (2015) employed single 
cell RNA-seq and advanced bioinformatics to characterise their organoid against human fetal 
cerebral cortex. Similarly, multiple time points would be necessary to monitor the 
development over time as proteins may not exhibit linear trends.  
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Similarity between exogenous and endogenous neurons for the purposes of integration into 
existing synaptic circuitry has been discussed previously (Chapter 1). Proteomic analysis has 
demonstrated a shift towards a more developed, increasingly plastic culture of neurons by 
culturing cortical neurons on aligned PLLA nanofibres, suggesting a benefit of 3D culture to 
developing an implant to facilitate cortical rewiring. 
 
 
 
 
 
 
 
 
 
 
 
 
142 
 
Chapter 6: Characterisation of the Organoid using 
Nanostring nCounter Analysis 
6.1 Introduction 
Further molecular characterization of the organoid was performed using the Nanostring 
platform. The Nanostring platform quantifies hundreds of target mRNA molecules using 
reporter probes. Each reporter probe has 35-50 bases that are specific to the target gene and a 
fluorescent barcode specific to the target. Reporter probes are allowed to hybridise with mRNA 
of the sample and then immobilized and using an electrical current, aligned within the nCounter 
cartridge. To quantify the expression level of a specific gene, the number of barcodes specific 
to the target gene is counted within the cartridge and tabulated (Kulkarni, 2011). Due to the 
specificity of RNA/probe binding, Nanostring quantification was employed to enhance the 
specificity of the characterization of the organoids relative to the shotgun approach of mass 
spectrometry. 
6.2 Methods 
6.2.1 RNA isolation 
RNA was isolated from primary cortical neurons on day 11 of growth on a control surface (poly-
l-lysine and laminin, described Chapter 2) or aligned PLLA nanofibres (described Chapter 2). 
 
RNA was extracted using a Zymo RNA miniprep kit. Briefly, cells were lysed using RNA lysis buffer 
which was subsequently diluted with an equal volume of ethanol (99%) and vortexed. The 
mixture was transferred to the Zymo spin columns and centrifuged, flow through was discarded. 
RNA Prep Buffer (400uL) was added to the column and centrifuged, discarding the flow through. 
RNA Wash Buffer (700uL) was added to the spin column which was centrifuged and the 
flowthrough discarded. In column DNase treatment was performed. DNase I (40µl) was added 
to each of the columns, incubated at room temperature for 15 minutes before proceeding to 
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the next washing step. RNA Wash Buffer (400uL) was added to the columns and centrifuged for 
2 minutes to ensure that the wash buffer was removed. The column was then transferred to an 
RNase free tube and 50uL of RNase free water was added to the column and used to elute the 
RNA upon centrifugation. All centrifugation was performed at 12,000g for 30 seconds at room 
temperature unless stated otherwise. RNA was stored at -80oC until use. 
 
6.2.2 RNA concentration and purification 
Zymo RNA Clean and Concentrator kit was used to purify the RNA and concentrate the samples 
for use with the Nanostring. Briefly, dilute RNA samples were diluted in RNA Binding Buffer at a 
2:1 ratio and mixed. An equal volume of ethanol (99%) was added and mixed. The sample was 
then transferred to a Zymo spin column and centrifuged for 30 seconds, discarding the flow 
through. RNA Prep Buffer (400uL) was added to the column and centrifuged, discarding the 
flowthrough. RNA wash buffer (700uL) was added to the column and centrifuged, discarding the 
flowthrough. RNA Wash Buffer (400uL) was added to the column which was centrifuged for 2 
minutes to ensure total removal of the buffer. The spin column was then transferred to an 
RNase free collection tube and RNA was eluted by addition of 6uL of RNase free water and 
centrifugation.  All centrifugation was performed at room temperature at 12,000g for 30 
seconds unless stated otherwise.  
 
6.2.3 RNA Quantification  
RNA quantification was performed using a Nanodrop 8000 for both the purity and the 
concentration. A 260/280 ratio between 1.8 and 2.1 and a 260/230 ratio of between 1.8 and 
2.1 was within the range for use on the Nanostring. RNA concentration was required to be 
greater than 25ng/µl. Samples were stored at -80°C until usage.   
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6.2.4 Nanostring nCounter XT Gene Expression Assay for Gene 
Expression Profiling 
For the Nanostring nCounter assay, 8 samples were extracted with the purity required. The 
murine Neuropathology profiling panel was used, consisting of 760 genes that were functionally 
annotated by Nanostring. Samples (150ng total RNA) were hybridized for 20 hours at 65°C with 
8µL of reporter probe and 2µL of capture probe. After hybridization, excess probe was removed 
from the samples using an nCounter Prepstation and magnetic beads. Samples were then 
immobilized on a streptavidin-coated cartridge. The cartridge was then scanned using an 
nCounter digital analyser to gather raw data which was then processed using Nanostring’s 
nCounter Advanced Analysis Software (v.4.0). Normalisation was performed using housekeeper 
genes selected from the dataset that exhibited the lowest degree of variation. Quality control 
checks were performed within the software; no samples were flagged as needing to be removed 
from analysis. Differential Expression, Cell Type Profiling and Pathway analysis were all 
performed using the nSolver Advanced Analysis module (V.2.0.115) once normalization had 
been performed. Significant deregulation of genes was confirmed if a Benjamini-Yekutieli p 
value was less than 0.05.  
 
6.2.5 Orthogonal Validation 
Several genes overlapped between the mass spectrometry and the Nanostring panel. 
Regression analysis was used to determine the degree of correlation between observed fold 
changes for the protein and RNA, as quantified by mass spectrometry and Nanostring nCounter 
assay respectively. 
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6.2.6 Artificial Neural Network Inference (ANNI) 
Network inference was performed using the ANNI described in Chapter 5 using the previously 
described methodology. Data input into the ANNI consisted of 152 significantly deregulated 
genes. Data was then visualized in Cytoscape and the BiNGO plugin was used to determine 
enriched gene ontologies amongst the deregulated genes.  
 
6.3 Results  
Orthogonal validation was attempted for the Nanostring; overlapping proteins between the 
mass spectrometry dataset were compared to the Nanostring dataset to determine the degree 
of correlation. Poor correlation was observed (figure 6.1). Further validation of this dataset is 
needed.  
 
 
 
 
 
 
Figure 6.1: Orthogonal validation. No validation was possible using the mass spectrometry dataset for the Nanostring. 
All deregulated genes were compared to protein fold changes at varying stringency levels (A) Correlation between 
deregulated genes and proteins with >70% confidence value within the mass spectrometry dataset (B) Correlation 
between deregulated genes and proteins with >50% confidence value within the mass spectrometry dataset (C) 
Correlation between deregulated genes and any protein detected within the mass spectrometry dataset  
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The Nanostring nCounter analysis annotates its genes with processes associated with each of 
the genes including plasticity, development and ageing (figure 6.2A), neurotransmission (figure 
6.2B), neuron-glia interaction (figure 6.2C), neuroinflammation (figure 6.2D), structure and 
compartmentalization (figure 6.2E) and metabolism (figure 6.2F). Of the described processes, 
all showed extensive down-regulation of genes.  
 
Figure 6.2 illustrates the directionality of the fold change but does not illustrate how the genes 
are affecting the listed process. Global significance score was used as a metric to understand 
how processes were affected; if a gene with inhibitory activity within a process exhibits 
decreased expression, that process is stimulated. The distinction is not captured by heatmaps. 
Figure 6.3A visualizes the shift in various processes from the control to the organoid whilst figure 
6.3B exhibits their global significance score. All processes other than “Neuronal Cytoskeleton” 
showed a negative fold change for the organoid relative to the control (figure 6.3A). However, 
referring to figure 6.3B, carbohydrate metabolism also displays an overall increase in activity. 
For each of the processes, replicates are displayed in figure 6.4. Interestingly, data from the 
organoids appears more homogenous than the controls for all of the tested processes.  
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Significant alterations were observed for many of the neural cellular sub-populations. Whilst 
neurons did not exhibit a significant fold change (figure 6.6 and 6.7A; t(6) = 1.09, p = 0.41872), 
all other cell types did (Astrocytes, figure 6.7B; t(6) = 2.578, p = 0.041872. Oligodendrocytes, 
figure 6.7C; t(6) = 7.314, p = 0.0003333. Microglia, figure 6.7D; t(6) = 7.718, p = 0.000369. 
Endothelial cells, figure 6.7E; t(6) = 5.893, p = 0.00106).  
 
 
 
 
 
 
 
Figure 6.6: Molecular quantification of sub-population within the CNS. (A) Line graph representation of the fold 
changes of the cellular sub-populations (B) Heatmap visualisation for each of the replicates for each of the cellular 
sub-populations. 
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Figure 6.7: Box plots for each of the cell populations. Unpaired t-tests were used to test for significance (A) Neurons 
exhibited no significant difference between cell counts for the control and the aligned PLLA nanofibres (t(6) = 1.09, 
p = 0.41872) (B) A significant decrease in astrocytes was observed due to culture of the neuron on PLLA nanofibres 
(t(6) = 2.578, p = 0.041872)  (C) A significant decrease in oligodendrocyte count was observed for cells cultured on 
aligned PLLA nanofibres (t(6) = 7.314, p = 0.0003333) (D) A significant decrease in microglia  was observed due to 
culture of the neuron on PLLA nanofibres (t(6) = 7.718, p = 0.000369) (E) A significant decrease in endothelial cell 
count was observed due to culture of the neuron on PLLA nanofibres (t(6) = 5.893, p = 0.00106)  
Network analysis was performed for the Nanostring data using the same method that was used 
for the mass spectrometry data. The interactome of the 50 strongest influencers were visualised 
using Cytoscape (figure 6.8A). Within this network Aif1, Des and Ipcef1 were identified as key 
signalling hubs due to the extent of their signalling to other genes. Within this network, 
significantly overrepresented gene ontologies were identified using the BiNGO plugin of 
Cytoscape (figure 6.8B). The majority of processes appear to play a role in electrochemical 
activity; via synapses or ionic homeostasis.  
A B C 
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The nodes that were identified as signalling hubs (Aif1, Des and Ipcef1) were investigated to 
elucidate possible functions that they use to exert their influence (Table 6.1). Aif1, Des and 
Ipcef1 were identified as hubs that are involved in regulating neuroinflammation and oxidative 
stress.  
 
Table 6.1: Summary of the sub-networks of important nodes identified in figure 6.8 
6.4 Discussion 
6.4.1 Correlation 
Orthogonal validation was used to validate the Nanostring analysis; mRNA expression compared 
against protein. The correlation between mRNA and protein was notably poor although is 
comparable to values observed for postnatal neuronal development (Breen et al, 2018); weak 
correlation is typically observed for dynamic systems in development. A weak negative 
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correlation was observed for the 3 stringencies of correlation (figure 6.1) and no significance 
was observed between RNA expression and protein expression. Interestingly, the ANNI data 
from the previous chapter (Chapter 5, figure 5.12) demonstrated that all of the strongest 
influences within the detected proteome were negative influences, forecasting downregulation 
of proteins.  The mRNA profiles of the organoid at a comparative time point are in agreement; 
the majority of mRNAs are downregulated and a negative correlation is observed although no 
significance was detected. Quantitative PCR or gene arrays would be required to validate the 
dataset.  
 
6.4.2 Mechanism of formation of the organoid 
Chapter 5 details the evidence for the hypothesised mechanism of formation of the organoid; 
close proximity induces synapse formation which drives development. In contrast to this, the 
Nanostring data exhibits a decrease in markers associated with plasticity and development 
(figure 6.2A), neural connectivity (figure 6.3B, 6.4N), axon and dendrite structure (figure 6.3B, 
6.4E), neurotransmitter release (figure 6.3, 4S), synthesis and storage (figure 6.3B, 6.4U) and 
vesicle trafficking (figure 6.3B, 6.4X). Whilst the two datasets appear contradictory, the 
temporal dynamics of gene expression and the ANN data aid in elucidating the mechanism. 
Whilst the proteome represents the present behaviours of the cell, the transcriptome 
represents what the cell will do; the future of the cell. The poor correlation between the two is 
frequently observed for dynamic and developing systems (figure 6.1A-C) (Breen et al, 2018). 
The mass spectrometry data in Chapter 5 exhibits upregulation of the synaptic protein SNP-25 
as a key regulator of the observed effects. In figure 5.9 of Chapter 5, the interactome exhibits 
mass negative influence on SNP-25; the interactome appears to be to pruning the synapses and 
reduce the total synaptic count. Within the Nanostring data, the mRNA displays an overall 
decrease in neural connectivity and synaptic behaviours (figure 6.2A, 6.5B, 6.5G, 6.5I, 6.5J, 6.5L), 
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validating the predictions of the ANNI. Similarly, within the mass spectrometry an up-regulation 
of RTN-4 was observed; a protein that plays a role in reducing axon branching and facilitating 
axon fasciculation (Uniprot). Within the Nanostring data, axon and dendrite structure were 
observed to decrease on the global significance scores (figure 6.3B), indicative of a reduction in 
growth and pruning of the axon. The expression of proteins detected by the mass spectrometer 
and interactions within the system predicted by the ANNI are observed to have a knock-on 
effect on to the transcribed mRNA that were detected by the Nanostring.  
 
The overgrowth of synapses and axons and subsequent pruning of the neural circuitry is a 
developmental process. The reason for this is yet unknown but allows for activity-dependent 
refinement of circuitry; regression is key to correct functionality (Riccomagno and Kolodkin, 
2015).  Evidence overwhelming indicates that synaptic pruning is occurring within the organoids 
at the time that the mRNA was extracted from the organoid. Synaptic mRNAs and neural 
connectivity genes were unanimously downregulated (figure 6.2A, 6.5B, 6.5G, 6.5I, 6.5J, 6.5L). 
Pathway analysis demonstrates downregulation of genes associated with glutamatergic, 
cholinergic, dopaminergic synapses (Appendix; table 7). Furthermore, many of these pathways 
overlap with and regulate the PI3K pathway, which was also detected independently of its 
involvement with other pathways. PI3K was shown to be negatively regulated in addition to 
being downregulated (Appendix; table 7); reduction in PI3K/Akt signalling has been documented 
to play a crucial role in both synaptic pruning and axonal pruning (Riccomagno and Kolodkin, 
2015). The processes of axonal and synaptic pruning are closely related, GSA analysis reveals a 
loss of “Axon and Dendrite Structure” (figure 6.3B). Proximity of neurites induces synapse 
formation (Peters et al, 1979; Braitenburg and Schüz, 1998). By reducing the axon and dendrite 
complexity and proximity, synaptic count is theoretically decreased.  
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Future work should aim to determine whether the synaptic pruning that is evident on the 
nanofibres is present in the control. Whilst it is possible that the nanofibres and the organoid 
recapitulate the developmental process of synaptic pruning, only one time point has been 
studied thus far. It is also possible that the neurons of the control underwent pruning earlier or 
later than the neurons of the organoid. Whilst the increase in synaptic protein expression, 
developed profile and greater proximity of the organoid suggests that they have generated 
more synapses and are thus more likely to undergo regressive synaptic pruning, it currently 
remains an unknown.  
 
6.4.3 Cellular sub-populations 
In Chapter 1, the various sub-cellular populations of the CNS were discussed. In brief, whilst 
neurons comprise the computational component of the CNS that leads to the overall 
functionality, oligodendrocytes and astrocytes are crucial supporting cells, providing metabolic 
and trophic support (Kandel, 2000). Endothelial cells also represent a key cellular sub-
population within the CNS that were not discussed previously, comprising the blood brain 
barrier, regulating the entry of immune cells, metabolites, drugs and ions in to the CNS (Johnson 
et al, 2018). Microglia resident macrophages within the CNS, and play a role in eliminating 
microbes, protein aggregates and synapses within the healthy and diseased brain (Colonna and 
Butovsky, 2017). Previous studies have demonstrated that the greater the similarity between 
exogenous and endogenous cells, the greater the degree of integration, thus by more closely 
mimicking the cellular populations, it is hypothesized that a greater degree of synaptic 
integration should be observed between endogenous circuitry and exogenous neurons. 
 
The Nanostring nCounter assay uses the abundance of several cell-specific genes to quantify the 
abundance of the cells themselves. By culturing dissociated cortex on the aligned PLLA 
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nanofibres, all cell populations were decreased in abundance (figure 6.6A) although this was not 
significant for neurons (figure 6.7A). Interestingly, this suggests that the significant increase in 
LDH that was observed previously (Chapter 4, figure 4.4) may be derived from the loss of non-
neuronal populations although further research is required as the nanofibres may have limited 
the proliferation rate of non-neuronal cells rather than increasing the cell death.  Astrocytes, 
oligodendrocytes, microglia and endothelial cells were all significantly decreased (figure 6.7B-
E). Whilst the mass spectrometry described in the previous chapter demonstrated an increase 
in developmental profile of neurons cultured on the nanofibres, the decrease in cellular 
heterogeneity of the culture may be a significant hindrance for the development of the implant. 
Use of astrocyte/oligodendrocyte/microglia/endothelial cell conditioned medium or a 
microfluidic system containing other cellular populations may be able to generate even more 
advanced physiological models for use as a high throughput in vitro model of the cerebral cortex.  
 
For an implant, the homogeneity of the neuronal culture is a double-edged sword. Astrocytes 
have demonstrated beneficial properties for exogenous and endogenous neurons upon 
implantation. One study found that co-culturing neurons with astrocytes prior to implantation 
aided in their differentiation and engraftment upon implantation (Roy et al, 2006). However, 
within a month of implantation, de-differentiation was observed, suggesting that exposure to 
soluble factors within the media in vitro were insufficient to maintain differentiation in vivo (Roy 
et al, 2006). In contrast, direct implantation of astrocytes in to a host with the endogenous 
neurons enhanced long term potentiation and propagated Ca2+ signals 3-fold faster than the 
control group (Han et al, 2013). A live cell population of astrocytes with positive feedback loops 
aids in the maintenance of some of the high level functions of the differentiated neurons but in 
the absence of these cell types, soluble factors appear to be able to partially replicate their 
effects. Wang et al (2016) provide a potential solution to the limited number of astrocytes 
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present on the nanofibres; the group attached glial derived neurotrophic factor (GDNF) to the 
surface of the nanofibres and observed increased engraftment of the attached neurons. 
Similarly, Low et al (2015) encapsulated retinoic acid and BDNF in to their nanofibres and 
attained sustained release of their molecules for up to 14 days. By doping GDNF or other 
neurotrophic factors in to the nanofibres, degradation of the fibres would lead to the release of 
the soluble factors that could serve to replace the missing astrocytes from the culture, 
potentially enhancing engraftment, differentiation and growth that has been limited by the 
homogenous culture. 
 
Oligodendrocyte count was observed to decrease (figure 6.6 and 6.7C) whilst genes associated 
with remyelination were also significantly reduced (figure 6.3B). White matter dysfunction is 
associated with numerous pathologies, affecting the temporal dynamics of neural networks 
(Nasrabady et al, 2018; Foong et al, 2000; Hattori et al, 2011), thus, due to their role in 
myelination and establishing neural dynamics through salutatory conduction, oligodendrocytes 
are a desirable feature of a cellular implant. Previous studies have shown oligodendrocytes aid 
in remyelination and functional repair (Faulkner and Keirstead, 2005), a desirable property for 
re-wiring studies. However, myelin is inherently inhibitory to neurite outgrowth and restricts 
neuronal plasticity (Silver et al, 2019). Thus, whilst remyelination is desirable, ideally, the 
process should occur after neurite growth and synaptic integration to prevent inhibition of the 
two processes. Within the cellular implant, low levels of oligodendrocytes during the initial 
implantation would be desirable with the potential second cellular delivery or stimulation of 
endogenous myelination to facilitate successful physiological re-wiring. Thus the decrease in 
oligodendrocyte count on the implant prior to implantation may be a desirable quality. The 
proposed mechanism for the loss of oligodendrocytes is discussed later in this chapter. 
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Microglia are effectors of both neurodegeneration and neuroprotection within the CNS during 
injury and regenerative processes. These distinctions appear to be due to distinct subclasses of 
microglia that are involved in early (M2 microglia) and late stages (M1 microglia); M1 microglia 
release inflammatory cytokines that can inhibit regeneration whilst M2 microglia secrete 
trophic factors and phagocytose toxic debris (Jin and Yamashita, 2016). Whilst activated 
microglia have been observed to decrease (figure 6.3B), no information on the subclass of 
microglia is available and based on cell count data alone, little can be inferred from this data 
about benefits or detriment to the implant. Further research is required however, as nanofibres 
have demonstrated the ability to polarise microglia to the anti-inflammatory phenotype (Pires 
et al, 2014) and the ANNI data suggests that the microglia represent a crucial effector in the 
observed changes to the organoid relative to the control (figure 6.8; Aif1).   
 
The observed decrease in endothelial cells is intriguing. Endothelial cell proliferation and 
differentiation is dependent on VEGF signaling (Mackenzie and Ruhrberg, 2012); an increase in 
VEGF should induce an increase in endothelial cell count, mass spectrometry showed an 
increase in VEGF (Chapter 5, figure 5.13). The absence of this increase in cell count is suggestive 
of cellular selection by the material itself; hydrophobic surfaces have previously been 
documented to inhibit endothelial growth (Ruardy et al, 1997). Upon implantation, rapid 
vascularization is desirable to limit hypoxia, ROS and ultimately, cell death (Sortwell et al, 2000). 
The global decrease in angiogenic markers (figure 6.3B) in addition to the decreased cellular 
profile of endothelial cells is a limitation to the implant although it should be noted that 
endothelial cells are rarely considered upon implantation of cells in to the CNS.    
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6.4.4 Network inference 
Within the interactome generated by ANNI and Cytoscape, 3 nodes are evident as crucial 
influencers; Aif1, Ipcef1 and Des. These 3 influencers are markers for microglia, ROS and 
pericytes respectively (Postler et al, 2000; Basu et al, 2012; Stapor et al, 2014).  
 
Aif1 is a marker for activated microglia and is downregulated, exerting negative influence on 
almost all genes that are connected with it. This hub appears to be associated with anti-
inflammatory effects, synaptic pruning and neuroprotection. Grik2 and Lrrk2 are both highly 
expressed by microglia (Yamada et al, 2006; Russo, 2019); the negative influence that Aif1 has 
on these two markers is likely just due to the loss of total microglia that is observed in figure 6.6 
and 6.7D. Similarly, Tmem119 and Fgf14 are markers for specific sub-types of microglia; 
macrophage derived microglia (Satoh et al, 2017) and satellite microglia respectively (Baalman 
et al, 2015). Whilst the loss of total microglia likely explains the negative influence that microglial 
marker Aif1 has on Tmem119, Fgf14 shows increased expression while strong negative 
influence is exerted on it (figure 6.8). Satellite microglia reside at the axon-initial segment of 
neurons and are theorised to play a role in synaptic pruning (Baalman et al, 2015), suggesting a 
possible increase in synaptic pruning. However, microglia are vital to the synaptic pruning of 
inhibitory synapses on Pvalb expressing GABAergic neurons (Chen et al, 2014; Nakayama et al, 
2018); loss of microglia (figure 6.6 and 6.7D) does exert a negative influence on Pvalb in figure 
6.8, suggesting a loss of inhibitory synaptic pruning. Microglia-dependent synaptic pruning is 
poorly characterised currently but Baalman et al (2015) suggest that microglia are heterogenous 
and many sub-populations may exist. The data appear to suggest that microglia are mediating 
pruning in different compartments for different sub-populations of neurons although extensive 
further characterisation is needed. Avp potentiates inflammatory markers (Szmydynger-
Chodobska et al, 2010); loss of activated microglia, as indicated by figures 6.3B and 6.4A, 
supports the negative influence that is exerted on Avp. Hdac7, Tnr and CamkiiD are all genes 
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that are expressed in response to inflammation; decreased activated microglia is indicative of 
decreased inflammation should exert negative influence on them, which is observed from Aif1 
(figure 6.7). However, their overall expression is still increased despite the negative influence, 
suggesting other influencers on their expression. Interestingly, 2 of the genes are 
neuroprotective via modulation of microglia activity (Tnr and HDAC7) (Genade and Lang, 2014; 
Kannan et al, 2013) whilst the literature only suggests that the third gene (Camkiid) is 
neuroprotective with little characterisation for the mechanism (Ye et al, 2019). Whilst a 
mechanism has not been determined experimentally, Camkiid has been observed to modulate 
expression of NF-κB (Shih et al, 2015) which is a known activator of microglia (Popiolek-Barczyk 
and Mika, 2016); the ANNI may have predicted a possible mechanism for Camkiid 
neuroprotection that has not yet been tested experimentally.  
 
Des is a marker of pericytes; pericytes control blood flow and are vital in the vascularization 
process (Stapor et al, 2014). Des is a secondary hub associated with anti-inflammatory effects. 
Under pathological conditions, pericytes can differentiate towards an inflammatory microglial 
fate (Sakuma et al, 2016). Increased expression of Des results in negative influence on Grik2 and 
Scn1a, which are both highly expressed in activated microglia (Yamada et al, 2006; Thei et al, 
2018), limiting inflammation. Additionally, Tnfrsf12a (a TNF receptor), PI3K and Tnr expression 
are all induced by inflammation (Gomez et al, 2016; Rustenhoven et al, 2017; Hedberg et al, 
2019); increased Des exerts negative influence on these 3 nodes, further supporting the role of 
pericytes in the organoid as an anti-inflammatory cell. 
 
Des also negatively influences Mbp (myelin basic protein) (figure 6.7). Physiologically, pericytes 
are capable of inducing differentiation of stem cells to an oligodendrocytic fate and supporting 
re-myelination of damaged white matter (Nowicki et al, 2018). This result is contradictory from 
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a physiological perspective. However, this is theorised to be due to the surface selecting for 
pericytes, at the cost of oligodendrocytes. Previously discussed is the property of PLLA to 
degrade to lactic acid which is then buffered to lactate. Lactate is capable of stimulating HIF-1α 
(Hée et al, 2015) which is capable of induces proliferation of pericytes (Geranmayeh et al, 2019). 
In contrast, lactic acid can also induce ROS (Riemann et al, 2011) which oligodendrocytes are 
particularly vulnerable to during maturation (French et al, 2009), thus PLLA can cause increased 
pericyte number and decreased oligodendrocytes.     
 
The third and final key node within the triad is Ipcef1; a marker that is upregulated during 
oxidative stress. The network of Ipcef1 overlaps with that of Des by a great degree which is 
unsurprising, given the physiological role of pericytes in reducing hypoxia/oxidative stress 
(Stapor et al, 2014). Similar to Des, Ipcef targets inflammatory markers, exerting a negative 
influence on them (Grik2, Scn1a, Tnr, Tnfrsf12a, Scn1a, Pik3ca). Thus, this node is another anti-
inflammatory node, however, the Ipcef1 node predominantly focuses on inflammation relating 
to ROS. Other effects of the influential Ipcef1 node include regulation of neuron morphology 
and connectivity. Ipcef1 negatively influences Dlgap1, a synaptic scaffold protein (Uniprot). 
Oxidative stress is known to induce an increase in synaptic count (Oswald et al, 2018), thus loss 
of oxidative stress should negatively affect synapses, supporting the theory that the organoids 
are undergoing synaptic pruning. Neuronal morphology is also influenced by Ipcef1; Ntng1 is 
negatively influenced by Ipcef1 and plays a role in neurite extension and axon guidance (Yaguchi 
et al, 2014). Ntng1 receives strong negative influence from Ipcef1 but still remains 
overexpressed, this may be due to the influence of nanofibre topography on axon guidance and 
extension (Yang et al, 2005). 
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Table 6.1 summarises the array of influences exerted by the 3 most influential genes. Figure 6.8 
shows the genes that are most influential in the generation of the organoids. The three crucial 
nodes appear to indicate a global shift towards and anti-inflammatory, anti-oxidant phenotype 
within the organoid.  
 
6.4.5 Processes relating to implantation 
Implantation remains the final goal for primary cortical neurons grown on the nanofibres. The 
Nanostring characterized various cellular processes that will aid or inhibit the survival of cells 
upon implantation. Upon implantation, the majority of cells die through loss of ECM and 
subsequent anoikis, withdrawal of trophic factors, hypoxia and ROS generation (Sortwell et al, 
2000). Plasticity is the most relevant aspect of the Nanostring quantification; in the absence of 
plasticity and synaptic integration of exogenous neurons in to endogenous neuronal circuitry, 
rewiring will not occur, although bystander effects (described in Chapter 1) may still benefit the 
host. Plasticity appears to decrease for neurons within the organoid (figure 6.2A), however, a 
reduction in oxidative stress is associated with reduced synapse formation (Kiffin et al, 2006). 
Mass spectrometry reveals extensive upregulation of anti-oxidant proteins (Appendix, table 6) 
whilst the Nanostring shows a decrease in oxidative stress (figure 6.3B; figure 6.5D), indicative 
of reduced synapse formation. Whilst the in vitro data suggests a loss of plasticity due to a loss 
of oxidative stress, this may be reverted in vivo as the implanted cells will be under extensive 
oxidative stress (Sortwell et al, 2000). Additionally, the up-regulation of antioxidant defences in 
conjunction with the decreased expression of markers of neuroinflammation (figure 6.2D) may 
aid the survival of neurons upon implantation.  
 
However, decreased expression of markers associated with angiogenesis (figure 6.4B), cytokines 
(figure 6.4H) and growth factors (figure 6.4J) are potential detriments to the survival and 
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integration of implanted neurons. After oxidative stress, Sortwell et al (2000) describe 
withdrawal of cytokines and growth factors as the second greatest detriment to the survival of 
endogenous neurons. In contrast, whilst promotion of angiogenesis by the implanted neurons 
would be ideal in order to limit hypoxia upon implantation, the suggested increase in pericyte 
number (the increase in Des expression, figure 6.8) may yield benefits due to their role as anti-
inflammatory mediators in addition to their involvement in vascularization and stabilization of 
the vascular structures (Stapor et al, 2014). Further quantification is required however, as the 
presence of pericytes is supported by the expression of Des, which whilst it is a pericyte marker 
(Stapor et al, 2014), is only a single indicator. Further validation is needed. 
 
6.4.6 Summary 
In the previous chapter, ANNI was used to hypothesise a mechanism by which the organoid 
develops a more developed profile relative to the 2D control. Within this chapter, RNA was 
quantified rather than proteins, shedding light on the processes that the cells are attempting to 
undertake. Synaptic pruning appears to be in progress, as demonstrated by the loss of plasticity 
(figure 6.2A), decrease in connectivity and synaptic marker expression (figure 6.2B, 6.5B, 6.5G, 
6.5I, 6.5J, 6.5L), decrease in oxidative stress (figure 6.3B) and increased expression of synaptic 
pruning markers such as caspase 3 and PI3K (Appendix; table 7). This is yet another 
developmental process that is poorly understood and lacks a model that is capable of 
representing it well. The breadth of the characterization afforded by the Nanostring has 
identified this yet further work and validation of the model is needed to confirm that synaptic 
pruning occurs at this time point. A time course of immunohistochemistry, western blotting or 
mass spec would be ideal; any of the three techniques performed at multiple time points would 
confirm the downregulation of synaptic markers that begins at 11 DIV would be confirmation of 
synaptic pruning.  
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The work presented within this chapter illustrates the importance of oxidative stress in plasticity 
and due to the extensive oxidative stress that the organoid will be under during implantation, 
this may serve to benefit the synaptic integration of the implant by increasing the plasticity of 
the organoid. Whilst the organoid appears to have shifted towards decreased angiogenesis 
relative to the control, neuroinflammation and oxidative stress have both decreased which will 
aid the  survival of neurons upon implantation.  
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Chapter 7: Optimisation of Transfection of Primary Cortical 
Neurons 
7.1 Introduction 
Thus far, experiments detail a method of generating a structure that is capable of re-wiring the 
cortex and the characterisation of the cellular structure. Upon implantation, a method of 
quantifying the ability of the implant to perform in vivo is needed. Implantation of neurons in 
to the CNS is rarely accompanied by integration of the exogenous cells into existing circuitry; 
the key feature of re-wiring the cortex. Whilst electrophysiological measurements are the gold 
standard for determining the degree of innervation of endogenous neural circuitry by 
exogenous cells, methods such as morphological analysis of implanted neurons, reversal of 
behavioural deficits caused by ablation and quantification of graft volume/density have all 
been employed (Wang et al, 2016; Tornero et al, 2013; Falkner et al, 2016). However, all of 
these methods have their own limitations. Morphological analysis of implanted cells requires 
the use of cells from different species of animals to allow for immunofluorescent 
differentiation between host and exogenous neurons, necessitating use of 
immunocompromised animals or immunosuppressants to prevent rejection (Brevig et al, 
2000) which may influence the behaviours of implanted cells. Additionally, whilst 
morphological analysis typically includes staining for synaptic markers to indicate integration 
into circuitry, it does not confirm mature electrophysiological behaviours. Similar to 
morphological analysis, quantification of graft volume/density requires immunocompromised 
or immunosuppressed animals and cannot confirm mature electrophysiological behaviours. 
Reversal of behavioural deficits is the ultimate goal of the ability to re-wire neural circuitry 
within the CNS, however, the precise mechanism that facilitates the reversal of behavioural 
deficits is not established by using this as a means of quantifying integration of neurons into 
existing circuitry. Implanted cells are capable of secreting factors that can promote 
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endogenous neurogenesis, modulate the immune system and provide trophic support, aiding 
in the behavioural recovery in the absence of synaptic re-wiring (Ma et al, 2015), thus the 
method can be used but requires validation and characterisation of the mechanism.  
 
To counter the limitations present in other methods, optogenetic control was opted for as the 
method of quantifying integration in to endogenous circuitry. A secondary method such as 
morphological analysis will be employed as a validation method, post-in vivo experiment. 
Optogenetics is a tool utilised to exert control over cellular activity using light to activate a 
transfected protein (Guru et al, 2015). The choice of protein that is transfected determines the 
cellular activity that is affected (depolarisation, hyperpolarisation or even modulation of 
biochemical signalling (Tischer and Weiner, 2015)) whilst the method of transfection 
determines the degree of expression and the sub-populations that are transfected (Guru et al, 
2015). The dependence on light allows for a high degree of temporal resolution whilst spatial 
resolution can be controlled by focus of the application of light and the location of the 
transfected cells. In vitro, spatial control is very high as individual dendritic spines can be 
targeted by laser (Packer et al, 2012) and their activity modulated but in vivo, limitations are 
more evident. Transfection of neurons in vivo is typically performed by administration of viral 
particles in to the desired region and diffusion of the viral particles decreases the accuracy of 
the transfection (Serruya et al, 2017). 
 
The goal of the implant is to create a non-physiological axonal path between two points that 
were not connected previously; such as visual and auditory cortex. In this example, any 
activation of the auditory cortex as a response to visual stimulus must have been transmitted 
via the implant due to the presence of the non-physiological neuronal path. However, the 
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property of nanofibres to induce alignment and neurite outgrowth may facilitate endogenous 
neuronal outgrowth along the nanofibres and thus, detection of visually-stimulated action 
potentials in auditory cortex may not be due to integration of exogenous neurons but instead, 
due to regrowth of endogenous neurons. By introducing a selective method of depolarising 
the exogenous neurons, integration of exogenous neurons can be confirmed. Detection of 
visually stimulated action potentials within the auditory cortex, in addition to the detection of 
light-evoked action potentials in the auditory cortex, indicates successful re-wiring of the 
cortex via the exogenous neurons. If a significant difference is detected between the visual 
stimulus-evoked response and the optogenetically-induced response, endogenous regrowth 
and subsequent integration has also occurred. Whilst the ability to generate a pathway that 
facilitates endogenous regrowth would bode well for brain repair, it is not the aim. 
 
An adeno associated virus (AAV) was chosen as the vector for the optogenetic transgenes. 
AAVs are replication incompetent in the absence of co-infection with other viruses (typically 
AAVs) and do not integrate into the genome, instead persisting as episomes within the nucleus, 
limiting the oncogenic potential of the virus (Naso et al, 2017).These two factors that make 
them ideal for gene therapy and in vivo uses. Relative to non-viral methods of transfection 
such as electroporation or lipofection, AAVs have low toxicity, high efficiency and can induce 
stable, long term transfection (Royo et al, 2008). Compared to other viral methods, AAV 
benefits from lower potential for oncogenesis. Lentiviral transfection has a comparable 
efficiency to AAV but due to the possibility of lentiviral integration in to the genome, it is 
associated with a non-zero chance of oncogenic transformation (though tumours do not 
typically occur without transfecting a transgene that targets tumour suppressor pathways) 
(White et al, 2017). 
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Upon delivery in to the cell, transgene expression is controlled by two key factors; AAV 
serotype and choice of the promoter. Multiple serotypes of AAV have been confirmed for AAVs 
each with a range of tissue tropisms and kinetics of expression (Zincarelli et al, 2008). Serotype 
AAV2 was selected to transfect the primary rodent cortical neurons. AAV2 has demonstrated 
minimal cytotoxicity in rodent cortical neurons (Howard et al, 2008) and additionally, at least 
one study has demonstrated that AAV2 can induce cell death in the absence of transduction 
with the transgene (Duverger et al, 2002); a factor that has the potential to select only the 
positively transfected cells. Promoter choice limits the ability of the AAV to depolarise non-
neuronal cells. hSyn is a highly specific neuronal promoter that allows long term expression of 
the transgene in the adult rodent brain (Gompf et al, 2015; Jgamadze et al, 2012) and cultured 
embryonic neurons (Kügler et al, 2003). In vivo use of hSyn as a promoter in the cortex has 
demonstrated a preference towards transfection of inhibitory neurons rather than excitatory 
neurons at low viral titers (Nathanson et al, 2009) although the multiplicity of infection (MOI) 
is difficult to quantify in vivo due to the diffuse nature of the transduction. In addition, low 
numbers of total transduced cells were present in the low titre conditions; high percentage of 
transfected cells indicates that both inhibitory and excitatory neurons had been transfected. 
At higher MOI, exposure of primary neurons to AAV2 with the hSyn promoter resulted in 
transfection which was representative of the neuronal sup-populations of the cortex; 80% of 
transfected neurons were excitatory whilst 20% were inhibitory neurons (Nathanson et al, 
2009). 
 
The transgene of choice to induce light-sensitivity in the primary cortical neurons is 
channelrhodopsin-2 (Chr2). Chr2 is a light-gated cation-selective ion channel naturally found 
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in Chlamydomonas reinhardtii that depolarise in response to 450nm light (Nagel et al, 2003). 
H134R is a gain of function mutation that produces larger photocurrents but slows down the 
kinetics of the channel. Chr2 has been used to optogenetically depolarise rodent cortical 
neurons in vivo (Fan et al, 2015; Kwon et al, 2015); use of Chr2 in conjunction with electrodes 
implanted downstream of the implant should allow the separation of the effects of 
endogenous re-growth and integration of exogenous neurons as discussed previously. Chr2 
has also demonstrated excellent biocompatibility; primate studies transfecting Chr2 have 
observed widespread expression of Chr2 with no histological abnormalities in neurons or glia 
and no cellular or antibody based immune reactions over several months (Han et al, 2009). 
 
7.2 Methods 
7.2.1 Co-localisation of the transfected fluorescent marker and 
DAPI within primary cortical neurons 
Primary cortical neurons were dissociated and cultured on PLL and laminin coated tissue 
culture plastic or uncoated PLLA nanofibres using protocols described previously (Chapter 2; 
section 2.2.2, 2.2.3, 2.2.6). Cells were plated at a density of 25,000 cells/cm2. For each material, 
cells were transfected with AAV-hSyn-hChr2(H134R)-mCherry at a range of multiplicity of 
infections (MOI) to determine the ideal concentration of viral particles. The MOI selected were 
101, 102,103, 104 whilst the control received only a media change with a volume equivalent to 
the volume used to deliver the viral particles. Cells were exposed to AAV overnight prior to a 
media change to virus-free media. Transfections were performed on 1 or 7 days in vitro (DIV). 
After 11 DIV, cells were fixed using 4% PFA for 20 minutes and nuclear stained with DAPI prior 
to fluorescent visualisation to determine the percentage of the cellular population that had 
been successfully transfected by the AAV. Cells were manually counted and were considered 
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to be successfully transfected if DAPI and mCherry co-localised. Results were validated with 
the Leica co-localisation software. 
3-factor ANOVA was used to determine the influence of MOI, the day of transfection and the 
substrate the cells are transfected upon on the efficiency of the transfection. 
7.2.2 Intracellular localisation of the channelrhodopsin-2 protein 
Primary cortical neurons were dissociated and cultured on poly-L-lysine and laminin coated 
plates as described previously (Chapter 2, section 2.2.2, 2.2.3, 2.2.4). Cells were plated at a 
density of 25,000 cells/cm2 and transfected at an MOI of 102. After 11 DIV, cells were fixed in 
4% PFA for 20 minutes and permeabilised with 0.1% Triton X-100 for 20 minutes. Cells were 
incubated in blocking buffer (3% BSA) for 1 hour at room temperature prior to incubation in 
primary antibody (anti-Chr2; 1:50 dilution in 3% BSA) overnight at 4°C. Cells were then 
incubated in secondary antibody (FITC-labelled anti-mouse IgG, 1:50) at room temperature for 
2 hours before nuclear staining with DAPI and subsequent visualisation. Three five minute 
washes of PBS were applied between each incubation period.  
7.2.3 Confirming functional expression of Chr2 in AAV-hSyn-
hChr2(H134R)-mCherry transfected primary cortical neurons 
Primary cortical neurons were dissociated and cultured on uncoated PLLA nanofibres using 
protocols described previously (Chapter 2, section 2.2.2, 2.2.3, 2.2.4). Briefly, cells were plated 
at a density of 25,000 cells/cm2. 24 hours after seeding, cells were transfected with AAV-hSyn-
hChr2(H134R)-mCherry at an MOI of 0, 101, 102,103, 104. Cells were maintained at 37oC in a 
humidified incubator at 5% CO2 for 10 days. At 10 DIV cells were loaded with Fura red-AM. 
Fura red-AM was added to the media to a final concentration of 5µM and incubated for 30 
minutes at 37oC. Cells were then washed with PBS prior to the addition of Kreb’s solution that 
the recordings were performed in. Recordings were performed on a BMG LABTECH Clariostar 
microplate reader. Measurements were taken every 0.21 seconds for 90 seconds. Baseline was 
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defined as the average of the first 5 values of the recording, baseline was removed by dividing 
each value by the baseline. Results were then expressed as a percentage of the control. Inter-
Ca2+ influx intervals and average change in amplitude of oscillations were quantified using a 
custom MATLAB script. 
 
7.2.4 Confirming the presence of nanoparticulates and 
quantification of nanoparticle size  
Untreated PLLA nanofibres and laser cut polyester sheets were incubated for 24 or 72 hours in 
500µL PBS at pH 7.4 in 24 well plates whilst the negative control was incubation of PBS alone. 
The supernatant was removed from the nanofibres and was subsequently loaded into a 
Zetaview Nanoparticle Tracking Analyzer. Nanoparticle sizes were tested for significance using 
an unpaired t-test. 
Nanoparticles were also visualised using the JSM-7100F SEM to visualise them. 5µL of 
supernatant was placed onto a carbon tape-coated SEM stub which was then sputter coated 
in a vacuum to remove the supernatant and coat the nanoparticles in 5nm of gold.  
 
7.2.5 Alterations to pH due to nanofibre degradation 
Untreated PLLA nanofibres were incubated for 0, 1, 3, 5, 7 or 14 days in 500µL PBS at pH 7.4 in 
24 well plates whilst the negative control was incubation of PBS alone. No pH change was 
observed for the PBS alone. The supernatant was removed from the nanofibres at each time 
point and the pH was tested using a pH meter. 
7.2.6 Morphological changes induced by transfection of primary 
cortical neurons with AAV-hSyn-hChr2(H134R)-mCherry 
Primary cerebral cortical neurons were isolated as described in Chapter 2, section 2.2.2 and 
seeded to poly-L-lysine and laminin (5µg/ml) coated tissue culture plastic at a cell density of 
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25,000 cells/cm2 in NbActiv1 medium and maintained at 37oC in a humidified incubator. 24 
hours after seeding, cells were transfected with AAV-hSyn-hChr2(H134R)-mCherry at an MOI 
of 102. Control cells and transfected cells were placed in the Incucyte S3 Live-Cell analysis 
system for 5 days. During these 5 days, neurite length, branch points, neurite bundle diameter 
and cell cluster diameter were measured. Images were taken every hour with 4 replicates and 
9 fields of vision per replicate. The neurite length, branch points and clustering behaviour of 
every cell within the field of vision were quantified by the Incucyte. Neurite bundle diameters 
were measured using ImageJ. Every 3 hours, the diameters of 10 neurite bundles were 
measured for 3 fields of vision as a single replicate; 3 replicates were used per time point. The 
alignment of neurites was quantified using the Directionality plugin of ImageJ. Every three 
hours, dispersion of neurites was measured for 3 fields of view as a single replicate; 3 replicates 
were used. Rate of neurite growth, rate of branching and cell clustering behaviours were then 
calculated from the data generated by the Incucyte and a t-test was used to check for 
significant differences between the control and transfected neuron cellular behaviours. 
 
7.2.7 mCherry as a method of tracking cell survival of cells in vivo 
Primary cortical neurons were seeded to aligned PLLA nanofibre scaffolds, fabricated as 
described in Chapter 2, section 2.2.6. Cells were seeded at a density of 25,000 cells/cm2. 
Neurons were transfected with AAV-hSyn-hChr2(H134R)-mCherry at an MOI of 102 at 3 DIV. 
At 7 DIV, fluorescent intensity was quantified using a BMG LABTECH Clariostar. Recordings 
were taken with an excitation wavelength of 570±15nm and an emission wavelength of 
620±20nm. For each cell density, 3 replicates of 3 neuronal cultures transfected at an MOI of 
102 were employed. An average fluorescence intensity was calculated for each cell density 
where then plotted to a scatterplot and a regression value was calculated to determine the 
correlation between fluorescence and cell count. 
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Fluorescence intensity of an area was calculated using images taken of cells transfected in the 
same manner that were then fixed for 20 minutes in 4% paraformaldehyde and nuclear stained 
with DAPI. Using ImageJ, fluorescence intensities were gathered for the background and 10 
clusters of cells per field of vision. For each replicate, 3 fields of vision were employed and 3 
replicates were used. Equation 5 was used to calculate background corrected total 
fluorescence (BCTF) which was then plotted against area.  
𝑩𝑪𝑻𝑭 
=  𝑰𝒏𝒕𝒆𝒈𝒓𝒂𝒕𝒆𝒅 𝑫𝒆𝒏𝒔𝒊𝒕𝒚 – (𝑨𝒓𝒆𝒂 𝒐𝒇 𝒔𝒆𝒍𝒆𝒄𝒕𝒆𝒅 𝒄𝒆𝒍𝒍 𝑿 𝑴𝒆𝒂𝒏 𝒇𝒍𝒖𝒐𝒓𝒆𝒔𝒄𝒆𝒏𝒄𝒆 𝒐𝒇 𝒃𝒂𝒄𝒌𝒈𝒓𝒐𝒖𝒏𝒅 𝒓𝒆𝒂𝒅𝒊𝒏𝒈𝒔) 
 
Equation 5: Calculating background corrected total fluorescence  
 
7.3 Results 
Cells were transfected with various MOIs of AAV-hSyn-hChr2(H134R)-mCherry, fixed and 
stained with DAPI. Manual quantification of the transfection efficiency revealed high levels of 
transfection for all conditions; subsequent validation with automated co-localisation software 
revealed the same trend although with much lower values (results not shown). This is a result 
of the method of the automated co-localisation; mCherry was primarily cytosolic whilst the 
DAPI stain is a nuclear stain. As a result, a proportion of the mCherrry will not overlap with the 
nuclear stain, thus lowering the values detected for the automated quantification of co-
localisation. From the multifactorial ANOVA, the substrate that neurons were cultured upon 
and the viral concentration had significant effects on the expression of mCherry (p = <0.001 
for each, figure 7.1B and 7.C respectively) whilst the time of transfection was not significant 
(figure 7.1D). However, interactions between factors were observed. Time of transfection 
became significant when comparing the co-localisation values between the two different 
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substrates, tissue culture plastic and PLLA nanofibres (figure 7.2A). Alone, viral concentration 
and substrate both significantly affected the expression of mCherry but an additional 
interaction was observed between the two factors (figure 7.2B). No significant interaction was 
found between the viral concentration and the time of transfection (figure 7.2C), however, 
results were bordering significance (p = 0.055). 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: Optimisation of transfection of primary cortical neurons with AAV-hSyn-hChr2(H134R)-mCherry. (A) 
Transfected neurons grown on PLLA nanofibers, stained with DAPI, mCherry co-localises with the nuclear stain. (B) 
Significantly higher transfection of cells was observed for neurons cultured on aligned PLLA nanofibers (unpaired t-
test: t(58) = 2.721, p = 0.0086) (C) Viral concentration significantly influences transfection efficiency (one-way 
ANOVA, F = 5.043, p = 0.0016. Dunnett‘s multiple comparison test. Control vs 10+1: p = 0.0063. Control vs 10+2: p 
= 0.0015. Control vs 10+3: p = 0.0042. Control vs 10+4: p = 0.3067) (D) Time of transfection did not significantly 
affect transfection efficiency (unpaired t-test: t(58) = 1.046, p = 0.30) 
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Nanoparticles were theorised to be the cause of increased transfection efficiency. 
Nanoparticulates were confirmed within the supernatant of nanofibres cultured in PBS which 
was then confirmed to originate from the laser cut polyester sheets (figure 7.3A and 7.3B), 
although it appears as though nanofibres can reduce the population size of the nanoparticles, 
potentially through binding the nanoparticles (figure 7.3B). No significant change was observed 
between the nanoparticulate populations between 0 and 3 DIV (figure 7.3C and 7.D). 
Incubation of PLLA nanofibres in an isotonic buffer is capable of inducing a significant decrease 
in pH within 24 hours that is maintained for up to 14 DIV (figure 7.3E). 
 
 
 
 
 
 
 
Figure 7.3: Possible mechanisms for the increased transfection efficiency observed for neurons grown on PLLA 
nanofibers. (A) No significant difference was detected between nanoparticulate diameter for nanoparticles isolated 
from polyester or PLLA NF supernatant (unpaired t-test: t(598) = 1.672, p = 0.0951) (B) A significantly larger number 
of nanoparticles were detected for the polyester alone condition (unpaired t-test: t(4) = 5.664, p = 0.0048) (C) No 
significant difference was observed between the nanoparticle diameters between day 1 and day 3 (unpaired t-test: 
t(964) = 1.191, p = 0.2388) (D) No significant difference was observed between the number of nanoparticles on day 
1 and day 3 (unpaired t-test: t(4) = 0.09054, p = 0.9322) (E) Significant reduction in pH of the supernatant that 
nanofibres were cultured in occurred over a two week period (one-way ANOVA: F = 664.5, p = <0.0001. Dunnett’s 
multiple comparison test. Day 0 vs Day 1: p = <0.0001. Day 0 vs Day 3: p = <0.0001. Day 0 vs Day 7: p = 0.0007. Day 
0 vs Day 14: p = 0.0003) 
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An MOI of 102 was selected as the optimal viral concentration. Initial immunostaining of cells 
transfected with an MOI of 102 revealed ubiquitous expression of the Chr2 protein across the 
entirety of the cell with notably high expression within the soma (figure 7.2D). Optogenetic 
control of cells was initially demonstrated using a Clariostar plate reader. Fura red-AM was 
loaded in to cells and cells were excited at a wavelength of 470±15nm; a wavelength which 
excites both the calcium indicator and the channelrhodopsin. All transfected cells demonstrate 
a increase in Ca2+ (indicated by an decrease in fluorescence) relative to the control. A dose 
dependent response was not observed for the MOI used to transfect the cells; cells transfected 
with 102 viral particles/cell demonstrated the greatest influx of Ca2+ in response to the 
depolarising wavelength of light whilst cells transfected with 101, 103 and 104 viral particles/cell 
demonstrated similar responses to each other (figure 7.4A). Analysis of the fluorescent values 
using MATLAB software revealed two distinct changes to the Ca2+ influxes. Average change in 
fluorescence exhibited a wide standard error margin and no significant difference between 
different MOIs (one-way ANOVA, F(3) = 1.422, p = 0.2960) but a trend toward negative average 
change to amplitude was observed for all transfected cells. Inter-oscillation intervals for the 
transfected neurons were significantly lower than those of the control cell (one-way ANOVA, 
F(107) = 17.4, p = 0.0055) and exhibited a viral dose-dependent response (figure 7.4C). 
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Figure 7.4: Optogenetic control of depolarisation of transfected primary cortical neurons (A) Control and transfected 
neurons were exposed to light at a wavelength of 473nm; all transfected cells demonstrated a subsequent decrease 
in fluorescence (increase in intracellular Ca2+) (B) Maximal % response for transfected cells upon photostimulation 
(C) Transfected cells exhibit negative average change in fluorescence; all transfected cells trended towards 
increasing Ca2+ (D) Transfected cells exhibit a significantly lower time between Ca2+ influxes than the control cells 
(one-way ANOVA, F = 7.162, p = 0.0055. Dunnett‘s multiple comparison test. Control vs 10+1: p = 0.0167. Control 
vs 10+2: p = 0.0156. Control vs 10+3: p = 0.0034. Control vs 10+4: p = 0.0034. 
Primary cortical neurons transfected with AAV-hSyn-hChr2(H134R)-mCherry demonstrated no 
change in morphology as a result of transfection. Real-time imaging was run for 4 days; hourly 
images of the cells were taken and subsequently analysed using the Incucyte software (figure 
7.5).  
 
 
 
 
0 1 0 0 2 0 0 3 0 0 4 0 0 5 0 0
7 0
8 0
9 0
1 0 0
1 1 0
T im e  (s e c o n d s )
%
 R
e
s
p
o
n
s
e
o
f 
C
o
n
tr
o
l
C o n tro l
1 0 + 1  M O I
1 0 + 2  M O I
1 0 + 3  M O I
1 0 + 4  M O I
C
o
n
tr
o
l
1
0
+
1
1
0
+
2
1
0
+
3
1
0
+
4
0 .0
0 .5
1 .0
1 .5
T
im
e
 b
e
tw
e
e
n
 C
a
2
+
 i
n
fl
u
x
e
s
 (
s
e
c
o
n
d
s
)
*
*
**
**
C
o
n
tr
o
l
1
0
+
1
1
0
+
2
1
0
+
3
1
0
+
4
-2 0
-1 5
-1 0
-5
0
5
A
v
e
r
a
g
e
 C
h
a
n
g
e
 i
n
 F
lu
o
r
e
s
c
e
n
c
e
(a
r
b
it
r
a
r
y
 u
n
it
s
)
C o n tr o l 1 0 + 1 1 0 + 2 1 0 + 3 1 0 + 4
0
5
1 0
1 5
2 0
V ira l C o n c e n tra t io n  (M O I)
P
e
a
k
 %
 r
e
s
p
o
n
s
e
A B 
C D 
181 
 
 
 
 
 
 
 
 
 
Figure 7.5: Real time tracking of morphological features of primary cortical neurons transfected by AAV using the 
Incucyte Live Cell Analysis system. Black = control, red = primary cortical neurons transfected by AAV (A) Neurite 
length (B) Cell clustering behaviour (C) Neurite branching (D) Neurite fasciculation 
Over a period of 4 days, control and transfected neurons were visualised using the Incucyte 
system and analysed using the associated software. Neurite length, branch points and cell 
clustering behaviours were not affected by the transfection process (figure 7.5). Neuronal rates 
of growth, branching, cell clustering behaviours and neurite bundle diameter were quantified 
over the 4 day period and were not significantly affected by transfection (figure 7.6). 
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Figure 7.6: Quantification of rates of growth for primary cortical neurons transfected by AAV (A) Neurite growth 
rate is not significantly altered by transfection (unpaired t-test: t(272) = 0.1266, p =  0.9025) (B) Cell clustering rate 
is not significantly altered by transfection (unpaired t-test: t(272) = 0.1152, p = 0.9083) (C) Neurite branching rate 
is not significantly altered by transfection (unpaired t-test: t(272) = 0.1266, p = 0.9025) (D) Neurite fasciculation is 
not significantly altered by transfection (unpaired t-test: t(40) = 0.6019, p = 0.5506) 
The linearity of cell number and fluorescence was calculated by seeding cells at different 
seeding densities, transfecting cells at an MOI of 102 and measuring the fluorescent intensity 
at the excitation wavelength of mCherry. Results indicate a strong positive correlation between 
the number of cells present and the fluorescence intensity (R2 = 0.744, p = <0.0001, figure 7.7A). 
Referring to the residuals however (figure 7.7B), non-Gaussian distribution of data is evident; 
the predictors are missing a variable. Cells that are clustered together in previous studies 
appeared to have a higher fluorescence intensity than those that are more dispersed. Plotting 
baseline corrected fluorescence intensity against area indicates a strong positive correlation 
(R2 = 0.8791, p = <0.0001) (figure 7.7C) and the residual plots (figure 7.7D) show Gaussian 
distribution of the residuals; the area predicts the fluorescent intensity. Results indicate that 
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whilst fluorescence is proportional to fluorescent intensity, the degree of clustering has an 
additional influence; potentiating the fluorescent signal. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7: Fluorescence relative to cell count and cell density (A) Fluorescence positively correlates with cell 
number (R2 = 0.744, p = <0.0001) (B) Residual plots for A; non-Gaussian distribution is observed, a variable is not 
accounted for by this model (C) Fluorescent intensity positively correlates with area of cells (R2 = 0.8791, p = 
<0.0001) (D) Residual plots for C; Gaussian distribution is observed, accounting for the area that cells occupy 
corrects the previous model.  
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7.4 Discussion 
7.4.1 Initial Optimisation 
A commercially available AAV (AAV-hSyn-hChr2(H134R)-mCherry, VectorCore) was selected 
for the transfection of primary cortical neurons. As previously discussed, viral serotype and 
promoter can be used to influence the expression of the transgene in a specific tissue. Studies 
that have employed the same AAV serotype and promoter as the commercially available AAV 
have utilised a diverse range of models such as in vivo models, primary cortical neurons, 
primary hippocampal neurons and cell lines (Nathanson et al, 2009; Zhang et al 2012; Fan et al 
2015; Kwon et al 2015; Michel et al, 2005; Duverger et al, 2002). Whilst these studies 
demonstrate successful transfection and expression of transgenes, transfection is performed 
using a range of MOIs from 103 to 108. Optimisation of transfection was needed. Transfection 
efficiency was quantified as the amount of DAPI stained cells that co-localised with mCherry. 
Multifactorial ANOVA was used to investigate how several factors can influence transfection. 
Relative to the control, the substrate that the neurons were grown on and the viral 
concentration had significant effects on the transfection efficiency (figure 7.1B and 7.1C).  
 
7.4.2 Mechanism for nanofibre induced transfection efficiency 
potentiation 
Neurons cultured on nanofibres displayed a significant increase in transfection efficiency and 
several factors may be the cause of this; porosity, acidification of the culture media, the 
creation of nanoparticulates or a combination of all three factors. Nanofibres are an inherently 
porous structure that facilitate diffusion of molecules (Loh et al, 2013). As the cells grow on 
the nanofibres and across the pores, a greater surface area of the cells is exposed to the virus-
bearing media and may be the cause of the increase in transfection efficiency. Whilst it is 
possible that porosity may enable greater exposure to the viral particles, at least one study has 
demonstrated the negative effect of porosity on the transfection of cells grown in three 
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dimensions, in two different cell lines (Xie et al, 2001), although this study was in mitotic cell 
lines rather than post-mitotic primary neurons. The acidification of the media caused by the 
degrading nanofibres (figure 7.3E) may play a role in the increased transfection efficiency. 
AAV2 particles are typically endocytosed via clathrin coated pits and escape the endosome in 
a low-pH dependent manner before trafficking to the nucleus along microtubules (Xiao and 
Samulski, 2012). The mechanism behind the viral escape is not fully characterised but is 
thought to be due to maturation of the viral particles induced by the low pH. The low pH 
induces conformational change, activating phospholipase A2, which subsequently lyses a pore 
in the endosome, facilitating escape in to the cytoplasm (Liu et al, 2012; Stahnke et al, 2011). 
The low pH of the extracellular media due to the degradation of the PLLA nanofibres may 
promote increased viral efficiency by allowing the virus to mature externally to the cell and 
bypassing the endosome entirely by entering the cell by lysing the cell membrane and entering 
the cytoplasm directly after maturation rather than escaping the endosome. Alternately, the 
low pH external to the cell may accelerate the acidification of the early endosome upon 
endocytosis, increasing the rate that viral particles mature and escape, thus escaping 
destruction by the lysosome/proteasome (Nonnenmacher and Weber, 2012). Both 
hypothetical mechanisms are dependent on entering the cytoplasm more rapidly than would 
normally be possible, minimising the chance of exposure to the lysosome and thus increasing 
the intracellular viral titre by reducing the degradation. Alternatively, nanoparticulates have 
previously been used as a means of delivering genes into cells for transfection, increasing the 
efficiency or altering the tropism of viral vectors (Panyam and Labhasetwar, 2003; Rajagopal 
et al, 2018; Mailander and Landfester, 2009). PLLA nanoparticles with a diameter of 80-210 nm 
have been previously confirmed to be able to penetrate HeLa cells, independent of the charge 
of the particle (Musyanovych et al, 2011). Using the Zetaview, the presence of nanoparticles 
was confirmed within the supernatant that PLLA nanofibres were cultured in, averaging 
approximately 130nm (figure 7.3A). It is possible that the presence of the nanofibres, and thus 
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nanoparticulates, may be the cause of the increased transfection efficiency. If this were the 
case, the virus may also have altered tropism and co-localisation studies may be needed to 
confirm that only neuronal cells are transfected and that the transfected neurons are 
approximately 80% glutamatergic and 20% GABAergic. However, no significant difference was 
observed in the nanoparticulate population (nanoparticle diameter or count) between D0 and 
D3, suggesting that the nanoparticles do not play a role in the significant increase in 
transfection. The presence of nanoparticulates is a possible concern for the purposes of 
implantation and nanoparticulates have demonstrated cyototixicty and genotoxicity, 
dependent on material and size (Yang et al, 2010). As they appear to originate from the 
polyester used to collect electrospun nanofibres (figure 7.3A), alterations to the 
electrospinning fabrication process may be required to reduce nanoparticle count.  
 
 Viral concentration significantly affected the transfection efficiency, however, a non-dose 
dependent effect was observed. Decreasing transfection efficiency was observed at the 
highest MOI of AAV tested; closer examination reveals that the significant decrease in 
transfection efficiency is only present for neurons transfected on PLLA nanofibres (figure 7.2C). 
For MOIs of 102, 103 and 104, elevated transfection efficiency is observed on nanofibres whilst 
at an MOI of 104, the transfection efficiency is approximately equal to the efficiency of 
transfection on the control surface. Further characterisation is required to determine the 
mechanism behind the non-dose dependent response. A possible mechanism for this would 
be steric hindrance. If the increase in viral transfection efficiency was due to the virus binding 
to the nanoparticles, then it is possible that an excessive number of viral particles sterically 
hindered the uptake of the viral particles in the cell, lowering the transfection efficiency. Steric 
hindrance of nanoparticulate-mediated transfection has been observed previously (Sung et al, 
2003). Alternatively, the nanofibres and viral particles in conjunction may have increased the 
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expression of inflammatory markers; inflammatory markers have previously been observed to 
reduce expression of transgenes although this was performed in primary liver cells (Breous et 
al, 2011).  
 
7.4.3 Light-Induced Depolarisation of Transfected Primary 
Cortical Neurons 
Whilst the transfection efficiency exhibited a non-dose dependent response to viral 
concentration, the electrophysiological activity of transfected cells in response to light was 
dose-dependent. Referring to figure 7.4, quantification of the electrophysiological activities of 
the cells, increasing viral concentration increased the responsiveness of cells to light: the 
higher the viral concentration, the shorter the time between Ca2+ influxes. This suggests that 
whilst a lower percentage of cells were transfected, those that were transfected exhibited a 
higher expression of the Chr2 transgene although protein quantification would be necessary 
to confirm this. This contradictory result is also observed by Howard et al (2008) for several of 
the tested AAV serotypes (although AAV2 was not amongst these). 
 
Interactions between factors were also noted to influence the transfection efficiency. An 
interaction between the time of transfection and the material that cells were cultured upon 
observed. Transfecting neurons at 3 DIV rather than 1 DIV significantly increased the 
transfection efficiency for neurons grown on nanofibres but not the PDL/laminin control. This 
may be due to the mechanism that AAV use to traffic in to the perinuclear space. Microtubules 
are utilised by the AAV particles to travel to the nucleus, disruption of the microtubules can 
inhibit the transfection efficiency (Xiao and Samulski, 2012). Hydrophobic surfaces can delay 
cytoskeletal development (Marote et al, 2016) whereas hydrophobic nanoparticles can disrupt 
physiological microtubule dynamics (Kuang and Xu, 2013); thus, rather than neurons cultured 
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on PLLA nanofibres displaying an elevation in transfection efficiency at later time points, AAV 
transfection may be inhibited at earlier time points. An interaction between viral concentration 
and the cell culture surface was also detected. However, the proposed mechanism for the 
increase in potency and efficacy of AAV particles grown on PLLA nanofibres has already been 
described in the previous paragraph (increased porosity, acidification of media and formation 
of nanoparticulates). 
 
Calcium influx was induced in transfected primary cortical neurons as a response to light, 
demonstrating photosensitivity and successful transfection of Chr2. To facilitate the recording 
of a large number of replicates, recordings were performed using a fluorescent plate reader. 
Whilst this facilitated high throughput collection of data, it prevented the use of multiple 
wavelengths of light for excitation and detection of emission due to the limitations of the plate 
reader. Due to this, a calcium indicator (Fura red-AM) that had an overlapping spectra with 
Chr2 was employed, allowing stimulation and recording simultaneously. All transfected cells 
exhibited a Ca2+ influx as a response to 470nm of light, regardless of MOI. This photosensitivity 
was not observed for the control. The raw data (figure 4A) indicates a viral dose-independent 
response whilst the time between Ca2+ influxes demonstrated a dose-dependent response 
(figure 7.4C). These seemingly contradictory results are likely a factor of cell survival. The 
Clariostar plate reader that was used to attain the fluorescent values measures a global 
fluorescence value of the well that cells are cultured in. Neurons transfected with a MOI of 1 
x102 exhibited the greatest decrease in total fluorescence because survival was likely to be 
higher at lower MOI than higher MOI, thus more cells were present to contribute to the total 
global fluorescence values. AAV2 demonstrates no cytotoxicity at MOI of 2 x 102 in cortical 
neurons yet at greater multiplicities of infection, significant increases in cytotoxicity are 
observed, despite being negligible relative to the cytotoxicity of other serotypes (Howard et al, 
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2008). In contrast, the quantification of the time between intervals exhibited a dose-
dependent response because the neurons that did survive the transfection likely expressed a 
higher quantity of Chr2 and thus, were more capable of depolarising as a response to light. 
 
7.4.4 Quantification of Morphological Alterations due to Chr2 
Transfection 
Although studies rarely note a morphological difference as a result of optogenetic transfection, 
at least one study has noted that Channelrhodopsin-2 transfection can alter the axonal 
morphology of rodent cortical neurons in vivo in an expression-dependent manner (Miyashita 
et al, 2013). Given that the formation of the organoids that were observed on aligned PLLA 
nanofibres were determined by neurite behaviours (Segev et al, 2003), it is key to confirm that 
the act of transfection with mCherry and Chr2 does not interfere with neurite behaviours or 
subsequent clustering. Primary cortical neurons on 2D tissue culture plastic were virally 
transfected with Chr2 and no morphological changes were observed. Unfortunately, due to 
the linear nature of the nanofibre networks, culture of neurons on nanofibres and visualisation 
using the Incucyte system resulted in false detection of neurites, thus the experiment was 
performed in conventional 2D culture to attain data in real-time. Whilst the mCherry 
expression could facilitate fluorescent tracking of the movement of cells on the nanofibres, 
expression was limited to the cell bodies and could not be detected by the Incucyte. However, 
the key difference between the selected 2D surface and the 3D nanofibre surface is the 
difference in wettability. The 2D tissue culture plastic is more hydrophilic and thus, cells are 
less likely to migrate and cluster on the surface (Ryans, 2008). However, migration across the 
surface to form cellular clusters was still observed on the hydrophilic 2D culture surface and 
thus, 2D culture was accepted as a model of transfected primary cortical neurons on 
nanofibres for initial testing. 
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7.4.5 Tracking of the exogenous neurons in vivo 
The fluorescent tag, mCherry, was proposed to have a use in the in vivo application of the 
transfected cells. As the mCherry within transfected cells fluoresces, a fluorescent in vivo 
imaging system (Perkin Elmer, IVIS Spectrum) was proposed as a means of tracking both the 
survival of cells within the implant and the rate of neurite extension. Red wavelengths of light 
are known to penetrate tissue to a greater degree than other wavelengths of light (van Gemert 
and Welch,1989), thus supporting the role of mCherry as a means of tracking the progress of 
growth upon implantation. However, referring to figure 7.1A, the signal from mCherry is 
notably weak and localised to the cell body; using confocal microscopy, no neurites were 
detected using mCherry as a fluorescent marker. It is unlikely that the extending neurites will 
be able to be detected in vitro. However, referring to figure 7.7A and 7.7C, a linear relationship 
was found between the fluorescent intensity at the emission wavelength of mCherry and the 
number of cells, suggesting that mCherry has the potential to be used as a means of monitoring 
the survival of the cells in vivo. This remains conditional on the detection limits of the IVIS 
imager; if the in vivo imager is capable of detecting the light through the skull of the implant 
recipient, this method can be utilised to assess cell survival. However, a limitation to 
quantifying cell number through fluorescence was evident in the residuals histogram (figure 
7B). The residual plots indicate non-Gaussian distribution when plotting fluorescence vs cell 
count; a factor other than cell number influences the fluorescence intensity. Quantification of 
fluorescence intensity using ImageJ demonstrated a robust correlation between the 
fluorescence intensity and the area of the cell cluster, despite correction of the fluorescence 
intensity based on area. The residual plots for this regression indicate Gaussian distribution 
(figure 7.7D), suggesting that the area is the missing predictor; the more densely packed the 
cells are, the greater the ability to detect the fluorescence intensity of the cells. Whilst this 
experiment was performed in 2D conventional culture, the clustered 3D nature of the cells to 
be implanted should aid in the in vivo detection of the cells.  
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7.4.6 Limitations to transfection of primary cortical neurons for 
the purpose of re-wiring the cortex 
A limitation for transfected cells is that AAV transfected primary neurons exhibit an increase 
in mitochondrial membrane potential post-transfection (Duverger et al, 2002). Whilst this is 
not enough to be considered cytotoxic, it can predispose the cells towards apoptosis, as seen 
in the study of Duverger et al (2002). Upon implantation, anoikis, ischaemia and withdrawal of 
trophic factors are present and are pro-apoptotic factors (Sortwell et al, 2000); an increase in 
mitochondrial membrane potential may induce a greater percentage of cells to undergo 
apoptosis than would if cells were implanted in the absence of AAV-mediated transfection. 
Whilst implanting at earlier developmental stages appears to increase the likelihood of 
synaptic integration of exogenous cells, this would likely increase the rate of apoptosis of 
implanted cells. 72 hours after AAV mediated transfection, there is a significant reduction and 
subsequent plateau in mitochondrial membrane potential (Duverger et al, 2002), thus the 
implantation of AAV-transfected primary cortical neurons should occur a minimum of 72 hours 
after transfection. 
 
7.5 Conclusion 
Neurons grown on aligned PLLA nanofibres have demonstrated the ability to generate 
electrically active cerebral cortical organoids whilst the work described in this chapter 
describes the methodology employed to transfect them with a transgene capable of 
determining the degree of integration upon implantation in to the in vivo cerebral cortex. 
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Chapter 8: Conclusions and future directions  
8.1 Summary 
 
In Chapter 3, several qualities were listed as desirable for exogenous neurons that were to be 
implanted into a host for the purposes of rewiring neural circuitry within the cerebral cortex. 
For the purposes of rewiring, neurons should: possess cortical areal identity, be embryonic, 
exhibit clustered cell bodies with aligned, fasciculated neurites and demonstrate electrical 
activity (Michelsen et al, 2015, Ideguchi et al, 2010; Gaspard et al, 2008; Espuny-Carmacho et 
al, 2013, Tang-Schomer et al, 2014, Dunnett and Bjorklund, 2017). Use of embryonic primary 
cortical neurons as a cellular model facilitates the electrical activity, cortical areal identity and 
early developmental stage. The research presented within this thesis indicates a method of 
generating the clustered cell bodies with aligned, fasciculated neurites. Proteomic analysis of 
these cellular architectures suggests that neurons within these structures are more developed 
and physiological than their 2D counterparts whilst the network inference and Nanostring aid 
in elucidating a mechanism. The electrical activity and responsiveness of the neurons to 
physiological agonists was also tested and confirmed, further reinforcing the capacity to use 
the primary cortical neurons cultured on aligned PLLA nanofibres as the basis for cellular 
implants for cortical rewiring.  
 
8.2 Current Limitations to Cortical Re-Wiring using the Aligned 
PLLA Nanofibre Derived Methodology 
Whilst the research presented describes a methodology to generate physiological cellular 
architectures using a material that is suitable for implantation and further in vivo studies, the 
next steps would be the engineering of a delivery system that is capable of injecting aligned 
nanofibres bearing cellular structures into the CNS in a way that is amenable to neuronal 
viability. Methods of delivery of nanofibres into the host typically do not preserve alignment 
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in a way that facilitates rewiring. Examples include placing of membranes on the surface of the 
brain (Tseng et al, 2013), insertion of bundled fibres in to cavities (Hwang et al, 2014; Jaiswal 
et al, 2013; Alvarez et al, 2014) and sectioning fibres and suspending them in a hydrogel (Rivet 
et al, 2015; Wang et al, 2016). The noteworthy exceptions include rolling the sheet in to a spiral 
and injecting this spiral (Nisbet et al, 2009) and placing the nanofibres in an external conduit 
for injection (Koh et al, 2010; Kim et al, 2008; Maclean, 2017). The two most viable options for 
delivery would be to draw them up into a needle for injection or to move the nanofibres into 
a protective conduit for implantation. Each presents limitations.  
 
Assuming that the nanofibre membrane could be electrospun into a shape with desirable 
diameters, drawing the nanofibres into the needle would require the application of shear 
stress upon the neurons of the implant. The generalised effects of shear stress on cells are 
extensive. Shear stress has demonstrated the ability to induce DNA damage, inhibit protein 
synthesis, increase nitric oxide synthesis and induce Ca2+ influx and if shear stress is high 
enough, inducing nitric oxide-dependent cell death (Triyoso and Good, 2004), thus mandating 
that shear stress be considered as an inhibitory factor for cellular delivery. No cell is predicted 
to be capable of surviving shear stress in excess of 105 dynes (Triyoso and Good, 2004), whilst 
200 dynes is capable of inducing instantaneous necrosis in a neuronal model (LaPlaca et al, 
1997). Neuron-specific effects of shear stress are also significant. Neurite outgrowth and 
alignment are influenced by shear stresses that are significantly lower than the forces that are 
capable of killing cells. As little as 5 microdynes were capable of inducing significant alterations 
to neurite directionality and inducing further neurite outgrowth (Kim et al, 2006). 
Electrophysiologically, 140 dynes/cm2 was capable of inducing significant alterations to the 
membrane permeability of primary cortical neurons, an effect which was observed to be rate 
dependent (LaPlaca et al, 2006). Permeable neurons within the culture were non-electrically 
194 
 
excitable whilst their non-permeable counterparts retained physiological spiking activity. 
Whilst high degrees of shear stress have negative consequences in regards to cellular viability, 
lower levels of shear stress will induce detachment from the surface and topographical 
reorganisation prior to this. Cellular adhesion to hydrophobic surfaces is notably poor 
(Valamehr et al, 2008) and the nanofibres of the implant exhibit hydrophobicity; shear stress 
may detach cells due to poor adherence. Segev et al (2003) state that neuronal cluster 
formation is due to neurites of cells contacting each other, exerting 150 microdynes of force 
on each other and if this 150 microdynes of force exceeds the adherent force the surface exerts 
on cells, cluster formation and migration occurs. Migration occurs on the nanofibres, thus from 
this it can be inferred that the force holding cells in place is below 150 microdynes, suggesting 
an upper limit for shear stress that can be applied to cells upon delivery. On the other hand, 
delivery of the organoid into the cortex within a conduit containing cellularised aligned 
nanofibres would shield the cells from the shear stress that is inherent to simply drawing up 
the nanofibres into a needle although testing would be required to determine the degree of 
shear stress generated by delivery in this way. The limitation to the conduit is the added 
dimensions of the implant. Smaller implants were associated with negative outcomes on the 
implant; increasing diameter positively correlates with decreasing neuronal staining and 
increased glial scarring (Spencer et al, 2017), indicative of greater glial scar formation which is 
a known neurodegenerative factor (McConell et al, 2009). These are the considerations for the 
next stage of development for an implant to rewire the cerebral cortex.  
 
8.3 Future directions and implications on the transplantation and 
modelling of neurons 
Within the thesis, the possibility that the organoid can be used as a high-throughput, 
developmentally advanced tissue model for use in the pharmaceutical industry has been 
discussed. In vitro cultures of neurons are inherently non-physiological whilst 3D cell culture 
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has yielded increasingly physiological responses in a number of aspects. Neuronal 3D cultures 
have an additional level of complexity relative to other tissues due to the complexity that is 
inherent to the function of the brain. Connections between neurons within the brain can occur 
at specific spatial nodes, specific temporal intervals or both (Köse-Dunn et al, 2017). In the 
absence of this level of connectivity, structure and thus function is fundamentally different 
between the in vivo and in vitro neurons, promoting the rise of differences in cellular 
behaviours. Generating representative 3D neural circuitry in vitro is difficult yet models that 
can do (henceforth referred to as Tissue Engineered Neural Networks – TENNs) so have 
numerous potential applications in vitro. The methods of generating organoids described 
within this thesis have the potential to be used in the following in vitro technologies as TENNs. 
 
8.3.1 Cerebral Cortical Organoids as Cellular Models for High-
Throughput 
Pharmacological/Toxicological Studies 
Electrically active 2D cultures do not represent the natural electrophysiology of neurons in vivo. 
Typically, neurons are allowed to grow to form networks with random topologies prior to 
experimentation yet electrophysiological activity is altered by topology and neurons in vivo 
have a highly defined architecture in vivo (Kandel, 2012). Random topologies of neurons have 
reduced ability to recruit monosynaptic excitatory post synaptic currents (EPSCs) and exhibit 
earlier development of synchronised bursting activity than patterned topologies, suggesting 
network structure plays a key role in determining cellular electrical behaviours (Marconi et al, 
2012). Whilst implementation of structure on 2D networks of dissociated neurons has a 
notable effect of the nature of the network that forms, implementing 3D topologies on 
dissociated neurons has a greater influence. Two dimensional cultures exhibit high levels of 
bursting and little random spike activity, in contrast to the low levels of bursting and high 
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random spiking that is observed in random networks that form in 3D. In addition, culture of 
random 3D networks results in desynchrony as multiple networks are formed and downstream 
signalling adds additional latency time in to network activity (Frega, 2016; Severino et al, 2016). 
Similar results have been observed when culturing neurons in 3D whilst controlling the 
topology of the neurites within the network. Dhobale et al (2018) used a hydrogel based 
cylindrical 3D structure with neuronal populations seeded to either end as a TENN. Calcium 
imaging revealed similar desynchronised regimes; highly synchronised activity locally with less 
synchronous long-range activity. The group also demonstrated anisotropic information flow 
through the 3D construct, similar to what is observed in vivo. Amongst other properties, 3D 
culture of neurons result in multiple networks that innervate each other rather than a single 
synchronous network, thus 3D neuronal cultures present a more biofidelic model of brain 
function than 2D cultures. 
 
Tang-Schomer et al (2014) formulated a brain-like tissue of silk donut structures with pores 
filled with a collagen hydrogel. The model exhibited elevated viability relative to the 2D and 
collagen hydrogel controls, increased expression of proteins involved with neuronal adhesion, 
regenerative growth and synaptogenesis and an improvement in electrophysiological activities. 
However, whilst the neurites were segregated from the soma, the neurites still exhibited a 
random topology. Similarly, Jo et al (2016) generated midbrain-like organoids from pluripotent 
stem cells that exhibited functional midbrain dopaminergic neural networks, GABAergic 
innervation and transcriptomic profiles that resemble prenatal midbrain neurons. The 
dopaminergic neurons were also capable of producing neuromelanin, a controversial molecule 
that has been indicated as a potential cause of Parkinson’s disease (Jo et al, 2016); a feat that 
has not been replicated in 2D culture. These results and many others demonstrate the utility 
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of 3D culture of neurons and the value of 3D cell culture for generating physiologically relevant 
tissues for study. 
 
 In contrast to the model of Tang-Schomer et al (2014), the TENN model described by Harris et 
al (2016) attempts to more closely mimic the 3D structure of the brain by generating aligned, 
fasciculated neurites, interconnecting 3D clusters of cell bodies (Tang-Schomer et al, 2014). 
The TENNs of Harris et al (2016) can theoretically be formulated as a bidirectional structure as 
both ends of the structure can be seeded, potentially with different neuronal subpopulations, 
and thus innervate each other. The bidirectional structure of the TENN serves two purposes; 
first, afferent and efferent connections are established and maintained, providing growth 
factors to cells within the TENN. Second, the bidirectional structure would also formulate a 
simple neural circuit. Due to the emergent functionality of neurons a neural circuit can be 
suggested to be the smallest unit of the central nervous system (CNS) (Yuste, 2015), and thus 
the TENN may be more representative of true CNS tissue than traditional cultures. The 
restriction of the direction of the neurite outgrowth may also result in improvement of the 
electrophysiological properties of the neurons as they extend neurites along the longitudinal 
axis of the TENN, thus some patterning is present. Patterned neurite outgrowth has been 
demonstrated to have some beneficial effects on electrophysiological activity (Marconi et al, 
2012).  
 
Whilst existing models of the brain such as organotypic cultures and 2D cultures are a 
functional model of the brain, 3D tissue engineered neural networks have demonstrated their 
role as a more biofidelic model of the brain electrophysiologically, transcriptomically and 
structurally. As a result, 3D neuronal cultures should increase the accuracy of cell models for 
traditional high-throughput applications such as those found in drug screening and toxicology. 
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Due to the ease of generation of the cerebral cortical organoids described within this thesis, 
they represent a promising method of generating the 3D architectures that are representative 
of the architectures found within the physiological neural circuitry. Further characterisation of 
the electrophysiological properties of the organoids is required before their use as biofidelic 
models of the brain for electrophysiological purposes. Frega et al (2016) developed a method 
of characterising 3D neuronal activity using a microelectrode array that may be suited to 
characterisation of the organoid to sufficient spatiotemporal resolution.  
 
8.3.2 Cerebral Cortical Organoids as a Macro-Neuronal Circuit In 
Vitro  
2D cultures have been generated that mirror specific networks such as the cortical-striatal 
pathway (Peyrin et al, 2011), cortical-thalamic (Kanagasabapathi et al, 2012) and the 
hippocampal-entorhinal pathway (Berdichevsky et al, 2011). Several studies have gone beyond 
patterning the neural network and have replicated specific physiological circuits, in addition to 
those that have generated the entire cortical regions with numerous complexed micro-circuits 
(Lancaster and Knoblich, 2013). These models demonstrate promotion of various 
advantageous properties such as elevated dendritic spine formation, synaptogenesis, arbor 
complexity and synchronisation of activity between cultures. However, the models only mimic 
the connection between two nodes within the CNS in a 2D manner. Other studies have 
generated circuits with numerous nodes in 3D. Choi et al (2013) generated a series of 
interconnected cortical neurospheres that expressed markers specific to the layers of the 
cortex. These connected neurospheres were utilised to test β-amyloid neurotoxicity. In 
contrast, Jeong et al (2015) differentiated cortical neural precursor cells in a series of channels 
and demonstrated interconnected neurospheres with mixed populations of cells, exhibiting 
electrical activity. 
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Whilst these structures have found use in developmental biology, toxicology and neuroscience, 
the idea of generating physiological neural structures can be taken further. The cortical 
organoids could be used to further the concept of generating in vitro circuitry by defining the 
network manually. With greater control over the seeding process, the organoids could be 
complexed similarly to the assembly of a circuit board, in order to generate advanced neural 
circuitry that is identical to the 3D structural architecture of the brain. As an example, Figure 
8.1 illustrates the direct and indirect pathways of movement, the degradation of which is 
associated with Parkinson’s disease. The architecture could roughly be approximated with a 
series of organoids seeded with glutamatergic, dopaminergic, GABAergic and cholinergic 
neurons. Studies for Parkinson’s disease that make use of an in vitro model typically use single 
cell populations in 2D culture. Often cell lines are employed due to ease of culture as such cell 
lines are capable of synthesising, metabolising and transporting dopamine although primary 
cells are still employed (Sridharan et al, 2015; Wang et al, 2014; Xu et al, 2014). One of the 
features of Parkinson’s disease is the disruption of global neural circuitry in addition to the loss 
of neurons of the substantia nigra (Kim et al, 2017) and as such, an in vitro model that 
simulated the full circuit would be of greater relevance than in vitro models that focus solely 
on loss of neurons. In addition, white matter alterations precede gray matter alterations and 
white matter damage correlates with cognitive impairment for Parkinson’s disease (Hattori et 
al, 2011), a 3D in vitro model with a greater focus on the white matter pathways is a necessity. 
In addition, white matter abnormalities have also been demonstrated to be involved with 
multiple other neurological pathologies such as Alzheimer’s disease (Lee et al, 2016; 
Rieckmann et al, 2016), autism (Ameis and Catani, 2015) and schizophrenia (Fujino et al, 2014). 
The involvement of white matter abnormalities in so many pathological states warrants an 
engineered tissue that allows for controlled growth of white matter pathways as an 
increasingly physiological model in order to better understand these conditions. The cerebral 
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cortical organoid described within this thesis compartmentalises the cells in to distinct grey 
and white matter regions and with further research in to methods of inducing myelination of 
the neurites, could represent a means of generating macro-neural circuitry.  
 
 
Figure 8.1: The direct and indirect motor pathways. The degeneration of these pathways is 
associated with Parkinson’s disease. Green = glutamatergic, red = GABAergic, blue = 
acetylcholinergic, purple = dopaminergic. The motor pathway could be simulated with multiple 
TENNs complexed to form the macro-circuit.  
8.3.3 Biomimetic Systems and Neurocontrollers 
Artificial systems mimic biological neural networks due to the efficiency, adaptability and 
robustness of the biological neural network, yet 2D cultures are a reductionist system relative 
to the complexity of the in vivo neural networks. The in vivo brain represents a small world 
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network, a topology that is adaptive, efficient and dynamic (Bassett and Bullmore, 2006) whilst 
2D conventional cultures are random networks. Small world networks have demonstrated the 
ability to reduce the learning time and error rate of artificial neural networks (Simard et al, 
2005) and are optimal for information storage (Labiouse et al, 2002). 3D neuronal cultures can 
form small-world topologies (Severino et al, 2016; Dhobale et al, 2018), meriting their use in 
biohybrid systems over 2D cultures. The multiple synchrony regimes observed in 3D cultures 
(Severino et al, 2016; Dhobale et al, 2018; Frega et al, 2016) are indicative of multiple networks 
or complex dynamics, further supporting the idea that 3D cultures may be capable of 
performing computations that 2D cultures are too reductionist to perform. In addition, 
fasciculation of axons has been hypothesised to promote more reliable electrophysiological 
behaviours (Davis et al, 2017). With the 3D nature and fasciculated neurites, the cerebral 
cortical organoids may represent an opportunity to generate physiological neural networks 
that can be mimicked to improve the adaptability, robustness and efficiency of algorithms.  
 
Additionally, due to the dynamic nature of biological systems, the field of robotics utilises 
hybrid systems of biological neural networks and artificial devices in order to overcome 
complex problems within the field (Vassanelli and Mahmud, 2016; Eiben et al, 2012). Multiple 
studies have demonstrated the ability to interface biological neurons with a synthetic body in 
order to study learning and plasticity and to develop algorithms that are tolerant to faults and 
are capable of self-repair (Webster-Wood et al, 2017). Dissociated neuronal cultures have been 
extensively used (DeMarse et al, 2001; Bakkum et al, 2004; Novellino et al, 2007; Warwick et 
al, 2010), however, the field would benefit from the use of more complex 3D neural structures. 
Neural architectures that mimic the in vivo architectures have been demonstrated to increase 
the effectiveness of these artificial devices (Webster-Wood et al, 2017). The studies listed thus 
far (DeMarse et al, 2001; Bakkum et al, 2004; Novellino et al, 2007; Warwick et al, 2010) utilise 
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dissociated neurons without imparting topologies upon them; random networks form from 
the dissociated neurons that are then restructured based on feedback loops and plasticity. Yet 
the problem remains that 2D randomly formed networks are less physiological than their 
organised 3D counterparts. At the time of writing, research utilising 3D neural architectures as 
neural controllers in artificial devices is limited. At least one group has utilised a neuromuscular 
circuit explant from Aplysia californica (Webster et al, 2017) whilst Frega et al (2016) 
developed a 3D neural network grown directly from dissociated neurons onto a microelectrode 
array and notes that it could be used as a biohybrid. Due to the nature of a tissue explant, the 
neuromuscular circuit explant from Aplysia californica suffers from the inherent organisation 
of the structure they are derived from; they are limited in size and structure is relatively 
determined with only plasticity to affect it (Webster et al, 2017). There is a need for self-
assembling, adaptable and organised 3D neural structure that could be fulfilled by the cortical 
organoids to provide the patterned, robust neural circuitry that is required for biohybrid 
systems. Study of the electrophysiological properties of the organoids within this thesis were 
relatively shallow and further characterisation and spatial analysis of connectivity would be 
required, ideally with a microelectrode array. 
 
8.3.4 Brain-machine interface 
Brain-machine interfaces (BMI) are a developing aspect of neuroscience and can be utilised for 
repair (such as the cochlear implant for hearing loss or deep brain stimulation for movement 
disorders (Serruya et al, 2017)) or eventually, enhancement. BMIs require 3 components: a 
sensor capable of recording from a population of neurons; a decoder that can interpret the 
electrophysiological signals into commands; and actuators (Hochberg et al, 2006). TENNs 
represent one strategy for a stable, long term sensor capable of recording/stimulating activity 
with high resolution within the cortex. Intracortical electrodes are have several benefits over 
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extra-cranial systems; higher resolution of neuronal signal recordings and the ability to directly 
interface with the substrate that controlled activities prior to injury/disease (reducing the 
amount of time between input and output) (Hochberg and Donoghue, 2006). However, chronic 
implantation of invasive electrodes typically results in progressive loss of signal. Due to the 
mismatch between the elastic modulus of the brain and the electrode, chronic shear and 
differential motion occurs, resulting in microtraumas and chronic inflammation (Harris et al, 
2011). Chronic inflammation occurs which is inherently neurodegenerative to the local 
neuronal population (McConnell et al, 2009). Methods of reducing the elastic modulus or 
reducing the shear stress/movement of the implant are being developed (Wu et al, 2015; Sohal 
et al, 2016; Sridharan et al, 2015) and a variety of methods of delivery that do not require 
needles, insertion shuttles or catheters are also being trialled (Harris et al, 2016; Vitale et al, 
2017). Whilst these improvements to the existing methodologies are yielding promising results 
and increasing tolerance for the implants, there is an alternative. 
 
Implanted intracortical electrodes attain their high resolution through their close contact to 
the neuron that originates the signal, in contrast to tools such as electroencephalography, 
which has low spatial resolution and poor source localisation due to the large distance between 
the origin and the point of signal recording (Hochberg and Donoghue, 2006). Due to the 
potential role for TENNs in re-wiring the brain as a long term implant, TENNs used to rewire 
must by necessity be non-inflammatory and possess a low elastic modulus to minimise glial 
scarring. As a result, TENNs could theoretically be used to reroute outputs to the surface of the 
brain, allowing for greater spatial resolution with a less invasive technique. The re-routing of 
connections could be achieved by inserting a unipolar TENN through the cortex, with the 
seeded end acting as a “biological electrode” and neurites extending within the niche of the 
TENN to the surface of the brain. Non-invasive, previously low resolution recording techniques 
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could then be used to detect neural signals from relatively deep regions of the cortex with a 
higher degree of resolution. Currently, only the Cullen research group (Harris et al, 2016; 
Adewole et al, 2017; Struzyna et al, 2018) have a TENN that possess the pre-requisites to 
perform the rewiring.  
 
8.4 Conclusion 
With the current stage of the research, aligned PLLA nanofibres can generate neurons with 
more accurate biochemical and morphological features than traditional 2D culture. In the 
immediate future, these biomaterial structures could be used within the pharmaceutical 
industry as models of neurons for drug discovery and toxicology. For all other applications, 
further validation studies are needed. For use in developmental neurobiology, time course 
data for the proteome and interactome would be needed to quantify the accuracy of the 
developmental programme of the neurons of the organoid relative to the developmental 
programme of the embryonic cerebral cortex. For regenerative medicine through rewiring, 
delivery remains a hurdle. Whilst the organoid can be self-assembled using the nanofibre 
membrane, it does not form in a controlled way, as discussed in Chapter 3. The laminar 
structure of the membrane is prohibitive to needle based insertion into the brain along ablated 
pathways and tailoring the structure towards a columnar structure would be necessary, 
possible with multiple sheets stacked to generate a 3D profile of the nanofibre sheets. 
Alternately, 3D columnar architectures of airgap electrospun nanofibres could be used to 
generate the desired implantable structures (Jha et al, 2011). Similar to the issues with 
regenerative medicine, assembly of macro-neuronal circuitry is dependent on the formation 
of the cellular structures in a controlled way. Further research using optical tweezers has been 
suggested as a means of combatting the random nature of seeding onto the membrane and 
controlling aggregation (Chapter 3).  
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In summary, the method of generating physiological architectures discussed within offers 
potential benefits to a wide range of industries and disciplines but for the purposes of rewiring 
of the cerebral cortex, a significant amount of additional work is required, most notably for the 
development of a delivery system.  
 
Appendix 
9.1 Cells and Tissues 
Item Catalogue number Company 
Sprague Dawley rat cortical 
neurons 
CKit Brainbits 
Pregnant Sprague Dawley rats - Charles River 
Table 1: Cells and tissues used throughout the PhD 
 
9.2 Reagents 
 
Item Catalogue number Company 
Trypan blue 1450021 Biorad 
NbActiv1 NbActiv1500 Brainbits 
Hibernate-E without Ca2+ HECA Brainbits 
Protein inhibitor cocktail 539197 Calbiochem 
Nanostring Murine 
Neuropathology Panel 
N/A Nanostring 
RNeasy mini kit 74104 Qiagen 
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T25 cell culture flasks 83.391 Sarstedt 
T75 cell culture flasks 83.3911 Sarstedt 
6, 12, 24 well tissue culture 
plates 
83.3920, 83.3921, 83.3922 Sarstedt 
15ml and 50ml red top tubes 62.553.020, 62.559 Sarstedt 
Pipette filter tips; 10, 200 and 
1000 μL 
70.1130, 70.760.102, 
70.762.100 
Sarstedt 
Microtubes (0.5, 1.5 and 2ml) 72.699, 72.696, 72.708 Sarstedt 
Isopropanol N/A Sigma Aldrich 
Dimethyl Sulfoxide D2650 Sigma-Aldrich 
Penicillin-Streptomycin P4333 Sigma-Aldrich 
Poly-L-lactic acid 94829 Sigma-Aldrich 
Retinoic acid R2625 Sigma-Aldrich 
Papain P4762 Sigma-Aldrich 
Gentamicin G1397 Sigma-Aldrich 
Urea U5378 Sigma-Aldrich 
Octyl-Beta-Glycopyranoside O8001 Sigma-Aldrich 
Dithiothreitol D9779 Sigma-Aldrich 
Triton X-100 X100 Sigma-Aldrich 
Paraformaldehyde 158127 Sigma-Aldrich 
Glycine G8898 Sigma-Aldrich 
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Tris 10708976001 Sigma-Aldrich 
SDS 74255 Sigma-Aldrich 
Acrylamide A4058 Sigma-Aldrich 
HBSS (10x) without Ca2+, Mg2+ 
or phenol red 
14185045 Thermo Fisher Scientific 
StemPro Accutase A1110501 Thermo Fisher Scientific 
DMEM/F12, glutamax 
supplement 
31331028 Thermo Fisher Scientific 
Fetal bovine serum 10270106 Thermo Fisher Scientific 
Phosphate buffered saline, pH 
7.4 
10010023 Thermo Fisher Scientific 
Collagen type I, rat tail A1048301 Thermo Fisher Scientific 
Media 199, 10x 11825015 Thermo Fisher Scientific 
Phosphate buffered saline, 10x 
pH 7.4 
70011044 Thermo Fisher Scientific 
Neurobasal 21103049 Thermo Fisher Scientific 
B27 17504044 Thermo Fisher Scientific 
Glutamax 35050061 Thermo Fisher Scientific 
Lowry assay kit 23240 Thermo Fisher Scientific 
Hibernate-E with Ca2+ A1247601 Thermo Fisher Scientific 
Pierce LDH cytotoxicity assay kit 1354269 Thermo Fisher Scientific 
Fluovolt F10488 Thermo Fisher Scientific 
208 
 
Fura Red AM F3021 Thermo Fisher Scientific 
AAV-hSyn-hChr2(H134R)-
mCherry 
N/A Vectorcore 
RNA Clean and Concentrator-5 R1013 Zymo 
Table 2: Reagents used throughout the course of the PhD 
 
9.3 Antibodies 
Item Use Catalogue 
number 
Host 
species 
Application 
(dilution) 
Species 
reactivity 
Company 
Anti-beta III 
Tubulin antibody 
[2G10] (Alexa 
Fluor® 488) 
Primary ab195879 Mouse 
1:50 (IF), 
1:1000 (WB) Rat, 
human  
Abcam 
Anti-VDAC1 Primary D73D12 Rabbit 
1:1000 (WB) Mouse, 
rat, 
human 
Cell Signalling 
Technology 
Anti-mouse IgG, 
HRP linked 
Secondary 7076S Horse 
1:1000 (WB) 
- 
Cell Signalling 
Technology 
Anti-rabbit IgG, 
HRP linked 
Secondary 7074S Goat 
1:1000 (WB) 
- 
Cell Signalling 
Technology 
Anti-Chr2 [15E2] Primary 651180 Mouse 1:100 (IF) -  Progen 
Anti-Nestin (Rat-
401) 
Primary Sc-33677 Mouse 
1:50 (IF) Mouse, 
rat, 
human  
Santa-Cruz 
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Anti-βIII tubulin Primary Sc-51670 Mouse 
1:100 (IF)  Mouse, 
rat, 
human 
Santa-Cruz 
Anti-GFAP Primary Sc-65343 Mouse 
1:100 (IF) Rat, 
mouse, 
porcine, 
human 
Santa-Cruz 
Anti-mouse IgG-
TRITC 
Secondary T5393-.5ml Goat 
1:300 (IF) All mouse 
IgG 
subclasse
s, IgA and 
IgM 
Sigma Aldrich 
Fluorescein anti-
mouse IgG 
antibody 
Secondary FI-2000 Horse 
1:300 (IF) Mouse 
IgM, Rat 
IgG 
Vector 
Laboratories 
Table 3: Antibody concentration, specificity and uses  
 
9.4 Equipment  
Equipment  Company 
TC20 Cell Counter Biorad 
Western Blotting Tank Biorad 
Clariostar Fluorescent Plate Reader BMG Labtech 
ImageQuant LAS 4000 Fujifilm 
JBA5 Water Bath Grant instruments 
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Scanning Electron Microscope (JSM-7100F) Jeol  
Drop Shape Analyzer 10MK2 Kruss 
SP5 Confocal Microscope Leica 
Custom Electrospinning Rig N/A 
nCounter Analysis System 
Nanostring 
NE-1000 Syringe Pump New Era Pump Systems 
MCO-18AC- PE CO2 Incubator Panasonic 
TripleTOF 6600 Mass Spectrometer Sciex 
Stuart Sb162 Heated Magnetic Stirrer Sigma-Aldrich 
Heraeus Multifuge X3 Thermo Fisher Scientific 
CO2 Laser Cutter, SP series Trotec 
Table 4: Equipment and Suppliers of the equipment used throughout the PhD 
 
9.5 Software 
 
Software Company 
Morpheus Heatmaps Broad Institute 
Metacore Clarivate Analytics 
Advanced Imaging Data Analyzer (AIDA) v 3.44 Elysia-Raytest 
Graphpad Prism v7.0 Graphpad Software Inc 
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Statistical Package for the Social Sciences (SPSS) 
statistics 26 
IBM 
Cytoscape  Institute of Systems Biology 
ANNI algorithm 
John Van Geest Cancer Centre, Nottingham Trent 
University 
FIJI; ImageJ Open Source Software 
Table 5: Software used over the course of the PhD  
 
9.6 Mass Spectrometry raw data 
  
Protein 
Name 
Protein Fold 
Change 
(Control vs 
Nanofibres) 
log 2 Fold 
Change 
(Control vs 
Nanofibres) 
Confidence 
Value 
PRDX4 Peroxiredoxin-4 9.25 3.21 97.18% 
TBB2B Tubulin beta-2B chain 11.75 3.56 95.24% 
2AAB Serine/threonine-protein 
phosphatase 2A 65 kDa regulatory 
subunit A beta isoform 
2.95 1.56 93.04% 
CFDP1 Craniofacial development protein 1 13.24 3.73 92.91% 
CUTA Protein CutA 2.60 1.38 89.75% 
CK096 Uncharacterized protein C11orf96 
homolog 
2.26 1.18 89.52% 
COX2 Cytochrome c oxidase subunit 2 3.79 1.92 89.01% 
HS90A Heat shock protein HSP 90-alpha -5.17 -2.37 87.53% 
JUPI1 Hematological and neurological 
expressed 1 protein 
4.64 2.21 87.33% 
DPYL2 Dihydropyrimidinase-related protein 
2 
2.14 1.10 86.67% 
PTMS Parathymosin 2.54 1.35 86.53% 
INS1 Insulin-1 -6.53 -2.71 86.45% 
U2AF4 Splicing factor U2AF 26 kDa subunit 4.79 2.26 85.45% 
FABP7 Fatty acid-binding protein, brain 3.28 1.71 85.21% 
K2C1 Keratin, type II cytoskeletal 1 7.46 2.90 85.12% 
STMN2 Stathmin-2 3.83 1.94 84.55% 
AF1Q Protein AF1q 8.10 3.02 84.23% 
RS20 40S ribosomal protein S20 -4.87 -2.28 84.09% 
CPLX2 Complexin-2 -1.61 -0.69 84.05% 
RLA1 60S acidic ribosomal protein P1 4.77 2.25 83.56% 
PGRC1 Membrane-associated progesterone 
receptor component 1 
6.49 2.70 83.00% 
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MLP3B Microtubule-associated proteins 
1A/1B light chain 3B 
-11.05 -3.47 82.44% 
SRSF6 Serine/arginine-rich splicing factor 6 2.99 1.58 82.17% 
EF1D Elongation factor 1-delta 2.59 1.38 82.08% 
STMN1 Stathmin 3.43 1.78 82.03% 
MCRI1 Mapk-regulated corepressor-
interacting protein 1 
3.85 1.95 82.02% 
COX5A Cytochrome c oxidase subunit 5A, 
mitochondrial 
3.97 1.99 81.83% 
T22D1 TSC22 domain family protein 1 4.21 2.07 81.56% 
RAB18 Ras-related protein Rab-18 6.93 2.79 80.51% 
RTN3 Reticulon-3 -2.27 -1.18 80.26% 
KCRB Creatine kinase B-type -2.82 -1.50 79.88% 
BASP1 Brain acid soluble protein 1 -4.04 -2.01 79.36% 
NOVA1 RNA-binding protein Nova-1 2.54 1.34 79.28% 
G6PI Glucose-6-phosphate isomerase -6.11 -2.61 79.09% 
SCRN1 Secernin-1 3.32 1.73 79.01% 
RL13A 60S ribosomal protein L13a -3.24 -1.70 78.59% 
K2C73 Keratin, type II cytoskeletal 73 4.47 2.16 78.30% 
1433G 14-3-3 protein gamma 2.65 1.40 78.14% 
SCG2 Secretogranin-2 2.70 1.44 77.61% 
TERA Transitional endoplasmic reticulum 
ATPase 
-5.31 -2.41 77.53% 
MARE1 Microtubule-associated protein 
RP/EB family member 1 
-3.85 -1.94 77.53% 
RL17 60S ribosomal protein L17 -3.42 -1.77 77.13% 
CNTN1 Contactin-1 2.58 1.37 76.98% 
ENOA Alpha-enolase 2.20 1.14 76.56% 
NASP Nuclear autoantigenic sperm protein 3.11 1.64 76.55% 
K2C5 Keratin, type II cytoskeletal 5 5.22 2.38 76.45% 
KPYM Pyruvate kinase PKM -3.02 -1.59 76.34% 
PTN Pleiotrophin -8.84 -3.14 76.28% 
RRAS Ras-related protein R-Ras 2.14 1.10 76.19% 
TBCA Tubulin-specific chaperone A 2.48 1.31 76.16% 
ATPB ATP synthase subunit beta, 
mitochondrial 
4.41 2.14 76.04% 
ACBP Acyl-CoA-binding protein 6.00 2.59 76.00% 
HS90B Heat shock protein HSP 90-beta -1.77 -0.82 75.97% 
NSDHL Sterol-4-alpha-carboxylate 3-
dehydrogenase, decarboxylating 
2.71 1.44 75.88% 
H14 Histone H1.4 2.28 1.19 75.84% 
FUBP2 Far upstream element-binding 
protein 2 
2.62 1.39 75.67% 
MATR3 Matrin-3 -3.75 -1.91 75.58% 
ATIF1 ATPase inhibitor, mitochondrial 5.45 2.45 75.51% 
RMXRL RNA-binding motif protein, X 
chromosome retrogene-like 
-3.05 -1.61 75.51% 
CIRBP Cold-inducible RNA-binding protein 5.85 2.55 75.31% 
QCR1 Cytochrome b-c1 complex subunit 1, 
mitochondrial 
4.73 2.24 75.15% 
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CCD50 Coiled-coil domain-containing 
protein 50 
3.71 1.89 75.07% 
BIP 78 kDa glucose-regulated protein 2.11 1.08 74.84% 
SC22B Vesicle-trafficking protein SEC22b 3.04 1.60 74.74% 
THIL Acetyl-CoA acetyltransferase, 
mitochondrial 
3.62 1.86 74.62% 
RL26 60S ribosomal protein L26 -3.13 -1.65 74.57% 
H2AZ Histone H2A.Z -6.12 -2.61 74.54% 
RL5 60S ribosomal protein L5 -3.60 -1.85 74.49% 
FABPH Fatty acid-binding protein, heart -5.15 -2.37 74.40% 
AINX Alpha-internexin 2.22 1.15 74.29% 
VAMP2 Vesicle-associated membrane 
protein 2 
4.26 2.09 74.21% 
K22E Keratin, type II cytoskeletal 2 
epidermal 
6.57 2.72 74.01% 
ARP3 Actin-related protein 3 -2.92 -1.54 73.96% 
EIF3B Eukaryotic translation initiation 
factor 3 subunit B 
-2.87 -1.52 73.67% 
THIO Thioredoxin -4.72 -2.24 73.51% 
COX5B Cytochrome c oxidase subunit 5B, 
mitochondrial 
3.02 1.59 73.50% 
TYB10 Thymosin beta-10 4.34 2.12 73.44% 
DC1L1 Cytoplasmic dynein 1 light 
intermediate chain 1 
-4.70 -2.23 73.43% 
FSCN1 Fascin -2.55 -1.35 73.39% 
PSMD9 26S proteasome non-ATPase 
regulatory subunit 9 
2.98 1.57 73.35% 
DEST Destrin -3.21 -1.68 73.07% 
PPIA Peptidyl-prolyl cis-trans isomerase A 2.14 1.10 73.03% 
UCHL1 Ubiquitin carboxyl-terminal 
hydrolase isozyme L1 
3.03 1.60 73.00% 
STXB1 Syntaxin-binding protein 1 -3.17 -1.67 72.58% 
RS13 40S ribosomal protein S13 -3.56 -1.83 72.53% 
K1C10 Keratin, type I cytoskeletal 10 6.10 2.61 72.53% 
RTN4 Reticulon-4 2.84 1.51 72.48% 
G3P Glyceraldehyde-3-phosphate 
dehydrogenase 
-5.36 -2.42 72.41% 
ARPC2 Actin-related protein 2/3 complex 
subunit 2 
-2.44 -1.29 72.39% 
RS19 40S ribosomal protein S19 -8.47 -3.08 72.30% 
TCPD T-complex protein 1 subunit delta -3.67 -1.88 72.20% 
1433Z 14-3-3 protein zeta/delta 3.24 1.70 72.10% 
ARC1A Actin-related protein 2/3 complex 
subunit 1A 
-4.03 -2.01 72.04% 
RAN GTP-binding nuclear protein Ran -2.62 -1.39 71.90% 
DCX Neuronal migration protein 
doublecortin 
-3.04 -1.61 71.74% 
SF3B4 Splicing factor 3B subunit 4 3.94 1.98 71.46% 
ATP5J ATP synthase-coupling factor 6, 
mitochondrial 
12.22 3.61 71.43% 
RS12 40S ribosomal protein S12 2.47 1.30 71.33% 
MEA1 Male-enhanced antigen 1 7.55 2.92 71.31% 
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FAF1 FAS-associated factor 1 -3.16 -1.66 71.28% 
MAP1B Microtubule-associated protein 1B 2.20 1.14 71.16% 
ALBU Serum albumin 5.71 2.51 70.88% 
RS16 40S ribosomal protein S16 -5.73 -2.52 70.80% 
HGS Hepatocyte growth factor-regulated 
tyrosine kinase substrate 
2.07 1.05 70.70% 
KCY UMP-CMP kinase 4.38 2.13 70.42% 
DPYL3 Dihydropyrimidinase-related protein 
3 
2.25 1.17 70.40% 
RSSA 40S ribosomal protein SA -3.27 -1.71 70.33% 
UFD1 Ubiquitin fusion degradation protein 
1 homolog 
-4.76 -2.25 70.28% 
CH10 10 kDa heat shock protein, 
mitochondrial 
2.74 1.45 70.20% 
THIC Acetyl-CoA acetyltransferase, 
cytosolic 
3.71 1.89 69.90% 
KAD1 Adenylate kinase isoenzyme 1 2.81 1.49 69.69% 
CH60 60 kDa heat shock protein, 
mitochondrial 
2.72 1.45 69.52% 
1433T 14-3-3 protein theta -3.64 -1.86 69.51% 
PSB6 Proteasome subunit beta type-6 2.84 1.50 69.45% 
STIP1 Stress-induced-phosphoprotein 1 -2.34 -1.23 69.38% 
ODPB Pyruvate dehydrogenase E1 
component subunit beta, 
mitochondrial 
4.57 2.19 69.25% 
VIME Vimentin 3.33 1.74 69.25% 
RS14 40S ribosomal protein S14 -3.40 -1.76 69.17% 
MYG1 UPF0160 protein MYG1, 
mitochondrial 
4.19 2.07 69.10% 
TTC5 Tetratricopeptide repeat protein 5 -16.38 -4.03 68.84% 
CLIP2 CAP-Gly domain-containing linker 
protein 2 
2.87 1.52 68.83% 
PFD2 Prefoldin subunit 2 2.04 1.03 68.83% 
RL35A 60S ribosomal protein L35a -24.08 -4.59 68.73% 
RL12 60S ribosomal protein L12 -5.43 -2.44 68.69% 
RL22 60S ribosomal protein L22 -1.84 -0.88 68.65% 
IDHC Isocitrate dehydrogenase [NADP] 
cytoplasmic 
-2.27 -1.18 68.62% 
DC1I1 Cytoplasmic dynein 1 intermediate 
chain 1 
3.17 1.67 68.52% 
NDUV2 NADH dehydrogenase [ubiquinone] 
flavoprotein 2, mitochondrial 
2.57 1.36 68.42% 
PHB2 Prohibitin-2 -5.63 -2.49 68.31% 
TBB3 Tubulin beta-3 chain -3.38 -1.76 68.15% 
RL10 60S ribosomal protein L10 -8.24 -3.04 68.02% 
NOLC1 Nucleolar and coiled-body 
phosphoprotein 1 
-4.76 -2.25 67.72% 
RS23 40S ribosomal protein S23 -4.07 -2.02 67.65% 
FABP5 Fatty acid-binding protein, epidermal -4.31 -2.11 67.50% 
F10A1 Hsc70-interacting protein -3.00 -1.59 67.43% 
COF1 Cofilin-1 -2.64 -1.40 67.40% 
RL15 60S ribosomal protein L15 -1.91 -0.93 67.37% 
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NUCB1 Nucleobindin-1 4.76 2.25 67.22% 
TCTP Translationally-controlled tumor 
protein 
1.94 0.95 67.05% 
PEA15 Astrocytic phosphoprotein PEA-15 2.55 1.35 66.77% 
CALX Calnexin 3.43 1.78 66.75% 
K1C19 Keratin, type I cytoskeletal 19 7.30 2.87 66.70% 
TYB4 Thymosin beta-4 -7.41 -2.89 66.60% 
NTF2 Nuclear transport factor 2 2.41 1.27 66.60% 
CSN2 COP9 signalosome complex subunit 
2 
-2.83 -1.50 66.52% 
RS3 40S ribosomal protein S3 -3.60 -1.85 66.42% 
ATPD ATP synthase subunit delta, 
mitochondrial 
3.57 1.84 66.41% 
NDUS6 NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 6, mitochondrial 
2.99 1.58 66.28% 
RL27 60S ribosomal protein L27 -11.94 -3.58 66.13% 
PP14B Protein phosphatase 1 regulatory 
subunit 14B 
-3.96 -1.99 66.00% 
GRAP1 GRIP1-associated protein 1 3.09 1.63 65.63% 
AP2B1 AP-2 complex subunit beta -5.44 -2.44 65.60% 
MEP50 Methylosome protein 50 4.12 2.04 65.56% 
PPP6 Serine/threonine-protein 
phosphatase 6 catalytic subunit 
5.65 2.50 65.55% 
NDUAA NADH dehydrogenase [ubiquinone] 1 
alpha subcomplex subunit 10, 
mitochondrial 
5.33 2.42 65.44% 
MARE2 Microtubule-associated protein 
RP/EB family member 2 
3.39 1.76 65.34% 
NEUM Neuromodulin -3.10 -1.63 65.27% 
RS28 40S ribosomal protein S28 7.67 2.94 64.95% 
RAB1B Ras-related protein Rab-1B -2.08 -1.06 64.63% 
TRY3 Cationic trypsin-3 -6.37 -2.67 64.51% 
ROA3 Heterogeneous nuclear 
ribonucleoprotein A3 
-3.05 -1.61 64.47% 
CISY Citrate synthase, mitochondrial -4.53 -2.18 64.21% 
AK1A1 Alcohol dehydrogenase [NADP(+)] -3.70 -1.89 64.16% 
ELAV1 ELAV-like protein 1 -3.07 -1.62 63.99% 
QCR2 Cytochrome b-c1 complex subunit 2, 
mitochondrial 
-3.31 -1.73 63.86% 
ROA1 Heterogeneous nuclear 
ribonucleoprotein A1 
-2.98 -1.57 63.75% 
SMS Somatostatin 7.61 2.93 63.74% 
MOFA1 MORF4 family-associated protein 1 3.76 1.91 63.65% 
PDIA4 Protein disulfide-isomerase A4 -5.41 -2.44 63.52% 
40057 Septin-9 -3.99 -2.00 63.48% 
SFR1 Swi5-dependent recombination DNA 
repair protein 1 homolog 
2.17 1.12 63.16% 
GOGA2 Golgin subfamily A member 2 3.63 1.86 63.11% 
CSRP2 Cysteine and glycine-rich protein 2 -4.13 -2.05 63.03% 
PSB5 Proteasome subunit beta type-5 -4.68 -2.23 62.76% 
NUP62 Nuclear pore glycoprotein p62 -2.18 -1.12 62.75% 
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1433F 14-3-3 protein eta 6.15 2.62 62.75% 
PPID Peptidyl-prolyl cis-trans isomerase D -8.56 -3.10 62.72% 
ARP2 Actin-related protein 2 -2.44 -1.29 62.65% 
TRY1 Anionic trypsin-1 -1.90 -0.92 62.58% 
CDC37 Hsp90 co-chaperone Cdc37 1.33 0.41 62.57% 
DLRB1 Dynein light chain roadblock-type 1 2.18 1.12 62.43% 
PTMA Prothymosin alpha 2.02 1.01 62.32% 
INS2 Insulin-2 2.06 1.04 62.09% 
EF1A2 Elongation factor 1-alpha 2 -4.96 -2.31 62.04% 
TXD12 Thioredoxin domain-containing 
protein 12 
3.36 1.75 61.80% 
RS18 40S ribosomal protein S18 -5.49 -2.46 61.50% 
HBB1 Hemoglobin subunit beta-1 4.10 2.04 61.42% 
VGF Neurosecretory protein VGF 3.34 1.74 61.29% 
CATA Catalase 2.44 1.29 61.26% 
RL14 60S ribosomal protein L14 -3.14 -1.65 60.86% 
SYUB Beta-synuclein 3.19 1.67 60.65% 
HNRPM Heterogeneous nuclear 
ribonucleoprotein M 
-3.01 -1.59 60.53% 
DDX4 Probable ATP-dependent RNA 
helicase DDX4 
-2.54 -1.34 60.13% 
RS3A 40S ribosomal protein S3a -4.20 -2.07 60.08% 
IF4A2 Eukaryotic initiation factor 4A-II -1.45 -0.54 60.06% 
K2C1B Keratin, type II cytoskeletal 1b 6.39 2.68 60.03% 
TBB4B Tubulin beta-4B chain 1.82 0.86 59.87% 
RLA2 60S acidic ribosomal protein P2 3.05 1.61 59.86% 
DNJA2 DnaJ homolog subfamily A member 2 -4.70 -2.23 59.60% 
IMB1 Importin subunit beta-1 4.44 2.15 59.55% 
ALDH2 Aldehyde dehydrogenase, 
mitochondrial 
-8.73 -3.13 59.35% 
COR1B Coronin-1B -5.05 -2.34 59.29% 
NUCKS Nuclear ubiquitous casein and cyclin-
dependent kinase substrate 1 
-1.97 -0.98 59.16% 
ALDR Aldose reductase 1.96 0.97 59.02% 
EF1G Elongation factor 1-gamma -1.79 -0.84 58.93% 
SUMO2 Small ubiquitin-related modifier 2 1.47 0.56 58.77% 
DCTN2 Dynactin subunit 2 2.33 1.22 58.43% 
IF4A3 Eukaryotic initiation factor 4A-III -1.64 -0.71 58.40% 
TBB5 Tubulin beta-5 chain -2.82 -1.49 58.37% 
GNAO Guanine nucleotide-binding protein 
G(o) subunit alpha 
1.88 0.91 58.19% 
MARCS Myristoylated alanine-rich C-kinase 
substrate 
-3.35 -1.75 57.99% 
TIM8B Mitochondrial import inner 
membrane translocase subunit Tim8 
B 
6.24 2.64 57.77% 
ALDOA Fructose-bisphosphate aldolase A -4.24 -2.08 57.59% 
H15 Histone H1.5 3.03 1.60 57.40% 
MVD1 Diphosphomevalonate 
decarboxylase 
-3.25 -1.70 57.35% 
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PP2AB Serine/threonine-protein 
phosphatase 2A catalytic subunit 
beta isoform 
1.93 0.95 57.34% 
VIGLN Vigilin -2.97 -1.57 57.34% 
HSP7C Heat shock cognate 71 kDa protein 1.82 0.86 57.27% 
RS29 40S ribosomal protein S29 -4.82 -2.27 57.07% 
MLP3A Microtubule-associated proteins 
1A/1B light chain 3A 
-3.63 -1.86 57.05% 
NCAN Neurocan core protein 3.81 1.93 56.99% 
AP2S1 AP-2 complex subunit sigma -13.79 -3.79 56.90% 
SERA D-3-phosphoglycerate 
dehydrogenase 
4.88 2.29 56.87% 
ATPG ATP synthase subunit gamma, 
mitochondrial 
-9.70 -3.28 56.86% 
SYTC Threonine--tRNA ligase, cytoplasmic -6.36 -2.67 56.71% 
AATC Aspartate aminotransferase, 
cytoplasmic 
-6.54 -2.71 56.58% 
PSMD1 26S proteasome non-ATPase 
regulatory subunit 1 
-5.33 -2.41 56.56% 
PSA3 Proteasome subunit alpha type-3 -2.39 -1.26 56.45% 
APBA1 Amyloid beta A4 precursor protein-
binding family A member 1 
-3.84 -1.94 56.42% 
HSBP1 Heat shock factor-binding protein 1 2.74 1.45 56.37% 
ML12B Myosin regulatory light chain 12B -6.87 -2.78 56.26% 
VDAC2 Voltage-dependent anion-selective 
channel protein 2 
2.28 1.19 56.26% 
SNP25 Synaptosomal-associated protein 25 5.19 2.38 56.16% 
MARE3 Microtubule-associated protein 
RP/EB family member 3 
-2.75 -1.46 56.02% 
1433E 14-3-3 protein epsilon -3.80 -1.92 55.98% 
PA1B3 Platelet-activating factor 
acetylhydrolase IB subunit gamma 
-4.78 -2.26 55.91% 
RL10A 60S ribosomal protein L10a -4.28 -2.10 55.73% 
NFM Neurofilament medium polypeptide 3.71 1.89 55.69% 
SUCA Succinate--CoA ligase [ADP/GDP-
forming] subunit alpha, 
mitochondrial 
-3.14 -1.65 55.46% 
PCP4 Purkinje cell protein 4 2.99 1.58 55.29% 
TPM3 Tropomyosin alpha-3 chain 4.02 2.01 55.26% 
LDHA L-lactate dehydrogenase A chain -4.52 -2.18 55.24% 
RL8 60S ribosomal protein L8 -2.77 -1.47 55.12% 
GNAI3 Guanine nucleotide-binding protein 
G(k) subunit alpha 
-3.38 -1.76 54.99% 
RS5 40S ribosomal protein S5 -6.94 -2.80 54.98% 
PAK3 Serine/threonine-protein kinase PAK 
3 
-2.69 -1.43 54.86% 
GDIA Rab GDP dissociation inhibitor alpha -3.14 -1.65 54.63% 
GBRL2 Gamma-aminobutyric acid receptor-
associated protein-like 2 
-1.95 -0.96 54.63% 
NSF1C NSFL1 cofactor p47 2.40 1.26 54.60% 
RAB3A Ras-related protein Rab-3A 1.55 0.63 54.51% 
ATAT Alpha-tubulin N-acetyltransferase 1 -9.09 -3.18 54.49% 
RS15A 40S ribosomal protein S15a -5.77 -2.53 54.43% 
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GSTP1 Glutathione S-transferase P -1.32 -0.40 54.41% 
IF5A1 Eukaryotic translation initiation 
factor 5A-1 
-2.68 -1.42 54.35% 
HNRPD Heterogeneous nuclear 
ribonucleoprotein D0 
-2.45 -1.29 54.32% 
K1C42 Keratin, type I cytoskeletal 42 5.17 2.37 54.31% 
PA1B2 Platelet-activating factor 
acetylhydrolase IB subunit beta 
-3.79 -1.92 54.28% 
SDHB Succinate dehydrogenase 
[ubiquinone] iron-sulfur subunit, 
mitochondrial 
-6.98 -2.80 54.20% 
KAPCB cAMP-dependent protein kinase 
catalytic subunit beta 
-2.21 -1.14 54.19% 
ROA2 Heterogeneous nuclear 
ribonucleoproteins A2/B1 
3.13 1.65 54.17% 
PSA4 Proteasome subunit alpha type-4 -3.45 -1.79 54.16% 
OGA Protein O-GlcNAcase 4.50 2.17 54.06% 
DBNL Drebrin-like protein 3.41 1.77 53.98% 
STML2 Stomatin-like protein 2, 
mitochondrial 
-5.85 -2.55 53.95% 
ATOX1 Copper transport protein ATOX1 2.28 1.19 53.92% 
TBA1A Tubulin alpha-1A chain -2.25 -1.17 53.88% 
H4 Histone H4 -6.80 -2.77 53.81% 
PRDX2 Peroxiredoxin-2 1.83 0.87 53.76% 
IMDH2 Inosine-5'-monophosphate 
dehydrogenase 2 
-3.67 -1.87 53.73% 
CNN3 Calponin-3 -3.52 -1.82 53.68% 
COPG1 Coatomer subunit gamma-1 2.63 1.40 53.61% 
RAB5A Ras-related protein Rab-5A 7.10 2.83 53.51% 
RL34 60S ribosomal protein L34 -2.97 -1.57 53.38% 
CYTB Cystatin-B -4.42 -2.14 53.33% 
SIR5 NAD-dependent protein deacylase 
sirtuin-5, mitochondrial 
-2.29 -1.20 52.94% 
NPL4 Nuclear protein localization protein 4 
homolog 
-8.13 -3.02 52.93% 
PHOCN MOB-like protein phocein 2.68 1.42 52.92% 
CAN2 Calpain-2 catalytic subunit 1.95 0.97 52.77% 
NH2L1 NHP2-like protein 1 2.13 1.09 52.68% 
RS25 40S ribosomal protein S25 -3.61 -1.85 52.63% 
REEP5 Receptor expression-enhancing 
protein 5 
-9.07 -3.18 52.62% 
KAPCA cAMP-dependent protein kinase 
catalytic subunit alpha 
-7.31 -2.87 52.62% 
RL23 60S ribosomal protein L23 -2.06 -1.04 52.61% 
6PGD 6-phosphogluconate dehydrogenase, 
decarboxylating 
-3.80 -1.93 52.60% 
PSB4 Proteasome subunit beta type-4 -4.93 -2.30 52.37% 
SNX3 Sorting nexin-3 1.87 0.90 52.21% 
EMC2 ER membrane protein complex 
subunit 2 
-4.35 -2.12 52.19% 
RL13 60S ribosomal protein L13 -3.05 -1.61 52.16% 
PLD3 Phospholipase D3 -6.04 -2.59 52.15% 
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PCNA Proliferating cell nuclear antigen -6.23 -2.64 52.12% 
ARL3 ADP-ribosylation factor-like protein 3 -3.82 -1.93 52.12% 
PROF1 Profilin-1 -6.31 -2.66 52.07% 
1433B 14-3-3 protein beta/alpha 2.00 1.00 52.05% 
CPSM Carbamoyl-phosphate synthase 
[ammonia], mitochondrial 
2.08 1.05 51.96% 
SRSF2 Serine/arginine-rich splicing factor 2 5.19 2.38 51.88% 
NDKB Nucleoside diphosphate kinase B -4.31 -2.11 51.86% 
GDIB Rab GDP dissociation inhibitor beta -3.17 -1.67 51.83% 
ODPA Pyruvate dehydrogenase E1 
component subunit alpha, somatic 
form, mitochondrial 
-4.07 -2.02 51.82% 
RD23B UV excision repair protein RAD23 
homolog B 
-4.80 -2.26 51.82% 
UBE2N Ubiquitin-conjugating enzyme E2 N -2.88 -1.53 51.69% 
SAP Prosaposin 3.56 1.83 51.61% 
RS6 40S ribosomal protein S6 -4.88 -2.29 51.57% 
RSMN Small nuclear ribonucleoprotein-
associated protein N 
-3.38 -1.76 51.51% 
SYVC Valine--tRNA ligase -3.37 -1.75 51.44% 
H2A2A Histone H2A type 2-A -5.24 -2.39 51.39% 
COTL1 Coactosin-like protein -3.61 -1.85 51.37% 
ERF1 Eukaryotic peptide chain release 
factor subunit 1 
-3.23 -1.69 51.28% 
GSTM1 Glutathione S-transferase Mu 1 -2.07 -1.05 51.26% 
CNBP Cellular nucleic acid-binding protein -2.22 -1.15 51.12% 
PSA7 Proteasome subunit alpha type-7 -2.97 -1.57 51.07% 
KPRP Keratinocyte proline-rich protein 3.27 1.71 51.03% 
P5CR3 Pyrroline-5-carboxylate reductase 3 1.87 0.90 51.01% 
PP1R7 Protein phosphatase 1 regulatory 
subunit 7 
13.70 3.78 51.01% 
CAPR1 Caprin-1 2.72 1.44 50.77% 
AMRP Alpha-2-macroglobulin receptor-
associated protein 
2.74 1.46 50.75% 
HMGB1 High mobility group protein B1 -3.48 -1.80 50.62% 
PSB2 Proteasome subunit beta type-2 -8.46 -3.08 50.50% 
NONO Non-POU domain-containing 
octamer-binding protein 
3.42 1.78 50.44% 
PSA5 Proteasome subunit alpha type-5 2.15 1.11 50.42% 
4F2 4F2 cell-surface antigen heavy chain 2.46 1.30 50.42% 
AMPH Amphiphysin -3.15 -1.66 50.39% 
RL18A 60S ribosomal protein L18a -5.06 -2.34 50.35% 
ATP5E ATP synthase subunit epsilon, 
mitochondrial 
-8.04 -3.01 50.24% 
TBB2A Tubulin beta-2A chain -5.55 -2.47 50.14% 
PROF2 Profilin-2 3.37 1.75 50.01% 
PP2AA Serine/threonine-protein 
phosphatase 2A catalytic subunit 
alpha isoform 
-7.10 -2.83 50.00% 
UBA1 Ubiquitin-like modifier-activating 
enzyme 1 
-2.37 -1.24 49.95% 
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RS11 40S ribosomal protein S11 -4.49 -2.17 49.95% 
CBPE Carboxypeptidase E 2.89 1.53 49.86% 
ADRM1 Proteasomal ubiquitin receptor 
ADRM1 
2.67 1.42 49.75% 
ELOC Elongin-C -4.75 -2.25 49.45% 
ENOG Gamma-enolase 1.93 0.95 49.39% 
PRDX3 Thioredoxin-dependent peroxide 
reductase, mitochondrial 
-2.64 -1.40 49.27% 
RBM8A RNA-binding protein 8A 2.72 1.45 49.21% 
AN32A Acidic leucine-rich nuclear 
phosphoprotein 32 family member A 
-2.14 -1.10 49.15% 
PPAC Low molecular weight 
phosphotyrosine protein 
phosphatase 
2.10 1.07 49.10% 
CAP1 Adenylyl cyclase-associated protein 1 -3.86 -1.95 49.04% 
DC1L2 Cytoplasmic dynein 1 light 
intermediate chain 2 
-4.94 -2.30 48.85% 
NDRG3 Protein NDRG3 -2.31 -1.21 48.77% 
PTBP2 Polypyrimidine tract-binding protein 
2 
-4.87 -2.28 48.73% 
DDX1 ATP-dependent RNA helicase DDX1 -3.47 -1.80 48.70% 
SMCA4 Transcription activator BRG1 -3.16 -1.66 48.59% 
TOLIP Toll-interacting protein 3.54 1.83 48.55% 
PICAL Phosphatidylinositol-binding clathrin 
assembly protein 
-3.17 -1.66 48.51% 
GSTM5 Glutathione S-transferase Mu 5 6.62 2.73 48.49% 
MDHM Malate dehydrogenase, 
mitochondrial 
-2.71 -1.44 48.48% 
PDCD6 Programmed cell death protein 6 -6.26 -2.65 48.43% 
GPM6A Neuronal membrane glycoprotein 
M6-a 
-3.28 -1.71 48.40% 
CATB Cathepsin B 2.93 1.55 48.12% 
RL4 60S ribosomal protein L4 -1.82 -0.87 48.12% 
PCNP PEST proteolytic signal-containing 
nuclear protein 
3.67 1.87 48.09% 
PIMT Protein-L-isoaspartate(D-aspartate) 
O-methyltransferase 
5.20 2.38 48.04% 
EF1A1 Elongation factor 1-alpha 1 -3.68 -1.88 48.00% 
ATPO ATP synthase subunit O, 
mitochondrial 
-3.47 -1.80 47.98% 
TAU Microtubule-associated protein tau 1.96 0.97 47.94% 
PCYOX Prenylcysteine oxidase -5.32 -2.41 47.76% 
RL30 60S ribosomal protein L30 -2.37 -1.25 47.65% 
DREB Drebrin -2.02 -1.01 47.56% 
COPD Coatomer subunit delta -3.43 -1.78 47.53% 
SERB Phosphoserine phosphatase -2.34 -1.23 47.53% 
PABP1 Polyadenylate-binding protein 1 -2.62 -1.39 47.49% 
SOSB1 SOSS complex subunit B1 -3.15 -1.66 47.49% 
SYT1 Synaptotagmin-1 -3.69 -1.88 47.45% 
CALR Calreticulin -1.65 -0.72 47.44% 
PSB1 Proteasome subunit beta type-1 -2.35 -1.23 47.40% 
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CYC Cytochrome c, somatic -3.56 -1.83 47.28% 
TIM8A Mitochondrial import inner 
membrane translocase subunit Tim8 
A 
2.83 1.50 47.25% 
FETUA Alpha-2-HS-glycoprotein -5.79 -2.53 47.18% 
CD47 Leukocyte surface antigen CD47 2.96 1.56 46.91% 
CSK21 Casein kinase II subunit alpha -3.12 -1.64 46.90% 
PP1B Serine/threonine-protein 
phosphatase PP1-beta catalytic 
subunit 
-3.49 -1.80 46.82% 
RL28 60S ribosomal protein L28 -9.78 -3.29 46.74% 
RL11 60S ribosomal protein L11 -5.86 -2.55 46.71% 
FBRL rRNA 2'-O-methyltransferase 
fibrillarin 
-5.91 -2.56 46.68% 
EIF3G Eukaryotic translation initiation 
factor 3 subunit G 
-7.17 -2.84 46.67% 
CBR1 Carbonyl reductase [NADPH] 1 -4.44 -2.15 46.51% 
HXK1 Hexokinase-1 -6.15 -2.62 46.43% 
TPIS Triosephosphate isomerase -1.94 -0.96 46.07% 
TXNL1 Thioredoxin-like protein 1 3.86 1.95 46.05% 
CALM3 Calmodulin-3 -4.78 -2.26 46.03% 
C1QBP Complement component 1 Q 
subcomponent-binding protein, 
mitochondrial 
-5.64 -2.49 46.01% 
IPKA cAMP-dependent protein kinase 
inhibitor alpha 
3.24 1.70 46.00% 
PEPD Xaa-Pro dipeptidase -3.72 -1.89 45.90% 
TPD54 Tumor protein D54 4.76 2.25 45.78% 
RACK1 Receptor of activated protein C 
kinase 1 
-3.81 -1.93 45.72% 
SHLB1 Endophilin-B1 -4.68 -2.23 45.72% 
NP1L1 Nucleosome assembly protein 1-like 
1 
-2.95 -1.56 45.70% 
AN32B Acidic leucine-rich nuclear 
phosphoprotein 32 family member B 
11.08 3.47 45.69% 
MINK1 Misshapen-like kinase 1 -4.78 -2.26 45.66% 
TIM9 Mitochondrial import inner 
membrane translocase subunit Tim9 
-4.65 -2.22 45.66% 
MYL6 Myosin light polypeptide 6 2.25 1.17 45.64% 
KHDR3 KH domain-containing, RNA-binding, 
signal transduction-associated 
protein 3 
-5.02 -2.33 45.59% 
NCALD Neurocalcin-delta -3.32 -1.73 45.58% 
PEBP1 Phosphatidylethanolamine-binding 
protein 1 
-1.87 -0.90 45.57% 
RLA0 60S acidic ribosomal protein P0 -3.01 -1.59 45.57% 
FXR1 Fragile X mental retardation 
syndrome-related protein 1 
1.93 0.95 45.57% 
ENPL Endoplasmin -3.65 -1.87 45.53% 
MIF Macrophage migration inhibitory 
factor 
2.40 1.26 45.52% 
FUBP1 Far upstream element-binding 
protein 1 
2.84 1.51 45.52% 
ADT1 ADP/ATP translocase 1 -4.25 -2.09 45.51% 
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TIM13 Mitochondrial import inner 
membrane translocase subunit 
Tim13 
2.96 1.57 45.36% 
SPTN2 Spectrin beta chain, non-erythrocytic 
2 
-4.96 -2.31 45.34% 
VAPA Vesicle-associated membrane 
protein-associated protein A 
-1.56 -0.64 45.32% 
K1C14 Keratin, type I cytoskeletal 14 5.22 2.38 45.31% 
BZW1 Basic leucine zipper and W2 domain-
containing protein 1 
-1.83 -0.87 45.28% 
RL3 60S ribosomal protein L3 -3.18 -1.67 45.26% 
TIM10 Mitochondrial import inner 
membrane translocase subunit 
Tim10 
3.02 1.59 45.24% 
KIF5C Kinesin heavy chain isoform 5C 5.63 2.49 45.24% 
RL35 60S ribosomal protein L35 -9.54 -3.25 45.22% 
MDHC Malate dehydrogenase, cytoplasmic -6.18 -2.63 45.19% 
OGT1 UDP-N-acetylglucosamine--peptide 
N-acetylglucosaminyltransferase 110 
kDa subunit 
-2.26 -1.18 45.07% 
IF4H Eukaryotic translation initiation 
factor 4H 
-2.99 -1.58 45.05% 
MAT2B Methionine adenosyltransferase 2 
subunit beta 
-6.11 -2.61 44.89% 
VDAC3 Voltage-dependent anion-selective 
channel protein 3 
6.22 2.64 44.88% 
CUL3 Cullin-3 2.81 1.49 44.82% 
ABI1 Abl interactor 1 -3.86 -1.95 44.75% 
MK08 Mitogen-activated protein kinase 8 -3.63 -1.86 44.63% 
GDIR1 Rho GDP-dissociation inhibitor 1 1.90 0.92 44.62% 
SAHH Adenosylhomocysteinase -3.41 -1.77 44.58% 
RBM3 RNA-binding protein 3 11.01 3.46 44.57% 
CRKL Crk-like protein 2.77 1.47 44.52% 
COPB2 Coatomer subunit beta' -4.96 -2.31 44.45% 
HNRPK Heterogeneous nuclear 
ribonucleoprotein K 
-3.11 -1.64 44.38% 
DYL1 Dynein light chain 1, cytoplasmic -2.26 -1.18 44.21% 
TCPA T-complex protein 1 subunit alpha -2.10 -1.07 44.18% 
SLIT1 Slit homolog 1 protein -5.85 -2.55 44.13% 
PSA2 Proteasome subunit alpha type-2 -3.52 -1.81 44.12% 
RABE1 Rab GTPase-binding effector protein 
1 
6.35 2.67 44.10% 
PPM1G Protein phosphatase 1G 2.35 1.23 44.00% 
SET Protein SET -3.24 -1.70 43.85% 
HNRH1 Heterogeneous nuclear 
ribonucleoprotein H 
1.90 0.93 43.81% 
PRDX5 Peroxiredoxin-5, mitochondrial -2.11 -1.08 43.76% 
GCSH Glycine cleavage system H protein, 
mitochondrial 
3.56 1.83 43.74% 
TEBP Prostaglandin E synthase 3 -2.99 -1.58 43.73% 
SYYC Tyrosine--tRNA ligase, cytoplasmic -7.77 -2.96 43.67% 
VATB2 V-type proton ATPase subunit B, 
brain isoform 
2.01 1.00 43.64% 
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IF2A Eukaryotic translation initiation 
factor 2 subunit 1 
-2.62 -1.39 43.62% 
SYSC Serine--tRNA ligase, cytoplasmic -5.51 -2.46 43.61% 
AP2M1 AP-2 complex subunit mu -3.56 -1.83 43.50% 
AATM Aspartate aminotransferase, 
mitochondrial 
-7.35 -2.88 43.47% 
RTN1 Reticulon-1 8.26 3.05 43.46% 
PRS6A 26S protease regulatory subunit 6A 3.08 1.62 43.39% 
RB6I2 ELKS/Rab6-interacting/CAST family 
member 1 
2.81 1.49 43.33% 
NUDC Nuclear migration protein nudC 1.65 0.72 43.32% 
PDIA6 Protein disulfide-isomerase A6 -2.57 -1.36 43.30% 
MT3 Metallothionein-3 3.83 1.94 43.27% 
MTPN Myotrophin 2.76 1.46 43.26% 
SDHA Succinate dehydrogenase 
[ubiquinone] flavoprotein subunit, 
mitochondrial 
2.54 1.35 43.25% 
HNRDL Heterogeneous nuclear 
ribonucleoprotein D-like 
-2.25 -1.17 43.20% 
CXAR Coxsackievirus and adenovirus 
receptor homolog 
2.72 1.44 43.08% 
RS27A Ubiquitin-40S ribosomal protein 
S27a 
2.69 1.43 43.06% 
GARS Glycine--tRNA ligase -4.27 -2.10 43.03% 
AT1B1 Sodium/potassium-transporting 
ATPase subunit beta-1 
1.58 0.66 42.98% 
STX1B Syntaxin-1B -3.16 -1.66 42.98% 
ASNS Asparagine synthetase [glutamine-
hydrolyzing] 
-4.51 -2.17 42.94% 
PRS6B 26S protease regulatory subunit 6B 3.25 1.70 42.91% 
LSAMP Limbic system-associated membrane 
protein 
2.23 1.16 42.90% 
ES1 ES1 protein homolog, mitochondrial 4.98 2.32 42.89% 
PSB3 Proteasome subunit beta type-3 -5.93 -2.57 42.85% 
EIF3I Eukaryotic translation initiation 
factor 3 subunit I 
2.74 1.45 42.79% 
KHDR1 KH domain-containing, RNA-binding, 
signal transduction-associated 
protein 1 
-5.63 -2.49 42.79% 
CAZA2 F-actin-capping protein subunit 
alpha-2 
-1.85 -0.89 42.78% 
PPIB Peptidyl-prolyl cis-trans isomerase B -2.56 -1.35 42.76% 
RS7 40S ribosomal protein S7 -2.83 -1.50 42.67% 
PRDX1 Peroxiredoxin-1 -2.26 -1.18 42.61% 
PDIA3 Protein disulfide-isomerase A3 -2.55 -1.35 42.49% 
DX39B Spliceosome RNA helicase Ddx39b -10.09 -3.33 42.40% 
ATPA ATP synthase subunit alpha, 
mitochondrial 
-2.63 -1.39 42.34% 
RL29 60S ribosomal protein L29 2.16 1.11 42.33% 
AGRIN Agrin 7.63 2.93 42.33% 
HSP74 Heat shock 70 kDa protein 4 -2.89 -1.53 42.28% 
PSME1 Proteasome activator complex 
subunit 1 
-4.22 -2.08 42.25% 
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LYPA1 Acyl-protein thioesterase 1 -6.16 -2.62 42.19% 
RAB35 Ras-related protein Rab-35 -4.14 -2.05 42.04% 
LASP1 LIM and SH3 domain protein 1 2.06 1.04 42.02% 
PIPNA Phosphatidylinositol transfer protein 
alpha isoform 
-2.82 -1.49 42.01% 
PAIRB Plasminogen activator inhibitor 1 
RNA-binding protein 
4.15 2.05 41.96% 
SPTN1 Spectrin alpha chain, non-
erythrocytic 1 
-4.29 -2.10 41.95% 
MFGM Lactadherin -3.66 -1.87 41.95% 
CLH1 Clathrin heavy chain 1 -1.74 -0.80 41.90% 
AT1B3 Sodium/potassium-transporting 
ATPase subunit beta-3 
3.55 1.83 41.77% 
RL7A 60S ribosomal protein L7a -3.48 -1.80 41.72% 
RS2 40S ribosomal protein S2 -2.52 -1.34 41.64% 
GRP75 Stress-70 protein, mitochondrial 2.81 1.49 41.62% 
ZWINT ZW10 interactor -4.20 -2.07 41.55% 
SYPH Synaptophysin 1.79 0.84 41.38% 
HNRPU Heterogeneous nuclear 
ribonucleoprotein U 
-2.58 -1.36 41.29% 
CAPZB F-actin-capping protein subunit beta -5.49 -2.46 41.27% 
DDAH2 N(G),N(G)-dimethylarginine 
dimethylaminohydrolase 2 
2.14 1.10 41.18% 
ATP5I ATP synthase subunit e, 
mitochondrial 
-2.06 -1.04 41.17% 
DPYL1 Dihydropyrimidinase-related protein 
1 
-1.98 -0.99 41.15% 
SYDC Aspartate--tRNA ligase, cytoplasmic -6.20 -2.63 41.12% 
KCC2A Calcium/calmodulin-dependent 
protein kinase type II subunit alpha 
2.71 1.44 41.07% 
DPYL4 Dihydropyrimidinase-related protein 
4 
2.11 1.07 41.00% 
RL19 60S ribosomal protein L19 -2.48 -1.31 40.90% 
CDC42 Cell division control protein 42 
homolog 
-4.77 -2.25 40.88% 
STRN3 Striatin-3 2.49 1.32 40.84% 
GBB2 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-2 
-2.36 -1.24 40.83% 
APT Adenine phosphoribosyltransferase -2.10 -1.07 40.82% 
ILF2 Interleukin enhancer-binding factor 2 -2.21 -1.14 40.82% 
STAM2 Signal transducing adapter molecule 
2 
-7.79 -2.96 40.82% 
LA Lupus La protein homolog -4.06 -2.02 40.72% 
AT2B2 Plasma membrane calcium-
transporting ATPase 2 
-7.85 -2.97 40.66% 
PP1G Serine/threonine-protein 
phosphatase PP1-gamma catalytic 
subunit 
-4.61 -2.20 40.62% 
ADDA Alpha-adducin -4.44 -2.15 40.61% 
RU1C U1 small nuclear ribonucleoprotein C -7.24 -2.86 40.57% 
LZIC Protein LZIC 8.31 3.06 40.40% 
KPRB Phosphoribosyl pyrophosphate 
synthase-associated protein 2 
-12.95 -3.70 40.37% 
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IF5 Eukaryotic translation initiation 
factor 5 
-4.77 -2.25 40.32% 
PSA6 Proteasome subunit alpha type-6 2.15 1.11 40.24% 
F136A Protein FAM136A 2.28 1.19 40.11% 
RS15 40S ribosomal protein S15 -3.65 -1.87 40.07% 
OST48 Dolichyl-diphosphooligosaccharide--
protein glycosyltransferase 48 kDa 
subunit 
2.91 1.54 40.07% 
FA98A Protein FAM98A 4.24 2.09 40.06% 
NDUS4 NADH dehydrogenase [ubiquinone] 
iron-sulfur protein 4, mitochondrial 
-2.55 -1.35 40.04% 
MTAP2 Microtubule-associated protein 2 -3.71 -1.89 40.04% 
LDHB L-lactate dehydrogenase B chain -2.15 -1.10 40.03% 
HINT1 Histidine triad nucleotide-binding 
protein 1 
-3.71 -1.89 39.97% 
ERP29 Endoplasmic reticulum resident 
protein 29 
1.83 0.88 39.96% 
PDIA1 Protein disulfide-isomerase 2.38 1.25 39.96% 
DCTN1 Dynactin subunit 1 -4.71 -2.24 39.96% 
CRK Adapter molecule crk 11.70 3.55 39.84% 
AP1B1 AP-1 complex subunit beta-1 1.47 0.55 39.80% 
KIF2A Kinesin-like protein KIF2A -5.05 -2.34 39.71% 
ARL8B ADP-ribosylation factor-like protein 
8B 
-2.38 -1.25 39.64% 
ESTD S-formylglutathione hydrolase 2.50 1.32 39.59% 
PARK7 Protein DJ-1 1.52 0.60 39.58% 
BABA1 BRISC and BRCA1-A complex 
member 1 
5.29 2.40 39.47% 
GSTM4 Glutathione S-transferase Yb-3 5.09 2.35 39.45% 
DYN1 Dynamin-1 -4.78 -2.26 39.37% 
DPYL5 Dihydropyrimidinase-related protein 
5 
-2.41 -1.27 39.25% 
CREB1 Cyclic AMP-responsive element-
binding protein 1 
1.82 0.87 39.23% 
EZRI Ezrin -1.96 -0.97 39.20% 
CTBP1 C-terminal-binding protein 1 -3.74 -1.90 39.17% 
NPTN Neuroplastin -1.49 -0.58 39.17% 
GSK3B Glycogen synthase kinase-3 beta -1.74 -0.80 39.16% 
GBB4 Guanine nucleotide-binding protein 
subunit beta-4 
2.75 1.46 39.16% 
RB11B Ras-related protein Rab-11B 3.05 1.61 39.15% 
GRB2 Growth factor receptor-bound 
protein 2 
-2.91 -1.54 39.14% 
IF4E Eukaryotic translation initiation 
factor 4E 
-3.46 -1.79 39.07% 
LIS1 Platelet-activating factor 
acetylhydrolase IB subunit alpha 
-2.58 -1.36 39.03% 
ATP5H ATP synthase subunit d, 
mitochondrial 
5.47 2.45 39.01% 
SHOT1 Shootin-1 2.41 1.27 38.92% 
THIKA 3-ketoacyl-CoA thiolase A, 
peroxisomal 
2.39 1.26 38.88% 
ATG3 Ubiquitin-like-conjugating enzyme 
ATG3 
-1.42 -0.51 38.88% 
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SCOC Short coiled-coil protein -2.17 -1.12 38.88% 
ENPP5 Ectonucleotide 
pyrophosphatase/phosphodiesterase 
family member 5 
-4.87 -2.28 38.88% 
VATC1 V-type proton ATPase subunit C 1 -5.75 -2.52 38.88% 
ITPA Inosine triphosphate 
pyrophosphatase 
-9.51 -3.25 38.88% 
A4 Amyloid beta A4 protein 2.95 1.56 38.84% 
DLG2 Disks large homolog 2 4.49 2.17 38.83% 
SODC Superoxide dismutase [Cu-Zn] 4.34 2.12 38.80% 
PYGB Glycogen phosphorylase, brain form -2.86 -1.52 38.79% 
LGUL Lactoylglutathione lyase 3.18 1.67 38.77% 
DOPD D-dopachrome decarboxylase 2.70 1.43 38.68% 
HOME1 Homer protein homolog 1 -2.16 -1.11 38.65% 
IDI1 Isopentenyl-diphosphate Delta-
isomerase 1 
-2.50 -1.32 38.63% 
NCBP2 Nuclear cap-binding protein subunit 
2 
-4.28 -2.10 38.62% 
VPS29 Vacuolar protein sorting-associated 
protein 29 
-3.08 -1.62 38.55% 
ANM1 Protein arginine N-methyltransferase 
1 
-4.22 -2.08 38.54% 
PUF60 Poly(U)-binding-splicing factor PUF60 -2.40 -1.26 38.52% 
37500 Septin-2 1.83 0.87 38.47% 
AT1A3 Sodium/potassium-transporting 
ATPase subunit alpha-3 
2.21 1.14 38.45% 
MIC25 MICOS complex subunit Mic25 -7.64 -2.93 38.39% 
RS21 40S ribosomal protein S21 1.44 0.52 38.36% 
RINI Ribonuclease inhibitor 4.91 2.30 38.33% 
PPIG Peptidyl-prolyl cis-trans isomerase G -2.96 -1.57 38.30% 
DJB11 DnaJ homolog subfamily B member 
11 
-2.76 -1.46 38.24% 
GLRX1 Glutaredoxin-1 3.07 1.62 38.10% 
RAB14 Ras-related protein Rab-14 -7.45 -2.90 38.09% 
HNRPL Heterogeneous nuclear 
ribonucleoprotein L 
-2.27 -1.18 38.04% 
AIP AH receptor-interacting protein 2.57 1.36 38.02% 
BAX Apoptosis regulator BAX 1.78 0.83 37.94% 
PLPR3 Phospholipid phosphatase-related 
protein type 3 
2.23 1.16 37.90% 
VATE1 V-type proton ATPase subunit E 1 -5.36 -2.42 37.89% 
HPRT Hypoxanthine-guanine 
phosphoribosyltransferase 
-4.80 -2.26 37.84% 
GEPH Gephyrin -3.04 -1.60 37.84% 
PP1A Serine/threonine-protein 
phosphatase PP1-alpha catalytic 
subunit 
2.26 1.18 37.82% 
GBB1 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta-1 
-3.53 -1.82 37.75% 
40787 Septin-11 -2.60 -1.38 37.74% 
HNRPQ Heterogeneous nuclear 
ribonucleoprotein Q 
-2.53 -1.34 37.69% 
HYOU1 Hypoxia up-regulated protein 1 -3.80 -1.92 37.68% 
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PSA1 Proteasome subunit alpha type-1 -3.20 -1.68 37.67% 
SGTA Small glutamine-rich 
tetratricopeptide repeat-containing 
protein alpha 
2.47 1.30 37.61% 
PPM1B Protein phosphatase 1B 1.97 0.98 37.59% 
37865 Neuronal-specific septin-3 -4.20 -2.07 37.57% 
RUVB1 RuvB-like 1 -3.43 -1.78 37.54% 
GMFB Glia maturation factor beta 3.49 1.80 37.46% 
LRC59 Leucine-rich repeat-containing 
protein 59 
-4.41 -2.14 37.43% 
TCPE T-complex protein 1 subunit epsilon -2.94 -1.55 37.40% 
BACH Cytosolic acyl coenzyme A thioester 
hydrolase 
1.53 0.61 37.39% 
CLCB Clathrin light chain B 1.69 0.75 37.38% 
SCG3 Secretogranin-3 2.35 1.24 37.35% 
RL31 60S ribosomal protein L31 -1.61 -0.68 37.33% 
TPP2 Tripeptidyl-peptidase 2 -3.98 -1.99 37.33% 
SKP1 S-phase kinase-associated protein 1 -7.04 -2.82 37.28% 
NLTP Non-specific lipid-transfer protein -1.33 -0.41 37.28% 
AT5F1 ATP synthase F(0) complex subunit 
B1, mitochondrial 
-4.76 -2.25 37.24% 
RAB7A Ras-related protein Rab-7a 2.35 1.23 37.17% 
RAB1A Ras-related protein Rab-1A -3.04 -1.61 37.12% 
ECHM Enoyl-CoA hydratase, mitochondrial -2.05 -1.03 37.11% 
SF3A2 Splicing factor 3A subunit 2 -2.32 -1.22 37.11% 
NPM Nucleophosmin -2.63 -1.40 37.07% 
SEC13 Protein SEC13 homolog 1.82 0.87 36.96% 
TCPG T-complex protein 1 subunit gamma -2.16 -1.11 36.92% 
RL27A 60S ribosomal protein L27a -3.12 -1.64 36.90% 
ACLY ATP-citrate synthase -2.35 -1.23 36.84% 
TKT Transketolase -2.42 -1.28 36.72% 
SV2A Synaptic vesicle glycoprotein 2A 2.66 1.41 36.71% 
ICLN Methylosome subunit pICln 1.41 0.50 36.70% 
TLE3 Transducin-like enhancer protein 3 3.50 1.81 36.62% 
AP1M1 AP-1 complex subunit mu-1 -5.87 -2.55 36.62% 
EF2 Elongation factor 2 -1.67 -0.74 36.58% 
RCN2 Reticulocalbin-2 8.60 3.10 36.57% 
RL6 60S ribosomal protein L6 -1.38 -0.46 36.57% 
PLCB1 1-phosphatidylinositol 4,5-
bisphosphate phosphodiesterase 
beta-1 
-1.60 -0.67 36.56% 
TMEDA Transmembrane emp24 domain-
containing protein 10 
-2.63 -1.39 36.54% 
KCRU Creatine kinase U-type, 
mitochondrial 
-2.93 -1.55 36.53% 
TCPB T-complex protein 1 subunit beta -2.24 -1.16 36.45% 
NCAM1 Neural cell adhesion molecule 1 2.25 1.17 36.42% 
RL24 60S ribosomal protein L24 -4.16 -2.06 36.39% 
AOXA Aldehyde oxidase 1 -2.12 -1.09 36.32% 
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NEDD4 E3 ubiquitin-protein ligase NEDD4 -2.80 -1.48 36.31% 
ARLY Argininosuccinate lyase 3.54 1.83 36.30% 
ARHG7 Rho guanine nucleotide exchange 
factor 7 
-8.82 -3.14 36.29% 
MK01 Mitogen-activated protein kinase 1 1.49 0.57 36.24% 
DHE3 Glutamate dehydrogenase 1, 
mitochondrial 
-3.29 -1.72 36.21% 
ACTZ Alpha-centractin -3.18 -1.67 36.14% 
NEDD8 NEDD8 4.58 2.20 36.12% 
TRA2B Transformer-2 protein homolog beta -1.97 -0.98 36.02% 
MRP MARCKS-related protein -4.63 -2.21 35.91% 
NCKP1 Nck-associated protein 1 -1.74 -0.80 35.90% 
LIN7C Protein lin-7 homolog C -2.23 -1.16 35.68% 
WDR1 WD repeat-containing protein 1 7.83 2.97 35.62% 
PNPH Purine nucleoside phosphorylase 3.37 1.75 35.62% 
KLC1 Kinesin light chain 1 1.91 0.93 35.60% 
RPN1 Dolichyl-diphosphooligosaccharide--
protein glycosyltransferase subunit 1 
3.17 1.66 35.52% 
SH3G2 Endophilin-A1 2.05 1.04 35.34% 
NDKA Nucleoside diphosphate kinase A -5.60 -2.49 35.34% 
CDV3 Protein CDV3 homolog 2.88 1.53 35.30% 
FKBP4 Peptidyl-prolyl cis-trans isomerase 
FKBP4 
2.41 1.27 35.27% 
AP180 Clathrin coat assembly protein 
AP180 
-1.63 -0.70 35.13% 
ELAV2 ELAV-like protein 2 -4.34 -2.12 35.04% 
RS4X 40S ribosomal protein S4, X isoform -4.29 -2.10 34.95% 
CAND1 Cullin-associated NEDD8-dissociated 
protein 1 
-4.11 -2.04 34.89% 
RAP2B Ras-related protein Rap-2b -1.45 -0.54 34.87% 
CD59 CD59 glycoprotein 2.06 1.04 34.74% 
ALDOC Fructose-bisphosphate aldolase C 2.91 1.54 34.73% 
RL21 60S ribosomal protein L21 -3.75 -1.91 34.71% 
TMOD2 Tropomodulin-2 3.63 1.86 34.70% 
CAZA1 F-actin-capping protein subunit 
alpha-1 
-4.76 -2.25 34.68% 
CSN8 COP9 signalosome complex subunit 
8 
2.60 1.38 34.68% 
MAP4 Microtubule-associated protein 4 3.55 1.83 34.55% 
HNRPC Heterogeneous nuclear 
ribonucleoprotein C 
-2.81 -1.49 34.48% 
PFKAL ATP-dependent 6-
phosphofructokinase, liver type 
-5.16 -2.37 34.41% 
APEX1 DNA-(apurinic or apyrimidinic site) 
lyase 
1.88 0.91 34.33% 
OLA1 Obg-like ATPase 1 -5.38 -2.43 34.23% 
GLRX3 Glutaredoxin-3 2.26 1.18 34.17% 
OTUB1 Ubiquitin thioesterase OTUB1 -3.47 -1.80 34.17% 
PSB7 Proteasome subunit beta type-7 -2.54 -1.34 34.08% 
LMNB1 Lamin-B1 3.03 1.60 34.04% 
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PFKAM ATP-dependent 6-
phosphofructokinase, muscle type 
-4.60 -2.20 34.01% 
LIPA3 Liprin-alpha-3 -3.96 -1.98 33.96% 
HMCS1 Hydroxymethylglutaryl-CoA 
synthase, cytoplasmic 
-3.53 -1.82 33.96% 
DDAH1 N(G),N(G)-dimethylarginine 
dimethylaminohydrolase 1 
-4.38 -2.13 33.96% 
GNAS2 Guanine nucleotide-binding protein 
G(s) subunit alpha isoforms short 
5.38 2.43 33.91% 
DX39A ATP-dependent RNA helicase 
DDX39A 
2.46 1.30 33.89% 
NP1L4 Nucleosome assembly protein 1-like 
4 
2.78 1.47 33.88% 
PRPS1 Ribose-phosphate 
pyrophosphokinase 1 
-4.32 -2.11 33.88% 
NSF Vesicle-fusing ATPase -3.36 -1.75 33.82% 
PDXK Pyridoxal kinase 2.90 1.53 33.76% 
IDH3A Isocitrate dehydrogenase [NAD] 
subunit alpha, mitochondrial 
-8.27 -3.05 33.75% 
NUCB2 Nucleobindin-2 -3.83 -1.94 33.70% 
PHIPL Phytanoyl-CoA hydroxylase-
interacting protein-like 
-2.74 -1.45 33.68% 
VAT1 Synaptic vesicle membrane protein 
VAT-1 homolog 
-2.09 -1.07 33.64% 
TBA4A Tubulin alpha-4A chain -4.59 -2.20 33.63% 
CSK2B Casein kinase II subunit beta 2.13 1.09 33.53% 
HAP28 28 kDa heat- and acid-stable 
phosphoprotein 
-6.50 -2.70 33.53% 
DHB4 Peroxisomal multifunctional enzyme 
type 2 
-4.01 -2.00 33.50% 
GLNA Glutamine synthetase -4.43 -2.15 33.50% 
TPM1 Tropomyosin alpha-1 chain 4.37 2.13 33.45% 
CTTB2 Cortactin-binding protein 2 3.33 1.74 33.35% 
SYRC Arginine--tRNA ligase, cytoplasmic -4.03 -2.01 33.34% 
DNJA1 DnaJ homolog subfamily A member 1 -6.60 -2.72 33.34% 
THOP1 Thimet oligopeptidase -3.67 -1.88 33.32% 
SH3G1 Endophilin-A2 6.61 2.72 33.21% 
YBOX1 Nuclease-sensitive element-binding 
protein 1 
-3.02 -1.59 33.20% 
SYAC Alanine--tRNA ligase, cytoplasmic -3.11 -1.64 33.19% 
GAS7 Growth arrest-specific protein 7 6.32 2.66 33.13% 
STX7 Syntaxin-7 -6.57 -2.72 33.02% 
MYH9 Myosin-9 -3.79 -1.92 32.90% 
KCC2G Calcium/calmodulin-dependent 
protein kinase type II subunit gamma 
3.02 1.59 32.85% 
PHF5A PHD finger-like domain-containing 
protein 5A 
10.53 3.40 32.73% 
CAMKV CaM kinase-like vesicle-associated 
protein 
2.01 1.01 32.66% 
AGFG1 Arf-GAP domain and FG repeat-
containing protein 1 
-1.50 -0.58 32.59% 
KAP3 cAMP-dependent protein kinase 
type II-beta regulatory subunit 
1.99 0.99 32.52% 
CPSF5 Cleavage and polyadenylation 
specificity factor subunit 5 
-4.10 -2.03 32.35% 
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IMPA1 Inositol monophosphatase 1 -2.35 -1.23 32.27% 
6PGL 6-phosphogluconolactonase 2.71 1.44 32.23% 
RS9 40S ribosomal protein S9 -3.68 -1.88 32.12% 
RHOB Rho-related GTP-binding protein 
RhoB 
-1.70 -0.77 32.12% 
BAF Barrier-to-autointegration factor 2.37 1.24 32.11% 
ACL6B Actin-like protein 6B -2.21 -1.14 32.07% 
TALDO Transaldolase -3.89 -1.96 31.95% 
PALM Paralemmin-1 4.12 2.04 31.92% 
UCHL3 Ubiquitin carboxyl-terminal 
hydrolase isozyme L3 
4.62 2.21 31.91% 
38596 Septin-5 -3.73 -1.90 31.84% 
H31 Histone H3.1 -2.54 -1.35 31.76% 
CSN1 COP9 signalosome complex subunit 
1 
-9.31 -3.22 31.75% 
SYN1 Synapsin-1 -1.95 -0.97 31.73% 
PACN1 Protein kinase C and casein kinase 
substrate in neurons protein 1 
2.03 1.02 31.73% 
STX1A Syntaxin-1A -2.39 -1.26 31.70% 
TOM70 Mitochondrial import receptor 
subunit TOM70 
-4.01 -2.00 31.68% 
VDAC1 Voltage-dependent anion-selective 
channel protein 1 
-2.37 -1.25 31.65% 
TRFE Serotransferrin -3.50 -1.81 31.61% 
RALA Ras-related protein Ral-A -3.46 -1.79 31.56% 
TPM4 Tropomyosin alpha-4 chain -3.26 -1.70 31.48% 
PSMD2 26S proteasome non-ATPase 
regulatory subunit 2 
-3.95 -1.98 31.48% 
TFR1 Transferrin receptor protein 1 -2.52 -1.33 31.43% 
UCRI Cytochrome b-c1 complex subunit 
Rieske, mitochondrial 
-2.97 -1.57 31.39% 
PEF1 Peflin -2.47 -1.30 31.29% 
RS26 40S ribosomal protein S26 -1.60 -0.68 31.23% 
CNRP1 CB1 cannabinoid receptor-
interacting protein 1 
8.14 3.02 31.21% 
GPC2 Glypican-2 2.55 1.35 31.17% 
ADHX Alcohol dehydrogenase class-3 4.07 2.02 31.14% 
CA2D1 Voltage-dependent calcium channel 
subunit alpha-2/delta-1 
2.69 1.43 31.04% 
KI21B Kinesin-like protein KIF21B 3.29 1.72 31.03% 
DYHC1 Cytoplasmic dynein 1 heavy chain 1 -3.20 -1.68 30.89% 
AP2A2 AP-2 complex subunit alpha-2 -3.05 -1.61 30.87% 
METK2 S-adenosylmethionine synthase 
isoform type-2 
-4.01 -2.00 30.86% 
2ABA Serine/threonine-protein 
phosphatase 2A 55 kDa regulatory 
subunit B alpha isoform 
-1.94 -0.95 30.82% 
PPCEL Prolyl endopeptidase-like 7.43 2.89 30.82% 
BZW2 Basic leucine zipper and W2 domain-
containing protein 2 
-1.90 -0.93 30.80% 
PRS8 26S protease regulatory subunit 8 -3.62 -1.85 30.73% 
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PSD11 26S proteasome non-ATPase 
regulatory subunit 11 
-2.25 -1.17 30.60% 
VISL1 Visinin-like protein 1 2.10 1.07 30.59% 
RFOX2 RNA binding protein fox-1 homolog 2 -2.60 -1.38 30.49% 
OAT Ornithine aminotransferase, 
mitochondrial 
-2.35 -1.23 30.40% 
SAFB1 Scaffold attachment factor B1 -4.37 -2.13 30.27% 
I2BPL Interferon regulatory factor 2-
binding protein-like 
1.38 0.46 30.19% 
NDRG1 Protein NDRG1 -3.66 -1.87 30.14% 
MIC60 MICOS complex subunit Mic60 3.78 1.92 30.11% 
PPP5 Serine/threonine-protein 
phosphatase 5 
2.29 1.20 30.05% 
OPA1 Dynamin-like 120 kDa protein, 
mitochondrial 
-4.49 -2.17 30.04% 
DPP3 Dipeptidyl peptidase 3 2.61 1.38 30.01% 
FAS Fatty acid synthase -2.46 -1.30 29.99% 
GNAQ Guanine nucleotide-binding protein 
G(q) subunit alpha 
-4.43 -2.15 29.91% 
DLDH Dihydrolipoyl dehydrogenase, 
mitochondrial 
-2.28 -1.19 29.78% 
HNRPF Heterogeneous nuclear 
ribonucleoprotein F 
1.73 0.79 29.77% 
PPCE Prolyl endopeptidase -2.74 -1.46 29.77% 
TOP2A DNA topoisomerase 2-alpha -4.50 -2.17 29.64% 
MYH10 Myosin-10 -1.96 -0.97 29.50% 
DCTN4 Dynactin subunit 4 -8.46 -3.08 29.39% 
RL18 60S ribosomal protein L18 -2.35 -1.23 29.07% 
XPO1 Exportin-1 2.52 1.33 29.06% 
NUCL Nucleolin -3.08 -1.62 29.01% 
AL1A7 Aldehyde dehydrogenase, cytosolic 1 2.36 1.24 28.88% 
GPSM1 G-protein-signaling modulator 1 -2.68 -1.42 28.76% 
AT1A1 Sodium/potassium-transporting 
ATPase subunit alpha-1 
1.97 0.98 28.74% 
OPCM Opioid-binding protein/cell adhesion 
molecule 
1.71 0.78 28.71% 
MCES mRNA cap guanine-N7 
methyltransferase 
2.92 1.55 28.68% 
CSDE1 Cold shock domain-containing 
protein E1 
2.80 1.48 28.63% 
AN32E Acidic leucine-rich nuclear 
phosphoprotein 32 family member E 
-2.90 -1.54 28.55% 
HS105 Heat shock protein 105 kDa -4.82 -2.27 28.53% 
NRDC Nardilysin -7.45 -2.90 28.48% 
TWF1 Twinfilin-1 -1.83 -0.87 28.45% 
PP2BB Serine/threonine-protein 
phosphatase 2B catalytic subunit 
beta isoform 
-6.36 -2.67 28.45% 
EIF3D Eukaryotic translation initiation 
factor 3 subunit D 
-8.24 -3.04 28.43% 
H2A3 Histone H2A type 3 -6.85 -2.78 28.27% 
VAC14 Protein VAC14 homolog 5.24 2.39 28.20% 
ARF5 ADP-ribosylation factor 5 -2.83 -1.50 28.18% 
232 
 
SND1 Staphylococcal nuclease domain-
containing protein 1 
-5.54 -2.47 28.13% 
TIF1B Transcription intermediary factor 1-
beta 
-3.03 -1.60 28.13% 
NEB2 Neurabin-2 4.88 2.29 28.08% 
RL32 60S ribosomal protein L32 -2.93 -1.55 28.00% 
STX12 Syntaxin-12 -6.56 -2.71 28.00% 
SRC8 Src substrate cortactin 6.47 2.69 27.99% 
RHOA Transforming protein RhoA -1.24 -0.30 27.91% 
RS8 40S ribosomal protein S8 -2.44 -1.29 27.81% 
PURA Transcriptional activator protein Pur-
alpha 
-4.05 -2.02 27.79% 
FPPS Farnesyl pyrophosphate synthase -3.71 -1.89 27.77% 
SYK Lysine--tRNA ligase -6.53 -2.71 27.77% 
PRUN1 Protein prune homolog -2.57 -1.36 27.67% 
RL7 60S ribosomal protein L7 -2.50 -1.32 27.56% 
AL9A1 4-trimethylaminobutyraldehyde 
dehydrogenase 
3.56 1.83 27.55% 
CSN3 COP9 signalosome complex subunit 
3 
-2.67 -1.42 27.51% 
CATD Cathepsin D 2.11 1.08 27.41% 
RTCB tRNA-splicing ligase RtcB homolog -4.30 -2.10 27.40% 
KIF1B Kinesin-like protein KIF1B 2.10 1.07 27.38% 
SYNJ1 Synaptojanin-1 -3.15 -1.66 27.33% 
VATF V-type proton ATPase subunit F 3.47 1.79 27.32% 
DHPR Dihydropteridine reductase -3.91 -1.97 27.22% 
RUFY3 Protein RUFY3 -1.54 -0.62 27.17% 
KCC2D Calcium/calmodulin-dependent 
protein kinase type II subunit delta 
-1.85 -0.89 27.14% 
ACTN4 Alpha-actinin-4 -3.96 -1.98 27.09% 
ARF4 ADP-ribosylation factor 4 -5.15 -2.36 27.01% 
GRPE1 GrpE protein homolog 1, 
mitochondrial 
2.26 1.18 26.97% 
RS10 40S ribosomal protein S10 -2.88 -1.53 26.91% 
KAP2 cAMP-dependent protein kinase 
type II-alpha regulatory subunit 
2.19 1.13 26.57% 
RAB6A Ras-related protein Rab-6A 3.50 1.81 26.54% 
PRS7 26S protease regulatory subunit 7 -2.37 -1.25 26.35% 
COR1A Coronin-1A 2.84 1.50 26.35% 
QCR6 Cytochrome b-c1 complex subunit 6, 
mitochondrial 
1.57 0.65 26.34% 
CLCA Clathrin light chain A -2.18 -1.13 26.30% 
PRKRA Interferon-inducible double-stranded 
RNA-dependent protein kinase 
activator A 
1.58 0.66 26.30% 
GNAI1 Guanine nucleotide-binding protein 
G(i) subunit alpha-1 
3.29 1.72 26.21% 
EFTU Elongation factor Tu, mitochondrial -3.06 -1.62 26.05% 
CHP1 Calcineurin B homologous protein 1 -2.71 -1.44 25.96% 
EIF3A Eukaryotic translation initiation 
factor 3 subunit A 
-4.60 -2.20 25.87% 
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RAB2A Ras-related protein Rab-2A -2.03 -1.02 25.83% 
PRDX6 Peroxiredoxin-6 1.76 0.82 25.64% 
ARPC5 Actin-related protein 2/3 complex 
subunit 5 
-1.76 -0.81 25.57% 
ACTG Actin, cytoplasmic 2 4.02 2.01 25.38% 
EIF3C Eukaryotic translation initiation 
factor 3 subunit C 
6.52 2.71 25.27% 
BCAT1 Branched-chain-amino-acid 
aminotransferase, cytosolic 
-4.69 -2.23 25.07% 
DCLK1 Serine/threonine-protein kinase 
DCLK1 
-3.85 -1.95 24.98% 
CYBP Calcyclin-binding protein -2.77 -1.47 24.98% 
UBQL1 Ubiquilin-1 1.88 0.91 24.97% 
NALCN Sodium leak channel non-selective 
protein 
-2.21 -1.14 24.86% 
39326 Septin-7 -2.15 -1.11 24.85% 
TPR Nucleoprotein TPR 3.22 1.69 24.76% 
FKB1A Peptidyl-prolyl cis-trans isomerase 
FKBP1A 
1.64 0.71 24.74% 
PPT1 Palmitoyl-protein thioesterase 1 -1.51 -0.59 24.70% 
GLOD4 Glyoxalase domain-containing 
protein 4 
-1.86 -0.90 24.56% 
DDB1 DNA damage-binding protein 1 1.72 0.79 24.42% 
PSPC1 Paraspeckle component 1 1.93 0.95 24.38% 
HCD2 3-hydroxyacyl-CoA dehydrogenase 
type-2 
1.94 0.95 24.20% 
CLIP1 CAP-Gly domain-containing linker 
protein 1 
1.91 0.94 24.08% 
DC1I2 Cytoplasmic dynein 1 intermediate 
chain 2 
-2.25 -1.17 23.97% 
PHB Prohibitin -3.19 -1.67 23.69% 
CISD1 CDGSH iron-sulfur domain-
containing protein 1 
-3.29 -1.72 23.67% 
SSU72 RNA polymerase II subunit A C-
terminal domain phosphatase SSU72 
2.12 1.08 23.66% 
GSLG1 Golgi apparatus protein 1 -6.89 -2.78 23.57% 
LAT1 Large neutral amino acids 
transporter small subunit 1 
1.60 0.68 23.40% 
RAC1 Ras-related C3 botulinum toxin 
substrate 1 
-1.59 -0.67 23.36% 
E41L1 Band 4.1-like protein 1 2.68 1.42 23.26% 
RBBP7 Histone-binding protein RBBP7 3.82 1.93 23.23% 
MAP6 Microtubule-associated protein 6 1.89 0.92 23.22% 
TAGL3 Transgelin-3 -4.06 -2.02 23.07% 
SODM Superoxide dismutase [Mn], 
mitochondrial 
-3.25 -1.70 23.02% 
LMNA Prelamin-A/C 2.04 1.03 22.73% 
ILF3 Interleukin enhancer-binding factor 3 -2.67 -1.42 22.71% 
SNAA Alpha-soluble NSF attachment 
protein 
1.51 0.59 22.55% 
CSN4 COP9 signalosome complex subunit 
4 
-2.85 -1.51 22.43% 
KCC2B Calcium/calmodulin-dependent 
protein kinase type II subunit beta 
-2.51 -1.33 22.21% 
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PGK1 Phosphoglycerate kinase 1 -2.50 -1.32 22.16% 
CELF2 CUGBP Elav-like family member 2 2.28 1.19 21.94% 
SCOT1 Succinyl-CoA:3-ketoacid coenzyme A 
transferase 1, mitochondrial 
1.99 0.99 21.74% 
HDGF Hepatoma-derived growth factor 2.97 1.57 21.59% 
RASH GTPase HRas 1.23 0.30 21.51% 
SARNP SAP domain-containing 
ribonucleoprotein 
1.78 0.83 21.30% 
VPP1 V-type proton ATPase 116 kDa 
subunit a isoform 1 
1.35 0.44 20.85% 
STRAP Serine-threonine kinase receptor-
associated protein 
-4.54 -2.18 20.85% 
RL23A 60S ribosomal protein L23a 2.22 1.15 20.81% 
PA2G4 Proliferation-associated protein 2G4 -1.74 -0.80 20.79% 
ADDB Beta-adducin 5.38 2.43 20.64% 
SRGP2 SLIT-ROBO Rho GTPase-activating 
protein 2 
-4.23 -2.08 20.58% 
ACON Aconitate hydratase, mitochondrial -5.62 -2.49 20.15% 
NDUS1 NADH-ubiquinone oxidoreductase 75 
kDa subunit, mitochondrial 
2.64 1.40 19.92% 
ERLN2 Erlin-2 3.23 1.69 19.90% 
EIF3H Eukaryotic translation initiation 
factor 3 subunit H 
-2.71 -1.44 19.73% 
PRP19 Pre-mRNA-processing factor 19 -1.94 -0.96 19.61% 
MYO5A Unconventional myosin-Va 15.13 3.92 19.42% 
NCDN Neurochondrin -3.23 -1.69 19.11% 
RL36A 60S ribosomal protein L36a 1.63 0.71 18.58% 
PSD13 26S proteasome non-ATPase 
regulatory subunit 13 
2.53 1.34 18.38% 
RAP1B Ras-related protein Rap-1b -3.13 -1.65 18.24% 
SYUA Alpha-synuclein -7.26 -2.86 18.07% 
CD81 CD81 antigen -1.78 -0.83 17.91% 
XPP1 Xaa-Pro aminopeptidase 1 -1.50 -0.59 17.72% 
PAK1 Serine/threonine-protein kinase PAK 
1 
2.74 1.46 17.47% 
RS27 40S ribosomal protein S27 -1.20 -0.26 17.20% 
RPAB1 DNA-directed RNA polymerases I, II, 
and III subunit RPABC1 
4.14 2.05 17.13% 
CTNB1 Catenin beta-1 2.11 1.08 17.00% 
PLPP Pyridoxal phosphate phosphatase -1.72 -0.78 16.91% 
PGAM1 Phosphoglycerate mutase 1 -1.98 -0.99 16.75% 
PYGL Glycogen phosphorylase, liver form -2.75 -1.46 16.50% 
KINH Kinesin-1 heavy chain -1.76 -0.82 15.95% 
UB2V2 Ubiquitin-conjugating enzyme E2 
variant 2 
-3.82 -1.93 15.64% 
YKT6 Synaptobrevin homolog YKT6 -3.97 -1.99 15.06% 
SDCB1 Syntenin-1 8.07 3.01 15.01% 
ODO2 Dihydrolipoyllysine-residue 
succinyltransferase component of 2-
oxoglutarate dehydrogenase 
complex, mitochondrial 
4.14 2.05 14.23% 
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GCYB1 Guanylate cyclase soluble subunit 
beta-1 
-1.50 -0.59 14.11% 
APLP2 Amyloid-like protein 2 5.98 2.58 13.76% 
RIPR2 Protein FAM65B 1.47 0.55 12.43% 
RS24 40S ribosomal protein S24 -2.24 -1.16 12.25% 
TIPRL TIP41-like protein 4.76 2.25 11.36% 
CK5P2 CDK5 regulatory subunit-associated 
protein 2 
-1.40 -0.49 11.31% 
DYLT1 Dynein light chain Tctex-type 1 2.46 1.30 10.97% 
PP2BA Serine/threonine-protein 
phosphatase 2B catalytic subunit 
alpha isoform 
-1.22 -0.29 9.95% 
AT2A2 Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 2 
2.10 1.07 9.57% 
GATM Glycine amidinotransferase, 
mitochondrial 
1.91 0.94 5.86% 
BAG6 Large proline-rich protein BAG6 -2.20 -1.14 4.64% 
OX2G OX-2 membrane glycoprotein 1.35 0.43 2.52% 
KAD2 Adenylate kinase 2, mitochondrial -1.09 -0.13 1.54% 
SMCE1 SWI/SNF-related matrix-associated 
actin-dependent regulator of 
chromatin subfamily E member 1 
1.20 0.26 1.34% 
RBMX RNA-binding motif protein, X 
chromosome 
1.11 0.15 0.74% 
Appendix table 1: Raw data for the mass spectrometry described in Chapter 5 
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Probe 
Name 
Accession 
# 
NS Probe ID NF StDe
v of 
NF 
Cont
rol 
StDe
v of 
Cont
rol 
NF 
vs. 
Cont
rol 
P 
valu
e of: 
NF 
vs. 
Cont
rol 
t-
stati
stic 
of: 
NF 
vs. 
Cont
rol 
Gfap NM_00113
1020.1 
NM_00113102
0.1:610 
1276.
32 
507.
93 
187.
89 
95.8
3 
6.79 0.00 7.63 
Apoe NM_00130
5844.1 
NM_00130584
4.1:903 
3632.
65 
2484
.23 
396.
24 
420.
68 
9.17 0.00 5.13 
Idh1 NM_01049
7.2 
NM_010497.2:
495 
3076.
70 
705.
51 
1699
.56 
308.
91 
1.81 0.00 5.03 
Dcx NM_01002
5.2 
NM_010025.2:
8575 
4329.
49 
975.
29 
2483
.48 
479.
20 
1.74 0.00 4.69 
Snca NM_00922
1.2 
NM_009221.2:
285 
1093.
84 
230.
34 
625.
48 
93.8
6 
1.75 0.00 5.01 
Akt3 NM_01178
5.3 
NM_011785.3:
2494 
1015.
61 
263.
62 
577.
23 
113.
82 
1.76 0.00 4.36 
Cadm3 NM_05319
9.3 
NM_053199.3:
3295 
2623.
28 
841.
51 
1373
.75 
355.
89 
1.91 0.00 4.19 
Pla2g16 NM_13926
9.2 
NM_139269.2:
568 
230.6
1 
74.4
8 
104.
23 
26.4
5 
2.21 0.00 4.38 
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Nes NM_01670
1.3 
NM_016701.3:
2716 
103.7
4 
55.8
9 
33.2
1 
19.0
8 
3.12 0.00 3.85 
Vegfa NM_00102
5250.3 
NM_00102525
0.3:3015 
1536.
74 
378.
47 
920.
86 
252.
77 
1.67 0.00 3.72 
Nqo1 NM_00870
6.5 
NM_008706.5:
430 
833.2
0 
376.
70 
286.
82 
40.4
8 
2.90 0.00 5.24 
Syt4 NM_00930
8.3 
NM_009308.3:
1120 
4789.
17 
944.
53 
3097
.42 
552.
17 
1.55 0.01 3.81 
Slc1a2 NM_00107
7514.3 
NM_00107751
4.3:1675 
819.0
2 
299.
65 
414.
73 
71.8
6 
1.97 0.01 4.35 
Gnai3 NM_01030
6.2 
NM_010306.2:
354 
1360.
48 
262.
07 
923.
31 
189.
63 
1.47 0.01 3.49 
Becn1 NM_01958
4.3 
NM_019584.3:
1145 
1872.
60 
518.
80 
1129
.79 
267.
55 
1.66 0.01 3.57 
Atp6v0e NM_02527
2.2 
NM_025272.2:
585 
112.1
3 
27.4
8 
67.2
6 
19.2
5 
1.67 0.01 3.41 
Tnc NM_01160
7.1 
NM_011607.1:
5665 
304.5
6 
181.
61 
108.
81 
34.2
3 
2.80 0.01 3.85 
Pcna NM_01104
5.2 
NM_011045.2:
590 
954.2
5 
154.
71 
693.
74 
101.
70 
1.38 0.01 3.51 
Casp3 NM_00981
0.2 
NM_009810.2:
630 
645.8
4 
103.
15 
466.
20 
79.6
7 
1.39 0.01 3.27 
Aldh1l1 NM_02740
6.1 
NM_027406.1:
1340 
63.29 39.1
3 
20.1
5 
0.40 3.14 0.01 4.59 
Cxcl12 NM_02170
4.3 
NM_021704.3:
259 
419.6
5 
193.
06 
200.
24 
76.1
0 
2.10 0.01 3.24 
Rtn4 NM_19405
3.3 
NM_194053.3:
930 
4843.
22 
1124
.51 
3202
.29 
650.
94 
1.51 0.01 3.37 
Pten NM_00896
0.2 
NM_008960.2:
5160 
1426.
79 
347.
63 
959.
00 
167.
71 
1.49 0.01 3.38 
Ap3s1 NM_00968
1.5 
NM_009681.5:
610 
2251.
60 
526.
45 
1505
.08 
321.
16 
1.50 0.01 3.20 
Ppp3ca NM_00891
3.4 
NM_008913.4:
1675 
2020.
69 
444.
74 
1398
.94 
250.
78 
1.44 0.01 3.24 
Gnai2 NM_00813
8.4 
NM_008138.4:
971 
5150.
76 
1879
.68 
2812
.76 
940.
39 
1.83 0.01 3.15 
Cdc40 NM_02787
9.2 
NM_027879.2:
1606 
297.0
2 
79.4
7 
194.
11 
35.8
5 
1.53 0.01 3.26 
Sptbn2 NM_02128
7.1 
NM_021287.1:
6145 
1318.
35 
453.
39 
779.
86 
169.
34 
1.69 0.01 3.33 
Ipcef1 NM_00103
3391.2 
NM_00103339
1.2:180 
98.07 21.2
6 
149.
34 
39.4
4 
-1.52 0.01 -2.98 
Atp6v1d NM_02372
1.2 
NM_023721.2:
408 
2268.
15 
564.
03 
1515
.87 
351.
77 
1.50 0.01 3.05 
Dnaja2 NM_01979
4.4 
NM_019794.4:
1045 
956.9
8 
263.
56 
626.
85 
126.
39 
1.53 0.02 3.16 
Atp6v1h XM_00649
5434.2 
XM_00649543
4.2:1296 
2842.
42 
859.
05 
1796
.96 
440.
66 
1.58 0.02 3.05 
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Homer1 NM_14717
6.2 
NM_147176.2:
1165 
1021.
62 
198.
53 
732.
06 
144.
34 
1.40 0.02 2.96 
Fxn NM_00804
4.2 
NM_008044.2:
218 
675.3
0 
167.
17 
435.
34 
128.
60 
1.55 0.02 2.90 
Map2 NM_00863
2.2 
NM_008632.2:
5243 
4227.
01 
1222
.27 
2779
.50 
623.
54 
1.52 0.02 3.04 
Hif1a NM_01043
1.2 
NM_010431.2:
1294 
1963.
35 
463.
99 
1359
.10 
287.
85 
1.44 0.02 2.97 
Rhoa NM_01680
2.4 
NM_016802.4:
1885 
1495.
84 
279.
63 
1080
.45 
229.
39 
1.38 0.02 2.86 
Tbpl1 NM_01160
3.5 
NM_011603.5:
714 
1064.
84 
238.
37 
754.
94 
146.
74 
1.41 0.02 2.95 
Bax NM_00752
7.3 
NM_007527.3:
735 
348.2
7 
80.6
4 
221.
12 
85.5
9 
1.58 0.02 2.79 
Mgmt NM_00859
8.2 
NM_008598.2:
350 
111.9
1 
33.2
4 
69.0
6 
14.7
8 
1.62 0.02 3.04 
Mapk1 NM_01194
9.3 
NM_011949.3:
1210 
2917.
29 
877.
48 
1923
.31 
384.
58 
1.52 0.02 3.02 
Ppp2r5c NM_00113
5001.1 
NM_00113500
1.1:1400 
2783.
43 
842.
91 
1808
.66 
398.
51 
1.54 0.02 2.97 
Trem2 NM_03125
4.2 
NM_031254.2:
646 
41.02 19.2
5 
71.8
6 
15.7
5 
-1.75 0.02 -3.10 
Ddc NM_01667
2.4 
NM_016672.4:
1358 
34.78 7.90 50.6
1 
15.8
4 
-1.46 0.02 -2.75 
Gng2 NM_01031
5.4 
NM_010315.4:
1352 
1366.
42 
555.
76 
762.
75 
229.
65 
1.79 0.02 2.93 
Pak1 NM_01103
5.2 
NM_011035.2:
1615 
1894.
65 
550.
61 
1238
.33 
312.
62 
1.53 0.02 2.86 
Stat3 NM_21365
9.2 
NM_213659.2:
1360 
393.7
8 
130.
82 
245.
77 
52.5
3 
1.60 0.02 3.03 
Nptn NM_00914
5.2 
NM_009145.2:
1110 
2866.
32 
773.
89 
1983
.32 
355.
01 
1.45 0.02 2.91 
Dlg3 NM_00117
7778.1 
NM_00117777
8.1:2586 
1033.
12 
415.
38 
612.
79 
163.
89 
1.69 0.02 2.91 
Ctnnb1 NM_00761
4.2 
NM_007614.2:
2975 
3151.
72 
1266
.21 
1831
.82 
390.
64 
1.72 0.02 3.03 
Cntn1 NM_00115
9647.1 
NM_00115964
7.1:1070 
3257.
77 
1027
.73 
2160
.28 
437.
62 
1.51 0.02 2.89 
Prkce NM_01110
4.2 
NM_011104.2:
1510 
500.3
5 
122.
67 
359.
42 
78.0
4 
1.39 0.03 2.72 
Nell2 NM_01674
3.2 
NM_016743.2:
500 
4353.
92 
1336
.55 
2877
.68 
543.
10 
1.51 0.03 2.87 
Adam10 NM_00739
9.3 
NM_007399.3:
2390 
503.0
1 
92.2
9 
370.
61 
94.5
1 
1.36 0.03 2.60 
Kcnj10 NM_00103
9484.1 
NM_00103948
4.1:400 
175.8
4 
49.1
0 
114.
83 
26.6
6 
1.53 0.03 2.72 
Myh10 NM_17526
0.2 
NM_175260.2:
2540 
2031.
80 
608.
49 
1340
.68 
378.
94 
1.52 0.03 2.63 
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Sod1 NM_01143
4.1 
NM_011434.1:
406 
4283.
62 
1016
.94 
3027
.53 
644.
87 
1.41 0.03 2.68 
Rras NM_00910
1.2 
NM_009101.2:
282 
42.53 10.5
6 
27.5
1 
10.2
6 
1.55 0.03 2.58 
Entpd4 NM_02617
4.2 
NM_026174.2:
845 
120.4
1 
34.6
3 
82.1
1 
19.1
3 
1.47 0.03 2.66 
Inhbb NM_00838
1.3 
NM_008381.3:
1084 
23.63 5.27 35.8
8 
13.9
6 
-1.52 0.03 -2.54 
Gucy1b3 NM_01746
9.4 
NM_017469.4:
372 
732.6
4 
243.
84 
461.
27 
125.
37 
1.59 0.03 2.61 
Pgk1 NM_00882
8.2 
NM_008828.2:
36 
642.2
0 
100.
98 
497.
07 
90.9
9 
1.29 0.03 2.50 
Camk2b NM_00117
4053.1 
NM_00117405
3.1:2825 
1544.
56 
580.
56 
956.
47 
259.
30 
1.61 0.03 2.67 
Ppp3cb NM_00891
4.1 
NM_008914.1:
290 
5090.
79 
1740
.84 
3342
.43 
723.
91 
1.52 0.03 2.71 
Snrpa NM_00104
6637.1 
NM_00104663
7.1:880 
377.2
5 
81.3
3 
274.
22 
67.2
5 
1.38 0.03 2.49 
Clu NM_01349
2.2 
NM_013492.2:
354 
2071.
19 
810.
26 
1161
.02 
305.
72 
1.78 0.03 2.72 
Stx1a NM_01680
1.3 
NM_016801.3:
72 
2296.
80 
799.
63 
1472
.05 
446.
67 
1.56 0.03 2.54 
Arrb2 NM_14542
9.4 
NM_145429.4:
725 
712.9
7 
182.
12 
488.
90 
154.
06 
1.46 0.03 2.44 
Rab2a NM_02151
8.3 
NM_021518.3:
450 
8320.
94 
2548
.74 
5774
.24 
1193
.16 
1.44 0.04 2.56 
Vcp NM_00950
3.3 
NM_009503.3:
510 
5973.
93 
1657
.04 
4160
.02 
917.
15 
1.44 0.04 2.49 
Rit2 NM_00906
5.2 
NM_009065.2:
626 
321.1
5 
71.8
5 
231.
91 
60.1
0 
1.38 0.04 2.40 
Lrrc4 NM_13868
2.2 
NM_138682.2:
2790 
401.7
5 
102.
69 
288.
43 
62.7
7 
1.39 0.04 2.48 
Lars NM_13413
7.2 
NM_134137.2:
945 
1078.
05 
222.
21 
795.
12 
191.
97 
1.36 0.04 2.42 
Ppp3cc NM_00891
5.2 
NM_008915.2:
1020 
781.2
1 
238.
30 
547.
17 
107.
98 
1.43 0.04 2.55 
Syt7 NM_01880
1.3 
NM_018801.3:
990 
352.2
0 
134.
67 
221.
22 
64.7
6 
1.59 0.04 2.50 
Plxnc1 NM_01879
7.2 
NM_018797.2:
2120 
614.6
9 
269.
73 
383.
40 
83.6
7 
1.60 0.04 2.63 
Il13ra1 NM_13399
0.4 
NM_133990.4:
845 
30.65 9.95 20.8
1 
1.49 1.47 0.04 2.88 
Ppp2ca NM_01941
1.4 
NM_019411.4:
975 
6863.
10 
2011
.86 
4802
.16 
1242
.65 
1.43 0.04 2.40 
Pik3r1 NM_00102
4955.1 
NM_00102495
5.1:5664 
464.8
1 
120.
76 
340.
73 
65.9
0 
1.36 0.04 2.43 
Dlg4 NM_00110
9752.1 
NM_00110975
2.1:1866 
2750.
65 
855.
59 
1840
.33 
520.
04 
1.49 0.04 2.37 
239 
 
Tmem119 NM_14616
2.2 
NM_146162.2:
1550 
35.35 13.8
1 
53.9
5 
10.9
4 
-1.53 0.04 -2.56 
Bace1 NM_01179
2.4 
NM_011792.4:
3107 
729.1
2 
238.
87 
503.
47 
116.
74 
1.45 0.04 2.43 
Sox9 NM_01144
8.4 
NM_011448.4:
3540 
54.32 21.8
8 
28.6
1 
10.1
6 
1.90 0.05 2.45 
Atp6v0c NM_00972
9.3 
NM_009729.3:
569 
15226
.85 
5027
.39 
9999
.39 
3541
.53 
1.52 0.05 2.31 
Atf4 NM_00971
6.2 
NM_009716.2:
812 
10196
.18 
2418
.57 
7350
.83 
1903
.19 
1.39 0.05 2.31 
Eif2s1 NM_02611
4.3 
NM_026114.3:
665 
1677.
19 
316.
31 
1294
.87 
236.
73 
1.30 0.05 2.32 
Arhgef10 NM_00103
7736.1 
NM_00103773
6.1:1105 
36.17 10.7
2 
25.2
5 
6.17 1.43 0.05 2.34 
Sgpl1 NM_00916
3.3 
NM_009163.3:
1200 
344.6
2 
126.
63 
231.
60 
42.0
3 
1.49 0.05 2.49 
Gabrb3 NM_00807
1.3 
NM_008071.3:
4200 
219.3
3 
39.6
4 
169.
94 
37.6
1 
1.29 0.05 2.24 
Slu7 NM_14867
3.3 
NM_148673.3:
1034 
671.8
2 
107.
64 
520.
99 
132.
35 
1.29 0.05 2.22 
3110043O
21Rik 
NM_00108
1343.1 
NM_00108134
3.1:1020 
640.6
4 
173.
09 
449.
98 
145.
24 
1.42 0.05 2.22 
Meaf6 NM_02731
0.3 
NM_027310.3:
178 
414.4
4 
162.
33 
271.
02 
65.8
2 
1.53 0.05 2.39 
Gusb NM_01036
8.1 
NM_010368.1:
1735 
50.71 22.3
9 
29.6
4 
8.71 1.71 0.05 2.36 
Insr NM_01056
8.2 
NM_010568.2:
7814 
76.86 18.3
5 
55.3
4 
15.1
6 
1.39 0.05 2.20 
Slc12a5 NM_02033
3.2 
NM_020333.2:
5618 
483.8
9 
240.
31 
290.
33 
94.9
4 
1.67 0.05 2.33 
Pdgfrb NM_00880
9.1 
NM_008809.1:
1185 
20.87 2.12 29.4
4 
11.6
2 
-1.41 0.05 -2.30 
Sec23a NM_00914
7.2 
NM_009147.2:
1445 
1837.
01 
553.
93 
1314
.82 
266.
83 
1.40 0.06 2.31 
Atp6v0d1 NM_01347
7.3 
NM_013477.3:
640 
948.5
8 
295.
03 
652.
78 
208.
95 
1.45 0.06 2.19 
Mapt NM_00103
8609.2 
NM_00103860
9.2:1202 
3961.
93 
1149
.36 
2851
.92 
472.
20 
1.39 0.06 2.37 
Fam126a XM_00653
5824.2 
XM_00653582
4.2:826 
411.8
8 
152.
08 
276.
43 
64.0
0 
1.49 0.06 2.31 
Bad NM_00752
2.3 
NM_007522.3:
1146 
943.2
3 
217.
53 
675.
98 
217.
00 
1.40 0.06 2.15 
Ap2a2 NM_00745
9.3 
NM_007459.3:
2540 
3849.
78 
1287
.17 
2628
.15 
718.
66 
1.46 0.06 2.22 
Acaa1a NM_13086
4.3 
NM_130864.3:
626 
66.11 10.4
3 
52.2
3 
11.6
5 
1.27 0.06 2.14 
Plcb3 NM_00887
4.3 
NM_008874.3:
1880 
54.12 19.9
0 
33.5
6 
15.2
3 
1.61 0.06 2.14 
240 
 
Smn1 NM_01142
0.2 
NM_011420.2:
390 
686.1
1 
187.
60 
507.
34 
107.
91 
1.35 0.06 2.25 
Xab2 NM_02615
6.2 
NM_026156.2:
1616 
695.6
8 
184.
87 
495.
71 
160.
05 
1.40 0.06 2.13 
Des NM_01004
3.1 
NM_010043.1:
157 
46.09 34.4
6 
83.3
0 
18.6
2 
-1.81 0.06 -2.43 
Atp6v1a NM_00750
8.5 
NM_007508.5:
434 
1977.
96 
503.
43 
1488
.83 
289.
83 
1.33 0.06 2.22 
Stx1b NM_02441
4.2 
NM_024414.2:
570 
2678.
09 
838.
75 
1905
.59 
445.
72 
1.41 0.06 2.21 
Rad23b NM_00901
1.4 
NM_009011.4:
1585 
4809.
75 
1381
.75 
3534
.65 
727.
38 
1.36 0.06 2.23 
Calb1 NM_00978
8.4 
NM_009788.4:
343 
527.2
6 
191.
93 
355.
89 
65.2
9 
1.48 0.06 2.35 
Lypla1 XM_00649
5472.2 
XM_00649547
2.2:648 
854.0
8 
262.
71 
612.
55 
129.
28 
1.39 0.06 2.25 
Ehmt1 NM_00101
2518.2 
NM_00101251
8.2:2845 
483.7
6 
186.
97 
321.
81 
71.3
0 
1.50 0.06 2.31 
Cab39 NM_13378
1.4 
NM_133781.4:
2830 
1547.
76 
372.
48 
1187
.00 
232.
85 
1.30 0.06 2.17 
Mmp9 NM_01359
9.2 
NM_013599.2:
1570 
30.88 9.80 44.4
3 
10.5
0 
-1.44 0.06 -2.20 
Cntnap1 NM_01678
2.2 
NM_016782.2:
1105 
80.96 6.93 100.
35 
24.0
2 
-1.24 0.06 -2.17 
Phf21a NM_00110
9690.1 
NM_00110969
0.1:2324 
47.37 15.7
8 
30.6
8 
12.4
5 
1.54 0.06 2.11 
Polr2j NM_01129
3.2 
NM_011293.2:
70 
844.5
7 
200.
10 
638.
82 
123.
37 
1.32 0.06 2.18 
Prkcb NM_00885
5.2 
NM_008855.2:
8332 
226.8
8 
55.5
3 
170.
16 
24.8
8 
1.33 0.06 2.29 
F2 NM_01016
8.2 
NM_010168.2:
1010 
31.41 13.6
1 
48.3
4 
9.93 -1.54 0.06 -2.29 
Akt1 NM_00116
5894.1 
NM_00116589
4.1:898 
2071.
56 
640.
61 
1396
.34 
507.
17 
1.48 0.06 2.10 
Rdx NM_00110
4617.1 
NM_00110461
7.1:1384 
996.1
3 
262.
85 
746.
87 
156.
42 
1.33 0.06 2.17 
Pfn1 NM_01107
2.4 
NM_011072.4:
266 
4229.
86 
923.
07 
3184
.48 
800.
03 
1.33 0.06 2.09 
Map2k1 NM_00892
7.3 
NM_008927.3:
1695 
749.7
3 
139.
51 
555.
68 
172.
56 
1.35 0.06 2.08 
Tor1a NM_14488
4.1 
NM_144884.1:
220 
223.2
7 
35.2
3 
170.
24 
51.7
7 
1.31 0.07 2.09 
Acin1 NM_00108
5472.2 
NM_00108547
2.2:674 
1586.
99 
551.
14 
1131
.78 
265.
03 
1.40 0.07 2.19 
Unc13a NM_00102
9873.2 
NM_00102987
3.2:7755 
1744.
52 
649.
29 
1219
.82 
229.
19 
1.43 0.07 2.25 
241 
 
Gnptg NM_17252
9.3 
NM_172529.3:
95 
177.3
9 
27.9
9 
214.
60 
30.2
2 
-1.21 0.07 -2.13 
Mmp14 NM_00860
8.3 
NM_008608.3:
554 
318.0
7 
152.
38 
187.
35 
34.5
4 
1.70 0.07 2.36 
Cd68 NM_00985
3.1 
NM_009853.1:
636 
23.30 3.09 20.0
8 
0.21 1.16 0.07 2.50 
Epha4 NM_00793
6.3 
NM_007936.3:
2796 
145.7
0 
49.5
4 
104.
24 
26.7
1 
1.40 0.07 2.09 
Gnptab NM_00100
4164.2 
NM_00100416
4.2:1214 
423.9
5 
155.
20 
302.
59 
52.2
3 
1.40 0.07 2.24 
Dnm1l NM_00102
5947.1 
NM_00102594
7.1:2075 
1362.
31 
284.
66 
1064
.31 
202.
87 
1.28 0.07 2.11 
Cp NM_00104
2611.1 
NM_00104261
1.1:1750 
103.5
3 
60.2
3 
208.
89 
158.
71 
-2.02 0.07 -2.05 
App NM_00747
1.2 
NM_007471.2:
511 
7383.
33 
1707
.13 
5719
.20 
1126
.17 
1.29 0.07 2.13 
Gjb1 NM_00812
4.2 
NM_008124.2:
113 
47.82 20.3
0 
70.1
7 
10.2
5 
-1.47 0.07 -2.32 
B4galt6 NM_01973
7.2 
NM_019737.2:
1465 
903.4
7 
325.
45 
627.
41 
106.
09 
1.44 0.07 2.28 
Hras NM_00113
0443.1 
NM_00113044
3.1:240 
3124.
08 
888.
20 
2225
.80 
731.
77 
1.40 0.07 2.04 
Ugcg NM_01167
3.3 
NM_011673.3:
610 
1318.
71 
533.
46 
903.
95 
204.
71 
1.46 0.07 2.18 
Jam3 NM_02327
7.4 
NM_023277.4:
145 
292.9
7 
90.5
1 
214.
36 
42.9
1 
1.37 0.07 2.13 
Opa1 NM_00119
9177.1 
NM_00119917
7.1:2845 
714.4
5 
179.
76 
544.
09 
116.
59 
1.31 0.07 2.08 
Jun NM_01059
1.2 
NM_010591.2:
2212 
596.2
7 
179.
27 
408.
87 
163.
31 
1.46 0.07 2.01 
Npas4 NM_15355
3.4 
NM_153553.4:
580 
965.1
5 
449.
26 
545.
12 
367.
07 
1.77 0.07 2.01 
Prkaca NM_00885
4.3 
NM_008854.3:
699 
3241.
38 
1069
.68 
2245
.60 
773.
23 
1.44 0.07 2.02 
Mapk9 NM_20769
2.1 
NM_207692.1:
260 
874.4
8 
250.
41 
651.
17 
163.
77 
1.34 0.08 2.04 
Gtf2b NM_14554
6.1 
NM_145546.1:
346 
596.1
5 
113.
42 
468.
27 
116.
32 
1.27 0.08 1.98 
Cul1 NM_01204
2.3 
NM_012042.3:
919 
1370.
93 
290.
84 
1075
.21 
266.
66 
1.28 0.08 1.97 
Gsk3b NM_01982
7.3 
NM_019827.3:
2215 
2316.
06 
702.
80 
1715
.00 
421.
44 
1.35 0.08 2.02 
Fus NM_13914
9.2 
NM_139149.2:
15 
1877.
60 
433.
86 
1486
.62 
187.
51 
1.26 0.08 2.12 
Csnk2a2 NM_00997
4.3 
NM_009974.3:
1066 
1162.
44 
374.
14 
852.
10 
189.
61 
1.36 0.08 2.02 
Adra2a NM_00741
7.4 
NM_007417.4:
3594 
186.3
7 
33.5
9 
151.
82 
28.4
5 
1.23 0.08 1.98 
242 
 
Mapk10 NM_00108
1567.1 
NM_00108156
7.1:1496 
1421.
68 
452.
49 
1057
.97 
200.
22 
1.34 0.08 2.06 
Vip NM_01170
2.2 
NM_011702.2:
395 
212.4
2 
99.6
0 
344.
88 
172.
28 
-1.62 0.08 -1.94 
Mta1 NM_05408
1.2 
NM_054081.2:
955 
1167.
10 
396.
60 
827.
16 
226.
07 
1.41 0.08 1.97 
Ube3a NM_17301
0.3 
NM_173010.3:
2025 
1027.
82 
245.
70 
803.
00 
188.
61 
1.28 0.09 1.93 
Gpr37 NM_01033
8.2 
NM_010338.2:
1828 
117.5
2 
37.1
9 
84.1
8 
23.3
6 
1.40 0.09 1.95 
Sncaip NM_00119
9151.1 
NM_00119915
1.1:1385 
230.4
5 
78.5
1 
164.
61 
32.7
0 
1.40 0.09 2.04 
Gtf2h1 NM_00818
6.4 
NM_008186.4:
830 
408.5
0 
92.7
9 
323.
27 
65.6
0 
1.26 0.09 1.93 
Pqbp1 NM_00125
2528.1 
NM_00125252
8.1:212 
427.2
5 
82.6
4 
340.
41 
69.8
5 
1.26 0.09 1.91 
C1qa NM_00757
2.2 
NM_007572.2:
566 
26.77 13.3
4 
40.7
0 
11.4
4 
-1.52 0.09 -1.95 
Crebbp NM_00102
5432.1 
NM_00102543
2.1:3770 
849.5
4 
299.
11 
621.
96 
129.
51 
1.37 0.09 1.99 
Taf10 NM_02002
4.3 
NM_020024.3:
357 
1952.
77 
576.
41 
1347
.92 
597.
93 
1.45 0.09 1.89 
Synj1 NM_00104
5515.1 
NM_00104551
5.1:4090 
624.7
7 
157.
86 
493.
06 
101.
96 
1.27 0.09 1.94 
Gsr NM_01034
4.4 
NM_010344.4:
1507 
334.9
3 
117.
11 
237.
50 
66.7
7 
1.41 0.09 1.96 
Fasl NM_01017
7.3 
NM_010177.3:
645 
40.98 16.5
7 
58.1
8 
9.27 -1.42 0.09 -2.09 
Gnao1 NM_01030
8.3 
NM_010308.3:
754 
4346.
68 
1453
.32 
3190
.67 
642.
83 
1.36 0.09 2.01 
Snap91 NM_00127
7986.1 
NM_00127798
6.1:3170 
2855.
65 
1008
.11 
2087
.37 
449.
38 
1.37 0.09 1.99 
Glrb NM_01029
8.5 
NM_010298.5:
704 
777.4
7 
164.
25 
623.
59 
131.
97 
1.25 0.09 1.88 
Prkcg NM_01110
2.3 
NM_011102.3:
1580 
210.4
2 
78.1
6 
151.
52 
17.1
2 
1.39 0.09 2.10 
Cast NM_00981
7.1 
NM_009817.1:
1820 
21.22 3.08 31.4
3 
21.0
9 
-1.48 0.10 -1.92 
Rapgef2 NM_00109
9624.2 
NM_00109962
4.2:5580 
856.7
7 
266.
14 
657.
90 
118.
78 
1.30 0.10 1.95 
Scamp2 NM_02281
3.3 
NM_022813.3:
526 
156.6
3 
75.4
0 
105.
66 
21.4
9 
1.48 0.10 2.01 
Pla2g6 NM_00119
9023.1 
NM_00119902
3.1:768 
270.8
3 
114.
34 
176.
82 
69.5
4 
1.53 0.10 1.88 
Srsf4 NM_02058
7.2 
NM_020587.2:
524 
496.8
2 
187.
89 
354.
00 
103.
22 
1.40 0.10 1.88 
243 
 
Ncf1 NM_00128
6037.1 
NM_00128603
7.1:970 
42.78 19.9
7 
62.9
2 
15.9
2 
-1.47 0.10 -1.95 
Tada2b NM_00117
0454.1 
NM_00117045
4.1:3224 
402.4
8 
129.
38 
303.
15 
54.6
0 
1.33 0.10 1.93 
Trim28 NM_01158
8.3 
NM_011588.3:
1615 
2437.
70 
758.
52 
1800
.85 
520.
88 
1.35 0.10 1.83 
Tpm1 NM_02442
7.4 
NM_024427.4:
426 
894.6
2 
225.
67 
706.
96 
144.
54 
1.27 0.10 1.86 
Fos NM_01023
4.2 
NM_010234.2:
1330 
2624.
02 
1302
.62 
1477
.77 
1260
.18 
1.78 0.10 1.81 
Usp21 NM_01391
9.4 
NM_013919.4:
1590 
173.3
0 
54.8
1 
128.
92 
35.4
2 
1.34 0.10 1.84 
Drd4 NM_00787
8.2 
NM_007878.2:
962 
29.21 23.2
1 
50.1
4 
21.0
0 
-1.72 0.10 -1.84 
Ptdss2 NM_01378
2.4 
NM_013782.4:
844 
413.9
3 
134.
66 
304.
49 
86.9
8 
1.36 0.10 1.82 
Bcl2l1 NM_00974
3.4 
NM_009743.4:
200 
744.9
9 
261.
54 
551.
48 
140.
29 
1.35 0.11 1.85 
Slc11a1 NM_01361
2.2 
NM_013612.2:
945 
38.57 15.1
3 
55.7
6 
17.9
8 
-1.45 0.11 -1.86 
Ptdss1 NM_00895
9.3 
NM_008959.3:
1830 
860.3
1 
234.
14 
669.
26 
127.
75 
1.29 0.11 1.85 
Gsn NM_14612
0.3 
NM_146120.3:
624 
154.7
4 
61.6
3 
108.
59 
23.6
8 
1.43 0.11 1.92 
Ache NM_00959
9.3 
NM_009599.3:
1073 
78.23 31.9
6 
115.
06 
32.5
2 
-1.47 0.11 -1.83 
Xiap NM_00968
8.2 
NM_009688.2:
1654 
346.6
1 
96.4
1 
271.
65 
53.8
7 
1.28 0.11 1.83 
Gria1 NM_00125
2403.1 
NM_00125240
3.1:2476 
740.0
6 
221.
11 
570.
73 
100.
75 
1.30 0.11 1.86 
Gtf2h3 NM_18141
0.3 
NM_181410.3:
38 
220.4
6 
75.5
5 
163.
55 
30.3
0 
1.35 0.11 1.87 
Abl1 NM_00959
4.4 
NM_009594.4:
1378 
193.4
4 
51.7
8 
153.
99 
18.3
5 
1.26 0.11 1.90 
Park7 NM_02056
9.3 
NM_020569.3:
334 
1470.
88 
448.
69 
1090
.09 
369.
74 
1.35 0.11 1.74 
Sirt1 NM_01981
2.2 
NM_019812.2:
843 
140.4
2 
25.2
8 
117.
44 
21.8
1 
1.20 0.11 1.74 
Atp6v1e1 NM_00751
0.2 
NM_007510.2:
1025 
40.76 22.4
4 
64.4
8 
16.4
0 
-1.58 0.12 -1.84 
Cyp4x1 NM_00100
3947.1 
NM_00100394
7.1:564 
234.3
5 
61.2
5 
184.
71 
41.9
5 
1.27 0.12 1.73 
Hap1 NM_01040
4.3 
NM_010404.3:
2552 
192.5
9 
80.2
9 
128.
62 
59.6
3 
1.50 0.12 1.72 
Cck NM_03116
1.2 
NM_031161.2:
351 
296.8
3 
45.1
0 
374.
56 
114.
95 
-1.26 0.12 -1.72 
Ccnd1 NM_00763
1.1 
NM_007631.1:
2000 
37.27 12.0
7 
26.8
3 
9.39 1.39 0.12 1.72 
244 
 
Atxn2 NM_00912
5.2 
NM_009125.2:
3036 
1116.
86 
338.
96 
875.
98 
162.
64 
1.27 0.12 1.77 
Hnrnpm NM_00110
9913.1 
NM_00110991
3.1:606 
963.7
4 
194.
79 
778.
02 
187.
46 
1.24 0.12 1.69 
Ggt1 NM_00811
6.2 
NM_008116.2:
1025 
42.40 15.6
2 
62.7
6 
18.6
3 
-1.48 0.12 -1.77 
Sh3tc2 NM_17262
8.2 
NM_172628.2:
2150 
58.67 39.0
0 
91.9
0 
17.6
5 
-1.57 0.12 -1.87 
Cul2 NM_02940
2.3 
NM_029402.3:
2528 
1077.
69 
231.
78 
885.
15 
163.
52 
1.22 0.13 1.71 
Cnksr2 NM_17775
1.2 
NM_177751.2:
628 
1779.
09 
384.
03 
1385
.23 
456.
47 
1.28 0.13 1.67 
Ryr1 NM_00910
9.1 
NM_009109.1:
11830 
62.44 25.5
8 
87.6
2 
24.5
6 
-1.40 0.13 -1.72 
Raf1 NM_02978
0.3 
NM_029780.3:
550 
1383.
16 
427.
73 
1069
.72 
254.
44 
1.29 0.13 1.71 
Prkcsh NM_00892
5.1 
NM_008925.1:
1295 
2378.
84 
756.
42 
1811
.43 
475.
72 
1.31 0.13 1.70 
Tradd NM_00103
3161.2 
NM_00103316
1.2:562 
49.14 26.1
9 
71.8
1 
16.3
6 
-1.46 0.13 -1.75 
Ube2k NM_01678
6.3 
NM_016786.3:
1212 
84.24 18.0
9 
66.2
3 
17.1
8 
1.27 0.13 1.64 
Nsf NM_00874
0.2 
NM_008740.2:
395 
3585.
86 
1122
.68 
2799
.76 
585.
04 
1.28 0.13 1.71 
Sri NM_00108
0974.2 
NM_00108097
4.2:470 
454.1
1 
91.9
2 
379.
75 
54.2
9 
1.20 0.13 1.70 
Egr1 NM_00791
3.5 
NM_007913.5:
515 
945.6
8 
717.
74 
468.
81 
601.
70 
2.02 0.13 1.64 
Atp13a2 NM_02909
7.2 
NM_029097.2:
1360 
989.2
7 
294.
64 
763.
38 
204.
27 
1.30 0.13 1.66 
Tardbp NM_00100
3899.2 
NM_00100389
9.2:3060 
355.3
3 
73.3
6 
287.
32 
67.8
9 
1.24 0.14 1.63 
Fgf12 NM_00127
6419.1 
NM_00127641
9.1:632 
1740.
26 
405.
65 
1406
.29 
263.
03 
1.24 0.14 1.67 
Nr4a2 NM_00113
9509.1 
NM_00113950
9.1:1626 
710.1
1 
368.
55 
473.
21 
97.8
7 
1.50 0.14 1.76 
Avp NM_00973
2.2 
NM_009732.2:
52 
45.36 20.2
4 
62.6
1 
12.8
6 
-1.38 0.14 -1.72 
Slc18a3 NM_02171
2.2 
NM_021712.2:
845 
40.48 13.7
0 
52.4
6 
12.6
3 
-1.30 0.14 -1.65 
Cdk5 NM_00766
8.3 
NM_007668.3:
77 
545.4
1 
193.
72 
409.
16 
119.
39 
1.33 0.14 1.63 
Gpr4 NM_17566
8.4 
NM_175668.4:
212 
27.96 9.54 38.6
6 
15.1
7 
-1.38 0.14 -1.59 
Lsm7 NM_02534
9.2 
NM_025349.2:
37 
478.0
0 
123.
91 
383.
71 
86.2
5 
1.25 0.14 1.61 
245 
 
Phf2 NM_01107
8.2 
NM_011078.2:
3590 
462.3
9 
119.
93 
377.
39 
65.1
4 
1.23 0.15 1.64 
Magee1 NM_05320
1.3 
NM_053201.3:
2362 
470.2
5 
194.
98 
343.
61 
92.7
4 
1.37 0.15 1.63 
Plcb1 NM_01967
7.1 
NM_019677.1:
495 
484.2
2 
152.
24 
379.
79 
72.9
8 
1.27 0.15 1.64 
Ccnh NM_02324
3.2 
NM_023243.2:
960 
240.4
3 
63.3
9 
173.
13 
67.8
8 
1.39 0.15 1.54 
Ring1 NM_00906
6.3 
NM_009066.3:
243 
312.2
1 
86.1
9 
246.
87 
62.0
8 
1.26 0.16 1.56 
Psen2 NM_00112
8605.1 
NM_00112860
5.1:560 
265.3
7 
59.6
0 
220.
58 
44.8
9 
1.20 0.16 1.57 
Sf3a2 NM_01365
1.4 
NM_013651.4:
494 
395.2
5 
99.9
1 
324.
57 
58.4
4 
1.22 0.16 1.58 
Dlat NM_14561
4.4 
NM_145614.4:
2046 
1120.
35 
336.
35 
886.
70 
230.
97 
1.26 0.16 1.54 
Cacna1f NM_01958
2.2 
NM_019582.2:
4215 
27.50 8.46 35.8
4 
11.2
3 
-1.30 0.16 -1.51 
Mag NM_01075
8.2 
NM_010758.2:
1670 
26.16 5.88 33.4
9 
11.8
1 
-1.28 0.16 -1.51 
Mbp NM_01077
7.3 
NM_010777.3:
761 
94.97 18.2
7 
113.
71 
27.8
1 
-1.20 0.16 -1.50 
Fmr1 NM_00803
1.2 
NM_008031.2:
765 
726.3
4 
123.
54 
610.
06 
145.
59 
1.19 0.17 1.50 
Aars NM_14621
7.4 
NM_146217.4:
716 
2667.
20 
868.
36 
2092
.83 
421.
43 
1.27 0.17 1.56 
Nrxn1 NM_00134
6960.1 
NM_00134696
0.1:2013 
1295.
34 
277.
41 
1029
.69 
344.
53 
1.26 0.17 1.49 
Erbb3 NM_01015
3.1 
NM_010153.1:
1290 
54.03 29.8
6 
78.8
3 
15.5
6 
-1.46 0.17 -1.62 
Dagla NM_19811
4.2 
NM_198114.2:
685 
170.9
2 
72.7
8 
129.
11 
24.9
7 
1.32 0.17 1.57 
Itga5 NM_00131
4041.1 
NM_00131404
1.1:2622 
57.62 33.6
0 
84.3
3 
28.9
9 
-1.46 0.17 -1.52 
Negr1 NM_00103
9094.2 
NM_00103909
4.2:770 
1445.
69 
536.
18 
1112
.83 
219.
84 
1.30 0.17 1.56 
Stat1 NM_00928
3.3 
NM_009283.3:
1590 
125.9
4 
43.9
9 
95.6
6 
20.0
2 
1.32 0.17 1.55 
Cln3 NM_00114
6311.1 
NM_00114631
1.1:378 
32.45 7.72 40.9
1 
13.7
8 
-1.26 0.18 -1.45 
Nfe2l2 NR_13272
7.1 
NR_132727.1:
193 
146.5
9 
41.4
1 
118.
83 
21.7
4 
1.23 0.18 1.50 
Mtor NM_02000
9.2 
NM_020009.2:
2432 
486.0
4 
238.
80 
349.
61 
82.2
3 
1.39 0.18 1.54 
Fgf2 NM_00800
6.2 
NM_008006.2:
509 
68.46 20.9
9 
54.0
9 
9.21 1.27 0.18 1.52 
Grm5 NM_00114
3834.1 
NM_00114383
4.1:4242 
620.4
4 
143.
97 
516.
00 
119.
41 
1.20 0.18 1.45 
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Pdpk1 NM_00108
0773.2 
NM_00108077
3.2:856 
758.6
2 
269.
76 
599.
25 
119.
40 
1.27 0.19 1.49 
Trp53 NM_01164
0.1 
NM_011640.1:
1835 
20.30 0.42 20.0
0 
0.00 1.01 0.19 1.60 
Lsm2 NM_00111
0101.2 
NM_00111010
1.2:641 
20.00 0.00 21.2
7 
2.49 -1.06 0.19 -1.49 
Mal NM_00117
1187.1 
NM_00117118
7.1:685 
37.16 26.8
1 
54.7
7 
12.0
2 
-1.47 0.19 -1.53 
Tcerg1 NM_00103
9474.1 
NM_00103947
4.1:468 
881.9
5 
257.
95 
718.
31 
165.
65 
1.23 0.19 1.43 
Arhgap44 NM_00109
9288.1 
NM_00109928
8.1:904 
328.6
8 
147.
15 
240.
94 
79.4
3 
1.36 0.19 1.45 
Axin2 NM_01573
2.4 
NM_015732.4:
1120 
45.20 17.7
2 
33.8
3 
11.6
8 
1.34 0.19 1.40 
Palm NM_02312
8.4 
NM_023128.4:
548 
1738.
50 
579.
40 
1375
.29 
322.
31 
1.26 0.20 1.43 
Tgfb1 NM_01157
7.1 
NM_011577.1:
1470 
22.98 4.57 20.1
5 
0.40 1.14 0.20 1.54 
Trim37 NM_19798
7.2 
NM_197987.2:
972 
520.3
6 
185.
77 
412.
07 
83.3
9 
1.26 0.20 1.43 
Ins2 NM_00838
7.3 
NM_008387.3:
266 
58.14 37.1
3 
82.4
6 
21.3
4 
-1.42 0.20 -1.45 
Pik3cb NM_02909
4.3 
NM_029094.3:
1970 
491.9
6 
140.
77 
401.
15 
91.5
4 
1.23 0.20 1.39 
Ncam1 NM_00111
3204.1 
NM_00111320
4.1:740 
4127.
51 
1364
.68 
3232
.16 
1120
.70 
1.28 0.20 1.37 
Sirt2 NM_02243
2.4 
NM_022432.4:
435 
863.7
9 
244.
09 
697.
25 
185.
30 
1.24 0.20 1.38 
Slc6a3 NM_01002
0.3 
NM_010020.3:
1082 
54.11 40.7
2 
82.7
1 
19.1
1 
-1.53 0.20 -1.46 
Nfkbib NM_01090
8.4 
NM_010908.4:
382 
20.12 0.28 21.7
3 
3.29 -1.08 0.20 -1.42 
Mto1 NM_02665
8.2 
NM_026658.2:
1058 
20.00 0.00 22.5
8 
6.05 -1.13 0.21 -1.42 
Cers6 NM_17285
6.3 
NM_172856.3:
678 
497.8
5 
99.8
9 
427.
22 
83.5
9 
1.17 0.21 1.36 
Adcyap1 NM_00131
5503.1 
NM_00131550
3.1:2625 
462.1
3 
116.
46 
372.
27 
90.0
1 
1.24 0.21 1.38 
Gdnf NM_01027
5.2 
NM_010275.2:
460 
68.71 30.2
9 
92.5
4 
28.8
6 
-1.35 0.21 -1.37 
Pla2g4b XM_92509
5.2 
XM_925095.2:
310 
153.8
5 
49.9
9 
194.
65 
43.9
4 
-1.27 0.21 -1.38 
Adora1 NM_00100
8533.3 
NM_00100853
3.3:1603 
89.44 27.2
9 
110.
77 
21.5
2 
-1.24 0.21 -1.39 
Grin2a NM_00817
0.2 
NM_008170.2:
1788 
53.64 22.7
3 
67.2
4 
3.55 -1.25 0.21 -1.47 
247 
 
Polr2h NM_14563
2.2 
NM_145632.2:
100 
534.3
9 
146.
33 
439.
11 
100.
73 
1.22 0.22 1.34 
Mmp12 NM_00860
5.3 
NM_008605.3:
592 
67.68 61.0
5 
102.
74 
22.9
6 
-1.52 0.22 -1.43 
Aif1 NM_01946
7.2 
NM_019467.2:
55 
48.91 21.4
9 
63.4
4 
14.4
4 
-1.30 0.22 -1.37 
Rela NM_00904
5.4 
NM_009045.4:
645 
53.15 19.7
0 
39.8
5 
16.2
4 
1.33 0.22 1.30 
Gabrp NM_14601
7.3 
NM_146017.3:
484 
40.78 37.1
6 
60.8
8 
15.0
5 
-1.49 0.23 -1.39 
Tcirg1 NM_00113
6091.1 
NM_00113609
1.1:1345 
69.38 36.3
1 
92.1
4 
18.0
8 
-1.33 0.23 -1.37 
Gata2 NM_00809
0.4 
NM_008090.4:
2960 
38.08 18.0
6 
51.5
1 
13.3
4 
-1.35 0.23 -1.35 
Trpm2 NM_13830
1.2 
NM_138301.2:
2106 
103.8
4 
30.3
1 
125.
96 
23.4
9 
-1.21 0.23 -1.32 
Cldn5 NM_01380
5.4 
NM_013805.4:
975 
55.75 44.6
3 
81.7
7 
23.5
9 
-1.47 0.23 -1.35 
Sucla2 NM_01150
6.1 
NM_011506.1:
955 
1322.
58 
235.
66 
1136
.20 
264.
83 
1.16 0.23 1.27 
Mutyh NM_00115
9581.1 
NM_00115958
1.1:709 
70.07 26.5
6 
89.5
9 
24.3
2 
-1.28 0.23 -1.30 
Cxxc1 NM_02886
8.3 
NM_028868.3:
1749 
292.9
2 
89.8
2 
241.
10 
61.7
0 
1.21 0.24 1.28 
Hdac6 NM_01041
3.3 
NM_010413.3:
2195 
371.2
5 
148.
15 
290.
44 
79.4
9 
1.28 0.24 1.28 
Mapk8 NM_01670
0.3 
NM_016700.3:
970 
507.5
6 
162.
60 
384.
00 
160.
03 
1.32 0.24 1.25 
Tnfrsf12a NM_00116
1746.1 
NM_00116174
6.1:517 
109.5
9 
46.0
4 
146.
03 
55.6
8 
-1.33 0.24 -1.26 
Il6ra NM_01055
9.2 
NM_010559.2:
2825 
32.67 18.3
1 
44.7
7 
19.1
9 
-1.37 0.24 -1.25 
Taf4 NM_00108
1092.1 
NM_00108109
2.1:3016 
214.2
5 
57.8
6 
177.
60 
42.8
0 
1.21 0.24 1.26 
Dll4 NM_01945
4.2 
NM_019454.2:
542 
47.70 27.4
5 
64.3
9 
22.0
6 
-1.35 0.24 -1.27 
Myc NM_01084
9.4 
NM_010849.4:
630 
667.0
8 
197.
01 
540.
07 
175.
61 
1.24 0.25 1.23 
Chrna7 NM_00739
0.3 
NM_007390.3:
335 
377.6
8 
144.
99 
484.
98 
116.
97 
-1.28 0.25 -1.27 
Gad2 NM_00807
8.2 
NM_008078.2:
769 
1717.
84 
940.
71 
2421
.78 
1241
.88 
-1.41 0.25 -1.23 
Tnf NM_01369
3.2 
NM_013693.2:
514 
39.45 23.0
7 
53.5
6 
14.2
9 
-1.36 0.25 -1.28 
Erlec1 NM_02574
5.3 
NM_025745.3:
940 
645.8
0 
117.
76 
567.
16 
97.5
1 
1.14 0.25 1.23 
Ddx23 NM_00108
0981.1 
NM_00108098
1.1:2175 
381.9
0 
96.4
4 
325.
07 
68.6
6 
1.17 0.26 1.22 
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Cplx1 NM_00775
6.3 
NM_007756.3:
327 
285.4
6 
92.4
9 
225.
81 
100.
73 
1.26 0.26 1.20 
Hspb1 NM_01356
0.2 
NM_013560.2:
630 
50.70 22.3
3 
63.5
8 
14.5
9 
-1.25 0.26 -1.25 
Hdac2 NM_00822
9.2 
NM_008229.2:
1010 
48.68 31.4
9 
69.7
4 
20.5
3 
-1.43 0.26 -1.25 
Crtc2 NM_02888
1.2 
NM_028881.2:
1477 
46.89 20.3
4 
35.4
7 
14.3
6 
1.32 0.27 1.18 
Polr2k NM_00103
9368.1 
NM_00103936
8.1:323 
63.19 37.0
3 
82.7
7 
18.7
1 
-1.31 0.27 -1.22 
Grn NM_00817
5.3 
NM_008175.3:
2010 
158.6
2 
40.9
1 
133.
20 
27.0
8 
1.19 0.27 1.19 
Prkcq NM_00885
9.2 
NM_008859.2:
1210 
38.96 11.2
2 
30.7
3 
16.3
3 
1.27 0.28 1.15 
Adrb2 NM_00742
0.2 
NM_007420.2:
680 
31.07 26.6
8 
43.7
0 
13.6
5 
-1.41 0.28 -1.18 
Lmna NM_00100
2011.2 
NM_00100201
1.2:1611 
713.5
5 
143.
11 
613.
86 
144.
75 
1.16 0.28 1.15 
Cacna1c NM_00115
9535.1 
NM_00115953
5.1:1000 
89.53 31.9
9 
108.
69 
19.7
2 
-1.21 0.28 -1.19 
Ddit3 NM_00783
7.3 
NM_007837.3:
255 
1536.
57 
428.
75 
1856
.92 
412.
96 
-1.21 0.28 -1.18 
Grin3b NM_13045
5.2 
NM_130455.2:
2030 
23.34 6.79 28.4
4 
10.4
4 
-1.22 0.28 -1.14 
Il10ra NM_00834
8.2 
NM_008348.2:
2522 
67.83 41.4
3 
91.3
2 
15.1
1 
-1.35 0.28 -1.22 
Tbr1 NM_00932
2.3 
NM_009322.3:
2354 
231.2
5 
35.6
7 
202.
66 
52.0
8 
1.14 0.29 1.13 
Tnfrsf11b NM_00876
4.3 
NM_008764.3:
684 
71.05 41.2
4 
91.1
9 
16.0
4 
-1.28 0.29 -1.20 
Ccs XM_00653
1645.1 
XM_00653164
5.1:185 
266.3
4 
67.3
3 
229.
62 
43.4
9 
1.16 0.29 1.15 
Itpr2 NM_01058
6.1 
NM_010586.1:
4365 
28.03 5.14 23.8
4 
8.42 1.18 0.29 1.12 
Atrn NM_00973
0.2 
NM_009730.2:
1375 
640.7
0 
127.
78 
568.
68 
101.
16 
1.13 0.29 1.14 
Taf9 NM_02713
9.5 
NM_027139.5:
324 
508.7
8 
75.4
2 
421.
02 
159.
33 
1.21 0.29 1.13 
Sorl1 NM_01143
6.3 
NM_011436.3:
2720 
160.2
3 
39.3
1 
135.
22 
40.8
4 
1.18 0.29 1.11 
Efnb3 NM_00791
1.5 
NM_007911.5:
2880 
46.13 27.4
5 
60.7
8 
20.7
6 
-1.32 0.29 -1.13 
Drd2 NM_01007
7.2 
NM_010077.2:
630 
77.17 38.5
3 
96.6
1 
16.1
2 
-1.25 0.29 -1.17 
Cnot10 NM_15358
5.5 
NM_153585.5:
714 
213.7
5 
63.1
0 
182.
29 
38.3
2 
1.17 0.30 1.13 
Chrm5 NM_20578
3.2 
NM_205783.2:
1170 
54.45 25.1
8 
69.3
8 
21.6
2 
-1.27 0.30 -1.13 
249 
 
Entpd2 NM_00984
9.2 
NM_009849.2:
1016 
93.46 34.1
4 
73.1
3 
21.8
3 
1.28 0.30 1.13 
Cdk2 NM_01675
6.4 
NM_016756.4:
831 
179.0
5 
64.9
5 
143.
38 
29.8
0 
1.25 0.30 1.13 
Ldhc NM_01358
0.4 
NM_013580.4:
470 
51.66 42.1
2 
71.4
0 
22.1
7 
-1.38 0.30 -1.13 
Gtf2ird1 NM_00108
1464.1 
NM_00108146
4.1:1430 
464.4
1 
146.
43 
393.
57 
75.8
4 
1.18 0.30 1.12 
Optn NM_18184
8.4 
NM_181848.4:
1018 
175.5
2 
43.4
3 
138.
70 
68.0
6 
1.27 0.30 1.08 
Gnai1 NM_01030
5.1 
NM_010305.1:
470 
1916.
49 
365.
65 
1649
.16 
460.
32 
1.16 0.31 1.08 
P2ry12 NM_02757
1.3 
NM_027571.3:
439 
41.67 23.4
8 
54.7
3 
14.7
4 
-1.31 0.31 -1.12 
Islr2 NM_00116
1538.1 
NM_00116153
8.1:1782 
1753.
33 
660.
01 
1433
.39 
425.
71 
1.22 0.31 1.09 
Sirt7 NM_15305
6.2 
NM_153056.2:
575 
83.02 15.1
5 
74.6
5 
10.2
3 
1.11 0.32 1.08 
Tenm2 NM_01185
6.3 
NM_011856.3:
1452 
537.5
4 
189.
04 
454.
63 
81.0
7 
1.18 0.32 1.08 
Camk2g NM_00103
9138.1 
NM_00103913
8.1:2525 
33.77 5.07 40.3
9 
18.0
4 
-1.20 0.33 -1.04 
Dnm2 NM_00103
9520.1 
NM_00103952
0.1:1148 
40.62 27.9
2 
54.4
1 
20.2
3 
-1.34 0.33 -1.07 
Grm2 NM_00116
0353.1 
NM_00116035
3.1:2770 
273.0
0 
62.5
1 
239.
66 
53.4
2 
1.14 0.33 1.04 
Gga1 NM_14592
9.2 
NM_145929.2:
1896 
40.80 17.7
4 
50.7
0 
11.8
8 
-1.24 0.33 -1.07 
Scn1a NM_01873
3.2 
NM_018733.2:
1030 
259.0
8 
87.6
3 
325.
60 
131.
55 
-1.26 0.33 -1.03 
Cdk5r1 NM_00987
1.2 
NM_009871.2:
3280 
22.88 5.79 20.4
9 
1.40 1.12 0.33 1.09 
Flt1 NM_01022
8.3 
NM_010228.3:
1550 
48.38 33.2
7 
64.4
7 
16.9
6 
-1.33 0.33 -1.07 
Grin2d NM_00817
2.2 
NM_008172.2:
1201 
70.44 21.7
1 
84.2
1 
20.9
3 
-1.20 0.33 -1.04 
Mnat1 NM_00861
2.2 
NM_008612.2:
914 
298.7
3 
59.9
0 
262.
41 
58.9
8 
1.14 0.33 1.02 
Drd1 NM_01007
6.3 
NM_010076.3:
1785 
42.18 28.2
6 
56.9
8 
20.1
4 
-1.35 0.33 -1.04 
Epha5 NM_00793
7.3 
NM_007937.3:
2005 
1116.
30 
280.
29 
965.
65 
270.
51 
1.16 0.34 1.02 
Mmp19 NM_02141
2.2 
NM_021412.2:
1140 
47.42 23.4
1 
59.3
3 
12.7
2 
-1.25 0.34 -1.04 
Naglu NM_01379
2.2 
NM_013792.2:
2334 
20.64 1.52 22.4
3 
5.14 -1.09 0.34 -1.01 
Gpr84 NM_03072
0.1 
NM_030720.1:
315 
40.32 21.3
1 
49.9
1 
9.80 -1.24 0.35 -1.03 
250 
 
Tgfbr2 NM_00937
1.2 
NM_009371.2:
475 
46.48 22.4
8 
58.3
6 
16.1
7 
-1.26 0.35 -1.02 
Rab3a NM_00900
1.6 
NM_009001.6:
1272 
3165.
37 
1343
.46 
2547
.63 
850.
83 
1.24 0.35 1.00 
Cacnb2 NM_02311
6.3 
NM_023116.3:
735 
134.2
8 
39.6
3 
114.
31 
34.4
2 
1.17 0.35 0.99 
Chl1 NM_00769
7.2 
NM_007697.2:
2010 
1034.
35 
294.
49 
883.
81 
275.
44 
1.17 0.35 0.97 
Dld NM_00786
1.4 
NM_007861.4:
252 
1270.
90 
247.
65 
1119
.06 
290.
93 
1.14 0.36 0.97 
Aqp4 NM_00970
0.2 
NM_009700.2:
130 
20.00 0.00 20.0
8 
0.21 -1.00 0.36 -1.00 
C4a NM_01141
3.2 
NM_011413.2:
4186 
20.00 0.00 20.2
1 
0.56 -1.01 0.36 -1.00 
Egf NM_01011
3.3 
NM_010113.3:
1886 
20.00 0.00 21.7
9 
6.24 -1.09 0.36 -1.00 
Esam NM_02710
2.3 
NM_027102.3:
495 
20.00 0.00 20.9
5 
2.90 -1.05 0.36 -1.00 
Grin2b NM_00817
1.3 
NM_008171.3:
6340 
20.00 0.00 20.4
7 
1.33 -1.02 0.36 -1.00 
Lama2 NM_00848
1.2 
NM_008481.2:
208 
20.00 0.00 20.6
5 
1.90 -1.03 0.36 -1.00 
Mmrn2 NM_15312
7.3 
NM_153127.3:
2622 
20.00 0.00 20.9
9 
3.04 -1.05 0.36 -1.00 
Nol3 NM_03015
2.4 
NM_030152.4:
916 
20.00 0.00 22.0
3 
7.35 -1.10 0.36 -1.00 
Ntrk1 NM_00103
3124.1 
NM_00103312
4.1:1481 
20.00 0.00 20.2
1 
0.56 -1.01 0.36 -1.00 
Ube2n NM_08056
0.3 
NM_080560.3:
2376 
20.00 0.00 20.2
3 
0.62 -1.01 0.36 -1.00 
Supt7l NM_02815
0.1 
NM_028150.1:
180 
20.00 0.00 20.0
6 
0.15 -1.00 0.36 -1.00 
Adcy8 NM_00962
3.2 
NM_009623.2:
2655 
271.3
5 
51.5
3 
240.
67 
61.6
5 
1.13 0.36 0.97 
Myct1 NM_02679
3.2 
NM_026793.2:
180 
56.48 40.8
0 
72.4
6 
17.1
4 
-1.28 0.36 -1.01 
Oxr1 NM_00113
0163.1 
NM_00113016
3.1:2976 
915.0
6 
197.
87 
801.
06 
191.
98 
1.14 0.36 0.97 
Pde1b NM_00880
0.1 
NM_008800.1:
595 
99.01 30.2
0 
86.9
7 
14.3
1 
1.14 0.36 0.99 
Cul3 NM_01671
6.4 
NM_016716.4:
1662 
776.3
6 
172.
74 
680.
89 
168.
23 
1.14 0.36 0.96 
Gaa NM_00806
4.3 
NM_008064.3:
1390 
129.1
3 
50.7
0 
154.
28 
31.9
3 
-1.19 0.36 -0.99 
Pgam1 NM_02341
8.2 
NM_023418.2:
466 
3639.
50 
754.
91 
3253
.06 
602.
55 
1.12 0.37 0.96 
Itga7 NM_00839
8.2 
NM_008398.2:
2435 
21.46 2.02 23.2
3 
4.70 -1.08 0.37 -0.95 
Prkca NM_01110
1.3 
NM_011101.3:
6965 
109.2
3 
25.6
1 
96.9
5 
16.2
8 
1.13 0.37 0.96 
251 
 
L1cam NM_00847
8.3 
NM_008478.3:
3560 
904.7
2 
256.
24 
788.
58 
201.
17 
1.15 0.37 0.95 
Mapk3 NM_01195
2.2 
NM_011952.2:
825 
487.9
7 
72.0
4 
449.
84 
59.6
1 
1.08 0.37 0.95 
Uchl1 NM_01167
0.2 
NM_011670.2:
54 
56.96 31.0
3 
70.5
6 
13.0
4 
-1.24 0.37 -0.98 
Cxcr4 NM_00991
1.3 
NM_009911.3:
704 
49.10 28.7
4 
61.5
5 
17.0
7 
-1.25 0.37 -0.96 
Atf6 NM_00108
1304.1 
NM_00108130
4.1:4765 
20.08 0.17 20.0
0 
0.00 1.00 0.37 1.00 
Dlx2 NM_01005
4.2 
NM_010054.2:
1891 
20.87 2.12 20.0
0 
0.00 1.04 0.37 1.00 
Ninj2 NM_01671
8.2 
NM_016718.2:
244 
20.08 0.17 20.0
0 
0.00 1.00 0.37 1.00 
Plxnb3 NM_01958
7.2 
NM_019587.2:
2862 
20.01 0.02 20.0
0 
0.00 1.00 0.37 1.00 
Ppt1 NM_00891
7.3 
NM_008917.3:
1714 
20.08 0.17 20.0
0 
0.00 1.00 0.37 1.00 
Prpf31 NM_00115
9714.1 
NM_00115971
4.1:1765 
21.79 4.82 20.0
0 
0.00 1.09 0.37 1.00 
Ptprn2 NM_01121
5.2 
NM_011215.2:
4158 
20.92 2.25 20.0
0 
0.00 1.05 0.37 1.00 
Tlr2 NM_01190
5.2 
NM_011905.2:
255 
20.08 0.17 20.0
0 
0.00 1.00 0.37 1.00 
Brms1l NM_00103
7756.2 
NM_00103775
6.2:1770 
206.6
7 
60.0
1 
175.
68 
52.0
7 
1.18 0.38 0.93 
C6 NM_01670
4.2 
NM_016704.2:
170 
78.29 69.9
3 
104.
45 
20.7
8 
-1.33 0.38 -0.97 
Nkx6-2 NM_18324
8.3 
NM_183248.3:
265 
23.04 6.13 26.5
2 
8.61 -1.15 0.38 -0.92 
Notch1 NM_00871
4.2 
NM_008714.2:
1425 
270.7
7 
116.
50 
225.
86 
35.3
9 
1.20 0.38 0.96 
Polr2b NM_15379
8.2 
NM_153798.2:
1090 
305.9
6 
103.
72 
252.
95 
85.6
5 
1.21 0.38 0.91 
Nelfa NM_01191
4.2 
NM_011914.2:
930 
431.9
0 
109.
19 
384.
36 
84.0
2 
1.12 0.39 0.92 
Slc17a6 NM_08085
3.3 
NM_080853.3:
2825 
825.6
9 
215.
84 
694.
01 
275.
11 
1.19 0.39 0.91 
Shh NM_00917
0.3 
NM_009170.3:
2055 
76.48 44.5
2 
97.2
3 
33.0
4 
-1.27 0.39 -0.92 
Akt2 NM_00111
0208.1 
NM_00111020
8.1:2504 
213.7
5 
42.1
4 
193.
01 
34.1
7 
1.11 0.39 0.91 
Bche NM_00973
8.3 
NM_009738.3:
300 
54.56 39.1
0 
68.4
3 
17.2
5 
-1.25 0.39 -0.93 
Nmb NM_02652
3.2 
NM_026523.2:
500 
70.38 30.6
7 
84.4
9 
20.3
8 
-1.20 0.40 -0.91 
Atp8a2 NM_01580
3.2 
NM_015803.2:
185 
575.5
9 
208.
23 
495.
63 
126.
48 
1.16 0.40 0.89 
252 
 
Sf3b2 NM_03010
9.2 
NM_030109.2:
2654 
29.29 14.5
3 
36.3
0 
13.7
8 
-1.24 0.40 -0.88 
Chmp2b NM_02687
9.2 
NM_026879.2:
920 
21.22 3.08 20.0
8 
0.21 1.06 0.40 0.93 
Pla2g4f NM_00102
4145.2 
NM_00102414
5.2:2002 
36.11 21.0
3 
45.7
2 
17.1
5 
-1.27 0.41 -0.88 
Myd88 NM_01085
1.2 
NM_010851.2:
1595 
46.29 32.7
9 
59.8
7 
22.2
3 
-1.29 0.41 -0.87 
Nova1 NM_02136
1.1 
NM_021361.1:
370 
524.5
7 
183.
95 
451.
58 
101.
06 
1.16 0.41 0.88 
Grm1 NM_00111
4333.2 
NM_00111433
3.2:2125 
47.56 19.2
4 
55.4
8 
10.8
7 
-1.17 0.42 -0.88 
Atg5 NM_05306
9.5 
NM_053069.5:
774 
20.26 0.59 22.1
8 
8.10 -1.10 0.42 -0.87 
Grin1 NM_00816
9.2 
NM_008169.2:
492 
192.0
6 
71.7
4 
165.
13 
39.2
8 
1.16 0.42 0.86 
Xbp1 NM_01384
2.2 
NM_013842.2:
825 
1023.
81 
303.
94 
903.
54 
192.
49 
1.13 0.42 0.85 
Gss NM_00818
0.1 
NM_008180.1:
728 
215.7
8 
76.8
6 
185.
18 
52.4
4 
1.17 0.43 0.82 
Shank2 NM_00108
1370.2 
NM_00108137
0.2:4930 
93.51 32.4
9 
79.8
4 
23.7
4 
1.17 0.43 0.82 
Cadps NM_00104
2617.1 
NM_00104261
7.1:3524 
2794.
64 
942.
92 
2452
.18 
591.
94 
1.14 0.43 0.83 
Plekho2 NM_15311
9.2 
NM_153119.2:
406 
71.25 12.8
4 
64.7
9 
14.5
0 
1.10 0.44 0.81 
Trf NM_13397
7.2 
NM_133977.2:
1940 
28.91 14.8
2 
34.7
2 
11.3
1 
-1.20 0.44 -0.81 
Lamb2 NM_00848
3.3 
NM_008483.3:
712 
81.81 30.5
0 
68.2
2 
22.3
9 
1.20 0.44 0.81 
Il6 NM_03116
8.1 
NM_031168.1:
200 
106.7
2 
27.4
2 
94.5
4 
23.9
8 
1.13 0.44 0.81 
Psmb8 NM_01072
4.2 
NM_010724.2:
362 
42.75 20.1
7 
50.9
4 
12.3
4 
-1.19 0.44 -0.82 
Slc9a6 NM_17278
0.3 
NM_172780.3:
1479 
26.25 8.02 30.9
3 
14.3
8 
-1.18 0.45 -0.79 
Sncb NM_03361
0.2 
NM_033610.2:
676 
149.3
2 
32.6
1 
167.
88 
44.0
6 
-1.12 0.45 -0.79 
Cpt1b NM_00994
8.2 
NM_009948.2:
924 
43.75 14.4
3 
50.0
4 
11.7
7 
-1.14 0.45 -0.80 
Efna5 NM_20765
4.2 
NM_207654.2:
1130 
103.3
6 
28.2
7 
113.
75 
15.2
2 
-1.10 0.46 -0.79 
Tbp NM_01368
4.3 
NM_013684.3:
70 
295.9
0 
86.1
3 
263.
31 
59.4
1 
1.12 0.47 0.76 
Ep300 NM_17782
1.6 
NM_177821.6:
4305 
468.1
1 
123.
16 
413.
77 
138.
78 
1.13 0.47 0.75 
Gdpd2 NM_02360
8.3 
NM_023608.3:
1438 
31.79 8.37 27.8
5 
12.4
0 
1.14 0.47 0.74 
253 
 
Tie1 NM_01158
7.2 
NM_011587.2:
2715 
23.95 7.15 21.7
7 
2.80 1.10 0.47 0.77 
Sorcs3 NM_02569
6.3 
NM_025696.3:
1868 
237.6
2 
63.8
1 
266.
32 
70.8
4 
-1.12 0.48 -0.74 
Gstp1 NM_01354
1.1 
NM_013541.1:
421 
159.2
5 
77.6
1 
188.
00 
38.7
8 
-1.18 0.48 -0.77 
Frmpd4 NM_00103
3330.2 
NM_00103333
0.2:4690 
187.4
5 
51.2
1 
165.
58 
51.9
2 
1.13 0.48 0.74 
Plcl2 NM_01388
0.3 
NM_013880.3:
475 
969.2
2 
212.
67 
885.
23 
195.
28 
1.09 0.48 0.73 
Pmp22 NM_00888
5.2 
NM_008885.2:
395 
127.0
9 
43.8
0 
110.
96 
28.8
7 
1.15 0.49 0.74 
Cdk5rap3 NM_03024
8.1 
NM_030248.1:
248 
205.9
8 
74.2
8 
181.
60 
50.3
2 
1.13 0.49 0.72 
Pvalb NM_01364
5.3 
NM_013645.3:
60 
30.23 15.4
3 
35.1
9 
10.7
7 
-1.16 0.50 -0.71 
Ngf NM_00111
2698.1 
NM_00111269
8.1:630 
41.34 23.9
9 
49.8
0 
19.6
7 
-1.20 0.50 -0.71 
Src NM_00102
5395.2 
NM_00102539
5.2:968 
386.7
9 
166.
58 
333.
99 
85.5
3 
1.16 0.50 0.71 
Arsa NM_00971
3.4 
NM_009713.4:
2802 
160.9
0 
46.7
3 
143.
43 
32.8
8 
1.12 0.50 0.70 
Fgf14 NM_20766
7.3 
NM_207667.3:
692 
95.67 23.9
9 
87.0
4 
19.7
6 
1.10 0.51 0.69 
Chat NM_00989
1.2 
NM_009891.2:
584 
45.10 22.4
1 
51.7
9 
11.5
3 
-1.15 0.51 -0.71 
Npy NM_02345
6.2 
NM_023456.2:
230 
670.5
3 
199.
40 
600.
65 
157.
49 
1.12 0.51 0.68 
Epha6 NM_00793
8.2 
NM_007938.2:
3730 
56.54 51.3
3 
70.8
6 
27.5
2 
-1.25 0.52 -0.69 
U2af2 NM_13367
1.3 
NM_133671.3:
131 
125.6
9 
51.6
0 
109.
75 
27.1
5 
1.15 0.53 0.66 
Napsa NM_00843
7.1 
NM_008437.1:
1144 
21.22 3.08 20.3
5 
0.98 1.04 0.53 0.68 
Epo NM_00794
2.2 
NM_007942.2:
216 
23.05 7.42 25.8
0 
9.67 -1.12 0.53 -0.65 
Prl NM_01116
4.1 
NM_011164.1:
115 
47.81 39.2
9 
58.3
8 
12.1
4 
-1.22 0.53 -0.68 
Ryr2 NM_02386
8.1 
NM_023868.1:
3720 
78.89 31.0
3 
87.8
9 
15.1
5 
-1.11 0.54 -0.66 
Cd44 NM_00985
1.2 
NM_009851.2:
3075 
72.50 39.3
4 
83.8
1 
20.0
8 
-1.16 0.54 -0.66 
Gal3st1 NM_00117
7691.1 
NM_00117769
1.1:1197 
84.83 36.7
9 
97.2
5 
24.9
1 
-1.15 0.54 -0.66 
Gad1 NM_00807
7.4 
NM_008077.4:
746 
810.9
6 
511.
61 
1005
.92 
638.
94 
-1.24 0.54 -0.64 
Casp6 NM_00981
1.3 
NM_009811.3:
360 
75.56 35.8
9 
88.1
6 
22.8
6 
-1.17 0.54 -0.65 
254 
 
Kel NM_03254
0.3 
NM_032540.3:
1020 
40.94 24.4
5 
48.5
2 
19.6
9 
-1.19 0.54 -0.63 
Plcb4 NM_01382
9.2 
NM_013829.2:
242 
86.04 6.41 95.1
6 
38.4
0 
-1.11 0.55 -0.63 
Grm8 NM_00817
4.2 
NM_008174.2:
1770 
72.48 43.7
9 
85.1
5 
17.6
3 
-1.17 0.55 -0.65 
Pik3ca NM_00883
9.1 
NM_008839.1:
1255 
863.5
7 
207.
84 
794.
32 
184.
80 
1.09 0.55 0.62 
Nefl NM_01091
0.1 
NM_010910.1:
1303 
385.8
5 
118.
55 
424.
26 
58.3
5 
-1.10 0.55 -0.64 
Park2 NM_01669
4.3 
NM_016694.3:
648 
142.3
0 
54.4
7 
128.
24 
20.3
7 
1.11 0.55 0.63 
Nrg1 NM_17859
1.2 
NM_178591.2:
1116 
97.77 47.0
8 
110.
86 
23.1
9 
-1.13 0.56 -0.62 
Ide NM_03115
6.2 
NM_031156.2:
500 
631.0
9 
182.
94 
576.
88 
144.
36 
1.09 0.56 0.60 
Grin2c NM_01035
0.2 
NM_010350.2:
2408 
40.88 16.9
4 
47.0
1 
19.6
0 
-1.15 0.56 -0.60 
Pkn1 NM_00119
9593.1 
NM_00119959
3.1:1380 
140.8
1 
45.4
7 
129.
25 
21.4
2 
1.09 0.57 0.60 
Psmb9 NM_01358
5.2 
NM_013585.2:
540 
91.33 34.3
2 
101.
93 
26.5
1 
-1.12 0.57 -0.59 
Dgkb NM_17868
1.4 
NM_178681.4:
1798 
115.4
3 
23.8
5 
107.
15 
26.5
8 
1.08 0.57 0.58 
Nefh NM_01090
4.3 
NM_010904.3:
3384 
43.81 14.8
2 
50.1
7 
19.2
4 
-1.15 0.58 -0.58 
Stx2 NM_00794
1.2 
NM_007941.2:
225 
153.7
7 
56.9
1 
139.
14 
29.0
5 
1.11 0.58 0.59 
Gabrr3 NM_00108
1190.1 
NM_00108119
0.1:635 
81.92 71.9
2 
96.2
1 
24.5
3 
-1.17 0.58 -0.59 
Dlgap1 NM_02771
2.3 
NM_027712.3:
1654 
204.6
5 
34.0
6 
218.
61 
51.2
0 
-1.07 0.58 -0.57 
Cers4 NM_02605
8.4 
NM_026058.4:
1458 
34.15 11.8
2 
30.1
0 
13.2
3 
1.13 0.59 0.56 
Mmp16 NM_01972
4.3 
NM_019724.3:
3075 
598.1
0 
133.
85 
559.
05 
112.
73 
1.07 0.59 0.57 
Ret NM_00108
0780.1 
NM_00108078
0.1:5175 
88.43 28.6
0 
97.3
7 
24.5
6 
-1.10 0.59 -0.56 
Ang NM_00744
7.2 
NM_007447.2:
425 
20.84 2.05 20.3
3 
0.92 1.03 0.60 0.56 
Fn1 NM_01023
3.1 
NM_010233.1:
2627 
96.89 33.5
0 
112.
47 
65.2
6 
-1.16 0.60 -0.55 
Lclat1 NM_00117
7967.1 
NM_00117796
7.1:2646 
121.2
9 
32.7
0 
129.
91 
21.0
7 
-1.07 0.60 -0.55 
Gfpt1 NM_01352
8.3 
NM_013528.3:
718 
1061.
19 
305.
14 
982.
36 
200.
58 
1.08 0.60 0.55 
Ppargc1a NM_00890
4.2 
NM_008904.2:
690 
325.1
4 
75.7
6 
349.
86 
87.2
0 
-1.08 0.60 -0.55 
255 
 
Bcl2 NM_00974
1.3 
NM_009741.3:
1844 
194.7
5 
36.6
0 
207.
40 
42.6
3 
-1.06 0.60 -0.54 
Angpt2 NM_00742
6.3 
NM_007426.3:
2020 
32.75 17.1
9 
28.9
3 
12.2
8 
1.13 0.60 0.54 
Smpd4 NM_00116
4610.1 
NM_00116461
0.1:1136 
63.36 27.1
5 
70.5
5 
12.8
1 
-1.11 0.60 -0.55 
Nfkbia NM_01090
7.2 
NM_010907.2:
646 
122.8
8 
22.4
8 
116.
69 
16.0
0 
1.05 0.61 0.54 
Cntn4 NM_00110
9751.1 
NM_00110975
1.1:590 
147.1
8 
54.8
6 
162.
63 
52.3
3 
-1.11 0.61 -0.53 
Kif3a NM_00844
3.3 
NM_008443.3:
2474 
27.85 11.1
8 
25.2
3 
7.84 1.10 0.61 0.53 
Rims1 NM_05327
0.1 
NM_053270.1:
90 
461.4
6 
115.
61 
505.
42 
193.
96 
-1.10 0.61 -0.52 
Mecp2 NM_01078
8.2 
NM_010788.2:
755 
287.8
8 
63.8
6 
270.
37 
61.5
7 
1.06 0.61 0.52 
Efr3a NM_13376
6.3 
NM_133766.3:
1062 
73.77 28.4
1 
88.8
2 
64.6
0 
-1.20 0.61 -0.52 
Grik2 NM_01034
9.2 
NM_010349.2:
256 
265.8
2 
52.5
2 
286.
93 
99.2
0 
-1.08 0.62 -0.52 
Scn2a1 NM_00109
9298.3 
NM_00109929
8.3:173 
835.0
2 
231.
75 
769.
60 
248.
60 
1.09 0.62 0.51 
Pls1 NM_00103
3210.3 
NM_00103321
0.3:1815 
21.04 1.77 20.5
6 
1.62 1.02 0.63 0.50 
AI464131 NM_00108
5515.2 
NM_00108551
5.2:1232 
71.16 35.3
9 
80.6
5 
27.7
3 
-1.13 0.63 -0.51 
Hexb NM_01042
2.2 
NM_010422.2:
805 
57.58 24.7
9 
63.0
2 
10.8
0 
-1.09 0.63 -0.51 
Spast NM_01696
2.2 
NM_016962.2:
1530 
192.8
6 
107.
20 
162.
99 
98.2
0 
1.18 0.63 0.50 
Taf4b NM_00110
0449.1 
NM_00110044
9.1:4090 
28.48 14.2
0 
25.7
0 
7.32 1.11 0.64 0.50 
Actn1 NM_13415
6.2 
NM_134156.2:
2688 
264.9
8 
69.1
7 
247.
13 
52.3
5 
1.07 0.64 0.49 
Itgax NM_02133
4.2 
NM_021334.2:
327 
21.43 3.71 20.6
5 
1.90 1.04 0.64 0.49 
Adcy5 NM_00101
2765.4 
NM_00101276
5.4:219 
113.0
6 
22.8
9 
105.
82 
32.8
3 
1.07 0.64 0.48 
Cacna1b NM_00104
2528.1 
NM_00104252
8.1:4345 
334.5
7 
79.8
7 
315.
88 
68.6
1 
1.06 0.65 0.48 
Tnr NM_02231
2.3 
NM_022312.3:
3195 
167.3
8 
41.7
3 
157.
36 
36.9
4 
1.06 0.65 0.47 
Prf1 NM_01107
3.2 
NM_011073.2:
1350 
26.49 11.4
9 
28.8
0 
6.95 -1.09 0.66 -0.46 
Slc1a1 NM_00919
9.2 
NM_009199.2:
869 
147.9
0 
27.2
3 
156.
26 
35.9
6 
-1.06 0.66 -0.45 
256 
 
Egfl7 NM_00116
4564.1 
NM_00116456
4.1:168 
82.94 41.7
7 
92.3
8 
22.2
7 
-1.11 0.66 -0.46 
Mmp2 NM_00861
0.2 
NM_008610.2:
2376 
130.8
3 
44.9
1 
120.
31 
32.8
9 
1.09 0.66 0.45 
Igf1r NM_01051
3.2 
NM_010513.2:
3390 
109.2
4 
36.0
8 
101.
23 
18.6
0 
1.08 0.67 0.46 
Ugt8a NM_01167
4.4 
NM_011674.4:
138 
76.07 31.7
8 
83.8
6 
23.7
4 
-1.10 0.67 -0.44 
Ptgs2 NM_01119
8.3 
NM_011198.3:
675 
30.08 7.19 32.3
5 
13.0
7 
-1.08 0.68 -0.42 
Ntng1 NM_00116
3351.1 
NM_00116335
1.1:1090 
214.6
8 
64.4
3 
200.
86 
48.1
7 
1.07 0.70 0.40 
Olfm3 NM_15315
7.3 
NM_153157.3:
888 
322.3
3 
61.4
9 
304.
83 
95.2
2 
1.06 0.70 0.40 
Epha7 NM_00112
2889.1 
NM_00112288
9.1:844 
488.8
6 
89.1
2 
458.
06 
174.
52 
1.07 0.70 0.40 
Ctse NM_00779
9.3 
NM_007799.3:
1290 
41.09 25.0
7 
45.6
2 
15.6
3 
-1.11 0.71 -0.39 
Nf1 NM_01089
7.2 
NM_010897.2:
2705 
451.1
7 
125.
93 
425.
35 
130.
36 
1.06 0.71 0.38 
Comt NM_00774
4.3 
NM_007744.3:
625 
41.56 18.9
8 
37.4
8 
16.9
5 
1.11 0.72 0.37 
Calb2 NM_00758
6.1 
NM_007586.1:
1250 
88.35 33.2
2 
82.2
3 
18.6
1 
1.07 0.72 0.37 
Mapkapk2 NM_00855
1.1 
NM_008551.1:
1991 
107.8
2 
32.0
2 
101.
17 
32.3
2 
1.07 0.73 0.35 
Gria2 NM_00103
9195.1 
NM_00103919
5.1:300 
1544.
00 
326.
24 
1637
.67 
621.
47 
-1.06 0.73 -0.35 
Epha3 NM_01014
0.3 
NM_010140.3:
1716 
26.74 13.3
5 
28.8
6 
10.4
4 
-1.08 0.74 -0.35 
Chd4 NM_14597
9.2 
NM_145979.2:
1090 
141.8
1 
53.0
4 
131.
72 
41.0
1 
1.08 0.74 0.35 
Arc NM_01879
0.2 
NM_018790.2:
2715 
78.71 34.9
8 
85.3
1 
35.9
8 
-1.08 0.75 -0.33 
Pink1 NM_02688
0.2 
NM_026880.2:
688 
120.9
1 
45.1
6 
113.
74 
21.5
5 
1.06 0.75 0.34 
Dbh NM_13894
2.3 
NM_138942.3:
254 
23.04 9.28 24.3
8 
7.20 -1.06 0.75 -0.33 
Lrp1 NM_00851
2.2 
NM_008512.2:
1310 
190.3
2 
41.4
0 
182.
14 
51.9
9 
1.04 0.76 0.31 
Efna1 NM_01010
7.4 
NM_010107.4:
437 
20.72 1.49 20.4
7 
1.33 1.01 0.76 0.31 
Cntnap2 NM_00100
4357.2 
NM_00100435
7.2:3985 
213.5
8 
68.7
5 
223.
92 
39.1
0 
-1.05 0.76 -0.32 
Hpgds NM_01945
5.4 
NM_019455.4:
194 
49.23 29.6
0 
53.4
2 
18.4
9 
-1.09 0.77 -0.31 
Cln8 NM_01200
0.3 
NM_012000.3:
762 
95.89 28.0
2 
100.
90 
31.7
0 
-1.05 0.77 -0.30 
257 
 
Apc NM_00746
2.3 
NM_007462.3:
645 
186.1
9 
67.7
6 
171.
07 
125.
28 
1.09 0.78 0.29 
Gria4 NM_00111
3180.1 
NM_00111318
0.1:1274 
119.6
1 
57.6
9 
131.
81 
77.9
2 
-1.10 0.79 -0.27 
Cspg4 NM_13900
1.2 
NM_139001.2:
1530 
132.3
0 
35.6
2 
136.
84 
24.5
8 
-1.03 0.80 -0.26 
Creb1 NM_00103
7726.1 
NM_00103772
6.1:2734 
209.0
0 
80.9
0 
197.
01 
59.5
6 
1.06 0.81 0.26 
Slc32a1 NM_00950
8.2 
NM_009508.2:
2616 
789.3
0 
468.
76 
859.
68 
650.
13 
-1.09 0.81 -0.25 
Gls NM_00111
3383.1 
NM_00111338
3.1:976 
1570.
69 
354.
24 
1521
.58 
397.
01 
1.03 0.81 0.24 
Camk2d NM_00102
5439.1 
NM_00102543
9.1:1315 
647.2
5 
200.
48 
626.
94 
88.2
9 
1.03 0.83 0.23 
Htra2 NM_01975
2.3 
NM_019752.3:
1088 
182.9
6 
42.2
8 
188.
13 
43.4
9 
-1.03 0.83 -0.22 
Cntf NM_17078
6.2 
NM_170786.2:
110 
60.50 19.1
2 
58.4
1 
13.7
5 
1.04 0.83 0.22 
Sp1 NM_01367
2.2 
NM_013672.2:
6580 
36.63 17.7
9 
38.7
6 
18.9
6 
-1.06 0.84 -0.21 
Lpar1 NM_01033
6.2 
NM_010336.2:
230 
27.80 10.9
1 
26.6
4 
11.5
3 
1.04 0.84 0.20 
Atp2b3 NM_17723
6.3 
NM_177236.3:
1485 
98.15 29.0
1 
95.3
3 
18.5
2 
1.03 0.84 0.20 
Hmox1 NM_01044
2.2 
NM_010442.2:
610 
316.7
4 
129.
84 
332.
44 
157.
35 
-1.05 0.85 -0.20 
Mfn2 XM_00653
5920.1 
XM_00653592
0.1:692 
444.1
6 
86.9
0 
452.
96 
65.9
8 
-1.02 0.85 -0.20 
Prpf3 NM_02754
1.4 
NM_027541.4:
1486 
183.3
3 
50.3
7 
188.
45 
44.4
4 
-1.03 0.85 -0.19 
Ntf3 NM_00874
2.2 
NM_008742.2:
305 
126.2
8 
55.6
8 
121.
91 
23.1
0 
1.04 0.85 0.19 
Slc4a10 NM_00124
2380.1 
NM_00124238
0.1:1118 
382.8
8 
88.5
6 
393.
76 
110.
87 
-1.03 0.86 -0.18 
Nmnat2 NM_17546
0.3 
NM_175460.3:
67 
228.0
2 
85.6
1 
218.
89 
94.6
5 
1.04 0.86 0.18 
Col4a2 NM_00993
2.3 
NM_009932.3:
5600 
210.6
2 
58.2
2 
215.
66 
39.1
1 
-1.02 0.87 -0.17 
Ubqln1 NM_15223
4.2 
NM_152234.2:
3460 
22.77 8.15 23.3
5 
7.31 -1.03 0.88 -0.15 
Nos1 NM_00871
2.2 
NM_008712.2:
2985 
30.02 5.65 30.8
5 
15.2
5 
-1.03 0.88 -0.15 
Wfs1 NM_01171
6.2 
NM_011716.2:
2975 
52.31 24.7
9 
54.4
8 
22.2
4 
-1.04 0.88 -0.15 
Cers1 NM_13864
7.3 
NM_138647.3:
414 
34.75 11.1
2 
33.7
3 
15.2
1 
1.03 0.89 0.15 
Sox10 XM_12813
9.6 
XM_128139.6:
2646 
55.03 17.1
2 
56.2
3 
14.3
6 
-1.02 0.89 -0.15 
258 
 
Pla2g4a NM_00886
9.2 
NM_008869.2:
1525 
31.54 18.9
2 
30.5
8 
10.9
2 
1.03 0.90 0.13 
Hdac1 NM_00822
8.2 
NM_008228.2:
470 
337.6
5 
134.
73 
329.
84 
52.3
0 
1.02 0.90 0.13 
Car2 NM_00980
1.4 
NM_009801.4:
437 
89.17 50.0
0 
91.8
7 
19.8
6 
-1.03 0.90 -0.13 
Col4a1 NM_00993
1.2 
NM_009931.2:
4116 
21.96 3.80 21.7
1 
3.81 1.01 0.90 0.13 
Slc2a1 NM_01140
0.3 
NM_011400.3:
2190 
45.05 25.9
0 
43.6
3 
14.3
9 
1.03 0.91 0.12 
Dot1l NM_19932
2.1 
NM_199322.1:
5490 
126.0
3 
26.7
0 
128.
03 
31.5
6 
-1.02 0.91 -0.12 
Ngfr NM_03321
7.3 
NM_033217.3:
1995 
32.27 9.42 31.4
0 
18.7
6 
1.03 0.91 0.12 
Nos2 NM_01092
7.3 
NM_010927.3:
3715 
22.22 3.39 21.9
9 
4.12 1.01 0.91 0.12 
Emp2 NM_00792
9.2 
NM_007929.2:
3196 
66.65 23.8
5 
65.2
3 
11.9
3 
1.02 0.91 0.12 
Inpp4a NM_17297
1.2 
NM_172971.2:
1624 
154.8
8 
78.8
8 
150.
51 
49.0
7 
1.03 0.92 0.11 
Cacna1d NM_02898
1.2 
NM_028981.2:
2935 
296.8
9 
93.8
0 
292.
63 
65.3
6 
1.01 0.93 0.09 
Gabra1 NM_01025
0.4 
NM_010250.4:
905 
634.6
8 
144.
66 
642.
69 
152.
28 
-1.01 0.93 -0.09 
Pla2g4e NM_17784
5.4 
NM_177845.4:
1016 
27.87 7.52 27.4
7 
10.5
0 
1.01 0.93 0.09 
Nostrin NM_18154
7.3 
NM_181547.3:
1452 
21.43 3.71 21.2
8 
4.10 1.01 0.94 0.08 
Lrrk2 NM_02573
0.3 
NM_025730.3:
4475 
62.44 19.5
9 
63.5
4 
29.0
7 
-1.02 0.94 -0.07 
Gria3 NM_01688
6.3 
NM_016886.3:
390 
202.5
8 
41.0
8 
200.
83 
66.0
9 
1.01 0.95 0.06 
Atp7a NM_00110
9757.2 
NM_00110975
7.2:1200 
106.6
2 
47.0
8 
105.
34 
23.7
0 
1.01 0.95 0.06 
Ager NM_00742
5.2 
NM_007425.2:
361 
21.62 4.26 21.7
3 
3.30 -1.00 0.96 -0.05 
Cacna1a NM_00757
8.3 
NM_007578.3:
1655 
391.8
0 
107.
55 
394.
71 
112.
42 
-1.01 0.96 -0.05 
Adcy9 NM_00962
4.1 
NM_009624.1:
3640 
143.9
7 
40.0
8 
143.
02 
29.2
4 
1.01 0.97 0.04 
Ikbkb NM_01054
6.2 
NM_010546.2:
498 
115.8
0 
44.8
8 
116.
76 
41.3
3 
-1.01 0.97 -0.04 
Egfr NM_20765
5.2 
NM_207655.2:
1335 
48.01 14.2
0 
48.3
9 
20.7
3 
-1.01 0.97 -0.04 
Notch3 NM_00871
6.2 
NM_008716.2:
550 
34.34 8.49 34.5
7 
15.9
4 
-1.01 0.98 -0.03 
Hdac7 NM_01957
2.2 
NM_019572.2:
3706 
117.8
9 
41.5
4 
117.
34 
26.0
4 
1.00 0.98 0.03 
Sla NM_00102
9841.1 
NM_00102984
1.1:75 
105.1
8 
16.7
0 
104.
97 
20.7
0 
1.00 0.98 0.02 
259 
 
Pcsk2 NM_00879
2.3 
NM_008792.3:
2915 
35.92 12.3
3 
35.7
4 
15.3
2 
1.00 0.98 0.02 
Npc1 NM_00872
0.2 
NM_008720.2:
2645 
20.92 2.25 20.9
1 
2.76 1.00 0.99 0.01 
Egr2 NM_01011
8.2 
NM_010118.2:
1785 
27.33 11.7
2 
27.3
4 
11.4
6 
-1.00 1.00 0.00 
Appendix table 2: Raw Nanostring nCounter data  
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